<SEC-DOCUMENT>0001680367-21-000057.txt : 20211109
<SEC-HEADER>0001680367-21-000057.hdr.sgml : 20211109
<ACCEPTANCE-DATETIME>20211109163151
ACCESSION NUMBER:		0001680367-21-000057
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		54
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211109
DATE AS OF CHANGE:		20211109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Shattuck Labs, Inc.
		CENTRAL INDEX KEY:			0001680367
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				812575858
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39593
		FILM NUMBER:		211392733

	BUSINESS ADDRESS:	
		STREET 1:		500 W. 5TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		512-900-4690

	MAIL ADDRESS:	
		STREET 1:		500 W. 5TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sttk-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d,d:5f8bafd131ed43f6b9f8eec3c99a61c2--><html xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:sttk="http://www.shattucklabs.com/20210930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sttk-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl8yLTEtMS0xLTA_d5bb7110-98d5-427b-b2e8-97dad39d0820">0001680367</ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl80LTEtMS0xLTA_4a613fd1-26a2-4f1d-bd32-9877f906d41a">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl81LTEtMS0xLTA_01d1f0dd-3792-4f95-9d36-7989660b1488">2021</ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl82LTEtMS0xLTA_bb850aa6-9919-4717-855c-aa64889940fd">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl83LTEtMS0xLTA_3028673c-d06e-4204-b880-efa7109fb80d">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi0wLTEtMS0w_f1acb055-7b86-4c00-997d-facea2ac076f">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sttk-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i93a317c1a7d84009b921894351c426c0_I20211101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a4198438794812abb2a3e7db2d6f87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58e597f9f7d46458c21b5a0f8ab9047_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic334605d7f4246e181eb1c8111b616b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c4a2cabec5f4f27845ee6841b8be4df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie96ef38430374065aa351d78dde24230_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfe2dbcff99405cb545328603445374_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i539441c1f66142d988ac8a86e1e60786_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6723234f96b643e39508fa8cd095b0be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecbf0ce013994b84a0cccab6bf9a37cf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieecbc9f345de45c8985aa172294da8c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1affb3b7e9094b82acca963bb310ca93_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eafc60eecc549488af6e45cca422737_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib85362d00b9044bfa041363b53990d12_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifceed151b34344ed86926861240827c3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647bbb979fc246cd8580c17d002c985d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422b3aaa79e941b292e79ba9cc1d14be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9cca7a385d4bf9aa954d58badb8169_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0448f37d4bcf4007a6cb6cf701810497_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94489e3bdc0a4a6c8676351116f086b7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb983b0880943a3816d1b106ac9db6b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0848129044470a9b012f37f9e64867_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a3d9d9644d4497a319db83511ea7a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3a4962c656b42f3a8214dfcc801e8d5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0c872b9d01144a280f248a1e16beef6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2734afb6faf8484a9447edac1f84134e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6dbb88304d4595865f7e6425907d5e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96ac7f784c484cb6b645b04089e32903_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ed9359c48a4172993da7b129d56e5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b72630e4874757aac99920f0790b3f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc4e64d4ece4416db8aa1774732dcf60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba4476799e6c43e9b11f139b87f6e3eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db48e68792b4cb48b1ababe34ca2b87_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f046b755a624db096bbc2345de726fc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6afcf491686b407a8a99dbe8013777f9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb02004041e34aeea7a968c4f7d726f2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65da78330c124c72b6daf2f158858f87_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1c37493a8ff4212aee79aea73e76b60_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95620647f2f44d4aba93d095901e26f6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fff4b70e84e4503b828997e45293717_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16bf9ea147614ea3979c329a7c40111e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de96e067aed44aabf2d79bbccfb2d4a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36be3855f8b4adbaeb7b5fb0bf4460f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc7158f78fe423f8b8d304e7f23a82c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae6291564a37483d8bb66b65731f4101_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c0536199104f62b96d3be8d78a773e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45c4fa1189d41e6b75f3b2c4224f632_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f763e24d914335a16f2797cbdcda54_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a2d81f76074762b59a86c90d441d3e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180732543f574734a093e1fdd359c31e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca3a5a03c7944b58f29193146f4a6f0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc5b787ecb8c4de78e65e2d9759d48a4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c24c935fc14f9d9bb20f6d1b1478e7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b2e4eca1d1b49aab71c8126e08eba38_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ae5c9d2028648418dd51b0c2b0a3cbd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86c197370694420e8139fb6bcd63799c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b9b9e789cd442da7cfa75ff1ec86c0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb009f0275b4b66b6ea526dcbca7e9f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d43c4f21e4f400181e8380a945fa403_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c391d040a942e288e05836aa0b34d9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebf65494900a4dfa992c067bfe66b21e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b32de77fd41426fb9250157c316291b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbfd6109d71a41d88ac7cd90ef87419a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc7e714b56844a881c19fc1a46f7a81_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf10a010e6f24e1ead5edad126efe989_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74d3aa8f82514539b0c9f923f0819cdb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdec66eb26c346dead446844d3d02964_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf949b23f20d4f72b56403c3fbb43149_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d5a84837714480a2462e3255a83730_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">sttk:OperatingAccountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e6d73e46e34e999b3a2520c34da2bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21077307da9c4396a282390e1aaac1c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">sttk:OperatingAccountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385459190ef7464a90ce28ba7fe7883d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebaf8f49a6941a0976a2367d5cc1bfb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e370dfdd2f54ea4bad75c57602b4f93_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9abbbff0f64c4386a4848428859c93ba_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6638d6e20b5438bbca39e3e66ef5663_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib919ed52ea1544a19151e99891e1459d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b470f64d144b129fbaa7ad42808a35_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf359afbf3d0464cbc86a41f24df0d16_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib884e0584c7e460bb651ba32ee4192a7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida0e12191e2b43dbaece2abe6a654ebf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic89ca81d8e0f45f3a4c92829a40b2cce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf97f887b14842219aa9e7a7b036371c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92a6e56c17649fab1775c0e60491710_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i194ff9146a844c808f5d4fb8b42bb2e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib605418e82994024ac2bd308fcb0a15e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8b88813b564305a3bb126dd933c59e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i603740bc9b8f4f0ca57d85369f7746a2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4dbadf32e44468af44b532a149cff7_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376022fb5be548d7b02b791a7e12fad2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00fdc47817734e7ca45bf62b16f9b05b_I20201014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-14</xbrli:startDate><xbrli:endDate>2020-10-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3e8f93f0194647bd923c62f2e5dc30_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf00a598b8c6468a94061606fb02f883_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i960ac8b054b342bca15ba993defe9d57_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8f4bd6f6784868a4bd2c6922fc91f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43e49e14bbd84c24b4f815c8d1dfae1e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i835dbb9acf224e57a9b3e913c4fd5221_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf510c1ae944ae08e8125331902ce05_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f271066a7004316b41caf3035fe59f9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b7aad25409a4bcd8dceb360cb97572a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ee9db78b134988a76150158dd2ccfb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f9516b552346dd9f85244630963fdf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1e9586e3094edfbbdb9d027470e968_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127f4a4b929a4584b3d952f63d22eadf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib024077106554c22ae7c122e594a1c2b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd69357ae18f462e8804de875b0c3a5c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2da1c40adc24adf8f575ee3530eea18_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if068c55e44bb4ae2a4f17a023aa75fd7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1661a0a2b3aa4bcca5712ebab54e17ae_D20170801-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sttk:RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sttk:CumulativeEffectChangeOfAccountingEstimateAxis">sttk:CumulativeEffectChangeOfAccountingEstimateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7842c9c91ac44eb081775b9eeb02a4f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sttk:TakedaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:115%">WASHINGTON, DC 20549 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgw_95bb4e6a-6268-40dd-bc59-0fddea0aa4ee">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"></td><td style="width:13.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmUzNDYxOWZlOWVmNDMyN2JhMWVlODAzNTU3ZmIwYzIvdGFibGVyYW5nZTo2ZTM0NjE5ZmU5ZWY0MzI3YmExZWU4MDM1NTdmYjBjMl8wLTAtMS0xLTA_68a57b33-6b0e-4e55-afec-e43b4c8a6e1e">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8xMzg_aeffc0c9-c9ab-460f-a055-279e7220110f">September 30, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.057%"><tr><td style="width:1.0%"></td><td style="width:16.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6MGZmMzY1ZmQxZjBiNDVkZTk4NWJkYzE4ZmZmYzMzYjkvdGFibGVyYW5nZTowZmYzNjVmZDFmMGI0NWRlOTg1YmRjMThmZmZjMzNiOV8wLTAtMS0xLTA_d3e763e7-fa87-4449-8347-6b1f9422ee93">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For the transition period from      to      </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Commission File Number: <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDY5_13b1521f-5611-4ebb-8fd7-e6c79267a823">001-39593</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20.5pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcw_bf8f6b43-cd78-4abe-8e74-dba021f2cc7d">Shattuck Labs, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:34.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmE2Mzc4ZTFlZWE3NGY5YzlkMGVkODI3ZWRiNzIwMDUvdGFibGVyYW5nZTo2YTYzNzhlMWVlYTc0ZjljOWQwZWQ4MjdlZGI3MjAwNV8wLTAtMS0xLTA_040e5866-6807-49fd-bfdc-7ed687b13ea5">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmE2Mzc4ZTFlZWE3NGY5YzlkMGVkODI3ZWRiNzIwMDUvdGFibGVyYW5nZTo2YTYzNzhlMWVlYTc0ZjljOWQwZWQ4MjdlZGI3MjAwNV8wLTItMS0xLTA_2c7bd2e6-5143-4e33-8900-38868394b2fa">81-2575858</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Identification Number)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcx_6cc53c30-e485-4e8b-a8c7-aa6830150fa0">500 W. 5th Street</ix:nonNumeric>, <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc1_759a0ce3-d222-4280-a44c-c7f6c75546bb">Suite 1200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc2_e7b56b0e-8e0f-4137-9600-68a702fe5649">Austin</ix:nonNumeric>, <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc4_51a47230-1536-43f3-b75f-4bfd22b6ec4a">TX</ix:nonNumeric> <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgy_8c80a39d-1246-4b04-9f64-017eafd7ee43">78701</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(<ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgz_bd2fbc1f-5bf5-4d20-9523-9e90b7eae679">512</ix:nonNumeric>) <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcz_559ad2f8-f1e9-4e34-b04c-862cc239819c">900-4690</ix:nonNumeric> </span></div><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.673%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Address of principal executive offices including zip code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:85%">Former name, former address and former fiscal year, if changed since last report: N/A</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:85%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTAtMS0xLTA_bdc46603-9a93-4be0-85a8-bfcdc81ed143">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTEtMS0xLTA_9932613f-1a49-46b6-b55b-276559a5029d">STTK</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTItMS0xLTA_8a79ae28-f1d8-43b2-b16c-ecd6d3f446f4">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDg0_682f0c78-8799-4315-8090-b64d51984919">Yes</ix:nonNumeric>  &#9746;    No &#9744;</span></div><div style="margin-top:3pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDg1_2675e429-097e-4438-a575-f65e42af69f1">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-top:3pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:18.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Large accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8xLTAtMS0xLTA_76d2c154-f43b-4b59-b884-6f29249c7a6f">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8xLTMtMS0xLTA_5a6be9d8-4f5a-489c-aadd-b5d50c27cded">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8yLTMtMS0xLTA_1cfecc27-81ca-4e87-a0c7-f8ae02b2fc3e">&#9746;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc5_9b5dcce7-cc14-4baf-8f5e-eb8f3ff7356e">&#9744;</ix:nonNumeric> </span></div><div style="text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc0_810bcb7d-5c25-4b2b-b0d8-72a3c73ef477">&#9744;</ix:nonNumeric>    No  &#9746;</span></div><div style="text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November 1, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i93a317c1a7d84009b921894351c426c0_I20211101" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDAw_1c060b4e-8a2a-4080-8c0c-df4e3b757689">42,246,539</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:3pt;text-indent:24.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_16">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_16">Balance Sheets as of September 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_19">Statements of Operations and Comprehensive Loss for the Three and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_19"> Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_19"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_19">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_19">30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_22">Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_22"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_25">Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_25"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_28">Notes to the Unaudited Interim Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_61">Item 2</a>.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_97">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_103">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_109">Item 1</a>A.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_112">Item </a>2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_112">Unregistered Sales of Equity Securities and Use of Proceeds </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_115">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_118">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_121">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_124">Item&#160;</a>6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_124">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="#i5f8bafd131ed43f6b9f8eec3c99a61c2_127">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, financing needs, plans or intentions relating to products and markets, and business trends and other information referred to under the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; or the negative of these terms, and similar expressions intended to identify forward-looking statements. Forward-looking statements are not historical facts and reflect our current views with respect to future events. Given the significant uncertainties, you should not place undue reliance on these forward-looking statements. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in this Quarterly Report on Form 10-Q. Such risks, uncertainties and other factors include, among others, the following: </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">the timing of the initiation, progress and expected results of our preclinical studies, our clinical trials and our research and development programs; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability to retain the continued service of our key executives and to identify, hire and retain additional qualified professionals; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability to advance product candidates into, and successfully complete, preclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the timing or likelihood of regulatory filings and approvals; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the commercialization of our product candidates, if approved; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability and the potential to successfully manufacture and supply our product candidates for clinical trials and for commercial use, if approved; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the pricing, coverage and reimbursement of our product candidates, if approved; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the implementation of our business model, strategic plans for our business and product candidates; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our technology platforms, including our ARC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and GADLEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product candidates and other product candidates, including the defense of such intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our potential need to obtain additional licenses of third-party technology that may not be available to us or are available only on commercially unreasonable terms, and which may cause us to operate our business in a more costly or otherwise adverse manner that was not anticipated;</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability to enter into strategic arrangements and/or collaborations and to realize the potential benefits of such arrangements; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our estimates regarding the market opportunity for our product candidates, if approved; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our estimates regarding expenses, capital requirements and needs for additional financing and our ability to obtain additional capital; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our financial performance;</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">developments relating to our competitors and our industry, including competing product candidates and therapies; and</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the ongoing COVID-19 pandemic and associated public health guidance measures.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be other factors that may cause our actual results to differ materially from the forward-looking statements expressed or implied in this Quarterly Report on Form 10-Q, including factors disclosed in &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; You should evaluate all forward-looking statements made in this Quarterly Report on Form 10-Q in the context of these risks and uncertainties. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the risks, uncertainties and other factors referred to above and elsewhere in this Quarterly Report on Form 10-Q may not contain all of the risks, uncertainties and other factors that may affect our future results and operations. Moreover, new risks will emerge from time to time. It is not possible for our management to predict all risks. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statements contained in this Quarterly Report on Form 10-Q speak only as of the date hereof and not of any future date, and we expressly disclaim any intent to update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_13"></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_16"></div><hr style="page-break-after:always"/><div style="min-height:22.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BALANCE SHEETS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September&#160;30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNC0xLTEtMS0w_5d8cc030-ae37-4ded-9e27-ba2a534e460b">85,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNC0zLTEtMS0w_20a1d2a1-bad7-471a-8bfb-8cabf5320317">157,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNS0xLTEtMS0w_a285a883-30a6-4953-95fc-c5f27dea2703">205,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNS0zLTEtMS0w_bc19d59b-eef2-4de4-bb66-7dede020ec0c">177,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNi0xLTEtMS0w_afeac9fa-64ca-4934-8de8-739ab0c94de6">11,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNi0zLTEtMS0w_fef9698c-5528-4ab0-9ccb-ab3816942959">10,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNy0xLTEtMS0w_bb6b2c34-70b7-4a20-976d-5097553137c6">301,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNy0zLTEtMS0w_574350fc-2a78-42e3-835e-5d2e29d729ba">345,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOC0xLTEtMS0w_917bf8e2-c2e5-4315-9e51-3716941b2fa4">8,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOC0zLTEtMS0w_287d3fc5-b07a-4da1-90bc-aad926e60104">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOS0xLTEtMS0w_7fbc6f33-9590-44a6-8ee1-4eab0dc80d45">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOS0zLTEtMS0w_bd56ee69-fda8-4866-8284-6a123f77b15d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTAtMS0xLTEtMA_f8ceffab-7af1-44ad-88d7-3a65c9ff2fd1">310,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTAtMy0xLTEtMA_98a45834-8598-4485-b671-965534f10910">348,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTQtMS0xLTEtMA_5db2a912-7488-4539-a68c-e20fe6222184">3,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTQtMy0xLTEtMA_944a7367-b4dd-4b52-9c07-841c7ceabae0">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTUtMS0xLTEtMA_fb030559-71d0-4f6a-b7d6-3c305630b5c0">13,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTUtMy0xLTEtMA_10e82637-a90d-465c-8e3c-5fa5a945f114">7,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTYtMS0xLTEtMA_41c92bbc-ddb1-4f68-ac2b-b4c3390f45b1">2,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTYtMy0xLTEtMA_f543b5cf-3380-45ed-a405-48870b9b10ff">7,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTctMS0xLTEtMA_66d1dabc-7d18-4ff3-bec7-550391b85108">19,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTctMy0xLTEtMA_7bbf2fa6-a856-4489-8dbe-a97c49f3e9ce">16,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMS0xLTEtMTcxMjU_1901d6e4-7223-4681-bf4e-a2d0b307ef12">27,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMy0xLTEtMTcxMjU_f4a8a1b1-efd1-4458-b1ee-bf6c829cdb72">21,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMS0xLTEtMTM1NTc_e252bfa7-66bb-430d-9eb2-2d68e1322359">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMy0xLTEtMTM1NTc_ddf58a8e-82c4-424e-b293-3ba06d5c14e1">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjAtMS0xLTEtMA_148573c1-28bd-4066-8097-6fd3031135b0">49,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjAtMy0xLTEtMA_d0e5a33a-4a36-40d9-b90d-e60c21a7ab45">39,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjEtMS0xLTEtMA_c4ef7e0d-7b6b-44c3-82e8-03f4e7697e7a"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjEtMy0xLTEtMA_de5ce6cb-b911-41df-94ae-08715d7fe2f2"></ix:nonFraction></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzE5_4367695c-a3bd-4611-b4b5-f2086801f7a8"><ix:nonFraction unitRef="usdPerShare" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzE5_f9326f4c-4ca3-4a8f-8cfa-552413694b41">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzMz_96caad9e-4ff1-46fa-8390-afdd2846174c"><ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzMz_a107cedf-8a98-4e26-a765-249942b218d5">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzU1_75631d18-2872-49b4-8de9-98118cfe7061"><ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzU1_ed44acc5-a72f-471f-98d1-11e995f252f4">42,241,981</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzYy_e5426870-c173-4e88-a87f-df318f31af53">41,779,183</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzkw_24367ef8-4e84-4f72-89aa-9f69c8753b78">41,767,431</ix:nonFraction> shares outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMS0xLTEtMA_fbc5fa6c-2efc-4b41-851d-79a9f7f27fcb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMy0xLTEtMA_d38aaae5-38d0-42c6-b54a-716114cd4232">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjQtMS0xLTEtMA_3dd743d0-142f-443f-ba33-5171d6eda965">387,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjQtMy0xLTEtMA_fe8f8304-a7e7-487e-9346-a31464a3b6e3">382,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjUtMS0xLTEtMA_a51e7c41-a89d-42a6-8710-d06b857ae3af">1,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjUtMy0xLTEtMA_2890f254-98af-47b1-91b6-3e75ed6fc39d">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjYtMS0xLTEtMA_e2ff2c4c-d261-458c-986e-c91619a5909d">124,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjYtMy0xLTEtMA_febf56d5-402e-481c-822f-422b44502a05">72,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjctMS0xLTEtMA_f76af572-199f-4da9-ab29-aa72b73b0a1e">261,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjctMy0xLTEtMA_b50329fc-5c44-4da0-9bda-5ecd4d5cf948">309,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjgtMS0xLTEtMA_39cac91f-fb17-4cd6-927f-fe0a66279c7a">310,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjgtMy0xLTEtMA_f3f7be95-99c6-4b94-b72a-7b6a8311973c">348,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited interim condensed financial statements</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts) </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi0wLTEtMS0w_f1acb055-7b86-4c00-997d-facea2ac076f">Collaboration revenue - related party</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi0yLTEtMS0w_2d9c0b0a-73b6-4dbf-b97d-ca5d21dd4050">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi00LTEtMS0w_86a528e7-baa7-4780-8b1b-81a67d589395">2,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi02LTEtMS0w_ca6b58f2-0198-43ae-a5ee-b60cbe968e5f">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi04LTEtMS0w_7e389548-4f7c-453a-b1e0-54a5b9c69952">8,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC0yLTEtMS0w_bb7ac85c-b510-456f-9e68-dc40acd67fc1">15,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC00LTEtMS0w_27889e5d-c353-427d-a008-4730850a500d">11,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC02LTEtMS0w_5a04adf4-b173-46e7-ada1-482b33d95328">40,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC04LTEtMS0w_f2a54856-81c9-497f-b4df-827fd76fe26c">27,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS0yLTEtMS0w_bb55008f-473e-44b3-8bab-05e9f465ea95">4,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS00LTEtMS0w_98f75b4d-045c-4e93-9e5f-991d19e4f939">2,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS02LTEtMS0w_38db8a34-4334-4ec4-a72d-907300d25d1e">14,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS04LTEtMS0w_cb660519-84c2-44ba-9f2d-cab1bad748bc">5,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi0yLTEtMS0w_1f84e37b-8000-4363-9259-ef2602279c57">19,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi00LTEtMS0w_21bf2b6e-de45-4691-94d8-0e90fdbd5247">14,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi02LTEtMS0w_f99d09ab-bd3a-484e-9434-6051c3e843d8">54,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi04LTEtMS0w_ccb54c55-9c0b-4156-89af-d0c05438cc0b">33,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy0yLTEtMS0w_cc73576c-ecfe-45b2-87fa-2d003075823e">17,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy00LTEtMS0w_23b435f7-a26a-47b0-8f84-0799b8734c8a">11,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy02LTEtMS0w_ddaab30c-09ff-4cec-af94-6ebf9c5df379">54,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy04LTEtMS0w_fe42b08a-e3fb-43ba-ae99-6b13dee6926b">24,920</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtMi0xLTEtMA_e56cc38e-b95c-48ab-bef8-0816c7f9f5f1">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtNC0xLTEtMA_2fad4df2-4b73-4c5f-8ffc-4b1debc2eb13">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtNi0xLTEtMA_33a4fed1-e27b-4e5f-aa77-b20683b1d6c9">1,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtOC0xLTEtMA_fc6aa55f-548c-470e-84e4-d1abf619d9bf">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtMi0xLTEtMA_fdcf7740-2c47-4af2-9255-091720bad7b5">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtNC0xLTEtMA_9748c5fb-5547-4444-b399-dd5a78ab1e39">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtNi0xLTEtMA_980e6c8f-b3b3-4146-8ad4-20df2ae5c699">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtOC0xLTEtMA_dcf40075-3092-4d6e-a523-2bb03d798ccb">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItMi0xLTEtMA_e0865ecb-2792-4bfd-b692-fa9b3ae284cb">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItNC0xLTEtMA_c5aa9ce8-b605-437d-afed-44bdcbe589c3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItNi0xLTEtMA_f0562675-f570-4ec2-8c3c-59e7e89abe96">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItOC0xLTEtMA_a07565d4-78f2-4c08-aafd-07cecad33374">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtMi0xLTEtMA_9ef5757a-c910-4610-8929-2a76b67885cf">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtNC0xLTEtMA_0e5a9913-1e9f-4aa5-b6a5-b77c91876919">11,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtNi0xLTEtMA_2d85f8af-e104-46b7-b0dc-4c7a4dc34717">52,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtOC0xLTEtMA_927e9f68-ae84-446e-a324-8f5b630fca25">24,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtMi0xLTEtMA_ac8d4c91-74f3-46f9-a787-9073e4806e09">207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtNC0xLTEtMA_6e75341c-b658-4043-99e0-21091680ac3a">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtNi0xLTEtMA_9378db31-0ae5-41d6-96f3-f7b4c08bbfcc">1,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtOC0xLTEtMA_ec8666f2-e345-467a-a1e7-c7c664e4ed82">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtMi0xLTEtMA_fab8a514-fde0-4cb8-998f-2b33f45c26aa">17,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtNC0xLTEtMA_e011e050-dd25-48d6-8180-c0ff2e3ea70b">11,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtNi0xLTEtMA_55bad109-f427-4b88-ac39-1a5330619fad">54,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtOC0xLTEtMA_cc883d5c-f88b-4f52-b6ca-73e2c3f552fd">24,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share &#8211; basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctMi0xLTEtMA_24a40f49-7128-49d5-9e44-4c7ee05ebeee"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctMi0xLTEtMA_b3f0819c-2c87-4279-8f9c-405a3c3a1c27">0.41</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNC0xLTEtMA_79efd573-6281-46dd-9822-5f791fc2eb37"><ix:nonFraction unitRef="usdPerShare" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNC0xLTEtMA_a927c1d6-f4da-4d72-a7df-bb3e25e035ef">1.54</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNi0xLTEtMA_a434ca0a-51e8-455a-8e66-fceb214e1cf2"><ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNi0xLTEtMA_b48e2e8d-ac34-4627-a8f7-972b569ca2a9">1.26</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctOC0xLTEtMA_033ab070-f378-40ab-b2a8-4d78826ba11d"><ix:nonFraction unitRef="usdPerShare" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctOC0xLTEtMA_d9e930e7-6976-44ad-9d9d-de7738bcfd2a">3.21</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding &#8211; basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtMi0xLTEtMA_399f946e-9a69-435f-8dce-2f315602f54f"><ix:nonFraction unitRef="shares" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtMi0xLTEtMA_ea08f51c-d341-4670-ae86-3fe9197360b1">42,155,981</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNC0xLTEtMA_cc464389-4f0e-4762-95b0-8a751961932a"><ix:nonFraction unitRef="shares" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNC0xLTEtMA_d59f113b-e6ec-4d72-a854-bfef001fda52">7,700,371</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNi0xLTEtMA_b16684a3-da6c-4d34-9d9e-3c98aa648939"><ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNi0xLTEtMA_cfb651b8-4ff3-4456-856e-9ee88417712d">41,946,852</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtOC0xLTEtMA_52a08b9b-ba58-4ae4-9b7b-6ad94c151eb1"><ix:nonFraction unitRef="shares" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtOC0xLTEtMA_dd3be0ab-4dd8-47e6-b307-640d515c277c">7,656,077</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited interim condensed financial statements</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_22"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share amounts)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.314%"><tr><td style="width:1.0%"></td><td style="width:37.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Deficit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i37a4198438794812abb2a3e7db2d6f87_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0xLTEtMS0w_ab38046a-8d8f-4e04-b305-cfc0989ac38e">41,767,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i37a4198438794812abb2a3e7db2d6f87_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0zLTEtMS0w_0ba1ec02-f69b-4b5f-8df7-bd820559920c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id58e597f9f7d46458c21b5a0f8ab9047_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy01LTEtMS0w_7f899a3e-db3d-45ad-9f98-6e58f06c4086">382,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic334605d7f4246e181eb1c8111b616b0_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy03LTEtMS0w_817a2a5f-a20a-44b2-a6d1-7f5a7081d840">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7c4a2cabec5f4f27845ee6841b8be4df_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy05LTEtMS0w_4c6e702e-6b95-478e-bbab-e5428a621bf6">72,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0xMS0xLTEtMA_61e73801-0815-42f2-bc3e-00f1f18498f9">309,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xLTEtMS0zMDg_6420f2e9-225f-4be7-9ca0-32dab055546c">13,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie96ef38430374065aa351d78dde24230_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC01LTEtMS0zMDg_6656b638-cda3-40b8-bcfc-b1f6de636044">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xMS0xLTEtMzA4_251ce7b9-7af7-4716-80b9-6cec6e1f11be">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNS0xLTEtMS0zMDg_413d465e-d6d1-4386-bccc-81e82557ae5d">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie96ef38430374065aa351d78dde24230_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi01LTEtMS0zMDg_507ef3ef-3d76-450f-81a2-8d2f1067bbfb">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi0xMS0xLTEtMzA4_394d0941-3682-4888-93dd-8d135f44a912">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cfe2dbcff99405cb545328603445374_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy03LTEtMS0zMDg_4aa88ac7-90d8-4375-96bc-fa5059ddac3d">597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy0xMS0xLTEtMzA4_a9edbeb2-f3be-4523-b5ab-edb7779c02a9">597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i539441c1f66142d988ac8a86e1e60786_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC05LTEtMS0zMDg_d8e9e66d-0f0f-4612-becc-b06d9de7327a">11,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC0xMS0xLTEtMzA4_9695c0bb-34ae-4769-be64-94c512a8d49c">11,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6723234f96b643e39508fa8cd095b0be_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xLTEtMS0zMDg_806de3ba-662c-4656-a62f-030cc6ee8386">41,786,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6723234f96b643e39508fa8cd095b0be_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0zLTEtMS0zMDg_f928d284-f5ff-425c-8778-c9a8a3fe0af3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iecbf0ce013994b84a0cccab6bf9a37cf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS01LTEtMS0zMDg_159c323e-8150-4cd4-a122-ea093ba0c364">383,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieecbc9f345de45c8985aa172294da8c5_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS03LTEtMS0zMDg_37a74bff-b5b7-4846-aed9-9bdd2537baf5">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1affb3b7e9094b82acca963bb310ca93_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS05LTEtMS0zMDg_80e8576d-4dc5-4a4b-818d-9e9f773966f3">83,906</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1eafc60eecc549488af6e45cca422737_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xMS0xLTEtMzA4_39069d2d-cbea-4b4b-bfb4-440f32cda124">298,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtMS0xLTEtMzQ2_73f49f4f-e039-4e58-aa65-3adb5a081665">324,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtNS0xLTEtMzQ2_92c79e47-8621-499c-b43c-2140a0d4799f">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtMTEtMS0xLTM0MA_0266e687-0f5f-417d-8816-4a7948fc67b8">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTEtMS0xLTEtMzQ2_d4681aed-eef6-425a-b2a7-34067eb4ce1f">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTItNS0xLTEtMzQ2_6fe55b3a-5af2-4523-b143-e5871ae04a91">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTItMTEtMS0xLTM0MA_cd010ce7-a314-4ec7-88a3-f09200f82bcc">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifceed151b34344ed86926861240827c3_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTMtNy0xLTEtMzQ2_161eb18f-275d-468d-beee-2c6ef3962392">960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTMtMTEtMS0xLTM0MA_db99d53f-0dcc-4f02-9c8c-22a7d423840d">960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i647bbb979fc246cd8580c17d002c985d_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTQtOS0xLTEtMzQ2_f66912b4-576d-400e-b2c4-5c18d8ea68b4">23,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTQtMTEtMS0xLTM0MA_bd0a477c-121b-48f2-9d5e-d916cd4025b8">23,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMS0xLTEtMzQ2_0f1dfab4-8d5b-4978-977c-b2a0aa3594c9">42,115,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMy0xLTEtMzQ2_799f4bbd-20e5-4c13-ab8c-c98eadc86174">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i422b3aaa79e941b292e79ba9cc1d14be_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtNS0xLTEtMzQ2_d89fd7c2-7f2d-4326-9781-31b0554109e1">386,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i8f9cca7a385d4bf9aa954d58badb8169_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtNy0xLTEtMzQ2_b2b03413-13d4-4f06-b709-4fb1d5f38f6d">1,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0448f37d4bcf4007a6cb6cf701810497_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtOS0xLTEtMzQ2_5d89fb5d-d8d9-4a42-8364-37855d89cbb2">107,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i94489e3bdc0a4a6c8676351116f086b7_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMTEtMS0xLTM0MA_2e6fdc2d-2c45-45d8-8c37-def74127620b">277,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options and ESPP purchases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xLTEtMS0w_d4ba5b92-5a75-4dd8-9d32-eb8111e4d258">124,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930" decimals="-3" name="sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC01LTEtMS0w_7345c771-7775-4be1-abcc-61223f2476aa">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" name="sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xMS0xLTEtMA_7f9d8377-25a5-418c-b126-7be50f85e9c0">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNS0xLTEtMS0w_d5ea532d-b4fc-4baa-9bec-4407a37d44f0">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi01LTEtMS0w_15eb0025-55d7-4fdc-ae11-f9c04c9d9327">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi0xMS0xLTEtMA_95e620d5-ac32-4001-8a11-335dcfa418af">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0eb983b0880943a3816d1b106ac9db6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy03LTEtMS0w_8232d630-b6d4-48a0-bef9-e31e8fd37ea0">207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy0xMS0xLTEtMA_a93e6e30-0145-41e3-946d-20f48e178add">207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3a0848129044470a9b012f37f9e64867_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC05LTEtMS0w_681d8118-f81c-40c8-a11b-5f4622af285a">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC0xMS0xLTEtMA_e0b320ef-3d3c-4b82-b575-dc3ad0eea3ff">17,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i37a3d9d9644d4497a319db83511ea7a4_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xLTEtMS0w_fd4a6fe7-7f8a-491c-9ef4-12187aaa9f6f">42,241,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i37a3d9d9644d4497a319db83511ea7a4_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0zLTEtMS0w_34c631f5-74f0-44cf-bd9a-85ce3bb79867">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3a4962c656b42f3a8214dfcc801e8d5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS01LTEtMS0w_4b3f49b3-65da-4bb9-a589-93e398346fba">387,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id0c872b9d01144a280f248a1e16beef6_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS03LTEtMS0w_bfd7bb90-fe02-4c50-9971-754724219852">1,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2734afb6faf8484a9447edac1f84134e_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS05LTEtMS0w_7296e447-92a6-465e-b8cb-6b687aea5128">124,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xMS0xLTEtMA_7ece402e-c4be-4b3a-a1c0-5479f7fc1046">261,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited interim condensed financial statements</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_367"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.187%"><tr><td style="width:1.0%"></td><td style="width:31.950%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.702%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.702%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="72" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020</span></div></td></tr><tr style="height:41pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series A Redeemable Convertible <br/>Preferred Stock &#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series B Redeemable Convertible <br/>Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series B-1 Redeemable Convertible <br/>Preferred Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Gain (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Deficit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Deficit</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares &#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares &#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount &#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMS0xLTEtMjUx_84f56a48-8271-41ff-a9e5-ec531398de00">1,093,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMy0xLTEtMjUx_3e195c19-1786-4de6-8392-8bd5471beaaa">49,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="idf6dbb88304d4595865f7e6425907d5e_I20191231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtNS0xLTEtMjUx_22b1998d-eb5a-4e52-a665-8f95220a325e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idf6dbb88304d4595865f7e6425907d5e_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtNy0xLTEtMjUx_2f44d095-2fd8-4919-a3e1-084d97711291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i96ac7f784c484cb6b645b04089e32903_I20191231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtOS0xLTEtMjUx_6efc836d-b903-4fa2-b1bb-d4807ce5b94e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i96ac7f784c484cb6b645b04089e32903_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTEtMS0xLTI1MQ_c8340444-cc75-4cc5-ad85-906676f7d6eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie8ed9359c48a4172993da7b129d56e5d_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTQtMS0xLTI1MQ_721c3757-3aa7-4084-be1f-09d8d6c64ee0">7,600,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8ed9359c48a4172993da7b129d56e5d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTYtMS0xLTI1MQ_e6977a19-df70-469a-8d1e-21a5d8f261a3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i19b72630e4874757aac99920f0790b3f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTgtMS0xLTI1MQ_7bd0aff6-6fd6-4eff-827d-a661016dd824">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc4e64d4ece4416db8aa1774732dcf60_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjAtMS0xLTI1MQ_196f67bf-86d4-4229-8577-2deee0874d74">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iba4476799e6c43e9b11f139b87f6e3eb_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjItMS0xLTI1MQ_815b6078-1054-4666-a5a1-8f4c2561c637">35,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9db48e68792b4cb48b1ababe34ca2b87_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjQtMS0xLTI1MQ_7d505f51-e658-4c59-a5ba-f7f36b8f08a0">34,548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sale of Series B redeemable convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzQtNS0xLTEtMjUx_1031276f-7af8-4b26-b756-4dcf995a3643">550,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzQtNy0xLTEtMjUx_cca621c8-a926-43cc-90ba-61717f3e254d">34,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMTQtMS0xLTI1MQ_e5356834-0f46-472c-bbfd-e733f5206dc4">28,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5f046b755a624db096bbc2345de726fc_D20200101-20200331" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMTgtMS0xLTI1MQ_ae80dad6-d9de-4684-b3d2-6e11874e02f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMjQtMS0xLTI1MQ_5b6f736f-222f-4b13-91b1-0692ecd5fd64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzYtMTQtMS0xLTI1MQ_4c5a71b2-12b2-4df5-8562-d323b919a14e">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5f046b755a624db096bbc2345de726fc_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzctMTgtMS0xLTI1MQ_ce671901-7919-4cf5-b5b8-043bd0be2b89">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzctMjQtMS0xLTI1MQ_b2a8de93-761f-4f57-a06d-37cca25f59a7">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6afcf491686b407a8a99dbe8013777f9_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzgtMjAtMS0xLTI1MQ_38c1fd4f-7adc-4db7-83b7-c6338442db3e">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzgtMjQtMS0xLTI1MQ_02b5ccf7-8c1d-4b56-922a-0dd3c7fcd2e5">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifb02004041e34aeea7a968c4f7d726f2_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzktMjItMS0xLTI1MQ_244c8d53-2a6b-4830-9805-6438bf617338">6,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzktMjQtMS0xLTI1MQ_b95ea786-396e-441a-b19f-b088c041662c">6,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i65da78330c124c72b6daf2f158858f87_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTEtMS0xLTI1MQ_4163e79d-b65a-44ce-bdc5-ea406abff994">1,093,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65da78330c124c72b6daf2f158858f87_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTMtMS0xLTI1MQ_d2ff0a62-20dd-4e36-a4a2-e6744ead1fc7">49,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id1c37493a8ff4212aee79aea73e76b60_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTUtMS0xLTI1MQ_fee95a8c-7a1e-4bf3-a0a4-ab1131ca0a0f">550,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id1c37493a8ff4212aee79aea73e76b60_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTctMS0xLTI1MQ_793cfddd-3b43-4dfa-aba5-3de140467018">34,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i95620647f2f44d4aba93d095901e26f6_I20200331" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTktMS0xLTI1MQ_e81617c3-63ee-4f63-a728-7299ff2611fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i95620647f2f44d4aba93d095901e26f6_I20200331" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTExLTEtMS0yNTE_5bdd250c-435a-483a-9fce-a1fe9f5c50d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fff4b70e84e4503b828997e45293717_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE0LTEtMS0yNTE_36813429-8dab-4d1d-96c1-d7fcea23be33">7,634,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fff4b70e84e4503b828997e45293717_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE2LTEtMS0yNTE_a4252aef-89fd-447e-8077-b8bd271b5354">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i16bf9ea147614ea3979c329a7c40111e_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE4LTEtMS0yNTE_ca87f769-b449-4453-b751-2f38b3d5c6a5">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9de96e067aed44aabf2d79bbccfb2d4a_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTIwLTEtMS0yNTE_376bc862-d56a-4f0f-a777-69e7a5f82dad">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib36be3855f8b4adbaeb7b5fb0bf4460f_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTIyLTEtMS0yNTE_e0289711-831b-4337-936e-594290655c3b">42,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i8bc7158f78fe423f8b8d304e7f23a82c_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTI0LTEtMS0yNTE_ead79d38-3463-4310-a003-f0eaf99ded1c">40,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sale of Series B redeemable convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sale of Series B-1 redeemable convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iae6291564a37483d8bb66b65731f4101_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEyLTktMS0xLTI1MQ_00c9f6a9-0f55-4a78-aca1-ef845251a3fe">1,319,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iae6291564a37483d8bb66b65731f4101_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEyLTExLTEtMS0yNTE_1667cb2d-ecd4-4234-a1a8-daef7e1782c0">82,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTE0LTEtMS0yNTE_00a69f80-f822-4380-b5d8-251e99fb7517">20,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTE4LTEtMS0yNTE_2e046d07-3625-471b-a9a6-0f398cb3ebf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTI0LTEtMS0yNTE_05268225-b544-4f51-9260-46705b9ae322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE0LTE0LTEtMS0yNTE_e9912391-ed7a-40a7-93ab-0820089e06e7">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE1LTE4LTEtMS0yNTE_65d4c091-5855-4cb9-a6a1-8691debb0218">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE1LTI0LTEtMS0yNTE_8fae3350-96d9-4506-9954-e126b01989f8">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i31c0536199104f62b96d3be8d78a773e_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE2LTIwLTEtMS0yNTE_7c3d5651-87ae-4d1e-a4ad-edf85e89bede">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE2LTI0LTEtMS0yNTE_f3bc72a7-da79-404d-9183-4ed253345060">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia45c4fa1189d41e6b75f3b2c4224f632_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE3LTIyLTEtMS0yNTE_ea87ca88-3b07-4fd5-bc0c-66742a20b35d">6,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE3LTI0LTEtMS0yNTE_22f40083-2722-4f57-b779-df41bedc6bae">6,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at June&#160;30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i46f763e24d914335a16f2797cbdcda54_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTEtMS0xLTI1MQ_0d8461fc-ab5b-4efa-88d8-d5ac966ee715">1,093,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i46f763e24d914335a16f2797cbdcda54_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTMtMS0xLTI1MQ_25bca5c9-b73f-445f-bab9-03eea2e9c2c6">49,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic8a2d81f76074762b59a86c90d441d3e_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTUtMS0xLTI1MQ_dd3f71cc-adce-44d1-b362-cf187a805eb6">550,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic8a2d81f76074762b59a86c90d441d3e_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTctMS0xLTI1MQ_0158be75-1f2f-4f3d-8032-a338443e2ebc">34,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i180732543f574734a093e1fdd359c31e_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTktMS0xLTI1MQ_078ae559-ba27-42c6-b022-ce9556f6aef8">1,319,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i180732543f574734a093e1fdd359c31e_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTExLTEtMS0yNTE_a20eb592-31d6-471a-9aa5-e7391b8b5c44">82,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE0LTEtMS0yNTE_ab17c9aa-55c3-4bff-a683-376def174cc7">7,659,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE2LTEtMS0yNTE_8145c8dc-cf27-4370-9cfa-2c78550d72ee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icca3a5a03c7944b58f29193146f4a6f0_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE4LTEtMS0yNTE_353642be-bc21-4b46-95e1-eabe1895a013">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc5b787ecb8c4de78e65e2d9759d48a4_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTIwLTEtMS0yNTE_2668c06c-9622-4159-bb31-76cb9c8fdfeb">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id9c24c935fc14f9d9bb20f6d1b1478e7_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTIyLTEtMS0yNTE_a99eecfc-cfd2-45b6-840e-f737f034d783">48,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2b2e4eca1d1b49aab71c8126e08eba38_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTI0LTEtMS0yNTE_21c4e498-b5bc-4dd2-b888-93f91883afe6">47,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series B-1 additional issuance costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2ae5c9d2028648418dd51b0c2b0a3cbd_D20200701-20200930" decimals="-3" name="sttk:TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIwLTExLTEtMS0yNTE_b4570120-4b23-45bd-b035-a4534e05653f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i86c197370694420e8139fb6bcd63799c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTE0LTEtMS0yNTE_9f65f9b5-633a-491a-91d9-a7ddb8bc75e6">115,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTE4LTEtMS0yNTE_6831b471-95fc-4d3b-9de4-32b380ff85bd">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTI0LTEtMS0yNTE_a75393b8-62c9-4097-8aa5-8ef9e8d2fddc">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vesting of common stock previously subject to vesting requirements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i86c197370694420e8139fb6bcd63799c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIyLTE0LTEtMS0yNTE_d03e6224-4b8f-4aaa-a6eb-18fa88d08276">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIzLTE4LTEtMS0yNTE_d99dca64-ee43-4ca1-b7ed-369b9eb2df04">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIzLTI0LTEtMS0yNTE_982f37c4-28b7-4aa2-8226-4649aa4f3ab7">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i55b9b9e789cd442da7cfa75ff1ec86c0_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI0LTIwLTEtMS0yNTE_0809e23b-f4c7-41a9-beb7-f4bf015ae888">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI0LTI0LTEtMS0yNTE_dcd40a7b-5386-4395-b8de-d81b03fb4003">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cb009f0275b4b66b6ea526dcbca7e9f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI1LTIyLTEtMS0yNTE_515aeb97-a837-42fa-a25a-759f3b3c65db">11,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI1LTI0LTEtMS0yNTE_7e2ff64e-048a-4de6-a453-57c89edb827d">11,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i8d43c4f21e4f400181e8380a945fa403_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTEtMS0xLTI1MQ_71a4c02f-48a3-499d-a017-b2eb2b47aa7f">1,093,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8d43c4f21e4f400181e8380a945fa403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTMtMS0xLTI1MQ_ee296261-faf7-40b5-840b-cef1ee28988f">49,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTUtMS0xLTI1MQ_9f936f49-6ce7-4ad7-8335-a7ab5d9929d5">550,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTctMS0xLTI1MQ_71ec2756-9777-4894-aea7-3188f8f9feda">34,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTktMS0xLTI1MQ_7e8a5b92-3255-4fd7-a1ab-81fad5f75203">1,319,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTExLTEtMS0yNTE_3bc77ddd-e972-410d-9380-b91477452091">82,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i8b32de77fd41426fb9250157c316291b_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE0LTEtMS0yNTE_1bca9b6f-3d08-43dd-9456-ffcf7c7c467d">7,779,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8b32de77fd41426fb9250157c316291b_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE2LTEtMS0yNTE_6336f366-ac49-4d9c-9806-b55e546ea6e0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibbfd6109d71a41d88ac7cd90ef87419a_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE4LTEtMS0yNTE_f99dad98-b8a5-4bb1-854a-c0ce56b858be">1,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5dc7e714b56844a881c19fc1a46f7a81_I20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTIwLTEtMS0yNTE_882026ea-0306-46bb-96ca-74a9cae85512">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icf10a010e6f24e1ead5edad126efe989_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTIyLTEtMS0yNTE_48bc0a86-5be7-4cc3-b5b1-8daea9a64f34">60,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i74d3aa8f82514539b0c9f923f0819cdb_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTI0LTEtMS0yNTE_532d79db-5d65-46da-96f5-5d2fc785c474">58,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited interim condensed financial statements</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_25"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF CASH FLOWS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMy0xLTEtMS0w_3e3d8857-22f9-4fea-8875-e95d6aa173ca">52,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMy0zLTEtMS0w_63d5c925-6a5f-4cf0-b5c8-dbc441eebe0f">24,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0xLTEtMS0xMzUxMw_ac218fb3-dbab-491e-8d35-45babc683821">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0zLTEtMS0xMzUxMw_57b20f6a-04f3-4a89-aa5a-fe5fb923a9c4">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0xLTEtMS0w_a8118752-06ed-4cfa-9f3c-bba9bcd6dd95">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0zLTEtMS0w_fdf38a79-d25b-4b6b-9e70-be1b2d08add8">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accretion (amortization) of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNy0xLTEtMS0w_81a3eb70-83b8-4ba5-b943-f44ca60ef12a">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNy0zLTEtMS0w_81e0f9be-f076-403b-afc4-d6d311e1c6ba">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfOS0xLTEtMS0w_8d91ee21-d538-42b3-9c89-5a568b64bef6">1,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfOS0zLTEtMS0w_72d66497-7ee5-4b57-8739-4a4061ae49d2">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTAtMS0xLTEtMA_418aee68-b063-4378-ae79-fe677cf9ec4a">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTAtMy0xLTEtMA_2feadd70-6188-41da-9e5f-2367c4cd9b45">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTEtMS0xLTEtMA_99b7d025-4a4a-493e-b5c6-975956785473">846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTEtMy0xLTEtMA_555ac97c-34bc-40b9-b935-448e4f29bcd8">1,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTItMS0xLTEtMA_43b64789-f744-4042-ae38-1962090aee65">6,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTItMy0xLTEtMA_7c30f1c1-b236-4edb-af5d-3e0e17da2141">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTMtMS0xLTEtMA_dded0050-d580-4a92-a12c-cadbbbab1a0a">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTMtMy0xLTEtMA_bb0e7bc7-a8c8-4bd9-80b8-8ddb17ae8feb">5,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="sttk:IncreaseDecreaseInDeferredRentCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTQtMS0xLTEtMA_50cfebe1-2683-441b-b461-40c8ef7396d0">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" name="sttk:IncreaseDecreaseInDeferredRentCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTQtMy0xLTEtMA_215bf7eb-425a-4b97-8b5e-f06a2a86f3da">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTUtMS0xLTEtMA_510be5e8-c0dc-44e7-9c7e-1c6511464cf3">38,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTUtMy0xLTEtMA_2875fd46-ae66-4626-9b07-7fa0ab14a293">19,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTgtMS0xLTEtMA_5f3b0899-55e5-4615-8598-5eb4b5944b98">5,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTgtMy0xLTEtMA_deefc1b6-6632-4dbd-9bba-db5b391f39f4">526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sale and maturities of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTktMS0xLTEtMA_8d657ec4-a33c-4d73-af63-8a901a4482f7">134,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTktMy0xLTEtMA_8dd564d5-7b39-4ca1-9b54-108101e26af1">31,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjAtMS0xLTEtMA_4a8a69a9-115b-4818-9da4-1c78317baa6e">165,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjAtMy0xLTEtMA_1131e23f-7716-418d-90ec-2a9e94d73586">5,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjEtMS0xLTEtMA_812ef08e-0046-48e9-a26f-b5bc0c7b9e75">36,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjEtMy0xLTEtMA_30e89e08-851a-4824-b35d-d7d6861d143b">25,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise of stock options and ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMS0xLTEtMTM1MzQ_01eb70a7-3508-4fa6-a53c-bcd036671938">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMy0xLTEtMTM1MzQ_23c61acb-0ac1-42bb-a934-41669af18e1a">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments for public offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMS0xLTEtMA_ae53692b-c798-4da0-bd08-9f07ea5cc7e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMy0xLTEtMA_dfb85f93-1103-45df-b4c4-d2dec47d66cc">1,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the sale of Series B redeemable convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifdec66eb26c346dead446844d3d02964_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjUtMS0xLTEtMA_61eb5281-8240-4992-9002-8dcde929bbb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjUtMy0xLTEtMA_72532141-a651-41e1-a038-cbd9f305afea">34,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the sale of Series B-1 redeemable convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf949b23f20d4f72b56403c3fbb43149_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjYtMS0xLTEtMA_aeaa175f-42fd-4a6e-97e2-7681d2576f4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjYtMy0xLTEtMA_790bfdc0-05c1-4f4c-90d0-9091b10c6611">82,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjgtMS0xLTEtMA_08782eeb-ae56-4a4f-9616-85f80b5ddbda">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjgtMy0xLTEtMA_52e15de0-79e5-40c9-9491-2044984c6fbc">116,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjktMS0xLTEtMA_c121af2e-8c59-4326-97ed-85d65007953a">72,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjktMy0xLTEtMA_f08ec996-a282-4f1d-a9b0-900fdd06bdd9">121,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzAtMS0xLTEtMA_dc1ce9a6-ab88-4d0f-86d0-db280c532fe9">157,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9db48e68792b4cb48b1ababe34ca2b87_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzAtMy0xLTEtMA_49be4350-444a-435e-9330-ff67e4b55106">7,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzEtMS0xLTEtMA_46c49ffa-d668-4d92-b582-d10ebe98c251">85,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74d3aa8f82514539b0c9f923f0819cdb_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzEtMy0xLTEtMA_8e3bd085-a5e2-452b-9305-9a08800a3e33">128,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosures of non-cash financial activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on short-term investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzQtMS0xLTEtMA_7382b94a-eb16-4f8f-b164-781b2d90e0bb">1,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzQtMy0xLTEtMA_42428c5e-1260-4611-b639-2ee779f4e88c">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued public offering costs in other assets</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="sttk:StockIssuanceCostsIncurredDuringNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzUtMS0xLTEtMTQy_09d12913-21aa-4427-a50f-9367db43d2c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="sttk:StockIssuanceCostsIncurredDuringNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzUtMy0xLTEtMTM4_820d6597-2e86-40aa-8535-d2ca25e91c73">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid amounts related to purchases of property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzYtMS0xLTEtMTI5NTk_3c38f1a5-1a3a-4bf2-afee-05ec5b9dee99">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzYtMy0xLTEtMTI5NjU_2ab79127-746e-408a-b628-5cdb81043c21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited interim condensed financial statements</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_31"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfMzc5NQ_7cf12131-925d-4e3c-a878-3625c4c251b2" continuedAt="i1fa74eb321e0435fabdb5d7334b9582b" escape="true">Organization and Description of Business </ix:nonNumeric></span></div><ix:continuation id="i1fa74eb321e0435fabdb5d7334b9582b"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck Labs, Inc. (the &#8220;Company&#8221;) was incorporated in 2016 in the State of Delaware and is a clinical-stage biopharmaceutical company developing dual-sided fusion proteins, including its ARC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and GADLEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms, as novel classes of biologic medicines capable of multifunctional activity with potential applications in oncology and inflammatory diseases. Using its proprietary technology, the Company is building a pipeline of therapeutics, initially focused on the treatment of solid tumors and hematologic malignancies. The Company has two clinical-stage product candidates, SL-172154 and SL-279252, and has several compounds in preclinical development. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred losses and negative cash flows from operations since inception and has an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfODQz_792007eb-02ab-468a-a26b-7c7c6432c4f6">124.9</ix:nonFraction> million as of September&#160;30, 2021. The Company anticipates incurring additional losses and negative cash flows from operations until such time, if ever, that it can generate significant sales of its product candidates currently in development, and is highly dependent on its ability to find additional sources of funding in the form of licensing of its technology, collaboration agreements and/or public and private debt and equity financings. Adequate additional funding may not be available to the Company on acceptable terms, or at all. The failure to raise funds as and when needed could have a negative impact on the Company&#8217;s financial condition and ability to pursue its clinical operations, research and development and commercialization of its product candidates. Management believes that the Company&#8217;s cash and cash equivalents and short-term investments of $<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfMTY4OQ_ffe48361-1cb8-4b4d-bd64-d66cbf7d8b47">290.2</ix:nonFraction> million as of September&#160;30, 2021 are sufficient to fund projected operations of the Company into the second half of 2024. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;10, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The virus and actions taken to mitigate its spread have had, and are expected to continue to have, a broad adverse impact on the economies and financial markets of many countries, including the geographical areas in which the Company operates and conducts its business and in which the Company&#8217;s partners operate and conduct their business. The Company is currently following the recommendations of local health authorities to minimize exposure risk for its team members and visitors. However, the scale and scope of this pandemic is unknown and the duration of the business disruption and related financial impact cannot be reasonably estimated at this time. While the Company has implemented specific business continuity plans to reduce the potential impact of COVID-19, there is no guarantee that the Company&#8217;s continuity plans will be successful. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has already experienced disruptions to its business such as work-from-home orders for offices and similar disruptions have occurred for its partners. Specifically, the outbreak has caused disruptions in its ability to manufacture clinical trial materials, including the acquisition of raw materials needed for such manufacturing, enrollment and treatment of patients in clinical trials in process and slowdowns and shutdowns of the laboratories and other service providers that are being relied upon in the development of the Company&#8217;s product candidates. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic or any other health epidemic may impact the Company&#8217;s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of COVID-19 and the actions to mitigate its impact, among others. Accordingly, the COVID-19 pandemic could have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</span></div></ix:continuation><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_34"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODE_aadff70f-965e-46b0-a1a1-8be037ced9f6" continuedAt="i8772473dc65e452d9195991caad80588" escape="true">Basis of Presentation and Summary of Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="i8772473dc65e452d9195991caad80588" continuedAt="i7bd61f3c33f6481dadaa8ce7e51a3898"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTQ_b6989cb2-0256-4edd-ac5d-6c92294c47e9" continuedAt="i763e91cdb3144c2080e9419c8e139c9b" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7bd61f3c33f6481dadaa8ce7e51a3898" continuedAt="i7ae87e3d692a4672a36d7586b0a75dd1"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i763e91cdb3144c2080e9419c8e139c9b" continuedAt="if2da46207ba94a87b266514f452b92c5">Unaudited Interim Financial Statements </ix:continuation></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if2da46207ba94a87b266514f452b92c5">In the opinion of management, the accompanying interim financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company&#8217;s financial position, its results of operations, statements of changes in redeemable convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the interim periods presented. Operating results for interim periods presented are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. These interim financial statements, presented herein, do not contain all required disclosures under GAAP for annual financial statements. The accompanying unaudited interim financial statements should be read in conjunction with the annual audited financial statements and related notes in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</ix:continuation> </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODY_d4d9c66d-5dc0-4d1d-93f1-9f13cf149bcf" continuedAt="i3f14920f749f4c02ad4a3aeb9e47b34f" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates, if any, are recorded in the period in which they become known and actual results could differ from management&#8217;s estimates. A</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f14920f749f4c02ad4a3aeb9e47b34f">change in the Company&#8217;s estimates occurred in the second quarter of 2021, which impacted the Company&#8217;s revenue recognition and related balance sheet accounts.</ix:continuation> See Note 8 to the Company&#8217;s unaudited interim condensed financial statements included elsewhere in this Quarterly Report on Form 10-Q for further information.</span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTA_b892cd72-65a3-47a5-9f93-082ea5152115" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon the sale of an asset or paid upon the transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. Fair value measurements are classified and disclosed in one of the following categories: </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets the reporting entity has the ability to access as of the measurement date; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are classified based on the lowest level of input that is significant to the measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The determination of the fair values stated below takes into account the market for its financial assets and liabilities, the associated credit risk and other factors as required. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including short-term investments and accounts payable, approximate fair value due to the short-term nature of those instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODc_2fc2142c-4519-43ab-af48-ea17ba53b130" continuedAt="ie9a7f7b38c214e548ce9a64541fb0153" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at two accredited financial institutions in amounts that exceed federally-insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company invests in only highly-rated debt securities that management believes protects the Company from risk of default and impairment of value. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7ae87e3d692a4672a36d7586b0a75dd1" continuedAt="ifb74309428e248deaed15f6d73b65e7c"><ix:continuation id="ie9a7f7b38c214e548ce9a64541fb0153" continuedAt="icb916b585697497a8f3daf29482da2d0"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue is derived from its collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (&#8220;Takeda&#8221;) (see Note 8). </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is highly dependent on a single third-party contract manufacturing organization (&#8220;CMO&#8221;) to supply drug products for its research and development activities of its programs, including clinical trials and non-clinical studies. These programs could be adversely affected by a significant interruption in the supply of such drug products. </span></div></ix:continuation><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb916b585697497a8f3daf29482da2d0">The Company is highly dependent on three contract research organizations (&#8220;CROs&#8221;) and a limited number of third-party service providers to manage and support its clinical trials. These programs could be adversely affected by a significant disruption in services provided by these CROs and third parties.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTY_065a43af-4315-4872-8811-a6bf11459e9d" continuedAt="i58a789931d6d419e8bf15b34ee5b1e6c" escape="true">Cash and Cash Equivalents </ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i58a789931d6d419e8bf15b34ee5b1e6c">The Company considers all demand deposits with financial institutions and all highly liquid investments with original maturities of 90 days or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents consisted of $<ix:nonFraction unitRef="usd" contextRef="i91d5a84837714480a2462e3255a83730_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTQ4Mg_e93fa48c-b87e-4a32-b4a2-74fbb0edb573">14.0</ix:nonFraction> million held in operating accounts and $<ix:nonFraction unitRef="usd" contextRef="i28e6d73e46e34e999b3a2520c34da2bb_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTUxMw_9dffaa94-d239-4291-a245-d34e4317bec9">71.1</ix:nonFraction> million held in money market funds as of September&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i21077307da9c4396a282390e1aaac1c7_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTU5NA_dbe29b17-b16c-4074-ba5a-fdf0e2bf9757">2.7</ix:nonFraction> million held in operating accounts, $<ix:nonFraction unitRef="usd" contextRef="i385459190ef7464a90ce28ba7fe7883d_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTYyNQ_9bbac408-cf62-4764-a49e-209d82fbad32">80.2</ix:nonFraction> million held in money market funds and $<ix:nonFraction unitRef="usd" contextRef="i6ebaf8f49a6941a0976a2367d5cc1bfb_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTY1OQ_eaac4f09-be62-4fe9-ac26-e17e5813dad9">75.0</ix:nonFraction> million held in government obligations as of December&#160;31, 2020.</ix:continuation> </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzc_531f8e98-f954-4104-8c7b-8cbaf787d9ed" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of highly-rated U.S. Treasury securities with maturities of more than three months but less than one year at the date of purchase. The Company classifies its short-term investments at the time of purchase as available-for-sale securities. Available-for-sale securities are carried at fair value. The Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on January 1, 2020, which amended its accounting for available-for-sale debt securities. Credit impairments are recorded through an allowance rather than a direct write-down of the security and are recorded through a charge to the statements of operations. Unrealized gains or losses not related to credit impairments are recorded in accumulated other comprehensive income, a component of stockholders&#8217; equity, until realized. The Company reviews available-for-sale debt securities for impairments related to credit losses and other factors each quarter. As of September&#160;30, 2021, there were no impairments related to credit losses of short-term investments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzg_474a8a06-a64b-4a48-a86a-0d069c313263" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Offering Costs</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs will be recorded against gross proceeds.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="sttk:TemporaryEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzk_66fa4481-4110-40d2-a180-13fe6284b616" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records shares of redeemable convertible preferred stock at their respective fair values on the date of issuance, net of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#8217; equity on the balance sheet because the shares contain liquidation features that are not solely within the Company&#8217;s control. Upon the completion of the Company&#8217;s initial public offering (&#8220;IPO&#8221;) in the fourth quarter of 2020, all outstanding shares of the Company&#8217;s redeemable convertible preferred stock were converted into common stock. See Note 6 to the Company&#8217;s unaudited interim condensed financial statements included elsewhere</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Quarterly Report on Form 10-Q for further information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTE_da19a851-ea02-4a56-a59a-36c5e3b0d7c7" continuedAt="i53a03b80c1434dfa8f75171aa4ce3829" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue is recognized in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). Arrangements with collaborators may include licenses to intellectual property, research and development services, manufacturing services for clinical and commercial supply and participation on joint steering committees. The Company evaluates the promised goods or services in the contract to determine which promises, or group of promises, represent performance obligations. In contemplation of whether a promised good or service meets the criteria required of a performance obligation, the Company considers the stage of development of the underlying intellectual property, the capabilities and expertise of the customer relative to the underlying intellectual property and whether the promised goods or services are integral to or dependent on other promises in the contract. When accounting for an arrangement that contains multiple performance obligations, the Company must develop </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ifb74309428e248deaed15f6d73b65e7c" continuedAt="ie04cb71c34a642759bbc8f954ce3e130"><ix:continuation id="i53a03b80c1434dfa8f75171aa4ce3829" continuedAt="i487403ea5b0f4a23bfd25c1f9f9e66d6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgmental assumptions, which may include market conditions, reimbursement rates for personnel costs, development timelines and probabilities of regulatory success to determine the stand-alone selling price for each performance obligation identified in the contract. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the amendment of an existing agreement, the Company evaluates whether the amendment represents a modification to an existing contract which would be recorded through a cumulative catch-up to revenue, or a separate contract. If it is determined that it is a separate contract, the Company will evaluate the necessary revenue recognition through the five-step process described below. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company concludes that a contract should be accounted for as a combined performance obligation and recognized over time, the Company must then determine the period over which revenue should be recognized and the method by which to measure revenue. The Company generally recognizes revenue using a cost-based input method. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes collaboration revenue when its customer or collaborator obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the following five steps are performed: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">identify the contract(s) with a customer;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">identify the performance obligations in the contract; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">determine the transaction price; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">allocate the transaction price to the performance obligations within the contract; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">recognize revenue when (or as) the entity satisfies a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company only applies the five-step model to contracts when it determines that it is probable it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within the contract to determine whether each promised good or service is a performance obligation. The promised goods or services in the Company&#8217;s arrangements may consist of a license, or options to license, the Company&#8217;s intellectual property and research, development and manufacturing services. The Company may provide options to additional items in such arrangements, which are accounted for as separate contracts when the customer elects to exercise such options, unless the option provides a material right to the customer. Performance obligations are promises in a contract to transfer a distinct good or service to the customer that (i)&#160;the customer can benefit from on its own or together with other readily available resources and (ii)&#160;are separately identifiable from other promises in the contract. Goods or services that are not individually distinct performance obligations are combined with other promised goods or services until such combined group of promises meet the requirements of a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract. Consideration may be fixed, variable or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most-likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes variable consideration in the transaction price to the extent it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie04cb71c34a642759bbc8f954ce3e130" continuedAt="ia92f85b301494639a42ad603e0de52d7"><ix:continuation id="i487403ea5b0f4a23bfd25c1f9f9e66d6" continuedAt="if9c64630356f43b1a0fb84c90b0dd7cc"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded as deferred revenue. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received prior to satisfying the revenue recognition criteria are recognized as deferred revenue in the Company&#8217;s accompanying balance sheet. Deferred revenues expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability. Deferred revenues not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as non-current liabilities. </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Company&#8217;s collaboration revenue arrangements may include the following: </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up-front License Fees: If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Milestone Payments: At the inception of an agreement that includes research and development milestone payments, the Company evaluates each milestone to determine when and how much of the milestone to include in the transaction price. The Company first estimates the amount of the milestone payment that the Company could receive using either the expected value or the most-likely amount approach. The Company primarily uses the most-likely amount approach as that approach is generally most predictive for milestone payments with a binary outcome. The Company then considers whether any portion of that estimated amount is subject to the variable consideration constraint (that is, whether it is probable that a significant reversal of cumulative revenue would not occur upon resolution of the uncertainty). The Company updates the estimate of variable consideration included in the transaction price at each reporting date which includes updating the assessment of the likely amount of consideration and the application of the constraint to reflect current facts and circumstances. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalties: For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i)&#160;when the related sales occur or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not granted a development and commercialization license nor recognized any revenue related to sales-based royalties or milestone payments based on the level of sales. </span></div></ix:continuation><div style="margin-top:6pt;text-indent:27pt"><ix:continuation id="if9c64630356f43b1a0fb84c90b0dd7cc" continuedAt="i226bfda3354445d08f5180e5cd9c3d30"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and Development Services: The Company will record costs associated with development and process optimization activities as research and development expenses in the statements of operations and comprehensive loss consistent with ASC 730, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company considered the guidance in ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i226bfda3354445d08f5180e5cd9c3d30"> and will recognize the payments received from these agreements as revenue when the related costs are incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODk_eb4ebca5-123a-4b46-834a-05c1b07c0115" continuedAt="if497978cd9834db28dda8ad2ac3ab77c" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred, and include salaries, stock-based compensation and other personnel-related costs, equipment and supplies, depreciation, preclinical studies, clinical trials and manufacturing development activities. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of the Company&#8217;s ongoing research and development activities are conducted by third-party service providers, including contract research and manufacturing organizations. The Company accrues for expenses resulting from obligations under agreements with CROs, CMOs and other outside service providers for which payment flows do not match the periods over which materials or services are provided to the Company. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia92f85b301494639a42ad603e0de52d7" continuedAt="if19644bfb31449aaa2c1e4cc27ed3cc0"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if497978cd9834db28dda8ad2ac3ab77c">Accruals are recorded based on estimates of services received and efforts expended pursuant to agreements established with CROs, CMOs and other outside service providers. These estimates are typically based on contracted amounts applied to the proportion of work performed and determined through analysis with internal personnel and external service providers as to the progress or stage of completion of the services. In the event advance payments are made to a CRO, CMO or outside service provider, the payments will be recorded as a prepaid asset which will be amortized as the contracted services are performed. As actual costs become known, the Company adjusts its accruals and prepaid assets accordingly. Inputs, such as the services performed, the number of patients enrolled or the study duration, may vary from the Company&#8217;s estimates, resulting in adjustments to research and development expense in future periods. The Company makes significant judgements and estimates in determining the accrual and/or prepaid balance in each reporting period and changes in these estimates may result in material changes to the Company&#8217;s accruals that could materially affect the Company&#8217;s results of operations.</ix:continuation> </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODg_77f8eb62-639d-47c0-9441-8d96bdbc667d" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during each period. Diluted loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as redeemable convertible preferred stock, convertible notes, stock options and unvested shares of restricted stock, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, dilutive securities are not included in the calculation as the impact is anti-dilutive. </span></div><div style="margin-top:6pt;text-indent:27pt"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTM_fd9750f2-b97d-4c7e-a60e-fe7eecb604fe" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:68.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3e370dfdd2f54ea4bad75c57602b4f93_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0xLTEtMS0w_bf71ec97-14e7-48a7-999a-328ae4ed890f"><ix:nonFraction unitRef="shares" contextRef="i9abbbff0f64c4386a4848428859c93ba_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0xLTEtMS0w_f76a8dd3-94c1-4f35-b30b-15e65e0a100c">2,491,187</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib6638d6e20b5438bbca39e3e66ef5663_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0zLTEtMS0w_b54a0e05-e4ca-4986-a3c7-1e6937531786"><ix:nonFraction unitRef="shares" contextRef="ib919ed52ea1544a19151e99891e1459d_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0zLTEtMS0w_e68c799c-2656-4925-9c6c-0f8885d308dd">2,538,225</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock as converted to common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i19b470f64d144b129fbaa7ad42808a35_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0xLTEtMS0xMzQ3MQ_4658f593-5dc1-4d32-8337-e8ffb0e94e46"><ix:nonFraction unitRef="shares" contextRef="ibf359afbf3d0464cbc86a41f24df0d16_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0xLTEtMS0xMzQ3MQ_519135ba-3abe-4667-afad-4ea23de36151">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib884e0584c7e460bb651ba32ee4192a7_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0zLTEtMS0xMzQ3MQ_c90cbce2-efb5-41a9-8320-08efe582d991"><ix:nonFraction unitRef="shares" contextRef="ida0e12191e2b43dbaece2abe6a654ebf_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0zLTEtMS0xMzQ3MQ_cf77d3ab-5b8a-4db3-a8dc-a1d3852271bc">20,300,253</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic89ca81d8e0f45f3a4c92829a40b2cce_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0xLTEtMS0w_855905c0-eaf8-45d5-a479-cc947b4cb49c"><ix:nonFraction unitRef="shares" contextRef="icf97f887b14842219aa9e7a7b036371c_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0xLTEtMS0w_c4a07dbc-4b28-4115-8515-3a04f3339f3d">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib92a6e56c17649fab1775c0e60491710_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0zLTEtMS0w_5317de1c-4558-4e39-9dbd-de3546b54022"><ix:nonFraction unitRef="shares" contextRef="i194ff9146a844c808f5d4fb8b42bb2e5_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0zLTEtMS0w_e5aa174c-d2fd-4f03-9a54-31453a6cd4ad">16,789</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0xLTEtMS0w_9db749f6-3c99-4989-9971-d232a68aa670"><ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0xLTEtMS0w_f8730bad-ce9b-43af-a48a-cd9f58e74fe8">2,491,187</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0zLTEtMS0w_3b64a4dc-06e7-40b0-a048-bff421ecef09"><ix:nonFraction unitRef="shares" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0zLTEtMS0w_cf43f19d-a9be-4590-8cc5-1afdf0b3bba3">22,855,267</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODQ_08c40216-63d7-4e6a-88ee-388592f03c35" continuedAt="i7589b3b781694a5eb5ae4fa73ff06af1" escape="true">Other Comprehensive Income (Loss) </ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7589b3b781694a5eb5ae4fa73ff06af1">Other comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) is comprised of the net loss and unrealized gains and losses on short-term investments.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODU_9704dd3a-be4f-41aa-a789-975e1603b775" continuedAt="i7a1c38afd6724544990bb034bf3da202" escape="true"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU No. 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes: Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU removes certain exceptions to the general principles in ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company adopted this pronouncement effective January 1, 2021 and it did not have a material impact on the financial statements or related disclosures. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements (not yet adopted) </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-indent:27pt"><ix:continuation id="if19644bfb31449aaa2c1e4cc27ed3cc0" continuedAt="i85b49faf8ede46458e4843328266fecf"><ix:continuation id="i7a1c38afd6724544990bb034bf3da202" continuedAt="ie705657e293d4f1f8d57d742661eeb66"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No.&#160;2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i85b49faf8ede46458e4843328266fecf"><ix:continuation id="ie705657e293d4f1f8d57d742661eeb66">which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The FASB deferred the effective date of this ASU until the annual periods beginning after December 15, 2021. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures.</ix:continuation></ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTMw_aa3433d7-c5f0-4e7c-84a3-2057ab85ab01" continuedAt="ie4e6da52941b4040ad1eb19ffe44190e" escape="true">Short-Term Investments </ix:nonNumeric></span></div><ix:continuation id="ie4e6da52941b4040ad1eb19ffe44190e"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTMx_06d54dff-f5c0-40a9-930b-556f9f2279de" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s available for sale short-term investments by major security type (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized <br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized<br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy0xLTEtMS0w_08225b31-b79f-4484-a478-cf13ea6eb8de">206,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy0zLTEtMS0w_9c1099cb-8d44-4071-b941-7ba3b336d4e2">1,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy01LTEtMS0w_a73a3024-b1f3-4f85-9fcf-bca0b9fdb1eb">205,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC0xLTEtMS0w_5bf29313-9dfd-4a64-bad1-d1b72cef02cb">206,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC0zLTEtMS0w_5b76e6fd-bb2f-4b05-976c-03c8011643d4">1,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC01LTEtMS0w_079fc356-4b17-4810-a3bb-6d3de69a5a34">205,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized <br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy0xLTEtMS0w_6ed080d9-6d6a-440f-b2d9-7b650253e965">177,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy0zLTEtMS0w_961f0646-f250-468d-ba26-b5e5d2aa9ed4">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy01LTEtMS0w_20cc5178-e499-4b9e-a021-9576b37e26bb">177,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC0xLTEtMS0w_05c2a6b2-bb2e-401d-b6a7-3c363203d3ff">177,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC0zLTEtMS0w_2ee48ecf-1f4f-49bd-a241-9573ab2f0d95">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC01LTEtMS0w_8f9f37da-6c0d-4c43-914e-78ed4c0c535f">177,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:1pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term investment instruments and cash and cash equivalents are classified using Level&#160;1 inputs within the fair value hierarchy and are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Debt securities as of September&#160;30, 2021 have an average maturity of <ix:nonNumeric contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" format="ixt-sec:duryear" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTIx_52d9f78c-d56d-416a-ab8a-d6915f97f7b6">0.48</ix:nonNumeric> years.</span></div></ix:continuation><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_40"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RleHRyZWdpb246ZjYyNDBmOTI5N2FhNDM4ZGE0OTMzYWMxMTU5ZTE2MzJfOTY_55f9d2e6-3b20-48e4-95be-b5aa7e8ebd04" continuedAt="if574c692350547ddb47932fbb72c33c8" escape="true">Accrued Expenses </ix:nonNumeric></span></div><ix:continuation id="if574c692350547ddb47932fbb72c33c8"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RleHRyZWdpb246ZjYyNDBmOTI5N2FhNDM4ZGE0OTMzYWMxMTU5ZTE2MzJfOTU_cc5909ae-9738-4e7f-b340-bb65bcbeda66" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (amounts in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development contract costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedResearchAndContractCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMS0xLTEtMS0w_7fa55b5d-997c-4d39-b036-61cafc9190d7">10,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedResearchAndContractCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMS0zLTEtMS0w_f132f898-c592-4a50-95a8-28add9b93f3a">5,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMi0xLTEtMS0w_a78fd922-c888-4a95-9d23-5181db95a98f">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMi0zLTEtMS0w_b87e5dad-e371-4d06-9033-3e21284f0128">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMy0xLTEtMS0w_83b4e20d-76a4-4d66-b44c-11784ba7fd78">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMy0zLTEtMS0w_44914e60-cb6a-4385-862f-b8ee49885705">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfNC0xLTEtMS0w_b5664bca-5922-45c2-a1a0-5f544d829ad2">13,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfNC0zLTEtMS0w_31aaa34e-025f-4175-aa48-6fffe982d701">7,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_43"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMjM3Ng_8253b480-23e0-461a-89f3-a2040ac7ea7f" continuedAt="i0ee1ab99ce434eeb85ed2c10caab1c4c" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="i0ee1ab99ce434eeb85ed2c10caab1c4c" continuedAt="i1b952a55b781488b9cc105c3cfe72e46"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases </span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMjM3Nw_e1a7adaf-d409-4950-835e-e3d54e15fa56" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments, by year and in aggregate, under non-cancelable operating leases consist of the following as of September&#160;30, 2021 (amounts in thousands): </span></div><div style="margin-top:6pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMC0xLTEtMS0w_75276b28-0645-4ca6-958b-08429ab23a6c">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMS0xLTEtMS0w_41dfa453-31e8-4297-8696-1f3fd2983293">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMi0xLTEtMS0w_0c469d1a-7ba3-4cfe-8e5c-778e45b715a1">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMy0xLTEtMS0w_f3a1a103-2dd9-4c74-9608-a16088db672f">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNC0xLTEtMS0w_78745916-5b22-456c-8e2f-0d64c637c37d">1,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNS0xLTEtMS0w_ecb88607-3e2b-4168-a15a-41ea9c351c1d">2,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum lease payments </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNi0xLTEtMS0w_dec765a8-bfca-4a0e-ad12-4ab0c2d03dce">7,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heat License Agreement </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a license agreement with Heat Biologics Inc. (&#8220;Heat&#8221;), the Company is required to make payments of up to $<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sttk:LicenseAgreementRoyaltyPaymentsMaximum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMzU1_d60f6b33-44d1-4877-9ab3-9dd5c225e81a">20.6</ix:nonFraction> million in aggregate for the achievement of specified development, regulatory and commercial sales milestones for certain licensed products.&#160;The Company is required to pay Heat a percentage of </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1b952a55b781488b9cc105c3cfe72e46" continuedAt="i26d64fc14b014070ba37d075871a259b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upfront fees or other non-royalty payments not tied to milestone events that it receives in connection with certain sublicenses of the licensed patents.&#160;The Company is also required to pay Heat a royalty on all of its worldwide net sales, those of its affiliates, and sublicenses of certain licensed patents in the low single digits. The Company has <ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfODkz_f578e3e8-3b12-4cdf-9108-e7cc3215c3c0">no</ix:nonFraction>t recorded a liability for the payments aforementioned given the achievement of specified development, regulatory and commercial sales milestones for certain licensed products is not probable as of the balance sheet date.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in various legal actions arising in the ordinary course of business. As of September&#160;30, 2021, management was not aware of any existing, pending or threatened legal actions that may have a material impact on the financial position, results of operations or cash flows of the Company. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations </span></div></ix:continuation><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i26d64fc14b014070ba37d075871a259b">Contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude contingent liabilities for which the Company cannot reasonably predict future payment. The Company&#8217;s contractual obligations result primarily from obligations for various CMOs and CROs, which include potential payments that may be required under its agreements. The contracts also contain variable costs and milestones that are hard to predict as they are based on such things as patients enrolled and clinical trial sites. The timing of payments and actual amounts paid under CMO and CRO agreements may be different depending on the timing of receipt of goods or services or changes to agreed-upon terms or amounts for some obligations. Such agreements are cancellable upon written notice by the Company and, therefore, are not long-term liabilities.</ix:continuation> </span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_46"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:PreferredStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfNTgx_d1b051c4-9d54-4181-a0b8-220653e90dc4" continuedAt="iaf8371fd87444502a8cc7d53dbeb6d0f" escape="true">Preferred Stock </ix:nonNumeric></span></div><ix:continuation id="iaf8371fd87444502a8cc7d53dbeb6d0f"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company entered into various stock purchase agreements with new and existing investors pursuant to which the Company sold an aggregate <ix:nonFraction unitRef="shares" contextRef="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMTk1_0ae68aa9-2cd0-4f47-9621-171e964128d8">550,571</ix:nonFraction> shares of Series B redeemable convertible preferred stock and <ix:nonFraction unitRef="shares" contextRef="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMjYw_94adeb34-4330-466c-b8b9-db2811dc1663">1,319,964</ix:nonFraction> shares of Series B-1 redeemable convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930" decimals="5" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzI2_a018d4a5-afc7-4463-9f23-3e9730599f54"><ix:nonFraction unitRef="usdPerShare" contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930" decimals="5" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzI2_e726ab8b-633b-4d82-9dfc-5b2c14b8a5d2">62.88051</ix:nonFraction></ix:nonFraction> per share for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzU5_445128d4-fcfd-449c-a8a4-a69aeb7d1d7c">117.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Series A, Series B and Series B-1 redeemable convertible preferred stock converted into common stock upon the completion of the Company&#8217;s IPO and the rights, preferences and terms are no longer applicable.</span></div></ix:continuation><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_49"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0Mw_3c911613-c974-4694-8349-af938330f47f" continuedAt="i63d8c221b5b540c0917acae8c0818f60" escape="true">Stock-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="i63d8c221b5b540c0917acae8c0818f60" continuedAt="id9fc5ae4ab5d46869a8aac73786217b3"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company adopted the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;) which, as of the adoption date, replaced the 2016 Stock Incentive Plan. Under the 2020 Plan, the share reserve automatically increases on January 1st of each year beginning in 2021 and ending with a final increase on January 1, 2030 in an amount equal to <ix:nonFraction unitRef="number" contextRef="i603740bc9b8f4f0ca57d85369f7746a2_I20200930" decimals="INF" name="sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNDAz_00ddb420-fdfa-4f19-a87f-7a99ece9c840">4</ix:nonFraction>% of the Company&#8217;s outstanding common shares on December 31st of the preceding calendar year. The Board of Directors may provide that there will be no increase in the share reserve for any such year or that the increase in the share reserve may be smaller than would otherwise occur. The Board of Directors authorized an increase of <ix:nonFraction unitRef="shares" contextRef="ice4dbadf32e44468af44b532a149cff7_D20210101-20210101" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNzM4_77f57d56-512f-4fb8-8aee-fea5f0b494af">445,809</ix:nonFraction> shares available for issuance under the 2020 Plan effective as of January 1, 2021, and as of September&#160;30, 2021 there were <ix:nonFraction unitRef="shares" contextRef="i376022fb5be548d7b02b791a7e12fad2_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfODQ4_105e9cad-4ef8-4d82-8ec7-d162765486d9">3,951,085</ix:nonFraction> shares available for future grants. The 2020 Plan permits the granting of options and restricted stock. The terms of the agreements under the 2020 Plan are determined by the Company&#8217;s Board of Directors. The Company&#8217;s awards vest based on the terms in the agreements and generally vest over <ix:nonNumeric contextRef="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTE0Mg_5b86fd73-1560-4cc7-a745-f647e632a1ba">four years</ix:nonNumeric> and have a term of <ix:nonNumeric contextRef="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTE2NA_c907a3e1-4a52-444b-8ef9-0551b4ce5f11">10</ix:nonNumeric> years. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (&#8220;2020 ESPP&#8221;) became effective in connection with the Company&#8217;s IPO. A total of <ix:nonFraction unitRef="shares" contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4NQ_7a4451ef-7048-4bae-8c3b-e08305213bcb">395,795</ix:nonFraction> shares of common stock were reserved for issuance under the 2020 ESPP. Eligible employees may purchase shares of common stock under the 2020 ESPP at <ix:nonFraction unitRef="number" contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTQ3Mw_9f561d56-0405-4313-bc69-319d5909c8d6">85</ix:nonFraction>% of the lower of the fair market value of the Company&#8217;s common stock as of the first or the last day of each offering period. Employees are limited to contributing <ix:nonFraction unitRef="number" contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTYzOQ_a6caf802-8d95-401e-aea6-051a01ebba5d">15</ix:nonFraction>% of the employee&#8217;s eligible compensation and may not purchase more than $<ix:nonFraction unitRef="usd" contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014" decimals="0" format="ixt:num-dot-decimal" name="sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTcxMw_fb4b2729-0a67-4c1a-863e-d8c38c6d3a82">25,000</ix:nonFraction> of stock during any calendar year or more than <ix:nonFraction unitRef="shares" contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTc2Mw_b933b726-5714-4eef-bf67-203e1c88f857">600</ix:nonFraction> shares during any one purchase period. The 2020 ESPP share reserve automatically increases on January 1st of each calendar year, for <ix:nonNumeric contextRef="i5f3e8f93f0194647bd923c62f2e5dc30_D20210101-20210101" format="ixt-sec:durwordsen" name="sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg5MDIyNQ_a415f433-0e47-4fb5-afd3-f4827d3ed99c">ten years</ix:nonNumeric>, commencing on January 1, 2021, in an </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id9fc5ae4ab5d46869a8aac73786217b3" continuedAt="i2eabcb00f8494283bbb84790579a5222"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount equal to <ix:nonFraction unitRef="number" contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014" decimals="INF" name="sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTk2Mw_f35154f2-7402-418d-b51d-dfae8c3b7456">1</ix:nonFraction>% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase of the share reserve for such year or that the increase in the share reserve for such year will be a smaller number of shares of common stock than would otherwise occur pursuant to the preceding sentence. Under the 2020 ESPP, the Company issued <ix:nonFraction unitRef="shares" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4OQ_72bdfde0-25d2-4f74-82d8-a2b3bee202c0"><ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4OQ_de8f8e4c-391d-41c8-aacc-808bf0066127">2,106</ix:nonFraction></ix:nonFraction> shares of common stock for aggregate cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY5Mw_71a7fbb4-ec71-4c8e-8602-d0c87be6fcda"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY5Mw_a42b5ff3-71ce-421d-a29a-9ac7abd647a6">0.1</ix:nonFraction></ix:nonFraction> million during the three months and nine months ended September 30, 2021. There were <ix:nonFraction unitRef="shares" contextRef="idf00a598b8c6468a94061606fb02f883_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg4OTIxMA_39df3b1c-6163-4865-9c44-e8e9391c1389"><ix:nonFraction unitRef="shares" contextRef="i960ac8b054b342bca15ba993defe9d57_D20200701-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg4OTIxMA_ded32b1a-7554-4340-a07e-4d9ce12de44f">no</ix:nonFraction></ix:nonFraction> shares of common stock issued during the three and nine months ended September 30, 2020.</span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0NQ_afab2097-2812-4bc0-8027-0fd258694f93" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim statements of operations and comprehensive loss (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.138%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iac8f4bd6f6784868a4bd2c6922fc91f8_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0xLTEtMS00MjA_0a3e1fa2-ba3d-4d87-8f68-2942a2502362">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i43e49e14bbd84c24b4f815c8d1dfae1e_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0zLTEtMS00MjA_bd80dde3-a2b2-44d8-8ba6-54412a353ab7">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i835dbb9acf224e57a9b3e913c4fd5221_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0xLTEtMS0w_ba291626-3086-47a6-b0ce-25d5a2ef3371">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cf510c1ae944ae08e8125331902ce05_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0zLTEtMS0w_a15a2ddd-a29a-4c5f-99c7-5914e07adcaa">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f271066a7004316b41caf3035fe59f9_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0xLTEtMS00MjA_ce92b687-2031-4ea8-b74c-41102520582c">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7aad25409a4bcd8dceb360cb97572a_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0zLTEtMS00MjA_814e4eef-4f0b-4620-8d09-98d5ce406c36">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id1ee9db78b134988a76150158dd2ccfb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0xLTEtMS0w_655ea6f5-f465-4ef2-b43a-f78f0b18ad02">2,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i06f9516b552346dd9f85244630963fdf_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0zLTEtMS0w_f7b62d59-1db9-44e9-972e-a8b256326527">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0xLTEtMS00MjA_88d2c83c-6a23-419c-9a2d-01ac5d31194f">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0zLTEtMS00MjA_c7d5ea9a-50aa-4605-a443-496039ed5c3e">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0xLTEtMS0w_79595ac4-10a4-4774-8b6b-1f909ea2906d">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0zLTEtMS0w_a12f3416-3e2a-4a4d-a5dd-49604dde9419">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0MA_869f84bc-a178-4562-8777-30733d55880d" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contract Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Years) </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS0xLTEtMS0w_f8be04c8-456a-4c13-9370-36b23945502a">2,742,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS0zLTEtMS0w_b3afec4d-9105-442d-832d-20af2e81a04e">7.95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iad1e9586e3094edfbbdb9d027470e968_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS01LTEtMS0w_037bbea2-2672-4d01-866d-fa0160b0846f">8.82</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMi0xLTEtMS0w_f4f81727-43c6-448d-ac5e-c806ef90db61">235,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMi0zLTEtMS0w_b7e47937-66f0-46c4-97a5-f3734d814be4"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMy0xLTEtMS0w_1e10bb07-b10b-4e57-afe5-b05cc6c613f4">460,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMy0zLTEtMS0w_94f9dab5-e325-4563-9433-badcd182afbf"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNC0xLTEtMS0w_a9469d0d-6fb3-46e9-9f7b-652166edb7ed">25,847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNC0zLTEtMS0w_3e6d8cb0-dda0-4cf4-ab98-ab3360c15324"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS0xLTEtMS0w_7e0c2b53-cffe-470d-a9fa-e4638000b7f5">2,491,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS0zLTEtMS0w_39928b50-cb05-4cea-98c8-23eab701ffe1">10.51</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS01LTEtMS0w_8c138e0e-a404-44e4-864f-289641870d35">8.18</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi0xLTEtMS0w_8d9a0544-5617-43c2-8fe8-38d9c00a0d44">2,458,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi0zLTEtMS0w_c21a8206-db76-4d7a-b6c8-c6d48df73050">10.41</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi01LTEtMS0w_d2c9bae3-853c-4434-8228-6b521644857d">8.17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at the end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy0xLTEtMS0w_5bc9a118-701b-45e0-82ed-c617c26126f7">1,186,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy0zLTEtMS0w_a1470040-0987-437f-90be-755c0ffc5fb4">4.32</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy01LTEtMS0w_7a5787ef-aafa-48d0-89f5-114f861ee5f6">7.66</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted during the nine months ended September&#160;30, 2021 had a weighted-average grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjgwMw_f1f387cb-cf82-4013-93ee-fae8151c214f">19.00</ix:nonFraction>. As of September&#160;30, 2021, unrecognized compensation cost for options issued was $<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjg3MQ_1caf0992-76b6-428b-a1c9-5e8cb6dd25aa">11.9</ix:nonFraction> million, and will be recognized over an estimated weighted-average amortization period of <ix:nonNumeric contextRef="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjk1Ng_777174d6-b7a2-4c8d-be70-7f22f985326b">2.5</ix:nonNumeric> years. The aggregate intrinsic value of options outstanding and exercisable as of September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzA0Mg_7979bc21-72c8-40be-b75a-84482d701e96"><ix:nonFraction unitRef="usd" contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzA0Mg_f5d73e99-c482-417a-b23c-c7652c3cb7aa">19.3</ix:nonFraction></ix:nonFraction> million. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model which takes into account inputs such as the exercise price, the estimated fair value of the underlying common stock at grant date, expected term, expected stock price volatility, risk-free interest rate and dividend yield. The fair value of stock options was determined using the methods and assumptions discussed below.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected term of employee stock options with service-based vesting is determined using the &#8220;simplified&#8221; method, whereby the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to the Company&#8217;s lack of sufficient historical data.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected stock price volatility is based on historical volatilities of comparable public entities within the Company&#8217;s industry. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The risk-free interest rate is based on the interest rate payable on U.S. Treasury securities in effect at the time of grant for a period that is commensurate with the expected term. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected dividend yield is <ix:nonFraction unitRef="number" contextRef="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNDE5Nw_22774862-9f1c-4954-a149-041f8c0964a2">0</ix:nonFraction>% because the Company has not historically paid, and does not expect for the foreseeable future to pay a dividend on its common stock. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Prior to the Company&#8217;s IPO, its Board of Directors periodically estimated the fair value of the Company&#8217;s common stock considering, among other things, contemporaneous valuations of its common stock prepared </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2eabcb00f8494283bbb84790579a5222"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by an unrelated third-party valuation firm. Subsequent to the Company&#8217;s IPO, the shares are issued at no less than the market price on date of grant.</span></div><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0MQ_fe5971a8-a1f6-4e53-8f41-6c90cb093ba3" escape="true"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of options granted under the Company&#8217;s 2020 Plan and shares issued under the Company&#8217;s 2020 ESPP were estimated throughout the nine months ended September&#160;30, 2021 using the Black-Scholes option-pricing model using the following weighted-average assumptions: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMC0xLTEtMS0w_da6f467b-745c-4929-b927-c36bf8535f81">6.08</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMS0xLTEtMS0w_dff515b0-3ba3-4d1a-8e3c-61c1fb3c9c39">81.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMi0xLTEtMS0w_3804087a-da6b-43ea-8355-a431ae42198c">0.98</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMy0xLTEtMS0w_d5209313-7703-4376-8391-1b3847fb9ffb">&#8212;</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNS0xLTEtMS0xMjU4NQ_82b59f65-de8d-4008-a67a-0b9ca7220856">0.50</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNi0xLTEtMS0xMjU4NQ_e1a6a7fe-a90e-4181-9fed-37e68466226a">81.08</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNy0xLTEtMS0xMjU4NQ_e5ea5dec-224e-4552-8630-d9991ad468d8">0.68</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfOC0xLTEtMS0xMjU4NQ_65519dd6-a13d-4dee-8be1-485af2ba9eed">&#8212;</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the restricted shares are considered the issuance of share-based payments as opposed to the sale of stock and as such, the Company has recognized compensation expense for these awards.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity relating to these shares:</span><ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0Mg_186495fe-c1f7-48c6-9fb6-c0922e3f1c43" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i127f4a4b929a4584b3d952f63d22eadf_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMS0xLTEtMS0w_0862a8d4-a682-4d34-b3f1-4593b92255c4">11,752</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ib024077106554c22ae7c122e594a1c2b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMi0xLTEtMS0w_b1d8e3e1-74aa-4d84-b5ac-657adbe6681e">11,752</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icd69357ae18f462e8804de875b0c3a5c_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMy0xLTEtMS0w_ee783d8a-ce00-4874-8440-b82ae5927640">&#8212;</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_52"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMjQ1Nw_0fd731ac-d079-4517-b85b-7ed1c6c1fb59" continuedAt="i545caed4c0ed4388863e674be7bb93ba" escape="true">Collaboration Agreement - Related Party</ix:nonNumeric></span></div><ix:continuation id="i545caed4c0ed4388863e674be7bb93ba" continuedAt="ie79798df94ad434b87b07504f1c1febf"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the Company entered into a Collaboration Agreement with Takeda related to the development of certain ARC molecules, as amended in April 2018, October 2018 and March 2020 (the &#8220;Collaboration Agreement&#8221;). The Collaboration Agreement was mutually terminated pursuant to a termination agreement dated November 8, 2021 (the &#8220;Termination Agreement&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Termination Agreement, the Company is not required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated. The termination of the Collaboration Agreement is a type II subsequent event and, therefore, had no impact on the Company's the financial statements as of September 30, 2021. The remaining deferred revenue will be recognized as revenue in the fourth quarter of 2021. The Company received cash of $<ix:nonFraction unitRef="usd" contextRef="ia2da1c40adc24adf8f575ee3530eea18_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromCollaborators" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTI4Mw_f63b413c-74d5-4a81-851d-8d48188978de">3.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if068c55e44bb4ae2a4f17a023aa75fd7_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCollaborators" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTI5OQ_c0c75990-997a-4522-99aa-29fbb23fd3c8">12.1</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively, from Takeda and has recognized total aggregate revenue of $<ix:nonFraction unitRef="usd" contextRef="i1661a0a2b3aa4bcca5712ebab54e17ae_D20170801-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTQxMw_20f7fa0b-6ac4-4862-b645-2f8aa1f23ee3">51.9</ix:nonFraction> million through September&#160;30, 2021 under the Collaboration Agreement.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue for the allocated up-front payments using a cost-based input measure. In applying the cost-based input method of revenue recognition, the Company used actual costs incurred relative to budgeted costs expected to be incurred for the combined performance obligation. In the second quarter of 2021, in</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">connection with the Company&#8217;s modifications to the SL-279252 clinical development plan and its intention to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expand the dose-escalation portion of its ongoing Phase 1 clinical trial, the estimated total costs related to the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-279252 development program increased. The increase in expected total cost of the development program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required to satisfy a specific performance obligation in the Collaboration Agreement, or the denominator in the cost-based input method, resulted in a cumulative-effect adjustment under ASC 250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Change in Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Actual consideration received and total revenue expected to be recognized in accordance with the development of SL-279252 under the Collaboration Agreement remain unchanged. The Company recognizes revenue related to the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursable cost as they are incurred. The effects of this change in the Company&#8217;s estimates were a $<ix:nonFraction unitRef="usd" contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUwMQ_58a42786-ebe7-423e-b2dd-bc6aff27db68">4.2</ix:nonFraction>&#160;million</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie79798df94ad434b87b07504f1c1febf">increase in 2021 net loss and a $<ix:nonFraction unitRef="usdPerShare" contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUzNw_0e162501-f859-41cc-b37f-b52fb56183f5"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUzNw_339213df-4f4f-403c-9d7c-4e623b860a91">0.10</ix:nonFraction></ix:nonFraction> increase in 2021 basic and diluted loss per share.</ix:continuation></span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_55"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81NS9mcmFnOmQxNGU2YzNmZWQ3NjQ1NDM5Yjc1ZGU0MTE3ZDk1YWM0L3RleHRyZWdpb246ZDE0ZTZjM2ZlZDc2NDU0MzliNzVkZTQxMTdkOTVhYzRfMjk5_8684b8df-7a73-45d8-a729-dfc635a002cb" continuedAt="ie1570995ca0f4e12a41031973097aa87" escape="true">Related-Party Transactions </ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1570995ca0f4e12a41031973097aa87">As of December 31, 2020, Takeda held an approximate <ix:nonFraction unitRef="number" contextRef="i7842c9c91ac44eb081775b9eeb02a4f3_I20201231" decimals="3" name="sttk:ShareholderOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81NS9mcmFnOmQxNGU2YzNmZWQ3NjQ1NDM5Yjc1ZGU0MTE3ZDk1YWM0L3RleHRyZWdpb246ZDE0ZTZjM2ZlZDc2NDU0MzliNzVkZTQxMTdkOTVhYzRfODg_d3f81877-2d78-4e9e-87b3-327a2bb10936">5.0</ix:nonFraction>% ownership interest in the Company&#8217;s outstanding shares. Considering the resignation of the Takeda director and percent ownership of the Company&#8217;s common stock as of December 31, 2020, the Company no longer considers Takeda a related party.</ix:continuation></span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed financial statements and related notes appearing in this Quarterly Report on Form 10-Q, as well as the audited financial statements, notes and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2020. This discussion and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section of this report entitled &#8220;Risk Factors.&#8221; You should carefully read the &#8220;Cautionary Note About Forward-Looking Statements&#8221; of this Quarterly Report on Form 10-Q and &#8220;Risk Factors&#8221; sections of our Annual Report on Form 10-K to gain an understanding of the important factors that could cause actual results to differ materially from the results described below. </span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_64"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. We believe our approach has the potential to fundamentally transform the therapeutic modulation of the immune system. We have created a novel approach to immune-modulation by designing biologics with structural characteristics that are not achievable by existing therapeutic modalities. Compounds derived from our proprietary ARC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Our initial product candidates are designed to be differentiated therapeutics addressing molecular targets that are well characterized and scientifically validated in immuno-oncology but are underexploited by current treatment modalities.</span></div><div style="margin-top:6pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Product Candidates</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SL-172154</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRP&#945; checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently conducting two Phase 1 clinical trials for SL-172154. The first is designed to evaluate the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of SL-172154 in patients with advanced, platinum resistant ovarian cancer. In November 2021, at the 36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> annual meeting of the Society for Immunotherapy of Cancer, we announced initial data from 15 patients in the first four dose-escalation cohorts from the monotherapy dose-escalation portion of this Phase 1 clinical trial. We expect to announce additional data from this ongoing monotherapy dose-escalation clinical trial in the second half of 2022. We plan to initiate a Phase 1B clinical trial evaluating SL-172154 in combination with liposomal doxorubicin in patients with ovarian cancer in the first half of 2022.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also conducting a second Phase 1 clinical trial evaluating SL-172154 in patients with cutaneous squamous cell carcinoma, or CSCC, or head and neck squamous cell carcinoma, or HNSCC, and we expect to announce initial data from the dose-escalation portion of this trial in the first half of 2022.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to conduct a third clinical trial, designed to evaluate the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of SL-172154 in patients with acute myeloid leukemia, or AML, and higher-risk myelodysplastic syndromes, or HR-MDS. We intend to study SL-172154 in a parallel staggered dose-escalation monotherapy and combination Phase 1A/B clinical trial. In AML, we intend to study SL-172154 in combination with azacitidine and venetoclax, and in HR-MDS and TP53 mutant AML, we intend to study </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-172154 in combination with azacitidine. We expect to announce initial data from this clinical trial in the second half of 2022.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also intend to continue to evaluate other drug combination opportunities for SL-172154 in ovarian cancer and other solid tumors.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SL-279252</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidate, SL-279252, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. We are evaluating SL-279252 in a Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. In November 2021, at the 36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> annual meeting of the Society for Immunotherapy of Cancer, we announced initial data from 43 patients in the first ten dose-escalation cohorts of this clinical trial. We intend to continue the dose-escalation portion of this ongoing Phase 1 clinical trial through additional dose levels and expect to announce additional data from the dose-escalation portion of this clinical trial in the second half of 2022.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARC Platform</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our clinical-stage ARC product candidates, our ARC platform is highly modular, and we possess a deep pipeline of preclinical immuno-oncology product candidates. We anticipate nominating an additional ARC-derived product candidate for clinical development in the first half of 2022. Longer-term, we may pursue additional disease areas, including autoimmune diseases, where we believe our dual-sided fusion protein platforms may provide advantages over current treatment modalities. </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GADLEN Platform</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In alignment with our strategy to leverage our expertise and intellectual property to build and expand novel platforms beyond our ARC platform, where dual-sided fusion proteins may provide advantages over existing therapeutic antibodies, we continue to invest in and advance our Gamma Delta T Cell Engager platform, known as GADLEN. </span></div><div style="margin-top:6pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Operations</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2016, we have devoted substantially all of our resources to developing and perfecting our intellectual property rights, conducting research and development activities, including undertaking preclinical studies of our product candidates, conducting clinical trials of our most advanced product candidates, manufacturing our product candidates, organizing and staffing our company, business planning and raising capital. We do not have any products approved for sale, and we have not generated any revenue from product sales. We have funded our operations as of the filing date of this Quarterly Report on Form 10-Q through the net proceeds from our IPO of approximately $213.5 million, the sale of redeemable convertible preferred stock for approximately $152.9&#160;million, the issuance of convertible notes for approximately $10.5&#160;million and payments received pursuant to our collaboration agreement with Takeda for approximately $82.0&#160;million. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021 and 2020, our net loss was $52.8&#160;million and $24.6&#160;million, respectively. We have not been profitable since inception, and as of September&#160;30, 2021, we had an accumulated deficit of $124.9&#160;million and $290.2&#160;million in cash and cash equivalents and short-term investments, respectively. We expect to continue to incur significant expenses and increasing operating losses in the near term. We expect our expenses will increase substantially in connection with our ongoing activities, as we: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">continue to advance the preclinical and clinical development of our clinical-stage product candidates, SL-172154 and SL-279252; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">initiate preclinical studies and clinical trials for additional product candidates that we may identify in the future; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">expand our operational, financial and management systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increase personnel and infrastructure to support our clinical development, research and manufacturing efforts; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">build out and expand our in-house process development and manufacturing capabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">continue to develop, perfect and defend our intellectual property portfolio; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">incur additional legal, accounting or other expenses in operating our business, including the additional costs associated with operating as a public company. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to generate significant product revenue unless and until we successfully complete development and obtain regulatory and marketing approval of, and begin to sell, one or more of our product candidates, which we expect will take several years. We expect to spend a significant amount in development and marketing costs prior to such time. We may never succeed in achieving regulatory and marketing approval for our product candidates. We may obtain unexpected results from our preclinical and clinical trials. We may elect to discontinue, delay or modify preclinical and clinical trials of our product candidates. A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. Accordingly, until such time as we can generate significant product revenue, if ever, we expect to continue to seek private or public equity and debt financing to meet our capital requirements. There can be no assurance that such funding may be available to us on acceptable terms, or at all, or that we will be able to commercialize our product candidates. In addition, we may not be profitable even if we commercialize any of our product candidates.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_67"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty as to the future effects of the ongoing COVID-19 pandemic, which may, among other things, materially impact our business, including our ongoing and planned clinical trials. We have experienced, and expect to continue to experience, delays in our SL-172154 and SL-279252 clinical trials as a result of the ongoing pandemic. Our manufacturing operations have been impacted by the ongoing pandemic, including delays with our third-party manufacturer and difficulties in obtaining raw materials needed to manufacture material for our clinical trials. Additionally, we have experienced, and expect to continue to experience, delays in enrolling patients, missed treatments for enrolled patients, and performance delays from certain third-party vendors supporting the SL-172154 and SL-279252 clinical trials, although the significance of any future delays is difficult to predict. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, due to public health guidance measures, we have in the past and may in the future implement a work-from-home policy for our employees, excluding those necessary to maintain minimum basic operations, which may negatively impact productivity, or disrupt, delay or otherwise adversely impact our business. For example, some of our research activities that require our personnel to be in our laboratories may be delayed. We may also experience delays or disruptions to our operations if and when our employees need to take time off work due to illness or other COVID-19-related impacts to our workforce. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the impact of the COVID-19 pandemic and work-from-home policies and other operational limitations mandated by federal, state and local governments as a result of the pandemic, certain of our research and development activities, including the conduct of preclinical studies, have been delayed and may be further delayed and other aspects of our business, such as the conduct of various corporate functions and the ability of our Board and management to provide oversight and guidance may be adversely impacted until such operational limitations are lifted. The COVID-19 pandemic or local outbreaks associated with the COVID-19 pandemic could result in difficulty manufacturing our product candidates, securing clinical trial site locations, CROs, and/or trial monitors and other critical vendors and consultants supporting our clinical trials. In addition, outbreaks or the perception of an outbreak near a clinical trial site location could impact our ability to enroll patients or to complete all scheduled physician visits for currently enrolled patients. These situations, or others associated with COVID-19 pandemic, could cause delays in our clinical trial plans and could increase expected costs, all of which could have a material adverse effect on our business and its financial condition. At the current time, we are unable to quantify the potential effects of the COVID-19 pandemic on our future operations.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_70"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2017, we entered into a Collaboration Agreement with Millennium Pharmaceuticals, Inc., or Takeda, a wholly-owned subsidiary of Takeda Pharmaceutical Company, Ltd., or the Collaboration Agreement. The Collaboration Agreement was subsequently amended in April 2018, October 2018 and March 2020. The Collaboration Agreement was mutually terminated pursuant to the termination agreement, or the Termination </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, dated November 8, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Termination Agreement, we are not required to satisfy any remaining performance obligations, we will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated. The termination of the Collaboration Agreement is a type II subsequent event and, therefore, had no impact to our financial statements as of September 30, 2021. The remaining deferred revenue will be recognized as revenue in the fourth quarter of 2021. </span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_73"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of our Results of Operation </span></div><div style="margin-top:6pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenue </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no products approved for commercial sale, and we have not generated any revenue from commercial product sales. Our total revenue to date has been generated solely from our Collaboration Agreement with Takeda, which was terminated in November 2021. We expect that any collaboration revenue we generate from any future collaboration partners will fluctuate from period to period.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received cash of $3.6 million and $12.1 million for the nine months ended September&#160;30, 2021 and 2020, respectively, from Takeda under the Collaboration Agreement. We have recognized total aggregate revenue of $51.9 million through September&#160;30, 2021 under the Collaboration Agreement and expect to recognize the remaining $30.1 million in the fourth quarter of 2021.</span></div><div style="margin-top:6pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expense </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses consist primarily of costs incurred in connection with the discovery and development of our product candidates. These expenses include: </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">expenses incurred under agreements with contract research organizations, or CROs, as well as investigative sites and consultants that conduct our preclinical studies and clinical trials; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">manufacturing and development expenses and the costs of acquiring and manufacturing preclinical study and clinical trial materials; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">analysis of manufacturing processes for optimization; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">employee-related expenses, including salaries, benefits and stock-based compensation; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">fees paid to consultants who assist with research and development activities; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">expenses relating to regulatory activities, including filing fees paid to regulatory agencies; </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">laboratory materials and supplies used to support our research activities; and </span></div><div style="margin-top:6pt;padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">allocated expenses for facility-related costs. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses by product candidate: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.256%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-172154</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-279252</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other pipeline candidates</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal costs, including personnel related benefits, facilities and depreciation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,137&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,804&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect our research and development expenses to increase significantly over the next several years as we conduct additional preclinical studies and clinical trials, including later-stage clinical trials, for our current and future product candidates and as we pursue regulatory approval of our product candidates.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of conducting the necessary preclinical and clinical research to obtain regulatory approval is costly and time consuming. The actual probability of success for our product candidates may be affected by a variety of factors including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">the safety and efficacy of our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">early clinical data for our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">investment in our clinical programs; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">the ability of collaborators to successfully develop our licensed product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">competition; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">manufacturing capability; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">commercial viability. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may never succeed in achieving regulatory approval for any of our product candidates due to the uncertainties discussed above. We are unable to determine the duration and completion costs of our research and development projects or when and to what extent we will generate revenue from the commercialization and sale of our product candidates, if ever. </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense consists primarily of personnel expenses, including salaries, benefits and stock-based compensation expense, for employees and consultants in executive, finance, accounting, legal, information technology and human resource functions. General and administrative expense also includes corporate facility costs, including rent, utilities, depreciation and maintenance, not otherwise included in research and development expense, as well as legal fees related to intellectual property and corporate matters and fees for accounting and consulting services. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our general and administrative expense will increase in the future to support our growing research and development activities and as a result of the increased costs of operating as a public company. These increases will likely include increased costs related to the hiring of additional personnel and fees to outside consultants, lawyers and accountants, among other expenses. Additionally, we anticipate increased costs associated with being a public company, including expenses related to services associated with maintaining compliance with the requirements of Nasdaq and the Securities and Exchange Commission, or SEC, insurance, and investor relations </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs. If any of our current or future product candidates obtains regulatory approval, we expect that we would incur significantly increased expenses associated with building a sales and marketing team. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest earned on our cash, cash equivalents and short-term investments, which consists of amounts held in a money market fund and at various times in short-term government and corporate obligations. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have not recorded any income tax benefits for the net operating losses, or NOLs, we have incurred or for our research and development tax credits, as we believe, based upon the weight of available evidence, that it is more likely than not that all of our NOLs and tax credits will not be realized. Our NOLs and tax credit carryforwards will begin to expire in 2036. We have recorded a full valuation allowance against our deferred tax assets at each balance sheet date.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_76"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended September 30, 2021 and 2020</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our results of operations for the three months ended September&#160;30, 2021 and 2020. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:46.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,580)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,741)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,410)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,829)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,581)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue decreased by $0.5&#160;million, or 22.0%, to $1.9&#160;million for the three months ended September&#160;30, 2021 from $2.4&#160;million for the three months ended September&#160;30, 2020. The decrease in collaboration revenue was primarily attributable to a decrease in manufacturing and process development on SL-279252 associated with the Collaboration Agreement.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $3.3&#160;million, or 28.2%, to $15.1&#160;million for the three months ended September&#160;30, 2021 from $11.8&#160;million for the three months ended September&#160;30, 2020. The increase was primarily due to an increase of $1.8 million as a result of an increase in headcount and expansion of our manufacturing and clinical development capabilities, an increase of $1.6 million in clinical, assay development and preclinical pipeline costs and an increase of $0.7 million in laboratory related costs, offset by a decrease of $0.8 million in manufacturing costs.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $1.9&#160;million, or 75.8%, to $4.3&#160;million for the three months ended September&#160;30, 2021 from $2.5&#160;million for the three months ended September&#160;30, 2020. The increase was primarily due to an increase of $1.0&#160;million in personnel-related costs driven by higher employee headcount needed </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to support our growing research and development activities and an increase of $0.7 million of costs associated with being a public company.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased by $0.2&#160;million to $0.3&#160;million for the three months ended September&#160;30, 2021 from $0.1&#160;million for the three months ended September&#160;30, 2020. The increase was primarily due to an increase in short-term investments in 2021 compared to 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Nine Months Ended September 30, 2021 and 2020</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our results of operations for the nine months ended September&#160;30, 2021 and 2020. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:46.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Dollar</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(54,515)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,920)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">310.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52,821)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,591)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28,230)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue decreased by $8.7&#160;million, or (100.7)%, to $(0.1)&#160;million for the nine months ended September&#160;30, 2021 from $8.6&#160;million for the nine months ended September&#160;30, 2020. We recognize revenue related to the development of SL-279252 under the Collaboration Agreement on a cost-based input method. In the second quarter of 2021, in connection with our modifications to the SL-279252 clinical development plan and our intention to expand the dose-escalation portion of the ongoing Phase 1 clinical trial, the expected program costs related to the SL-279252 development program increased. The increase in the expected total cost of the development program, or the denominator in the cost-based input method, resulted in a one-time negative revenue adjustment in the second quarter of 2021. Actual consideration received and total revenue expected to be recognized in accordance with the development of SL-279252 under the Collaboration Agreement remain unchanged.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $12.7&#160;million, or 45.7%, to $40.4&#160;million for the nine months ended September&#160;30, 2021 from $27.7&#160;million for the nine months ended September&#160;30, 2020. The increase was primarily due to an increase of $4.6 million as a result of an increase in headcount and expansion of our manufacturing and clinical development capabilities, an increase of $2.7 million in clinical, assay development and preclinical pipeline costs, an increase of $2.4 million in laboratory and facilities related costs, an increase of $2.3 million in manufacturing costs and an increase of $0.4 million in depreciation.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $8.3&#160;million, or 142.4%, to $14.1&#160;million for the nine months ended September&#160;30, 2021 from $5.8&#160;million for the nine months ended September&#160;30, 2020. The increase was primarily due to an increase of $4.5&#160;million in personnel-related costs driven by higher employee headcount needed to support our growing research and development activities and an increase of $3.0 million of costs associated with being a public company.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased by $1.5&#160;million to $1.9&#160;million for the nine months ended September&#160;30, 2021 from $0.5&#160;million for the nine months ended September&#160;30, 2020. The increase was primarily due to an increase in short-term investments in 2021 compared to 2020.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_79"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, our primary sources of liquidity have been generated through our Collaboration Agreement with Takeda and by sales of our preferred stock and common stock, including our IPO.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had an accumulated deficit of $124.9&#160;million and $290.2&#160;million of cash and cash equivalents and short-term investments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources and Funding Requirements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary uses of cash and cash equivalents and short-term investments are to fund our operations, which consist primarily of research and development expenditures related to our programs, product development costs, research expenses, administrative support, capital expenditures related to bringing in-house certain process</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and manufacturing capabilities and working capital requirements. We anticipate incurring additional net losses and negative cash flows from operations in the near future until such time, if ever, that we can generate significant sales of our product candidates currently in development. Our future funding requirements will depend on many factors, including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the scope, timing, progress and results of discovery, preclinical development, laboratory testing and clinical trials for our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs of process development and scale-up of a commercially ready manufacturing process to support registrational clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs of manufacturing our product candidates for clinical trials and in preparation for marketing approval and commercialization; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the extent to which we enter into collaborations or other arrangements with additional third parties in order to further develop our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending other intellectual property-related claims; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs and fees associated with the discovery, acquisition or in-license of additional product candidates or technologies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our ability to establish additional collaborations on favorable terms, if at all; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs required to scale up our clinical, regulatory and manufacturing capabilities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the costs of future commercialization activities, if any, including establishing sales, marketing, manufacturing, distribution and storage capabilities, for any of our product candidates for which we receive marketing approval; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until we obtain regulatory approval to market our product candidates, if ever, we cannot generate revenues from sales of our products. Even if we are able to sell our products, we may not generate a sufficient amount of product revenues to finance our cash requirements. Accordingly, we may seek to raise additional capital through equity offerings and/or debt financings or from other potential sources of liquidity, which may include new collaborations, licensing or other commercial agreements for one or more of our development programs or patent portfolios. There can be no assurance that such funding may be available to us on acceptable terms, or at all. The issuance of equity securities may result in dilution to stockholders and the issuance of debt securities may have rights, preferences and privileges senior to those of our common stock and the terms of any such debt securities could impose significant restrictions on our operations. The failure to raise funds as and when needed could have a negative impact on our financial condition and ability to pursue our business strategies. Additionally, if additional </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">funding is not secured when required, we may need to delay or curtail our operations until such funding is received, which would have a material adverse impact on our business prospects and results of operations.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash and cash equivalents and short-term investments as of September&#160;30, 2021 are sufficient to fund projected operations into the second half of 2024. The reduction in cash runway guidance from our last issued guidance is primarily attributable to increased clinical activities for SL-172154 and ongoing process development and manufacturing to support our ongoing and future clinical trials, including the development of a commercially ready manufacturing process in preparation for registrational clinical trials.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of our cash flows for the periods indicated: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.561%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,399)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,804)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Operating Activities </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash used in operating activities was $38.4&#160;million and primarily reflected our net loss of $52.8&#160;million, offset by noncash charges of $4.3&#160;million in stock-based compensation and $1.7&#160;million in depreciation expense and accretion of short-term investments and a $8.4&#160;million net increase in our operating assets and liabilities.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, net cash used in operating activities was $19.6&#160;million and primarily reflected our net loss of $24.6&#160;million, partially offset by noncash charges of $0.6 million in stock-based compensation and $0.4 million in depreciation expense and a $3.9&#160;million net increase in our operating assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash (Used in) Provided by Investing Activities </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash used in investing activities was $36.0&#160;million, of which $165.1 million was used to purchase short-term investments, $135.0&#160;million was received from the sale of short-term investments and $5.9&#160;million was used to purchase property and equipment, primarily attributable to our continued efforts to bring in-house certain process development, manufacturing and laboratory capabilities.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, net cash provided by investing activities was $25.2&#160;million, of which $31.3 million was received from the sale and maturities of short-term investments, $5.6&#160;million was used to purchase short-term investments and $0.5&#160;million was used to purchase property and equipment.</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Provided by Financing Activities </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash provided by financing activities was primarily from the exercise of stock options and ESPP purchases.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, net cash provided by financing activities was $116.0&#160;million and was primarily from the sale of our Series B and Series B-1 redeemable convertible preferred stock.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_82"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Other Commitments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the Contractual Obligations and Other Commitments disclosed in Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods presented, we did not have, nor do we currently have, any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. We do not engage in off-balance sheet financing arrangements. In addition, we do not engage in trading activities involving non-exchange traded contracts. We, therefore, believe that we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in these relationships. </span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_88"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, the accrual for research and development expenses, and the valuation of stock-based awards. We base our estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting policies are those policies which require the most significant judgments and estimates in the preparation of our financial statements. We believe that the assumptions and estimates associated with our most critical accounting policies are those relating to revenue, accrued research and development costs and stock-based compensation.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates disclosed in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 to our financial statements found elsewhere in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements applicable to our financial statements.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company as defined in the JOBS Act. Under the JOBS Act, an emerging growth company can take advantage of the extended transition period for complying with new or revised accounting standards and delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption from complying with new or revised accounting standards and, therefore, will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the benefits of relying on other exemptions and reduced reporting requirements under the JOBS Act. Subject to certain conditions, as an emerging growth company, we may rely on certain of these exemptions, including without limitation exemptions to the requirements for (1)&#160;providing an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to Section&#160;404(b) of the Sarbanes-Oxley Act and (2)&#160;complying with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We will remain an emerging growth company until the earlier of (a)&#160;the last day of the fiscal year (i)&#160;following the fifth anniversary of the completion of our initial public offering, (ii)&#160;in which we have total annual gross revenues of at least $1.07&#160;billion or (iii)&#160;in which we are deemed to be a &#8220;large accelerated filer&#8221; under the rules of the SEC, which </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the market value of our common stock that is held by non-affiliates exceeds $700.0&#160;million as of the prior June&#160;30th or (b)&#160;the date on which we have issued more than $1.0&#160;billion in non-convertible debt during the prior three-year period. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; as defined under the Exchange Act. We may continue to be a smaller reporting company if either (i)&#160;the market value of our stock held by non-affiliates is less than $250.0&#160;million or (ii)&#160;our annual revenue is less than $100.0&#160;million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0&#160;million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form&#160;10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation. </span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_97"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a smaller reporting company, as defined by Rule 12b-2 under the Securities and Exchange Act of 1934 and in Item 10(f)(1) of Regulation S-K, and are not required to provide the information under this item.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_100"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and our principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures. Based on this evaluation of our disclosure controls and procedures as of September&#160;30, 2021, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures as of such date are effective at the reasonable assurance level. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the third quarter of the year ending December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_103"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_106"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceedings. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_109"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to various risks, including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes from the risk factors disclosed in Item 1A of our Annual Report on Form 10-K.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_115"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_118"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_121"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2017, the Company entered into a Collaboration Agreement with Millennium Pharmaceuticals, Inc. (&#8220;Takeda&#8221;), a wholly-owned subsidiary of Takeda Pharmaceutical Company, Ltd. (as subsequently amended, the &#8220;Collaboration Agreement&#8221;). The Collaboration Agreement was mutually terminated by the parties thereto pursuant to a termination agreement dated November 8, 2021 (the &#8220;Termination Agreement&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Termination Agreement, the Company is not required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated. The foregoing description of the Termination Agreement is qualified in its entirety by reference to the full text of the agreement, which is filed as Exhibit 10.1 to this Quarterly Report on Form 10-Q.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth below.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1680367/000119312520263321/d69956dex31.htm">Amended and Restated Certificate of Incorporation of Shattuck Labs, Inc. (incorporated by reference from Exhibit 3.1 to Shattuck&#8217;s Current Report on Form 8-K filed on October 14, 2020 (Commission File No. 001-39593))</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1680367/000119312520263321/d69956dex32.htm">Amended and Restated Bylaws of Shattuck Labs, Inc. (incorporated by reference from Exhibit 3.2 to Shattuck&#8217;s Current Report on Form 8-K filed on October 14, 2020 (Commission File No. 001-39593))</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1680367/000119312520263321/d69956dex41.htm">Form of common stock certificate of Shattuck (incorporated by reference from Exhibit 4.1 of Shattuck&#8217;s Amendment No. 2 to Registration Statement on Form S-1 filed on October 8, 2020 (Commission File No. 333-248918))</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1680367/000119312520249204/d69956dex42.htm">Second Amended and Restated Investors&#8217; Rights Agreement, dated as of June 12, 2020, by and among Shattuck Labs, Inc. and certain of its stockholders (incorporated by reference from Exhibit 4.2 of Shattuck&#8217;s Amendment No. 2 to Registration Statement on Form S-1 filed on October 8, 2020 (Commission File No. 333-248918))</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="terminationagreement-ex101.htm">Takeda</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="terminationagreement-ex101.htm"> Termination </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="terminationagreement-ex101.htm">Agreement</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="sub-certxsection302xceoxq3.htm">Certification of the principal executive officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="sub-certxsection302xcfoxq3.htm">Certification of the principal financial officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32.1* (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="sub-certxsection906ofthesa.htm">Certification of the principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(b) under the Securities Exchange Act of 1934</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Instance Document </span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The cover page for this report, formatted in Inline XBRL (included in Exhibit 101)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The certifications on Exhibit 32 hereto are deemed not &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i5f8bafd131ed43f6b9f8eec3c99a61c2_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shattuck Labs, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Dr. Taylor Schreiber</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr.&#160;Taylor Schreiber</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(principal executive officer)</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Andrew R. Neill</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">Andrew R. Neill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:104%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(principal financial and accounting officer)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>terminationagreement-ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i76a4f145f0a94169a5ccc037410989a8_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit 10.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:200%">TERMINATION AGREEMENT</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Termination Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), dated as of November 8, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), is entered into by and between Millennium Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 40 Landsdowne Street, Cambridge, MA 02139 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Millennium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and Shattuck Labs, Inc., a Delaware corporation having its principal place of business at 500 W. 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> St., Suite 1200, Austin, TX 78701 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shattuck</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This Agreement refers to Shattuck or Millennium singularly as a &#8220;Party&#8221; or collectively as the &#8220;Parties&#8221;, and capitalized terms used herein without definition shall have the meaning set forth in the Collaboration Agreement (as defined below).</font></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Shattuck and Millennium entered into that certain Collaboration Agreement dated August 8, 2017, as amended on April 25, 2018, October 30, 2018, and March 31, 2020, and as further modified on February 11, 2019, June 25, 2019, and September 5, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Collaboration Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Millennium did not exercise its option to license SM1 and the Designated ARC Molecules prior to the expiration of their respective Development Terms and therefore such option has expired&#59;  and</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Shattuck and Millennium desire to mutually terminate the Collaboration Agreement and all rights and obligations related thereunder.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, intending to be legally bound and in consideration of the mutual provisions set forth in this Agreement, the Parties agree as follows&#58;</font></div><div style="margin-top:6pt;padding-right:-18pt;text-align:center;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE 1</font></div><div style="padding-right:-18pt;text-align:center;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TERMINATION</font></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mutual Termination of the Collaboration Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) In accordance with Section 8.2(b) of the Collaboration Agreement, effective as of the Effective Date and upon the terms and subject to the conditions of this Agreement, the Parties hereby mutually terminate the Collaboration Agreement such that (a) the rights, obligations, and liabilities of the Parties thereunder are irrevocably and unconditionally terminated, and (b) the Collaboration Agreement is of no further force or effect. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Based on the relevant provisions in Section 8.5(a) of the Collaboration Agreement&#58;</font></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.5pt">the license granted by Millennium under Section 6.2 of the Collaboration Agreement is immediately terminated&#59;</font></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. all unexercised DM Exclusive Options granted by Shattuck pursuant to Section 4.1(a) of the Collaboration Agreement are immediately terminated (all SM Exclusive Options having already been previously terminated)&#59; and</font></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. each Party will promptly return or destroy all Confidential Information of the other Party, provided that each Party may retain, subject to Article 7 of the Collaboration Agreement, (a) one (1) copy of the Confidential Information of the other Party in its archives solely for the purpose of establishing the contents thereof and ensuring compliance with its continuing obligations under the Collaboration Agreement, (b) any Confidential Information of the other Party contained in its laboratory notebooks or databases, and (c) any computer records or files containing such Confidential Information that have been created solely by its automatic archiving and back-up procedures, to the extent created and retained in a manner consistent with its standard archiving and back-up procedures, but not for any other uses or purposes&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Parties agree that Millennium will no longer support the preparation, filing, prosecution, maintenance, and control of &#91;***&#93; under the Collaboration Agreement. Shattuck will provide a final invoice to Millennium detailing any outstanding Prosecution Expenses in the Selected Countries (each term as defined in the Side Letter dated September 5, 2019, signed by and between the Parties) incurred prior to the Effective Date of this Agreement and for which Millennium has not already reimbursed Shattuck, and Millennium will pay such invoice in Dollars by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93; &#61; CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bank wire transfer in immediately available funds to the account listed in Section 5.6 of the Collaboration Agreement within &#91;***&#93; of Millennium&#8217;s receipt of such invoice.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Millennium represents and warrants that neither it, nor its Affiliates, have developed, made, conceived, or reduced to practice &#91;***&#93;. Shattuck represents and warrants that neither it, nor any of its Affiliates, have developed, made, conceived, or reduced to practice &#91;***&#93;. Notwithstanding the foregoing, in the case that any Patent Rights Covering &#91;***&#93; do exist, they will be abandoned by the Party controlling prosecution, unless the Parties otherwise agree in writing. Shattuck &#91;***&#93;, unless the Parties otherwise agree in writing. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) For clarity, the Parties agree that as a result of the termination of the Collaboration Agreement&#58; (1) Millennium has no rights to any Molecules, including DM1 and DM2, and Shattuck may in its sole discretion, among other things, further develop or dispose of DM1 and&#47;or DM2 by itself or with other parties&#59; (2) the ROFN Term is terminated and Millennium has no right of first negotiation relating to any &#91;***&#93; Molecule&#59; and (3) neither Party will have any ongoing restrictions or obligations under Section 2.9 of the Collaboration Agreement.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) Notwithstanding Section 1.1(a) above, Section 6.1 (ownership of IP) and Section 7 (Confidentiality) of the Collaboration Agreement shall survive its termination. All other sections of the Collaboration Agreement are hereby terminated.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Transfer Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Both the Material Transfer Agreement dated July 1, 2019 and amended April 10, 2020 and the Material Transfer and Feasibility Agreement dated July 10, 2019 (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MTAs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), signed by and between the Parties, have terminated in accordance with their terms. The Parties hereby confirm that (i) any remaining Materials provided by one Party to another under the MTAs were destroyed by the receiving Party&#59; (ii) no Out-Of-Scope Results were generated&#59; (iii) any documents or other tangible records that apply to Inventions and Data that do not constitute Out-of-Scope Results, all documents and other tangible objects containing or representing Confidential Information of the other Party or prepared based on Confidential Information of the other Party, and all copies thereof were destroyed by each Party (except for one (1) copy of any such documents remained for any continuing legal obligations)&#59; (iv) Millennium has provided all reports and data required to be disclosed to Shattuck under Article 5 of each of the MTAs&#59; (v) neither Party has developed, made, conceived, or reduced to practice &#91;***&#93; that may have been generated under the Material Transfer Agreement dated July 1, 2019&#59; and (vi) neither party may use &#91;***&#93; that was generated under the Material Transfer and Feasibility Agreement dated July 10, 2019 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">July 10 MTA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) nor file any patent application which includes &#91;***&#93; generated under such July 10 MTA. For the avoidance of doubt, nothing in this Agreement will be construed to limit either Party from conducting independent research and to develop intellectual property rights related to the same subject matter as the Research Programs of the MTAs provided that the research is not based on (a) the tangible materials or confidential information received from the other Party under either MTA or (b) the &#91;***&#93; generated under either MTA). All capitalized terms used in this Section 1.2 shall have the meaning set forth in the MTAs. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Press Release and Other Public Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Following the execution of this Agreement, Shattuck may issue a press release or other public statement announcing the entering into of this Agreement, as approved in writing in advance by Millennium.  Millennium has the right to respond, provided such response is consistent with any press release or other public statement previously made by Shattuck or otherwise approved in writing in advance by Shattuck, to any inquiries from the public resulting from such press release or other public statement. Except as required by the rules of any applicable stock exchange, each Party agrees not to issue any other press release or other public statement disclosing additional information with respect to this Agreement or the Collaboration Agreement, or using the name or trademark of the other Party or any of its respective employees, in either case, without the prior written consent of such Party&#59; provided that, if a Party is required to disclose this Agreement by the rules of any applicable stock exchange, the disclosing Party will provide the other Party with a copy of relevant portions of the proposed filing a reasonable time prior to such filing (and any material revisions to such portions of the proposed filing a reasonable time prior to the filing thereof), including any exhibits thereto disclosing terms or conditions of this Agreement, and will use reasonable and diligent efforts to obtain confidential treatment of the terms and conditions of this Agreement that such other Party requests be kept confidential, and will only disclose such terms and conditions that it is advised by counsel are legally required to be disclosed.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the Parties waives any right to prior written termination notice under the Collaboration Agreement. Each of the Parties agrees to release, acquit and forever discharge the other from any obligations, liability or claims</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of whatever kind or nature, in law or in equity, now known or unknown, suspected or unsuspected </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93; &#61; CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the extent that any of the foregoing arises from any action or failure to act under or relating to the Collaboration Agreement and each of the Parties represents that it does not reserve any right, claim or remedy of any nature under the Collaboration Agreement. The foregoing mutual releases do not discharge any rights or obligations set forth in this Agreement. The Parties agree that this Agreement is in full and complete settlement of the rights and obligations of the Parties in connection with the Collaboration Agreement. It is understood that this Agreement does not constitute an admission of any liability by any Party, including any admission of default or breach of the Collaboration Agreement.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the Parties represents to the other Party that (i) it has the requisite power and authority to execute and deliver this Agreement and to carry out its obligations hereunder, and that it has duly and validly executed and delivered this Agreement&#59; (ii) the execution, delivery and performance of this Agreement have been duly authorized by all necessary action on the part of such Party&#59; and (iii) this Agreement constitutes the valid and binding obligation of, and is enforceable against, such Party in accordance with its terms assuming due authorization, execution and delivery by the other Party. </font></div><div style="margin-top:6pt;padding-right:-18pt;text-align:center;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE 2</font></div><div style="padding-right:-18pt;text-align:center;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MISCELLANEOUS</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any one or more of the provisions of this Agreement is held to be invalid or unenforceable, the provision will be considered severed from this Agreement and will not serve to invalidate any remaining provisions hereof, unless the invalid or unenforceable provision is of such essential importance to this Agreement that it is to be reasonably assumed that the Parties would not have entered into this Agreement without the invalid or unenforceable provision. The Parties will make a &#91;***&#93; effort to replace any invalid or unenforceable provision with a valid and enforceable one such that the objectives contemplated by the Parties when entering this Agreement may be realized.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement and all questions regarding the existence, validity, interpretation, breach or performance of this Agreement, will be governed by, and construed and enforced in accordance with, the laws of the State of New York, U.S., without reference to its conflicts of law principles.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement, including the Schedules, may only be amended by a written document duly executed by authorized signatories of each of the Parties.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specific Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties acknowledge that, in view of the uniqueness of the transactions contemplated by this Agreement, a Party would not have an adequate remedy at law for money damages in the event that this Agreement has not been performed in accordance with its terms, and therefore agrees that the other Party shall be entitled to specific enforcement of the terms hereof in addition to any other remedy to which it may be entitled, at law or in equity.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Party (a) irrevocably consents to the exclusive jurisdiction and venue in any federal court of the U.S. located in the Southern District of New York, or, if any such court of the U.S. located in the Southern District of New York declines to accept jurisdiction over a particular matter, any state court located in New York, NY in connection with any matter based upon or arising out of this Agreement or the transactions contemplated hereby, and (b) agrees not to commence any legal proceedings relating to or arising out of this Agreement or the transactions contemplated hereby in any jurisdiction or courts other than as provided herein. Each Party waives and covenants not to assert or plead any objection that such Party might otherwise have to such jurisdiction, venue or process.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Binding Effect and Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement constitutes the entire agreement of the Parties with respect to the matters referred to herein and supersedes and merges all prior and contemporaneous negotiations, representations and understandings regarding the same.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Third Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement is for the sole benefit of the Parties, and its and their permitted successors and assigns, and nothing herein, express or implied, shall give or be construed to give to any person, other than the Parties, and such permitted successors or assigns, any legal or equitable rights hereunder.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the other express provisions of this Agreement, each Party agrees to use commercially reasonable efforts to cooperate with the other Party to execute additional instruments, documents and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93; &#61; CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements, and to give other further written assurances, as may be reasonably requested by the other Party to carry out and evidence the transactions contemplated by this Agreement.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties agree that the terms of this Agreement fully define all compensation, consideration, and benefits, monetary or otherwise, to be paid, granted or delivered by either Party to the other Party in connection with the termination herein.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be executed in counterparts, each of which counterparts, when so executed and delivered, will be deemed to be an original, and all of which counterparts, taken together, will constitute one and the same instrument. For purposes of execution, a copy of this Agreement or any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment hereto will be deemed an original (including a printed copy of a PDF file delivered via email or a facsimile transmitted telephonically via a fax machine).</font></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their respective duly authorized officers as of the date first above written.</font></div><div style="text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:35.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:41.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Millennium Pharmaceuticals, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher Hurff</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Hurff</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head, Oncology Business Development</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shattuck Labs, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Dr. Taylor Schreiber</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr.&#160;Taylor Schreiber</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93; &#61; CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>sub-certxsection302xceoxq3.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i497882590e664731ac3a8be95fe2da1d_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">Exhibit 31.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Taylor Schreiber, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">I have reviewed this Quarterly Report on Form&#160;10-Q of Shattuck Labs, Inc.&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) for the registrant and have&#58;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.074%"><tr><td style="width:1.0%"></td><td style="width:62.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; November 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Dr. Taylor Schreiber</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr.&#160;Taylor Schreiber</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Chief Executive Officer</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">(principal executive officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>sub-certxsection302xcfoxq3.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id9f3cb4a0972466fb32e7d3e63af32dc_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">Exhibit 31.2</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Andrew R. Neill, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:3.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">I have reviewed this Quarterly Report on Form&#160;10-Q of Shattuck Labs, Inc.&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) for the registrant and have&#58;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:62.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.769%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; November 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Andrew R. Neill</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">Andrew R. Neill</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:104%">Chief Financial Officer</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(principal financial and accounting officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>sub-certxsection906ofthesa.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i28d9a5f3222a4ceab36279aa51d75a49_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:7pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Shattuck Labs, Inc. (the &#8220;Company&#8221;) for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:3.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></td></tr></table></div><div style="padding-left:4.5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:3.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:35.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.162%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; November 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Dr. Taylor Schreiber</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dr. Taylor Schreiber</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Executive Officer</font></div><div style="margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">(principal executive officer)</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; November 9, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Andrew R. Neill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Andrew R. Neill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Financial Officer</font></div><div style="margin-top:2pt;padding-left:2pt;padding-right:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">(principal financial and accounting officer)</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2pt;padding-right:2pt"><font><br></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167;1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></div><div style="margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note&#58; A signed original of this written statement required by &#167;906 has been provided to Shattuck Labs, Inc. and will be retained by Shattuck Labs, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>sttk-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sttk="http://www.shattucklabs.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.shattucklabs.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVER" roleURI="http://www.shattucklabs.com/role/COVER">
        <link:definition>0001001 - Document - COVER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETS" roleURI="http://www.shattucklabs.com/role/BALANCESHEETS">
        <link:definition>1001002 - Statement - BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETSParenthetical" roleURI="http://www.shattucklabs.com/role/BALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - BALANCE SHEETS - Parenthetical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>1003004 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1004005 - Statement - STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTSOFCASHFLOWS" roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandDescriptionofBusiness" roleURI="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness">
        <link:definition>2101101 - Disclosure - Organization and Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandDescriptionofBusinessDetails" roleURI="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails">
        <link:definition>2402401 - Disclosure - Organization and Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails" roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails">
        <link:definition>2407403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestments" roleURI="http://www.shattucklabs.com/role/ShortTermInvestments">
        <link:definition>2108103 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestmentsTables" roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsTables">
        <link:definition>2309302 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails">
        <link:definition>2410404 - Disclosure - Short-Term Investments - Schedule of available for sale short-term investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestmentsNarrativeDetails" roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails">
        <link:definition>2411405 - Disclosure - Short-Term Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.shattucklabs.com/role/AccruedExpenses">
        <link:definition>2112104 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.shattucklabs.com/role/AccruedExpensesTables">
        <link:definition>2313303 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesScheduleofaccruedexpensesDetails" roleURI="http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails">
        <link:definition>2414406 - Disclosure - Accrued Expenses - Schedule of accrued expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.shattucklabs.com/role/CommitmentsandContingencies">
        <link:definition>2115105 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesTables">
        <link:definition>2316304 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails" roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails">
        <link:definition>2417407 - Disclosure - Commitments and Contingencies - Schedule of minimum lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2418408 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStock" roleURI="http://www.shattucklabs.com/role/PreferredStock">
        <link:definition>2119106 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockDetails" roleURI="http://www.shattucklabs.com/role/PreferredStockDetails">
        <link:definition>2420409 - Disclosure - Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.shattucklabs.com/role/StockBasedCompensation">
        <link:definition>2121107 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationTables">
        <link:definition>2322305 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>2423410 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails">
        <link:definition>2424411 - Disclosure - Stock-Based Compensation - Schedule of stock-based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofoptionactivityDetails" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails">
        <link:definition>2425412 - Disclosure - Stock-Based Compensation - Schedule of option activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofvaluationassumptionsDetails" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails">
        <link:definition>2426413 - Disclosure - Stock-Based Compensation - Schedule of valuation assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofrestrictedstockactivityDetails" roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails">
        <link:definition>2427414 - Disclosure - Stock-Based Compensation - Schedule of restricted stock activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementRelatedParty" roleURI="http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty">
        <link:definition>2128108 - Disclosure - Collaboration Agreement - Related Party</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementRelatedPartyDetails" roleURI="http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails">
        <link:definition>2429415 - Disclosure - Collaboration Agreement - Related Party (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.shattucklabs.com/role/RelatedPartyTransactions">
        <link:definition>2130109 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2431416 - Disclosure - Related-Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sttk_IncreaseDecreaseInDeferredRentCredits" abstract="false" name="IncreaseDecreaseInDeferredRentCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" abstract="false" name="AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_CumulativeEffectChangeOfAccountingEstimateDomain" abstract="true" name="CumulativeEffectChangeOfAccountingEstimateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_TemporaryEquityPolicyTextBlock" abstract="false" name="TemporaryEquityPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sttk_OperatingAccountMember" abstract="true" name="OperatingAccountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_ShareholderOwnershipPercentage" abstract="false" name="ShareholderOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" abstract="true" name="RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sttk_LicenseAgreementRoyaltyPaymentsMaximum" abstract="false" name="LicenseAgreementRoyaltyPaymentsMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_TakedaMember" abstract="true" name="TakedaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_SeriesB1PreferredStockMember" abstract="true" name="SeriesB1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sttk_CumulativeEffectChangeOfAccountingEstimateAxis" abstract="true" name="CumulativeEffectChangeOfAccountingEstimateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" abstract="false" name="StockIssuanceCostsIncurredDuringNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_A2020StockIncentivePlanMember" abstract="true" name="A2020StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" abstract="true" name="CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sttk_AccruedResearchAndContractCostsCurrent" abstract="false" name="AccruedResearchAndContractCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sttk_A2020EmployeeStockPurchasePlanMember" abstract="true" name="A2020EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>sttk-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BALANCESHEETS" xlink:type="simple" xlink:href="sttk-20210930.xsd#BALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/BALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_15590049-da31-422d-8eb7-707113ef24c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3d2eb5bf-2102-45c0-8672-58ad41ef3626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_15590049-da31-422d-8eb7-707113ef24c4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3d2eb5bf-2102-45c0-8672-58ad41ef3626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_58e2deb2-06af-4ddc-a01f-5af81c8f54bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_15590049-da31-422d-8eb7-707113ef24c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_58e2deb2-06af-4ddc-a01f-5af81c8f54bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_55467a9f-603f-444f-a463-9483dc69d324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_15590049-da31-422d-8eb7-707113ef24c4" xlink:to="loc_us-gaap_AssetsCurrent_55467a9f-603f-444f-a463-9483dc69d324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_92c56767-d921-48d7-8de4-cf90def1d0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_24e6a9fd-db2f-41d2-887f-2085f32b46b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_92c56767-d921-48d7-8de4-cf90def1d0c2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_24e6a9fd-db2f-41d2-887f-2085f32b46b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_727cd0e4-e3a7-4046-a28d-111eb5409423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_92c56767-d921-48d7-8de4-cf90def1d0c2" xlink:to="loc_us-gaap_Liabilities_727cd0e4-e3a7-4046-a28d-111eb5409423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_300c4072-b96a-4ca3-b5ab-334f57598264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_92c56767-d921-48d7-8de4-cf90def1d0c2" xlink:to="loc_us-gaap_StockholdersEquity_300c4072-b96a-4ca3-b5ab-334f57598264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_578a21d4-9a4a-4678-bba2-eebc1b64cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_59d11400-0b1d-46c6-93a1-5eb10c3dd93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_578a21d4-9a4a-4678-bba2-eebc1b64cdb2" xlink:to="loc_us-gaap_LiabilitiesCurrent_59d11400-0b1d-46c6-93a1-5eb10c3dd93d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_6479ccb4-b467-4f2a-a464-d8a3c0f95a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_578a21d4-9a4a-4678-bba2-eebc1b64cdb2" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_6479ccb4-b467-4f2a-a464-d8a3c0f95a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7b668fee-6514-45a5-9142-f8d839ebb8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_578a21d4-9a4a-4678-bba2-eebc1b64cdb2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7b668fee-6514-45a5-9142-f8d839ebb8c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_68d63298-dd77-4175-b3f4-808848fb72fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fd9cadfd-4885-42a9-aba9-3e0dcfe91cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_68d63298-dd77-4175-b3f4-808848fb72fc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fd9cadfd-4885-42a9-aba9-3e0dcfe91cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_8d0eb776-fbe0-4718-8d0c-44449c39b4c2" xlink:href="sttk-20210930.xsd#sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_68d63298-dd77-4175-b3f4-808848fb72fc" xlink:to="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_8d0eb776-fbe0-4718-8d0c-44449c39b4c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_baf6a752-5ee2-437f-aa0f-07e03509ee61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_68d63298-dd77-4175-b3f4-808848fb72fc" xlink:to="loc_us-gaap_AccountsPayableCurrent_baf6a752-5ee2-437f-aa0f-07e03509ee61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4effa083-ab1b-4ef9-be16-f5a3e0c96048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3806659a-9d54-4c60-993c-3e622f0baeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4effa083-ab1b-4ef9-be16-f5a3e0c96048" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3806659a-9d54-4c60-993c-3e622f0baeb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e127052f-c8bc-40a5-aca5-da2b63307f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4effa083-ab1b-4ef9-be16-f5a3e0c96048" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e127052f-c8bc-40a5-aca5-da2b63307f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1e5b202-e958-4515-8423-deb9020cd82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4effa083-ab1b-4ef9-be16-f5a3e0c96048" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1e5b202-e958-4515-8423-deb9020cd82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_eb6d3cb8-d0b7-496a-9b18-fd72ac2620d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4effa083-ab1b-4ef9-be16-f5a3e0c96048" xlink:to="loc_us-gaap_CommonStockValue_eb6d3cb8-d0b7-496a-9b18-fd72ac2620d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1e968232-6148-485d-80fb-0d10237b3f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_971994df-4e25-43e5-8c4a-d9bb69d87a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1e968232-6148-485d-80fb-0d10237b3f64" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_971994df-4e25-43e5-8c4a-d9bb69d87a58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_200e2ffe-b911-4967-adda-f60cec1b79cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1e968232-6148-485d-80fb-0d10237b3f64" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_200e2ffe-b911-4967-adda-f60cec1b79cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ec332d10-4045-40bc-bad8-fb98256a50d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1e968232-6148-485d-80fb-0d10237b3f64" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ec332d10-4045-40bc-bad8-fb98256a50d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7836b655-7817-4611-b2ba-0e3762477794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_977cc5ca-f5a8-4902-895f-f8da0365dd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7836b655-7817-4611-b2ba-0e3762477794" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_977cc5ca-f5a8-4902-895f-f8da0365dd0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_b7a390ec-b1d2-44ba-aa1c-1827d3e3f041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7836b655-7817-4611-b2ba-0e3762477794" xlink:to="loc_us-gaap_InvestmentIncomeInterest_b7a390ec-b1d2-44ba-aa1c-1827d3e3f041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_00413690-99d8-43bb-9a47-469732b9cd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b9d07974-77a2-48d5-ba87-80133070823b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_00413690-99d8-43bb-9a47-469732b9cd0b" xlink:to="loc_us-gaap_OperatingExpenses_b9d07974-77a2-48d5-ba87-80133070823b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f7c302b3-dad5-4d65-b8e1-8a02263c06e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_00413690-99d8-43bb-9a47-469732b9cd0b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f7c302b3-dad5-4d65-b8e1-8a02263c06e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_340a294b-0e03-4ecb-a225-567e46dd1aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_48538aed-ff38-4d6b-961d-cf00aa64fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340a294b-0e03-4ecb-a225-567e46dd1aaa" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_48538aed-ff38-4d6b-961d-cf00aa64fe2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_121eea99-fc70-41f6-a897-908ca1df1f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340a294b-0e03-4ecb-a225-567e46dd1aaa" xlink:to="loc_us-gaap_OperatingIncomeLoss_121eea99-fc70-41f6-a897-908ca1df1f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2c20935f-f789-472f-bfce-9ec510410eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c5fa79f7-1824-4a28-ad9e-35c1572b446f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2c20935f-f789-472f-bfce-9ec510410eb6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c5fa79f7-1824-4a28-ad9e-35c1572b446f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7c57d099-77f2-4b10-b072-d9e1c0135aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2c20935f-f789-472f-bfce-9ec510410eb6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7c57d099-77f2-4b10-b072-d9e1c0135aa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a2e6d2d3-576e-4be2-a7d2-d2993b451fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9889d132-4775-4d0e-98b6-d19de9703b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a2e6d2d3-576e-4be2-a7d2-d2993b451fb6" xlink:to="loc_us-gaap_NetIncomeLoss_9889d132-4775-4d0e-98b6-d19de9703b4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_75fafbd0-f6db-442f-a29b-bae0c9edd0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a2e6d2d3-576e-4be2-a7d2-d2993b451fb6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_75fafbd0-f6db-442f-a29b-bae0c9edd0b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_752d7776-3fcc-4cd9-8180-a8c49ce6890a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_49f419dd-b4e3-4322-b7a1-94e0f06c49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_752d7776-3fcc-4cd9-8180-a8c49ce6890a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_49f419dd-b4e3-4322-b7a1-94e0f06c49a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c524d6de-cb09-4f39-8c8e-54d279408b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_752d7776-3fcc-4cd9-8180-a8c49ce6890a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c524d6de-cb09-4f39-8c8e-54d279408b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f875beca-f068-4dc6-bce2-4e4292351dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_752d7776-3fcc-4cd9-8180-a8c49ce6890a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f875beca-f068-4dc6-bce2-4e4292351dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79d2c19f-3979-4213-918a-d2cac97cb5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_5ce53c94-fb08-4c99-ab4f-69ea8fd71eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79d2c19f-3979-4213-918a-d2cac97cb5d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_5ce53c94-fb08-4c99-ab4f-69ea8fd71eef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f6903e1-e1ee-4668-9662-cdd8fafb080e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79d2c19f-3979-4213-918a-d2cac97cb5d4" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f6903e1-e1ee-4668-9662-cdd8fafb080e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a584b79b-71f1-4886-a970-26c7f35641f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79d2c19f-3979-4213-918a-d2cac97cb5d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a584b79b-71f1-4886-a970-26c7f35641f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ee488db-5534-4779-aea8-43a90a08835f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_NetIncomeLoss_9ee488db-5534-4779-aea8-43a90a08835f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fac11c3c-6a67-4754-b1c0-ff5ce9cd5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_ShareBasedCompensation_fac11c3c-6a67-4754-b1c0-ff5ce9cd5f63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b29fe42b-8158-4fa4-8355-cb19f35cbd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b29fe42b-8158-4fa4-8355-cb19f35cbd2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_90d0308c-92b2-42ba-af56-4c0344e5b805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_90d0308c-92b2-42ba-af56-4c0344e5b805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_11bda290-6a8a-4bd7-815e-0401631f9587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_11bda290-6a8a-4bd7-815e-0401631f9587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_IncreaseDecreaseInDeferredRentCredits_ac7f3a18-73cd-40dc-972e-b9faa0907170" xlink:href="sttk-20210930.xsd#sttk_IncreaseDecreaseInDeferredRentCredits"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_sttk_IncreaseDecreaseInDeferredRentCredits_ac7f3a18-73cd-40dc-972e-b9faa0907170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1b34aae7-de92-4802-9739-400bec51b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_Depreciation_1b34aae7-de92-4802-9739-400bec51b957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1ed0a7b6-25d7-410a-acb9-f935e4de5317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1ed0a7b6-25d7-410a-acb9-f935e4de5317" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_751d1673-ad10-4611-a601-7bbc3a2f47c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_751d1673-ad10-4611-a601-7bbc3a2f47c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4f2c5714-6eff-423a-8ff7-c29391222dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d32a92c-c085-44bc-8fda-50cde4be7c8e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4f2c5714-6eff-423a-8ff7-c29391222dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b5bb953-1596-4afa-8f48-40b23ef02427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_25fc806b-803d-4c9c-8fd5-68b5dd2320f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b5bb953-1596-4afa-8f48-40b23ef02427" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_25fc806b-803d-4c9c-8fd5-68b5dd2320f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_ee6fcad0-2d7d-4b1d-a605-d684721e6bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b5bb953-1596-4afa-8f48-40b23ef02427" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_ee6fcad0-2d7d-4b1d-a605-d684721e6bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_fe938c19-b3f6-4e59-9017-e9256b1738b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b5bb953-1596-4afa-8f48-40b23ef02427" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_fe938c19-b3f6-4e59-9017-e9256b1738b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f8c981c-20ee-4f81-a833-d97423989d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5e7db7-7aa0-4ad6-9c61-9d341dddfd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f8c981c-20ee-4f81-a833-d97423989d62" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5e7db7-7aa0-4ad6-9c61-9d341dddfd4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_11d09855-267c-411b-a72e-2d547a049836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f8c981c-20ee-4f81-a833-d97423989d62" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_11d09855-267c-411b-a72e-2d547a049836" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#AccruedExpensesScheduleofaccruedexpensesDetails"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_57dd3c3e-8289-4b61-85b7-25d391745876" xlink:href="sttk-20210930.xsd#sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_587c32d5-e499-4741-ab19-42864b7cb66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_57dd3c3e-8289-4b61-85b7-25d391745876" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_587c32d5-e499-4741-ab19-42864b7cb66e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedResearchAndContractCostsCurrent_74bb6009-396d-468c-a6d6-e9e1294e94d3" xlink:href="sttk-20210930.xsd#sttk_AccruedResearchAndContractCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_57dd3c3e-8289-4b61-85b7-25d391745876" xlink:to="loc_sttk_AccruedResearchAndContractCostsCurrent_74bb6009-396d-468c-a6d6-e9e1294e94d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7a011535-4b08-4db5-b229-0abc6987df8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_57dd3c3e-8289-4b61-85b7-25d391745876" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7a011535-4b08-4db5-b229-0abc6987df8b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_077d15f3-8859-4318-8875-335340408bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_077d15f3-8859-4318-8875-335340408bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8d133c70-6b24-441a-abce-1e343a334e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8d133c70-6b24-441a-abce-1e343a334e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0d081752-c2f2-407b-917b-da94fb280a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0d081752-c2f2-407b-917b-da94fb280a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_681987a6-4c73-4953-b494-a386230e3dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_681987a6-4c73-4953-b494-a386230e3dee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_6ea0566e-8b5c-4793-9256-392805906e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_6ea0566e-8b5c-4793-9256-392805906e70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_834a46d6-7489-4a0e-915b-7574679ecc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_5c6c2a81-3c90-4c86-bab9-1d34507de4e9" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_834a46d6-7489-4a0e-915b-7574679ecc28" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>sttk-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="id0dc42ff243245a7947224e562feda7f_STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bfb8a659-a307-44bc-a26e-abd676a1f781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_SharesOutstanding_bfb8a659-a307-44bc-a26e-abd676a1f781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a4d9c47f-ba5e-4a52-8472-df876bd429fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockholdersEquity_a4d9c47f-ba5e-4a52-8472-df876bd429fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61607f73-5d73-47fe-8987-976a49170fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61607f73-5d73-47fe-8987-976a49170fa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e55619cb-4ba8-41ef-b92b-a536051384c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e55619cb-4ba8-41ef-b92b-a536051384c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_cde9d0ac-d4e0-4675-85e3-883b63405904" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_cde9d0ac-d4e0-4675-85e3-883b63405904" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_b4817569-eb6c-4cd8-86a2-5ef5419ebc8e" xlink:href="sttk-20210930.xsd#sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_b4817569-eb6c-4cd8-86a2-5ef5419ebc8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3aff1787-c6aa-43de-9efa-d4ad7421889b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3aff1787-c6aa-43de-9efa-d4ad7421889b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48866707-13a6-4c66-bdcf-e8a555bcfb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48866707-13a6-4c66-bdcf-e8a555bcfb5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9ddbb96-3c85-4123-8fb7-3223e8996669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9ddbb96-3c85-4123-8fb7-3223e8996669" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_360b83e6-66e8-4d6c-a105-d7882dad76dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_NetIncomeLoss_360b83e6-66e8-4d6c-a105-d7882dad76dc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3a9e3b1f-843c-495a-a524-bceed41e5ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5f357f80-c903-49e9-8b1d-412d91136f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_547acbdb-390a-408e-8f24-a75fe00fa4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_547acbdb-390a-408e-8f24-a75fe00fa4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a270cd24-8cf0-4ceb-a868-83a355268de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a270cd24-8cf0-4ceb-a868-83a355268de1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_91e6be8e-c108-4706-9386-069d9ba6ba5e" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_91e6be8e-c108-4706-9386-069d9ba6ba5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_cccde38f-9978-4b56-aeab-bd2ef3c06602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_cccde38f-9978-4b56-aeab-bd2ef3c06602" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_88ed5306-75dd-4ef1-86b5-9bf13cdda331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_92903faa-d280-4b1c-9111-b60c63ea18ff" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_92903faa-d280-4b1c-9111-b60c63ea18ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_630d9015-2624-46cb-b5f6-6fbada509709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:to="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a3f75304-c261-4928-b15f-9d78299954f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:to="loc_us-gaap_ClassOfStockDomain_a3f75304-c261-4928-b15f-9d78299954f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:to="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_6ff968a9-43b3-47e6-bf8a-1c20e4128d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_6ff968a9-43b3-47e6-bf8a-1c20e4128d62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a1877e69-a270-4956-bb3f-e12d6abc4356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a1877e69-a270-4956-bb3f-e12d6abc4356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_c7aa538a-03b2-4144-95f7-ff4be1941467" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_sttk_SeriesB1PreferredStockMember_c7aa538a-03b2-4144-95f7-ff4be1941467" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2ba9d773-7a04-4941-91fb-ef8e5603f240_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:to="loc_us-gaap_EquityComponentDomain_2ba9d773-7a04-4941-91fb-ef8e5603f240_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:to="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_198f8c16-1b1f-42aa-9ecd-1a13d4ceb6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_CommonStockMember_198f8c16-1b1f-42aa-9ecd-1a13d4ceb6c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_95bcedac-ceda-40d3-952e-03e2d454ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_95bcedac-ceda-40d3-952e-03e2d454ad33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b72f7f1c-1f64-4907-b332-3eb5ef3caf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b72f7f1c-1f64-4907-b332-3eb5ef3caf02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5f76a2e4-70f0-4fb0-b52f-288b6857ecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_RetainedEarningsMember_5f76a2e4-70f0-4fb0-b52f-288b6857ecf7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="extended" id="ia0c04e91770a48a68d333c5fc9432b14_STATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6185a6bc-909e-4eee-9478-34d56cb5da88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:to="loc_us-gaap_NetIncomeLoss_6185a6bc-909e-4eee-9478-34d56cb5da88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5510458f-8e92-431e-8ecc-b2a45edf6c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_ShareBasedCompensation_5510458f-8e92-431e-8ecc-b2a45edf6c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d0804ec9-a062-4a64-8896-db9a91a0c312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_Depreciation_d0804ec9-a062-4a64-8896-db9a91a0c312" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_a5e7f595-994a-4b02-917b-8ebfe8b39a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_a5e7f595-994a-4b02-917b-8ebfe8b39a5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5278fd-30f3-47ce-9c22-be3ee71cac85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5278fd-30f3-47ce-9c22-be3ee71cac85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9d98bd04-0c73-4ed4-8194-9100a417a90a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9d98bd04-0c73-4ed4-8194-9100a417a90a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_24b2e4e1-93d7-4cf7-a3ee-b807a575c411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_24b2e4e1-93d7-4cf7-a3ee-b807a575c411" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_adec80bb-5f31-4578-ab59-fdcca2cc0a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_adec80bb-5f31-4578-ab59-fdcca2cc0a21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4981ee39-c774-420c-8b3f-4c9452e2f0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4981ee39-c774-420c-8b3f-4c9452e2f0fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_IncreaseDecreaseInDeferredRentCredits_902328ca-118c-44e7-8481-66d3ade06a4c" xlink:href="sttk-20210930.xsd#sttk_IncreaseDecreaseInDeferredRentCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_sttk_IncreaseDecreaseInDeferredRentCredits_902328ca-118c-44e7-8481-66d3ade06a4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b022e583-34c6-45e6-804a-65cd1a270b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b022e583-34c6-45e6-804a-65cd1a270b99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8ee92aba-92d7-4282-8667-437999a47740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8ee92aba-92d7-4282-8667-437999a47740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93656ba6-8bb1-46bb-a77b-952dd00aacbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93656ba6-8bb1-46bb-a77b-952dd00aacbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_52700ca1-9e7e-42a6-add4-bdf687bfa4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_52700ca1-9e7e-42a6-add4-bdf687bfa4b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b117d472-6520-4f5f-b31a-6548cd91026c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b117d472-6520-4f5f-b31a-6548cd91026c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0ced8ae9-c281-48a4-8182-59f9fde05540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0ced8ae9-c281-48a4-8182-59f9fde05540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0d99fae4-90da-41b2-9f0a-33017ffb4e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0d99fae4-90da-41b2-9f0a-33017ffb4e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3d5cc766-f0f3-4082-a05d-64cc708a557d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3d5cc766-f0f3-4082-a05d-64cc708a557d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c598590-5b03-45cc-9b25-5a489190c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c598590-5b03-45cc-9b25-5a489190c8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a6129fe-814d-43a7-89f5-f8cf190ea40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a6129fe-814d-43a7-89f5-f8cf190ea40e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be9d39c4-0976-48ff-b2e6-aecc59dcb2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be9d39c4-0976-48ff-b2e6-aecc59dcb2e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_540020ab-b58d-4d07-a6f6-d951893feb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_80c7e284-3110-4884-9a68-f813f5cd6ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_80c7e284-3110-4884-9a68-f813f5cd6ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_07b4360e-c38c-49b0-8f0d-491daf3ca80d" xlink:href="sttk-20210930.xsd#sttk_StockIssuanceCostsIncurredDuringNoncashTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_07b4360e-c38c-49b0-8f0d-491daf3ca80d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d1055987-885b-45c0-b139-5b402451eca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d1055987-885b-45c0-b139-5b402451eca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6df7d05f-f552-49e4-83ce-26d2a5500036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:to="loc_us-gaap_ClassOfStockDomain_6df7d05f-f552-49e4-83ce-26d2a5500036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:to="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_ab6fbed0-d75b-4959-98cc-a97d39e22325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_ab6fbed0-d75b-4959-98cc-a97d39e22325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_660c2a31-450c-460d-81c1-da2d2f6d6c65" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:to="loc_sttk_SeriesB1PreferredStockMember_660c2a31-450c-460d-81c1-da2d2f6d6c65" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="if1a485ce73e14b49b7d2296a43108919_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a03da9be-54ed-4aee-9419-f1653394e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a03da9be-54ed-4aee-9419-f1653394e4a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_221bebcc-0b16-4aba-b346-b8ecea05e32b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_221bebcc-0b16-4aba-b346-b8ecea05e32b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_OperatingAccountMember_dab93b39-e954-4c2b-91ba-0d984126c561" xlink:href="sttk-20210930.xsd#sttk_OperatingAccountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_sttk_OperatingAccountMember_dab93b39-e954-4c2b-91ba-0d984126c561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_172c2434-ab9b-423c-a361-ce88732aea51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_us-gaap_MoneyMarketFundsMember_172c2434-ab9b-423c-a361-ce88732aea51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_61748a38-fee5-4a73-98f5-7ce52373b6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_61748a38-fee5-4a73-98f5-7ce52373b6ad" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails" xlink:type="extended" id="ic067d6172dae494892340452247426d2_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_58452e2c-4e78-43a4-af86-a1fc57c38790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_58452e2c-4e78-43a4-af86-a1fc57c38790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_55718709-5711-4a4b-bcf2-8ff1c1c101ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_55718709-5711-4a4b-bcf2-8ff1c1c101ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ba1cb23d-8644-4f7e-b05a-8418f2a48dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ba1cb23d-8644-4f7e-b05a-8418f2a48dbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_10f45839-3b63-4b60-982a-fc7ac057c988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_10f45839-3b63-4b60-982a-fc7ac057c988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_85440a4c-c43a-4687-be56-daa82a9908de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_RestrictedStockMember_85440a4c-c43a-4687-be56-daa82a9908de" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="extended" id="i2693051f2ef742c5b77cee1e0db23982_ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:to="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6a51aed-27f8-4b8f-a265-ebd3fb58d755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6a51aed-27f8-4b8f-a265-ebd3fb58d755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_fa0d7e46-2ff2-411e-9305-8765c29972a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_fa0d7e46-2ff2-411e-9305-8765c29972a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28649169-f551-4e71-9a1f-35112618fcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28649169-f551-4e71-9a1f-35112618fcb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3233bdd-2c28-423f-b0f2-b98fc2d17033_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e3233bdd-2c28-423f-b0f2-b98fc2d17033_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_60c240c2-f226-42db-97cf-1d8231471385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_60c240c2-f226-42db-97cf-1d8231471385" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/PreferredStockDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#PreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/PreferredStockDetails" xlink:type="extended" id="i44857e911269450988fbfe5cad63c059_PreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1ea30a76-5d1f-4799-991b-01f70cd42fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1ea30a76-5d1f-4799-991b-01f70cd42fcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_9b95974c-3aa8-4d05-a5bf-a37aff94488f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_9b95974c-3aa8-4d05-a5bf-a37aff94488f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2182b316-3051-4d81-bad1-4f0cb81123a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2182b316-3051-4d81-bad1-4f0cb81123a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de4f037c-2280-43fb-a20d-c01eef4a20c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:to="loc_us-gaap_ClassOfStockDomain_de4f037c-2280-43fb-a20d-c01eef4a20c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:to="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0a865e97-afcd-40fc-b7f2-9f1cfe3c72bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0a865e97-afcd-40fc-b7f2-9f1cfe3c72bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_166b3e88-6450-4a99-9277-5fa04bc5474d" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:to="loc_sttk_SeriesB1PreferredStockMember_166b3e88-6450-4a99-9277-5fa04bc5474d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="if5080fa3cc1d4e7ba2b886c3e88256c7_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_d105c035-dc17-41a9-8f02-15fa3041febd" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_d105c035-dc17-41a9-8f02-15fa3041febd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_befa47ed-d37e-4028-811c-814c00b6429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_befa47ed-d37e-4028-811c-814c00b6429a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_481e1657-3181-45ea-8d21-1b99bfb8f184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_481e1657-3181-45ea-8d21-1b99bfb8f184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6fd4603d-0803-44c5-ac7d-29b2789deb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6fd4603d-0803-44c5-ac7d-29b2789deb21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18cb6c30-a67c-4613-82c0-61aab7088bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18cb6c30-a67c-4613-82c0-61aab7088bbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b4981b03-f34d-486c-8c07-0b4187a5ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b4981b03-f34d-486c-8c07-0b4187a5ced5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_d5fe8cb3-a9c1-441c-8354-1d57b9b5a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_d5fe8cb3-a9c1-441c-8354-1d57b9b5a9e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_752738f0-2d4b-4a47-88dd-9b77af9c6e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_752738f0-2d4b-4a47-88dd-9b77af9c6e0c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_8e589b6e-8ea0-4707-bfd9-1c5125b61043" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_8e589b6e-8ea0-4707-bfd9-1c5125b61043" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_94afe130-b27e-41b7-81e0-dcfe7723c55c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_94afe130-b27e-41b7-81e0-dcfe7723c55c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_3d30fcc9-5f94-4c65-938a-060597a79603" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_3d30fcc9-5f94-4c65-938a-060597a79603" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_56390997-79ce-4109-9814-c239cdd12f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_56390997-79ce-4109-9814-c239cdd12f71" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2eab6d2f-ef07-4d29-9194-8d0eb35bacf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2eab6d2f-ef07-4d29-9194-8d0eb35bacf1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15982d98-5788-4630-b02b-cb443bd33560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15982d98-5788-4630-b02b-cb443bd33560" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_723146b9-e34c-4e87-a11f-0fcc15bd4570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_723146b9-e34c-4e87-a11f-0fcc15bd4570" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df67f67e-0a25-4982-9145-1c9b5de228b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df67f67e-0a25-4982-9145-1c9b5de228b7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fcfa4aeb-34da-405b-b38d-784604a16d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fcfa4aeb-34da-405b-b38d-784604a16d7c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4577ca81-6c5d-47ce-818f-41b7a55510de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4577ca81-6c5d-47ce-818f-41b7a55510de" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_10d972a8-e6c2-4551-adec-75640344b565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_10d972a8-e6c2-4551-adec-75640344b565" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:to="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:to="loc_us-gaap_PlanNameDomain_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:to="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020StockIncentivePlanMember_40df97a0-27be-4456-b289-80be693799a0" xlink:href="sttk-20210930.xsd#sttk_A2020StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:to="loc_sttk_A2020StockIncentivePlanMember_40df97a0-27be-4456-b289-80be693799a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020EmployeeStockPurchasePlanMember_70b95fcc-d43a-4049-993a-f2ec2f8d59a5" xlink:href="sttk-20210930.xsd#sttk_A2020EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:to="loc_sttk_A2020EmployeeStockPurchasePlanMember_70b95fcc-d43a-4049-993a-f2ec2f8d59a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:to="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_873829f6-3ab7-49ce-ae62-f9161abb6eca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_873829f6-3ab7-49ce-ae62-f9161abb6eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9583d5a0-9a2e-442c-b232-9e78a19d94ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:to="loc_us-gaap_RestrictedStockMember_9583d5a0-9a2e-442c-b232-9e78a19d94ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_23281afe-9d05-4304-8e8a-9cf9b5b660f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:to="loc_us-gaap_EmployeeStockOptionMember_23281afe-9d05-4304-8e8a-9cf9b5b660f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="extended" id="i7386c18db40d46ccaab64f9388bc2fc0_StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_815ef0d0-9715-40ec-a939-d83a7a1cb7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_815ef0d0-9715-40ec-a939-d83a7a1cb7a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ae5fda5e-d19f-4b53-bbbc-41af46cf8254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ae5fda5e-d19f-4b53-bbbc-41af46cf8254" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9291f860-4c9e-4fd7-9c4e-355931bdeff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9291f860-4c9e-4fd7-9c4e-355931bdeff0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofvaluationassumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails" xlink:type="extended" id="ie78e5081e01e4047866e27515dbf03a6_StockBasedCompensationScheduleofvaluationassumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_af4680d6-0391-4c6e-8979-1ae27cd16103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_af4680d6-0391-4c6e-8979-1ae27cd16103" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ad7af4c-a651-48de-9898-787543ad8ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ad7af4c-a651-48de-9898-787543ad8ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_593e8705-9e10-4f6c-aae0-8aee39cc992a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_593e8705-9e10-4f6c-aae0-8aee39cc992a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2d3f4-8887-4d68-9a73-af6efc5eee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2d3f4-8887-4d68-9a73-af6efc5eee23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:to="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c845864-dd00-4ac8-9a40-d435b8089608_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c845864-dd00-4ac8-9a40-d435b8089608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_57b32cff-81f2-431c-bbbe-24dfa43adb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:to="loc_us-gaap_EmployeeStockOptionMember_57b32cff-81f2-431c-bbbe-24dfa43adb7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:to="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_69d95937-2ce5-42b8-a65b-8b6206e331e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:to="loc_us-gaap_PlanNameDomain_69d95937-2ce5-42b8-a65b-8b6206e331e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:to="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020StockIncentivePlanMember_e245d663-8320-4e52-a5fe-6740fc8adb69" xlink:href="sttk-20210930.xsd#sttk_A2020StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:to="loc_sttk_A2020StockIncentivePlanMember_e245d663-8320-4e52-a5fe-6740fc8adb69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020EmployeeStockPurchasePlanMember_93e455a6-079e-41bd-84e5-495f0a9b3166" xlink:href="sttk-20210930.xsd#sttk_A2020EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:to="loc_sttk_A2020EmployeeStockPurchasePlanMember_93e455a6-079e-41bd-84e5-495f0a9b3166" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofrestrictedstockactivityDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails" xlink:type="extended" id="i781b14d75d4b4e4fb95084c6b752c70e_StockBasedCompensationScheduleofrestrictedstockactivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_554c1c5b-8d1a-42f6-93be-3f059664163c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_554c1c5b-8d1a-42f6-93be-3f059664163c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02882407-c571-499c-b887-c79e53864198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02882407-c571-499c-b887-c79e53864198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8d80ee15-2a93-40e0-bf3f-6241c4b39cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:to="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b0c1715-88e3-476f-8ea0-3347392de195_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b0c1715-88e3-476f-8ea0-3347392de195_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_36d3b9ae-31f2-4a84-a87e-4a1e95189164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:to="loc_us-gaap_RestrictedStockMember_36d3b9ae-31f2-4a84-a87e-4a1e95189164" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#CollaborationAgreementRelatedPartyDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails" xlink:type="extended" id="i9dad174e4eff4a19bfe11270aa804ca1_CollaborationAgreementRelatedPartyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_dbb08359-069d-40f8-a168-23fdcc68f9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_ProceedsFromCollaborators_dbb08359-069d-40f8-a168-23fdcc68f9a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_247302e2-7f11-43b9-abba-8c5530dce90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_247302e2-7f11-43b9-abba-8c5530dce90d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2538c7f4-777b-461c-ab05-d8bd2589c987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_NetIncomeLoss_2538c7f4-777b-461c-ab05-d8bd2589c987" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cd702ad8-8694-4691-b61f-5bfbbf5c7711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_EarningsPerShareBasic_cd702ad8-8694-4691-b61f-5bfbbf5c7711" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6ad7d1f8-9da6-45c2-bbd6-2526b2a763f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6ad7d1f8-9da6-45c2-bbd6-2526b2a763f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_87e529e4-35d1-42dd-af59-0972f987c049_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_87e529e4-35d1-42dd-af59-0972f987c049_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TakedaMember_d37359ae-c226-4866-80dd-10b60e579792" xlink:href="sttk-20210930.xsd#sttk_TakedaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:to="loc_sttk_TakedaMember_d37359ae-c226-4866-80dd-10b60e579792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7d10c437-ca1e-40b4-b07b-480fec78ec1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:to="loc_us-gaap_RelatedPartyDomain_7d10c437-ca1e-40b4-b07b-480fec78ec1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:to="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_3f920dcb-aa27-401b-9533-eccb3ea6097b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:to="loc_us-gaap_InvestorMember_3f920dcb-aa27-401b-9533-eccb3ea6097b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e640040d-3a19-4c82-91e4-6c9e3118663b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e640040d-3a19-4c82-91e4-6c9e3118663b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c1a9ffc9-ce39-4cd7-b96f-7a75dfef6a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c1a9ffc9-ce39-4cd7-b96f-7a75dfef6a88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_2765f302-d717-4b53-bc33-4aa4158c3a41_default" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_2765f302-d717-4b53-bc33-4aa4158c3a41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_e9bf8b0a-f27f-4362-95ed-4a1af468aa29" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_e9bf8b0a-f27f-4362-95ed-4a1af468aa29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b6b95385-8d18-4241-a1ae-e9813b55a165_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_b6b95385-8d18-4241-a1ae-e9813b55a165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_f7a81720-92ec-4c31-b540-70dc48eac6a3" xlink:href="sttk-20210930.xsd#sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:to="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_f7a81720-92ec-4c31-b540-70dc48eac6a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i244283240cff4d8d9febc11264d56588_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareholderOwnershipPercentage_e2e26d72-39d3-4f69-b454-e2f96d201cd5" xlink:href="sttk-20210930.xsd#sttk_ShareholderOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:to="loc_sttk_ShareholderOwnershipPercentage_e2e26d72-39d3-4f69-b454-e2f96d201cd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:to="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2f4cb31b-0242-41e9-82ff-a9515006c44d_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:to="loc_dei_EntityDomain_2f4cb31b-0242-41e9-82ff-a9515006c44d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:to="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TakedaMember_61539ce0-d877-442e-9e6c-cf81da0abd6b" xlink:href="sttk-20210930.xsd#sttk_TakedaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:to="loc_sttk_TakedaMember_61539ce0-d877-442e-9e6c-cf81da0abd6b" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>sttk-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sttk_OperatingAccountMember_1897407f-7f3b-4bde-87ed-0314006c443a_terseLabel_en-US" xlink:label="lab_sttk_OperatingAccountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Account</link:label>
    <link:label id="lab_sttk_OperatingAccountMember_label_en-US" xlink:label="lab_sttk_OperatingAccountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Account [Member]</link:label>
    <link:label id="lab_sttk_OperatingAccountMember_documentation_en-US" xlink:label="lab_sttk_OperatingAccountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_OperatingAccountMember" xlink:href="sttk-20210930.xsd#sttk_OperatingAccountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_OperatingAccountMember" xlink:to="lab_sttk_OperatingAccountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_2f896fb9-48dd-4328-9925-0d8c262a6f24_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_4a33f793-f5ff-43d2-b70d-4aef8523283a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_001030cf-abcf-421f-aa15-3bda14dda3b2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash financial activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_2ac51481-ff35-4460-bfb8-8c1c83665443_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cc905ef6-65ab-4e5f-bce6-caa25bc7bef0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of common stock previously subject to vesting requirements (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2aa88c79-5814-4e6e-a253-fecb9fcb0d39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_94cbb09e-e4f7-4fdd-9f41-04cf961e76f4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3255cd90-b767-418f-94ae-10b92574c563_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_42a4724c-5043-4394-ad32-b4c752792b7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7aefbf03-bf40-4ea0-a4b8-e17b2bb13d7a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_b1107689-1a4b-4bb3-b239-ae2352f58bcf_terseLabel_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in number of shares authorized, percentage of capital stock outstanding</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_label_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase In Number of Shares Authorized, Annual Increase Percentage</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_documentation_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase In Number of Shares Authorized, Annual Increase Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:to="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d8d9e05e-7c6b-4384-9307-b197dea28929_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_bfa6c99a-b585-4cd4-8f7d-2a6b46ff072c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0a027a68-140e-465d-a320-d1bea773d019_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c4815a44-2103-4259-a59a-c1f5e7392fde_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7b883c59-1354-4884-b386-4418121dfd9f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6f7666c2-9c59-419c-9ae1-62a6b26f3b84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6f497daf-94db-46ea-a7a7-85372fd89da0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_A2020EmployeeStockPurchasePlanMember_4799b0d8-39b0-4ae9-981f-6089e2ee8743_terseLabel_en-US" xlink:label="lab_sttk_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_sttk_A2020EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_sttk_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_sttk_A2020EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_sttk_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020EmployeeStockPurchasePlanMember" xlink:href="sttk-20210930.xsd#sttk_A2020EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_A2020EmployeeStockPurchasePlanMember" xlink:to="lab_sttk_A2020EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_20ee5d26-ddd5-43db-a0c3-7671582ce8e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_e325e21f-bfa3-41ef-9a9e-f3ec4da4558c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_cfd92695-fc01-4815-a764-07f9f0299b99_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_78336602-b554-4332-ac08-17a85a7ca9c2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_426ed59b-fd34-46ba-af3d-41529f6a06f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_db3f6676-d454-4c79-87d7-47df86a27389_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee during any one purchase period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_724f3920-50c2-4859-8128-f22c731990b0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_222d429f-eddb-4c1f-b5f1-3e66dc427a0f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7980a210-bb6e-447c-961a-ea93a923086a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_f6f8922a-d6ec-4444-9f8f-adaafcca627e_terseLabel_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate [Axis]</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_label_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate [Axis]</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_documentation_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:to="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_1a8b7336-df7a-4ae3-b08a-63b715c2b870_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_1d00bd4c-239c-42a7-a6bd-3bcffd3a3725_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a097404a-b682-4064-88b8-32c2374e3420_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_92aec38f-45a8-4aee-9f12-443594b2dff4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_6415cb8e-89cc-4809-b993-e6c4d15ba1ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross&#160;Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_be528ae9-9b59-4b58-82db-bed6653c4efd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bd2a414e-3a2b-44e9-b2d2-9eff0321da93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_68a6b653-f196-420e-8174-224d33637c63_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b3223363-0024-45be-9a72-aae862668cc3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d61f5849-3746-4abe-9eff-f89887cde033_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2026630f-6448-4f34-8668-cd4378a75bff_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_41581358-43bc-4d60-ba5a-44800b971a4b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_68158975-690d-4a99-a114-2465837ef0a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of available for sale short-term investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_AccruedResearchAndContractCostsCurrent_350dd94b-8ed4-40bf-9404-579525cd85c5_terseLabel_en-US" xlink:label="lab_sttk_AccruedResearchAndContractCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development contract costs</link:label>
    <link:label id="lab_sttk_AccruedResearchAndContractCostsCurrent_label_en-US" xlink:label="lab_sttk_AccruedResearchAndContractCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Contract Costs, Current</link:label>
    <link:label id="lab_sttk_AccruedResearchAndContractCostsCurrent_documentation_en-US" xlink:label="lab_sttk_AccruedResearchAndContractCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Contract Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedResearchAndContractCostsCurrent" xlink:href="sttk-20210930.xsd#sttk_AccruedResearchAndContractCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_AccruedResearchAndContractCostsCurrent" xlink:to="lab_sttk_AccruedResearchAndContractCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9f8354de-a008-4cef-ab22-d36afad22e95_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ea72dccd-771c-4bfe-a014-f9fc53cbfb3b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_df1f7912-92f6-4751-86a7-5211f3a5c9ef_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_57486218-5c56-42e7-918a-6426b2c9da53_terseLabel_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options and ESPP purchases (in shares)</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_label_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options Exercises And ESPP Purchases in Period</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_documentation_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options Exercised And ESPP Purchased in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:to="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_79e9b8f0-4f1c-4f15-ade2-b20168174bd3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_87ffb49b-d6b8-45ca-9c57-d814ec28cf05_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9351b5df-ae47-4a1f-b851-2520354ac5a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b2ce2154-7167-4731-bad8-ab7cfc86bba2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_88d9cf1b-f529-44d4-93b3-7d69dba3fe18_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_37366373-99a9-4f37-91b5-f0f46c26af5e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1dcda8da-3a75-4ec5-9a1e-d497596948b6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_833349f5-ed60-4068-aa9f-bc1194aca1fe_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e3862a16-bec8-48cf-86ad-c91bed1977df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_994047fa-b34b-45ef-848c-43d2debeef0f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_fb849a69-a792-4119-8e9a-6ee2a5a4d42e_terseLabel_en-US" xlink:label="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options and ESPP purchases</link:label>
    <link:label id="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_label_en-US" xlink:label="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised And ESPP Purchased</link:label>
    <link:label id="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_documentation_en-US" xlink:label="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised And ESPP Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:href="sttk-20210930.xsd#sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:to="lab_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_3481fe75-1065-4776-8452-6a5bbadf29cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (amortization) of short-term investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b5bc8c6-4936-4730-bc1e-8ceef2d28881_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_014cb4c8-0127-47ea-b37b-68df9d4f1307_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_75a0476e-3448-4cf9-a72a-86fbb81f4d7f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1c019bcc-9800-4f3b-a3de-cdb70f144d69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Remaining Contract Life (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0aba547d-698d-4646-ada8-75ecc44b4ce9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ec6ae5a9-9f17-4e36-a127-acad77fa7afd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_72e50f4b-25bd-4dd6-b575-bfab601150c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4248e81a-cdb1-468d-a268-339cc2942972_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue - related party</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_111a0588-2f24-43ea-8dca-18534b81d18a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c4818bd1-1ae4-49ad-b007-b9665a30d6aa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options and ESPP purchases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_e5673a18-c87b-49de-ace5-d0a07c3e68ea_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_618c3b75-7b48-47db-a4a4-b823fdad52e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_23690c6f-4c21-4256-b32f-18bbf66f98f5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_21771bab-bbf2-4b19-9d21-f7b63c987340_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9bba15c7-8464-41bb-b110-6555b9cf7dc8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_24456096-dd8b-4dbe-9861-cdb1508f7df9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_ShareholderOwnershipPercentage_2cb9cde1-ead6-4303-a062-4d6a98b408d0_terseLabel_en-US" xlink:label="lab_sttk_ShareholderOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder ownership percentage</link:label>
    <link:label id="lab_sttk_ShareholderOwnershipPercentage_label_en-US" xlink:label="lab_sttk_ShareholderOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Ownership Percentage</link:label>
    <link:label id="lab_sttk_ShareholderOwnershipPercentage_documentation_en-US" xlink:label="lab_sttk_ShareholderOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareholderOwnershipPercentage" xlink:href="sttk-20210930.xsd#sttk_ShareholderOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_ShareholderOwnershipPercentage" xlink:to="lab_sttk_ShareholderOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_4a063e92-21f0-43e5-9d4e-84cfc08d068f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a736d352-fff7-44df-8960-654a9d5bf577_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_ff8117b4-89f5-4228-a64e-6bd8d71aedce_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_A2020StockIncentivePlanMember_0e89e592-d8d4-4bb2-93d3-fb16bc518cae_terseLabel_en-US" xlink:label="lab_sttk_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan</link:label>
    <link:label id="lab_sttk_A2020StockIncentivePlanMember_label_en-US" xlink:label="lab_sttk_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_sttk_A2020StockIncentivePlanMember_documentation_en-US" xlink:label="lab_sttk_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020StockIncentivePlanMember" xlink:href="sttk-20210930.xsd#sttk_A2020StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_A2020StockIncentivePlanMember" xlink:to="lab_sttk_A2020StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d06149a3-719d-4278-a3af-7838a3d6268d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_91fa98c9-88ff-410f-8478-f10ee8df35d3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock in percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_76489587-ac83-4204-96d8-039e68bcff98_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_148bfa9e-2313-4efe-9661-042d56113b0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_0f9f029e-b2ac-44ff-84ef-d7fe51fda344_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_27782f81-9ab7-448d-9ba9-0d1c560d8e73_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collaborators</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_a27143fb-4b06-486e-a6ce-5ff1d14fae15_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b41723dd-ea55-4193-ab67-cabd8dd51356_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_faf5de7c-f1ca-4af4-a2b2-21d215c6d36e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_c544048c-2f08-4388-8a0c-eed3e1824cbd_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid amounts related to purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_356cb79f-cd48-4533-bf47-a85e85c80cd3_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_12926a8b-33d1-42c9-a9b7-3b43dcf7da3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_6e16b8b1-723a-4731-b640-0f69fe975e56_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_96b34c35-f90b-49fa-8b2d-31d811430282_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution limit in percentage of employee's eligible compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d2aaad6a-f542-4e6d-8bdf-bb138b88ff60_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2fc6ec9a-a219-44ac-ae37-9e5202f6ee4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_94c8a9f5-c916-4002-8a4e-b7e463504a62_negatedTerseLabel_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 additional issuance costs</link:label>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_label_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Additional Issuance Costs</link:label>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_documentation_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Additional Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:to="lab_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_29e24b72-1594-4815-8459-1c050e32976e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_d5d74e92-184d-447d-acd9-e7232840b101_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, average maturity term</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b8a6de6c-e957-4156-8b6a-343078ebe21a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_35b7a6b2-0a82-4c99-aea7-3d17fd323ab0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9c27c407-aeba-4824-b00f-aff13fdb081f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum_96f4dd2a-aed7-44c0-89f2-2c1a252a9165_terseLabel_en-US" xlink:label="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License agreement, maximum payment</link:label>
    <link:label id="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum_label_en-US" xlink:label="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement, Royalty Payments, Maximum</link:label>
    <link:label id="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum_documentation_en-US" xlink:label="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement, Royalty Payments, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:href="sttk-20210930.xsd#sttk_LicenseAgreementRoyaltyPaymentsMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:to="lab_sttk_LicenseAgreementRoyaltyPaymentsMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a44f2d0d-1e97-431f-854c-fccc26149c90_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8211; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7ce29cb5-ae1d-4ea2-be4f-82d59bcbe143_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in basic loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_8b9640ef-6a7a-42dc-a625-5f9b2436491b_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_07487689-8b96-43a3-8f20-d16ba6f75f28_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b10cf14a-78d7-4fd2-bada-cb922e67602a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd079ddb-5378-4648-a682-15c74a092720_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4d782b8b-492e-4e7a-8007-24432bd039c5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7535ad2-1adf-45ba-b761-fbc78b9fa6ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_93215401-2c67-43d2-a48a-b64bde9b9acf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestorMember_c7696026-e115-4a66-abd9-1cbc9e797afd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investor</link:label>
    <link:label id="lab_us-gaap_InvestorMember_label_en-US" xlink:label="lab_us-gaap_InvestorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestorMember" xlink:to="lab_us-gaap_InvestorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_38a2c0c3-3703-4099-9ee3-14b76fa11c6f_terseLabel_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, annual increase in number of shares authorized, term</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_label_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase In Number of Shares Authorized, Term</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_documentation_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase In Number of Shares Authorized, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:to="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_622cd571-de2e-43e6-b46f-5886a02a088f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_21d586b6-cc83-4c7c-ac28-3aed30ba5d7d_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_31a6c15a-1c5c-42ff-af80-b3e878697e06_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_32e95deb-bf8e-4de0-8ece-5d97902aa945_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock as converted to common stock</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_263c284a-f1ed-4389-bc2e-42751daa58f2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_c7342a12-e301-4d2a-8f65-cc10fa7cfc5f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_0d9729f5-58ec-4a22-a2de-90cf1520c9ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_29fb27c2-ac53-4c75-b3c3-7d0b047b6f4a_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_11cb49ab-bec3-465d-9990-69ec1646d653_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4741c4e8-1ac2-4c08-89fa-c0e1199d5ec5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding &#8211; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dbd97323-0584-4777-a73b-95f0a8886d56_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8211; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a070cad0-403b-4515-9ca7-a458d86a8974_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in diluted loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_2ed5f02c-2713-45c7-ab37-587164dec1bf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of preferred stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_b336e83a-946f-4e3a-932c-61a2e0e93829_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_27bc5b63-e3b6-49b1-bd52-a86d78ac9576_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_ac8f6d42-d08f-4b4f-a11e-696ff790307c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_720a500a-a571-493e-8b31-b974ceff093d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_beccf97d-f6dc-4ca5-8dab-6305ec87a61c_terseLabel_en-US" xlink:label="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued public offering costs in other assets</link:label>
    <link:label id="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_label_en-US" xlink:label="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred During Noncash Transaction</link:label>
    <link:label id="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_documentation_en-US" xlink:label="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred During Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:href="sttk-20210930.xsd#sttk_StockIssuanceCostsIncurredDuringNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:to="lab_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0631f993-cee8-4569-b453-0d3e5d25ead8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6f6cc032-a483-48db-b160-826cd49e3265_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_37e2f8fd-5ffe-4194-b4fb-48a091bb1323_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_985ce4da-c2a6-4ce8-8bde-45ea3b0997f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_TakedaMember_00d02ef0-de83-4191-ac99-7686fb312a01_terseLabel_en-US" xlink:label="lab_sttk_TakedaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda</link:label>
    <link:label id="lab_sttk_TakedaMember_label_en-US" xlink:label="lab_sttk_TakedaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda [Member]</link:label>
    <link:label id="lab_sttk_TakedaMember_documentation_en-US" xlink:label="lab_sttk_TakedaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TakedaMember" xlink:href="sttk-20210930.xsd#sttk_TakedaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_TakedaMember" xlink:to="lab_sttk_TakedaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_77e98420-fb5f-4e76-9871-3313043d8564_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_973bfa1b-b9a1-44e6-b7de-abf80636ea31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_303778e0-0895-49c5-9180-c3b20f5a88e4_terseLabel_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of redeemable convertible preferred stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_SeriesB1PreferredStockMember_9fc8ffba-b290-45cf-8b8a-cca4a1642dbe_terseLabel_en-US" xlink:label="lab_sttk_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_sttk_SeriesB1PreferredStockMember_label_en-US" xlink:label="lab_sttk_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Preferred Stock [Member]</link:label>
    <link:label id="lab_sttk_SeriesB1PreferredStockMember_documentation_en-US" xlink:label="lab_sttk_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_SeriesB1PreferredStockMember" xlink:to="lab_sttk_SeriesB1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ef4a29b2-3454-4edd-bbb4-c1c196944481_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_0e2ecfe5-bebf-405e-9c77-47aaacca92a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_dc8a2b93-93c0-4dcd-bf6b-feeaf521f897_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_54653c46-085c-4cbc-8db9-89132bb7050d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d9dc1641-8314-479f-bcd2-9f76f1d3e554_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_76e1a92c-8c27-4673-a849-ca45b1cdf638_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9737dfb2-4203-4bbf-8482-8449d9205e4a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_301925f0-4bd6-4713-94f2-36eb2e495e1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_011f10f6-5644-4f5f-8355-11f9f6ee64d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fd6adca4-a45c-466c-8ca1-abc631258d3f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de41532e-0d40-42b6-b8b3-0a58a1bf83e5_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_63443c00-c7e2-4c80-a4ec-70fb4168e994_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_cc34f3a6-b87c-4d6e-8965-1e34da03b41b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_5431e52a-71dc-4cd4-88d2-56abd3d6016f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_c6ff89da-f7ae-4bb4-983b-9f7208dab7e4_terseLabel_en-US" xlink:label="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision In Estimated Total Costs Related To Development Program</link:label>
    <link:label id="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_label_en-US" xlink:label="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision In Estimated Total Costs Related To Development Program [Member]</link:label>
    <link:label id="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_documentation_en-US" xlink:label="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision In Estimated Total Costs Related To Development Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:href="sttk-20210930.xsd#sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:to="lab_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b4491e61-a553-4bff-8dff-d62ebc8c5a92_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_19960c63-65c2-4d89-976f-69ed613389e5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_09a99ae7-293b-46f5-8b14-bce853b135f2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_c3ca9a0e-7daa-4c45-bc02-6ac1031dc2c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8570b58d-360c-4891-8bb0-eb25f6aa1412_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d7bb2d41-5c06-4f25-b6c2-c70c9ee5c805_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_34ae069e-4913-42b2-a648-322fab115486_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_43b3d78e-48ba-4a7c-b1bb-cde0567a17cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e49b762b-0abd-429c-b178-906e5028c423_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ee6be286-5884-43fe-8aee-2bb47e24d725_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_b745a943-5dc3-4006-bbfe-3f0080ef5f29_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense from operations</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d563b00b-30cb-4a8d-ba3c-8e4da83821e9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_c3d9a995-57ae-43d2-9ec4-16785bd178b1_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Obligations</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_TemporaryEquityPolicyTextBlock_68c69697-1bad-48ff-af73-da5a9f39bafd_terseLabel_en-US" xlink:label="lab_sttk_TemporaryEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_sttk_TemporaryEquityPolicyTextBlock_label_en-US" xlink:label="lab_sttk_TemporaryEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Policy Text Block]</link:label>
    <link:label id="lab_sttk_TemporaryEquityPolicyTextBlock_documentation_en-US" xlink:label="lab_sttk_TemporaryEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityPolicyTextBlock" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_TemporaryEquityPolicyTextBlock" xlink:to="lab_sttk_TemporaryEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e503c209-eb70-4d0e-9bbf-7ebbb0149d66_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_27ceb802-72b3-4ef4-97bf-f7bc11cbe9b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_5700bc29-5c7a-4745-88f6-9aa2b55813e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_277774dd-c269-4861-8955-3315f103c558_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3d9294a3-e548-4fe7-8091-f10e2e63bf17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_21f938dc-66a5-4a87-928a-6a7bf5aa68b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_fe0102b0-1cff-4f58-8317-cb74fec31356_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_d61c958a-55c9-46bd-8ff9-a9ce10aae33a_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_d752af2a-acd8-4edf-9578-a8854418f6b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future minimum rental payments for operating leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3d2f7e6a-7b01-48fa-89d5-33977d5ddd5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ae583717-d692-4b30-ad62-ae08ac11c643_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;average remaining contract life, outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_2fece764-695d-413e-8e48-dfde93e126e9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for public offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e26063dc-4140-4441-85fb-f2f7ec3af6cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1b441b5-61a6-42e3-8d76-2a5dfd2465a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b9ba2233-e5a3-4aee-a6e1-170074413cb9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1c601283-8043-4468-9c2c-c8ac4f848dcd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value: 300,000,000 shares authorized; 42,241,981 shares issued and outstanding at September&#160;30, 2021 and 41,779,183 shares issued and 41,767,431 shares outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cb388516-ad08-4a4e-b1b4-c7189667f150_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7b3793bd-d54d-483a-a2de-ed8c65d729a7_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_eb9f8712-1fc8-49b7-a5d2-82ecdccc5838_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average amortization period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d9700ce2-f28e-4bb8-8613-efebee120be9_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Unaudited Interim Financial Statements</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7f848b66-6a4e-4b69-bbb8-78b90cbf27c9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 5)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b1bad69b-a720-4c8e-9ca6-8fbc05fb4da4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_cf6810b2-e317-46c7-bf96-fb5e19374040_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9cf724c7-777d-4ebb-adf3-14c3cbc4b9df_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6e049b06-4135-4d7c-b56e-dd8ae0baacdb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;average remaining contract life, exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6b67ba6b-4cbd-4bbb-8409-bba6e650f229_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_a480ee70-e287-4c82-8ad2-3d92bf89dbc8_terseLabel_en-US" xlink:label="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_01d67078-5e6c-4fef-88a2-5523283871b6_totalLabel_en-US" xlink:label="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities And Employee-Related Liabilities, Current</link:label>
    <link:label id="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities And Employee-Related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:href="sttk-20210930.xsd#sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_a61a2670-3b01-4384-8524-dbcd8bfaeb41_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_84d24e11-93f0-4ff9-8efe-a1ae738470cd_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_a81a9f99-f2c9-4775-9dad-e0fd2faf1650_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock &#160;</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4521b5e8-b47e-4081-b57e-b962ed1a6b32_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c2259595-d6a8-473c-9921-1cada12600ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_beb0d5b1-74a5-4a1d-a8c9-ae8db6664e91_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_e8109529-450e-46b9-8935-7c29ed644b1e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bed90c48-75dd-410f-b927-1dfbbe0f982f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_594aad57-74e9-476e-a3ba-f057f1cd5ce7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_b7e3277e-c7b1-48c8-b1d2-b272d11aef55_terseLabel_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum value of shares per employee during any calendar year</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_label_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Shares Per Employee, Value</link:label>
    <link:label id="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_documentation_en-US" xlink:label="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Shares Per Employee, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:to="lab_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAbstract_24f24233-4eb1-4126-bb01-3e53c70aa269_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_731518f8-16bc-462c-9af0-255ebfbd971a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f372ec69-bcac-4390-ac24-556607e27af1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_c5aba681-70eb-4f04-bbf8-fbf9b5e60398_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_83316cac-ac92-46b9-8793-3b840b04cb8f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d878512d-94ee-42f8-924a-a7afaebc7f8d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_296b2002-5b39-42f1-9574-f67b446aac13_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_f2cb5e7e-ce59-4cd2-a7dd-4603a50dc42a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_e2760dd5-0f7a-4cff-a88c-399cac139bb8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cb83f060-3604-4ef5-afe3-6ff41b96bd0d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_cbfac40e-fb1a-4a58-aa06-f837bbf08bb4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3ba6557a-a0e3-49ac-9d47-dd471fb3d31a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_23ca13da-2de5-4cf6-a0de-a99c03b76ec2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, proceeds received</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_62a37e75-9454-4e11-8285-b5da4ad07006_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_adafab51-3979-414f-adc1-a4eb2eb06206_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_632dd8fd-159f-403c-a2f3-ac6ba4e27678_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f55b9882-6804-4355-b338-2d2b68328b42_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fa7041bc-6401-4979-8182-2945b4753d3c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39236770-63aa-41ff-bd6e-f006f950c47e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding &#8211; diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_40671e59-7dd9-4362-b7fb-fc7aed1626c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5e3ec770-0814-4110-876e-8a00fd778efb_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_dfd6bf02-5e54-4199-83f0-d2aff1328b9d_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_55aa5058-5c8e-4215-8e43-54d84933a3d8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:to="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3440612e-b4f7-4ef5-a577-0864ae779f81_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue - related party</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_71ad2a6f-c6ef-48ae-ba52-200402aa9a5b_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_60deb163-18d3-4b99-899f-a99c77a34d85_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2987f499-21b4-4269-8f52-8ff0db106890_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3e082f1d-6ac8-46f1-9828-87524daa662a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e5aa2888-404a-44ee-b19a-487400c2d4e9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_fef7aed3-4d0a-4390-9393-788c5ebf23f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of antidilutive securities excluded from computation of net loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_21539053-9a6d-4d76-9878-ccca7d41d839_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7ae5104f-d363-4b4b-88a9-b19e885b35f4_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1d838c1c-fcb4-4cf3-8428-8e571dc67433_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_175ea735-6db4-4425-83e2-376aef6fb821_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce6dbe56-dc36-44b7-8909-4a9f832a9768_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_88ff6137-6663-4bdc-b03d-a5102b1941b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0f1681e5-55fe-4a5b-aa28-d6f0d5dad126_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2789b3a1-871e-4ddb-b63a-161f7fe57533_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2a36f717-7ce5-4483-96d3-3918c30a161a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9520762a-d529-4a33-a0ff-72157f4a2e6f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_bdb9105b-1120-4eaa-b81e-498b70b068ef_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08491c70-573c-4463-8a9d-937eb6ae8e9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_ecf1a61b-35e9-4891-a0db-2a2f318ad5f0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_02190a15-5987-4d2b-8e02-729438332230_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement - Related Party</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_735ec816-8006-4d35-98c5-5c9d382f6d1c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term - years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_9e10a512-cd8d-4e53-89c0-0dc57fe1b678_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_275babf5-5c48-401b-a60c-9589b1e6f72c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of redeemable convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2fd0cbfd-11e7-47d2-a5e4-1eb0802a5825_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d0800d55-712b-4c7c-a06b-9c555eec7b8f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_579016f5-ca06-4cb5-a0e8-80e611dab4dd_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_4af86160-2cc6-49c0-84dc-ca07c398b13f_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_ecb71402-1c94-4258-abd5-554bc8f1a55c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b7c86b28-4506-411a-aae9-505b9e29b4b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_050c8111-038a-4e9b-9f18-f7530d570dff_terseLabel_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate, Adjustment</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_label_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate, Adjustment [Member]</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_documentation_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:to="lab_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_94da5458-1e5f-41f3-9ac2-6832549b46f8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c1d0a6d-fa62-4df9-ab4e-a8cc77abe128_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_676ab1f3-b463-41c4-a577-da9023b1a69d_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_dd62c981-a6af-4ba0-a64b-31f0cc1d763e_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fbe198d6-1b6c-4bfe-b3a4-be8eb05a7df0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_1fb18cf7-0922-4709-ab15-383f444695bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_cabdfa76-284d-4250-a6ec-878efa61662d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_63631629-17ff-4b22-a6e6-fef72b360b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_e96add03-4dd6-4021-9d73-6c8fb0b6303f_terseLabel_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate [Domain]</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_label_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate [Domain]</link:label>
    <link:label id="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_documentation_en-US" xlink:label="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Change Of Accounting Estimate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:to="lab_sttk_CumulativeEffectChangeOfAccountingEstimateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e5ffcead-b1c3-4aba-8a0e-3447c85c3761_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e73a1f02-7d6c-4cec-8b6b-a01ded18b505_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_4bd08208-af8e-4ba6-94c5-754ca30c2192_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8d759ea5-72ed-4253-bddd-735361b6d7be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sttk_IncreaseDecreaseInDeferredRentCredits_020c4e7e-54c9-48a1-bce5-27c2a3d8d984_negatedTerseLabel_en-US" xlink:label="lab_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_sttk_IncreaseDecreaseInDeferredRentCredits_label_en-US" xlink:label="lab_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent Credits</link:label>
    <link:label id="lab_sttk_IncreaseDecreaseInDeferredRentCredits_documentation_en-US" xlink:label="lab_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:href="sttk-20210930.xsd#sttk_IncreaseDecreaseInDeferredRentCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:to="lab_sttk_IncreaseDecreaseInDeferredRentCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b4873922-c3f0-4002-8192-45b4cad304d8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements (not yet adopted)</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a6da5104-210c-42ec-8306-9e182425aab5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_d33ed9c1-1d67-4dfe-9cf4-c716152f38ba_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_1125c41e-f5c7-4173-87d9-5c49674e75b8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of Series B redeemable convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_aa2c9fe7-b67b-4970-89f5-369dd1421558_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_47add9aa-5cfd-488c-9e27-7cfbd10a7cf7_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6bf13014-44cd-4d06-9c52-a7150f71ffac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1f438301-f6e6-46d8-87ea-95f90792b779_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_75b9e56b-dbac-42e8-8bb9-01ba391ee2cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b13dd304-d467-48e6-ba75-675f83b1f810_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f6716ce3-e8bb-4387-912d-f0c2a49690a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_96b6f6d4-a0c2-4478-b6a2-68f05ce62685_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a960795a-40dd-451b-9ca7-7279d049e1f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8dfbeb1a-cd52-4042-b8aa-1c3d487d0668_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_41fcc493-4b63-4f69-a06f-87fe27fe555f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0e16638c-45e4-48f7-83eb-1f617687dfd3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_f0ce1ded-47be-4b38-aab3-e52a06743ffd_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Description of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a79df8f-105d-4d0d-93cf-d8ce0eb05873_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_38714861-d29f-48ff-8fe7-898686be1874_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued royalty</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_b0521ab0-8fdf-4c9b-af33-413876575dfb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ddec1b5a-a5dc-4c88-b93a-0e20f55ef778_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related-Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_0f15bb4c-68d9-4ea8-8699-35bb79a3f1e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e879a02e-dd89-4c39-b23b-dc12d487ff17_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ded9252d-6102-4196-8bd4-73465697caa7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;average remaining contract life, vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>sttk-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:1495009e-5998-4d0d-a810-5b982fd2d04d,g:6de8a178-8cae-4588-9fe0-f6b82395519d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.shattucklabs.com/role/COVER" xlink:type="simple" xlink:href="sttk-20210930.xsd#COVER"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/COVER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8c0191e8-bce3-4eb1-af03-9d5d719ce91d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentType_8c0191e8-bce3-4eb1-af03-9d5d719ce91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d66ce5d6-cf94-4221-b7c5-422a8aae4cb1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentQuarterlyReport_d66ce5d6-cf94-4221-b7c5-422a8aae4cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_45052a3d-24e1-44b2-bd5c-16e1f4c4836e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentPeriodEndDate_45052a3d-24e1-44b2-bd5c-16e1f4c4836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3348c31a-67aa-4bdb-b204-4a3f64159927" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentTransitionReport_3348c31a-67aa-4bdb-b204-4a3f64159927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0fd6773c-ddff-4ec5-887d-cc62e50c91fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityFileNumber_0fd6773c-ddff-4ec5-887d-cc62e50c91fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c1bd47e4-81ae-42b1-a852-07be5d7c1756" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityRegistrantName_c1bd47e4-81ae-42b1-a852-07be5d7c1756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1e40c413-4368-42a4-9f7c-c31743adf0ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1e40c413-4368-42a4-9f7c-c31743adf0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e4216e72-07bb-4f25-b2ac-6a0fc343563e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityTaxIdentificationNumber_e4216e72-07bb-4f25-b2ac-6a0fc343563e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bb0cb8fd-f6a8-4516-8ce0-2a150fea67dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityAddressAddressLine1_bb0cb8fd-f6a8-4516-8ce0-2a150fea67dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_da721074-1e40-4d98-baa5-b6a9c55b9d7a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityAddressAddressLine2_da721074-1e40-4d98-baa5-b6a9c55b9d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fbac54f4-8861-4829-bde6-fcea4fbb01fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityAddressCityOrTown_fbac54f4-8861-4829-bde6-fcea4fbb01fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4264f86a-0438-4e8f-a651-a17a377b5690" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityAddressStateOrProvince_4264f86a-0438-4e8f-a651-a17a377b5690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3d7799e3-d8c3-4da8-9c30-9703975dbcc4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityAddressPostalZipCode_3d7799e3-d8c3-4da8-9c30-9703975dbcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a76ea76e-d114-4510-a8e2-0e757584f73e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_CityAreaCode_a76ea76e-d114-4510-a8e2-0e757584f73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f0d0310f-792a-4189-a7c6-9e6db4921f4b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_LocalPhoneNumber_f0d0310f-792a-4189-a7c6-9e6db4921f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_dfadd1a5-cf6c-462b-aa0a-7c3aa18c8058" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_Security12bTitle_dfadd1a5-cf6c-462b-aa0a-7c3aa18c8058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f0c0f086-0136-4538-998b-85e3af789e11" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_TradingSymbol_f0c0f086-0136-4538-998b-85e3af789e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d8bcd4c8-617b-4785-b9a0-f1f29705491e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_SecurityExchangeName_d8bcd4c8-617b-4785-b9a0-f1f29705491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a1f036da-937a-4568-91a6-b76da707c9e0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityCurrentReportingStatus_a1f036da-937a-4568-91a6-b76da707c9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0709d5b5-3a89-40e0-a940-caf455b5d3fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityInteractiveDataCurrent_0709d5b5-3a89-40e0-a940-caf455b5d3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a57449c6-f048-4a00-bdcb-1fc80626adc5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityFilerCategory_a57449c6-f048-4a00-bdcb-1fc80626adc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_74a14727-c3e4-47f1-931e-ee9c5da0093d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntitySmallBusiness_74a14727-c3e4-47f1-931e-ee9c5da0093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_716e8d33-66b1-41bd-87d4-2f3fd5237a19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityEmergingGrowthCompany_716e8d33-66b1-41bd-87d4-2f3fd5237a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_fe9264a6-04d1-4795-9268-8843bfd0d2ba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityExTransitionPeriod_fe9264a6-04d1-4795-9268-8843bfd0d2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d4b2ce56-704b-46cb-9086-063126e68d23" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityShellCompany_d4b2ce56-704b-46cb-9086-063126e68d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6dbe4bf1-7b4c-4d68-b2e4-4582e59a2b83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6dbe4bf1-7b4c-4d68-b2e4-4582e59a2b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d3c37c55-9ef2-40e2-9471-8d57409b4cc5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_EntityCentralIndexKey_d3c37c55-9ef2-40e2-9471-8d57409b4cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_47d1e014-75aa-4c13-b379-afaa4019b3c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_AmendmentFlag_47d1e014-75aa-4c13-b379-afaa4019b3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7c3c44f6-f553-4ca2-8e47-aa98a40debeb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentFiscalYearFocus_7c3c44f6-f553-4ca2-8e47-aa98a40debeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_71309dcf-2994-4479-a6c7-7c3bee0c5ea2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_DocumentFiscalPeriodFocus_71309dcf-2994-4479-a6c7-7c3bee0c5ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b8bc80b8-b670-42fb-9ffd-5d94b6f88deb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f61b571-11ac-4aa1-aeb1-8fdca6667540" xlink:to="loc_dei_CurrentFiscalYearEndDate_b8bc80b8-b670-42fb-9ffd-5d94b6f88deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BALANCESHEETS" xlink:type="simple" xlink:href="sttk-20210930.xsd#BALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a02a0292-9b57-4974-b3eb-90ba531a6898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a02a0292-9b57-4974-b3eb-90ba531a6898" xlink:to="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:to="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_179d3085-c5bf-4dd5-8b5d-e093d453c39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_179d3085-c5bf-4dd5-8b5d-e093d453c39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d7c23409-96e2-416a-a586-e39417787ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d7c23409-96e2-416a-a586-e39417787ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_04942971-d3f1-4810-9020-74d69014b03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_04942971-d3f1-4810-9020-74d69014b03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7eb7fac4-8ad9-479c-a707-ff0a399f86c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26e25f10-fcca-4889-838b-961de5b520a3" xlink:to="loc_us-gaap_AssetsCurrent_7eb7fac4-8ad9-479c-a707-ff0a399f86c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_00757678-638b-4fdf-ad62-1ae0886d6d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_00757678-638b-4fdf-ad62-1ae0886d6d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a6c8feab-aaeb-4f55-9cfe-c978adb9336b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a6c8feab-aaeb-4f55-9cfe-c978adb9336b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fcecf4af-c4f8-4ed2-a585-eaaede234348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_037c12bb-41f3-4902-bd00-f1cb12680407" xlink:to="loc_us-gaap_Assets_fcecf4af-c4f8-4ed2-a585-eaaede234348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a02a0292-9b57-4974-b3eb-90ba531a6898" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_89a42c2e-56ce-4f22-8c9e-3acbdf7f4c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:to="loc_us-gaap_AccountsPayableCurrent_89a42c2e-56ce-4f22-8c9e-3acbdf7f4c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_9fd09a2f-7965-4123-a05d-a20ae1fc0511" xlink:href="sttk-20210930.xsd#sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:to="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_9fd09a2f-7965-4123-a05d-a20ae1fc0511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d193a80-b330-4147-b1be-f96cbe372304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8d193a80-b330-4147-b1be-f96cbe372304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b69aba8a-8c3d-4518-b244-77681fb09372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_56b95b19-3d64-493f-9c58-deb822d79465" xlink:to="loc_us-gaap_LiabilitiesCurrent_b69aba8a-8c3d-4518-b244-77681fb09372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_18f9836b-d97a-4149-9130-4d9c9eca457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_18f9836b-d97a-4149-9130-4d9c9eca457c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_7a635813-23c3-4da4-ac82-e824315c13f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_7a635813-23c3-4da4-ac82-e824315c13f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_300200ff-f42f-4788-8ce6-ab5bee90bde3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_Liabilities_300200ff-f42f-4788-8ce6-ab5bee90bde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f38080b2-7102-48d7-b88d-d33d244772a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f38080b2-7102-48d7-b88d-d33d244772a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0748be23-9eb7-4b1f-be24-db6dc5394d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:to="loc_us-gaap_CommonStockValue_0748be23-9eb7-4b1f-be24-db6dc5394d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1f4a4c5a-98e1-4aeb-80df-6cff3d9638fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1f4a4c5a-98e1-4aeb-80df-6cff3d9638fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8e357e10-0606-4e3b-9eb9-70153d1ac445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8e357e10-0606-4e3b-9eb9-70153d1ac445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1eb1481b-23d9-462a-8f96-bf2e3e071486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1eb1481b-23d9-462a-8f96-bf2e3e071486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f8417f65-a0a6-4e1f-aea7-54f1767e6f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1acdaa7c-f7d8-43fd-95bd-870c32edc42d" xlink:to="loc_us-gaap_StockholdersEquity_f8417f65-a0a6-4e1f-aea7-54f1767e6f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc8e7f88-1340-4b83-974f-a30f15369a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d98a7109-2871-46a5-9475-6d253e96b765" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc8e7f88-1340-4b83-974f-a30f15369a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BALANCESHEETSParenthetical" xlink:type="simple" xlink:href="sttk-20210930.xsd#BALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_50ec9010-2583-4d8f-b035-aa8802cb37d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d165baad-70ff-4381-8039-00a397de4bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_50ec9010-2583-4d8f-b035-aa8802cb37d7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d165baad-70ff-4381-8039-00a397de4bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6598e82f-3c54-4da3-99d0-4a049b60185f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_50ec9010-2583-4d8f-b035-aa8802cb37d7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6598e82f-3c54-4da3-99d0-4a049b60185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ca437991-a351-4234-9a5b-85f238b1f19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_50ec9010-2583-4d8f-b035-aa8802cb37d7" xlink:to="loc_us-gaap_CommonStockSharesIssued_ca437991-a351-4234-9a5b-85f238b1f19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4c4ec197-0804-4b21-98a4-3d1e104257fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_50ec9010-2583-4d8f-b035-aa8802cb37d7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4c4ec197-0804-4b21-98a4-3d1e104257fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_eca5ed45-3529-410a-beab-ccd3cb91f60a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_eca5ed45-3529-410a-beab-ccd3cb91f60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8eaafcc2-5546-4839-8ca0-c57cf2a38388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8eaafcc2-5546-4839-8ca0-c57cf2a38388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d594b4a2-ae41-41c2-ba19-0a5039df423b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d594b4a2-ae41-41c2-ba19-0a5039df423b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4c66b6e5-9e72-4add-8578-a1372e18990d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d594b4a2-ae41-41c2-ba19-0a5039df423b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4c66b6e5-9e72-4add-8578-a1372e18990d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_013024fa-39c2-422f-b496-467892dc9b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d594b4a2-ae41-41c2-ba19-0a5039df423b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_013024fa-39c2-422f-b496-467892dc9b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d956ab34-1544-4c4e-aa31-98181c78265a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d594b4a2-ae41-41c2-ba19-0a5039df423b" xlink:to="loc_us-gaap_OperatingExpenses_d956ab34-1544-4c4e-aa31-98181c78265a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c38bab5-675f-48ab-9550-53b0a68cef68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c38bab5-675f-48ab-9550-53b0a68cef68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_db6bada3-3460-4ab9-8407-b1f1b464166e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_db6bada3-3460-4ab9-8407-b1f1b464166e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6e0e2b45-b666-42b4-9174-2962120e7498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_db6bada3-3460-4ab9-8407-b1f1b464166e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6e0e2b45-b666-42b4-9174-2962120e7498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_20ade53d-dbf2-46a6-bdde-8ff082124c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_db6bada3-3460-4ab9-8407-b1f1b464166e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_20ade53d-dbf2-46a6-bdde-8ff082124c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9b2a72e9-fd0d-40be-a85f-0c24bad08d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_db6bada3-3460-4ab9-8407-b1f1b464166e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9b2a72e9-fd0d-40be-a85f-0c24bad08d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dba47721-f0c0-45d6-90dd-784e3d786483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_NetIncomeLoss_dba47721-f0c0-45d6-90dd-784e3d786483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_23d5b196-d1e2-4469-b964-4f051741f959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_23d5b196-d1e2-4469-b964-4f051741f959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_80f18a56-c5d8-4559-9aaf-2ee68dcb2a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_80f18a56-c5d8-4559-9aaf-2ee68dcb2a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_46dc26f5-49fe-419a-8b4e-329f2c107493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_EarningsPerShareBasic_46dc26f5-49fe-419a-8b4e-329f2c107493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b8903e5b-02de-462c-b122-0496d023a2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b8903e5b-02de-462c-b122-0496d023a2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_71c675d3-367d-4177-996e-7c4ebfdc92be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_71c675d3-367d-4177-996e-7c4ebfdc92be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3bfeee2b-6aa7-4724-a5d0-349c01939ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_37047536-74b0-4afd-bf75-8e0b4eb6436c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3bfeee2b-6aa7-4724-a5d0-349c01939ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_780e49cf-9078-46eb-a5bc-126e11e52702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_780e49cf-9078-46eb-a5bc-126e11e52702" xlink:to="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3f75304-c261-4928-b15f-9d78299954f4" xlink:to="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_6ff968a9-43b3-47e6-bf8a-1c20e4128d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_6ff968a9-43b3-47e6-bf8a-1c20e4128d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a1877e69-a270-4956-bb3f-e12d6abc4356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a1877e69-a270-4956-bb3f-e12d6abc4356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_c7aa538a-03b2-4144-95f7-ff4be1941467" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_71e23405-4ff0-47e6-846a-916520bf0279" xlink:to="loc_sttk_SeriesB1PreferredStockMember_c7aa538a-03b2-4144-95f7-ff4be1941467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ba9d773-7a04-4941-91fb-ef8e5603f240" xlink:to="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_198f8c16-1b1f-42aa-9ecd-1a13d4ceb6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_CommonStockMember_198f8c16-1b1f-42aa-9ecd-1a13d4ceb6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_95bcedac-ceda-40d3-952e-03e2d454ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_95bcedac-ceda-40d3-952e-03e2d454ad33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b72f7f1c-1f64-4907-b332-3eb5ef3caf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b72f7f1c-1f64-4907-b332-3eb5ef3caf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5f76a2e4-70f0-4fb0-b52f-288b6857ecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_debba222-4b7c-4923-85d4-7ecc91c1f483" xlink:to="loc_us-gaap_RetainedEarningsMember_5f76a2e4-70f0-4fb0-b52f-288b6857ecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32ba1c87-167d-4e45-b808-8c25ee01ce4e" xlink:to="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bfb8a659-a307-44bc-a26e-abd676a1f781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_SharesOutstanding_bfb8a659-a307-44bc-a26e-abd676a1f781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a4d9c47f-ba5e-4a52-8472-df876bd429fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockholdersEquity_a4d9c47f-ba5e-4a52-8472-df876bd429fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61607f73-5d73-47fe-8987-976a49170fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61607f73-5d73-47fe-8987-976a49170fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e55619cb-4ba8-41ef-b92b-a536051384c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e55619cb-4ba8-41ef-b92b-a536051384c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_cde9d0ac-d4e0-4675-85e3-883b63405904" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod_cde9d0ac-d4e0-4675-85e3-883b63405904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_b4817569-eb6c-4cd8-86a2-5ef5419ebc8e" xlink:href="sttk-20210930.xsd#sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased_b4817569-eb6c-4cd8-86a2-5ef5419ebc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3aff1787-c6aa-43de-9efa-d4ad7421889b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3aff1787-c6aa-43de-9efa-d4ad7421889b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48866707-13a6-4c66-bdcf-e8a555bcfb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48866707-13a6-4c66-bdcf-e8a555bcfb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9ddbb96-3c85-4123-8fb7-3223e8996669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9ddbb96-3c85-4123-8fb7-3223e8996669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_360b83e6-66e8-4d6c-a105-d7882dad76dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_NetIncomeLoss_360b83e6-66e8-4d6c-a105-d7882dad76dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3a9e3b1f-843c-495a-a524-bceed41e5ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_SharesOutstanding_3a9e3b1f-843c-495a-a524-bceed41e5ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5f357f80-c903-49e9-8b1d-412d91136f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f9fa746a-223f-401d-8d04-6ccd9034c460" xlink:to="loc_us-gaap_StockholdersEquity_5f357f80-c903-49e9-8b1d-412d91136f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56a87f8c-31e6-47ee-a115-11ec4a4d6015" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_547acbdb-390a-408e-8f24-a75fe00fa4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_547acbdb-390a-408e-8f24-a75fe00fa4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a270cd24-8cf0-4ceb-a868-83a355268de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a270cd24-8cf0-4ceb-a868-83a355268de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_91e6be8e-c108-4706-9386-069d9ba6ba5e" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_91e6be8e-c108-4706-9386-069d9ba6ba5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_cccde38f-9978-4b56-aeab-bd2ef3c06602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_cccde38f-9978-4b56-aeab-bd2ef3c06602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_88ed5306-75dd-4ef1-86b5-9bf13cdda331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_88ed5306-75dd-4ef1-86b5-9bf13cdda331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_92903faa-d280-4b1c-9111-b60c63ea18ff" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts_92903faa-d280-4b1c-9111-b60c63ea18ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_630d9015-2624-46cb-b5f6-6fbada509709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1960fdaa-6eaa-4c15-b879-75634b5c55f4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_630d9015-2624-46cb-b5f6-6fbada509709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sttk-20210930.xsd#STATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4e8f5406-b57c-40c8-b570-aa5f863509a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e8f5406-b57c-40c8-b570-aa5f863509a8" xlink:to="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6df7d05f-f552-49e4-83ce-26d2a5500036" xlink:to="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_ab6fbed0-d75b-4959-98cc-a97d39e22325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_ab6fbed0-d75b-4959-98cc-a97d39e22325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_660c2a31-450c-460d-81c1-da2d2f6d6c65" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c371b2f9-367b-45fe-8014-cca62de7e46f" xlink:to="loc_sttk_SeriesB1PreferredStockMember_660c2a31-450c-460d-81c1-da2d2f6d6c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27392fa1-887f-4bf9-8568-497ce4ddd06e" xlink:to="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6185a6bc-909e-4eee-9478-34d56cb5da88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:to="loc_us-gaap_NetIncomeLoss_6185a6bc-909e-4eee-9478-34d56cb5da88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2350e99d-8669-4260-b2d7-63170506a6bb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5510458f-8e92-431e-8ecc-b2a45edf6c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_ShareBasedCompensation_5510458f-8e92-431e-8ecc-b2a45edf6c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d0804ec9-a062-4a64-8896-db9a91a0c312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_Depreciation_d0804ec9-a062-4a64-8896-db9a91a0c312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_a5e7f595-994a-4b02-917b-8ebfe8b39a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_a5e7f595-994a-4b02-917b-8ebfe8b39a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ea8c3958-2791-4419-97b0-649e56cecbe4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5278fd-30f3-47ce-9c22-be3ee71cac85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5278fd-30f3-47ce-9c22-be3ee71cac85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9d98bd04-0c73-4ed4-8194-9100a417a90a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9d98bd04-0c73-4ed4-8194-9100a417a90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_24b2e4e1-93d7-4cf7-a3ee-b807a575c411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_24b2e4e1-93d7-4cf7-a3ee-b807a575c411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_adec80bb-5f31-4578-ab59-fdcca2cc0a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_adec80bb-5f31-4578-ab59-fdcca2cc0a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4981ee39-c774-420c-8b3f-4c9452e2f0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4981ee39-c774-420c-8b3f-4c9452e2f0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_IncreaseDecreaseInDeferredRentCredits_902328ca-118c-44e7-8481-66d3ade06a4c" xlink:href="sttk-20210930.xsd#sttk_IncreaseDecreaseInDeferredRentCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_sttk_IncreaseDecreaseInDeferredRentCredits_902328ca-118c-44e7-8481-66d3ade06a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b022e583-34c6-45e6-804a-65cd1a270b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9573715-7469-4cc3-8640-d98d4d42f926" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b022e583-34c6-45e6-804a-65cd1a270b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8ee92aba-92d7-4282-8667-437999a47740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8ee92aba-92d7-4282-8667-437999a47740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93656ba6-8bb1-46bb-a77b-952dd00aacbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_93656ba6-8bb1-46bb-a77b-952dd00aacbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_52700ca1-9e7e-42a6-add4-bdf687bfa4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_52700ca1-9e7e-42a6-add4-bdf687bfa4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b117d472-6520-4f5f-b31a-6548cd91026c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4084274d-1f15-43fa-a79e-6416e3d64d50" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b117d472-6520-4f5f-b31a-6548cd91026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0ced8ae9-c281-48a4-8182-59f9fde05540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0ced8ae9-c281-48a4-8182-59f9fde05540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0d99fae4-90da-41b2-9f0a-33017ffb4e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0d99fae4-90da-41b2-9f0a-33017ffb4e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3d5cc766-f0f3-4082-a05d-64cc708a557d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3d5cc766-f0f3-4082-a05d-64cc708a557d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c598590-5b03-45cc-9b25-5a489190c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_781bf80c-7557-46e2-ad77-4bf7bab8f383" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c598590-5b03-45cc-9b25-5a489190c8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a6129fe-814d-43a7-89f5-f8cf190ea40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a6129fe-814d-43a7-89f5-f8cf190ea40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be9d39c4-0976-48ff-b2e6-aecc59dcb2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be9d39c4-0976-48ff-b2e6-aecc59dcb2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_540020ab-b58d-4d07-a6f6-d951893feb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_540020ab-b58d-4d07-a6f6-d951893feb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f3bacfc1-2ad5-49df-8538-d1cae0cd1147" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_80c7e284-3110-4884-9a68-f813f5cd6ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_80c7e284-3110-4884-9a68-f813f5cd6ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_07b4360e-c38c-49b0-8f0d-491daf3ca80d" xlink:href="sttk-20210930.xsd#sttk_StockIssuanceCostsIncurredDuringNoncashTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction_07b4360e-c38c-49b0-8f0d-491daf3ca80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d1055987-885b-45c0-b139-5b402451eca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1e309200-85ea-42ee-84e2-7daa5422f528" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d1055987-885b-45c0-b139-5b402451eca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="sttk-20210930.xsd#OrganizationandDescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b0e92917-6f97-44c9-9245-7cee38c84198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_65540f8e-eace-47c6-9015-5732a12d9797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b0e92917-6f97-44c9-9245-7cee38c84198" xlink:to="loc_us-gaap_NatureOfOperations_65540f8e-eace-47c6-9015-5732a12d9797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c6310a7-f619-46a7-9144-2a9f0c5d667d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_256fb353-62c1-49dd-a49c-e8311a00769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c6310a7-f619-46a7-9144-2a9f0c5d667d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_256fb353-62c1-49dd-a49c-e8311a00769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ca69f6b5-856e-41b6-91ea-dfb3184488de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c6310a7-f619-46a7-9144-2a9f0c5d667d" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ca69f6b5-856e-41b6-91ea-dfb3184488de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1dbef2b6-999d-4fb4-b505-3968b49f5ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2af273c5-1ce3-4b0e-8166-5c2c6d18b9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1dbef2b6-999d-4fb4-b505-3968b49f5ddc" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2af273c5-1ce3-4b0e-8166-5c2c6d18b9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0412a2dd-ccc2-4c82-a30c-309aefb2f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0412a2dd-ccc2-4c82-a30c-309aefb2f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_71ae3162-38b1-4d3f-9eb0-1aa01abc38c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_UseOfEstimates_71ae3162-38b1-4d3f-9eb0-1aa01abc38c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_8428aa1a-ca3b-4748-ad91-2fb63652eb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_8428aa1a-ca3b-4748-ad91-2fb63652eb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_3e7ad0d7-4eba-477f-9a28-af54fe50d298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_3e7ad0d7-4eba-477f-9a28-af54fe50d298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_f871d5d4-e6c4-4c1e-97ba-fa11027264ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_f871d5d4-e6c4-4c1e-97ba-fa11027264ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_b98af140-a701-4eda-b8a7-93ece9379c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_b98af140-a701-4eda-b8a7-93ece9379c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_832754b7-7a66-4ec6-bbcf-6ad75c88ee45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_832754b7-7a66-4ec6-bbcf-6ad75c88ee45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TemporaryEquityPolicyTextBlock_df770fa8-3e57-463d-a507-c28b26eb658e" xlink:href="sttk-20210930.xsd#sttk_TemporaryEquityPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_sttk_TemporaryEquityPolicyTextBlock_df770fa8-3e57-463d-a507-c28b26eb658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_da963721-787a-437e-867f-d38d210c8e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_da963721-787a-437e-867f-d38d210c8e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_787d439b-5343-4e15-ba24-9a714d83640c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_787d439b-5343-4e15-ba24-9a714d83640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_bd3eeab8-65dc-4d38-b6dd-c0ff0c0c4199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_bd3eeab8-65dc-4d38-b6dd-c0ff0c0c4199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_590b2aab-eaf0-4ccc-ba1c-1cc98e8bdd95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_590b2aab-eaf0-4ccc-ba1c-1cc98e8bdd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ec7296d3-98ad-4e67-97c1-028cf137da03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d6b76b5-ec1d-4863-b866-70b95b456f81" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ec7296d3-98ad-4e67-97c1-028cf137da03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9f805427-5bcd-49a0-be82-326e225b6235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_eb3ffcef-9681-42f5-b2be-1f1c482f26f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9f805427-5bcd-49a0-be82-326e225b6235" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_eb3ffcef-9681-42f5-b2be-1f1c482f26f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_734a10f8-ebc9-476e-ae38-9ec5bfe52d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_734a10f8-ebc9-476e-ae38-9ec5bfe52d18" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_221bebcc-0b16-4aba-b346-b8ecea05e32b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_OperatingAccountMember_dab93b39-e954-4c2b-91ba-0d984126c561" xlink:href="sttk-20210930.xsd#sttk_OperatingAccountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_sttk_OperatingAccountMember_dab93b39-e954-4c2b-91ba-0d984126c561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_172c2434-ab9b-423c-a361-ce88732aea51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_us-gaap_MoneyMarketFundsMember_172c2434-ab9b-423c-a361-ce88732aea51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_61748a38-fee5-4a73-98f5-7ce52373b6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5e62ef1a-18ad-4430-b495-177710a20195" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_61748a38-fee5-4a73-98f5-7ce52373b6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_544e56f9-21b2-4e90-9701-e06b4d36ee27" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a03da9be-54ed-4aee-9419-f1653394e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_e45691cc-700a-4cf0-b999-f157a7c96ee1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a03da9be-54ed-4aee-9419-f1653394e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d90d5118-2d16-4209-bf1a-8fe1d7be4d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d90d5118-2d16-4209-bf1a-8fe1d7be4d5a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_55718709-5711-4a4b-bcf2-8ff1c1c101ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ba1cb23d-8644-4f7e-b05a-8418f2a48dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ba1cb23d-8644-4f7e-b05a-8418f2a48dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_10f45839-3b63-4b60-982a-fc7ac057c988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_10f45839-3b63-4b60-982a-fc7ac057c988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_85440a4c-c43a-4687-be56-daa82a9908de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a8164807-7fd7-4d3e-82e9-957cdb0acb06" xlink:to="loc_us-gaap_RestrictedStockMember_85440a4c-c43a-4687-be56-daa82a9908de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d72f280d-0e21-4312-8696-5d635d307559" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_58452e2c-4e78-43a4-af86-a1fc57c38790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5231dfd-96da-40b7-af89-751be00fd30b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_58452e2c-4e78-43a4-af86-a1fc57c38790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestments" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestments"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0f8bd52a-ca29-4c87-aced-61247c63b56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_daa2924f-9db1-41c2-bd89-2fd928358a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0f8bd52a-ca29-4c87-aced-61247c63b56c" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_daa2924f-9db1-41c2-bd89-2fd928358a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsTables" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_12cf2b6d-dc9b-4f01-82c7-f892d9bb59a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1216c76b-fa09-43fe-b313-21d526a2153b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_12cf2b6d-dc9b-4f01-82c7-f892d9bb59a9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1216c76b-fa09-43fe-b313-21d526a2153b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fe5d89fe-54ea-470d-bb46-4e398681da1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fe5d89fe-54ea-470d-bb46-4e398681da1b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e3233bdd-2c28-423f-b0f2-b98fc2d17033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_60c240c2-f226-42db-97cf-1d8231471385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12cc6f4b-c76e-4a07-bb1f-8618ecef2e87" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_60c240c2-f226-42db-97cf-1d8231471385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c04fec22-bd6d-4af7-a8b5-11855da8e5f6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_36de5a50-87a0-48fe-94b5-fce31f480266" xlink:to="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6a51aed-27f8-4b8f-a265-ebd3fb58d755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6a51aed-27f8-4b8f-a265-ebd3fb58d755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_fa0d7e46-2ff2-411e-9305-8765c29972a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_fa0d7e46-2ff2-411e-9305-8765c29972a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28649169-f551-4e71-9a1f-35112618fcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAbstract_ea3a551b-db4b-43d9-8597-8a3287497fb9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28649169-f551-4e71-9a1f-35112618fcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#ShortTermInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cf72a5eb-8379-4481-9794-a0af1a1327ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_14800dd0-450d-4337-a003-4b129dc50ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cf72a5eb-8379-4481-9794-a0af1a1327ea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_14800dd0-450d-4337-a003-4b129dc50ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/AccruedExpenses" xlink:type="simple" xlink:href="sttk-20210930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_74b41eb2-8ae3-44b4-9644-27483c8d0d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_a605f3e4-69de-488d-a9df-3ca4a717a5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_74b41eb2-8ae3-44b4-9644-27483c8d0d02" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_a605f3e4-69de-488d-a9df-3ca4a717a5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="sttk-20210930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_a32711ba-405e-42ed-ba70-036ad2a61edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7ff8e181-7a1a-4869-af44-344c1e75ad8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a32711ba-405e-42ed-ba70-036ad2a61edb" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7ff8e181-7a1a-4869-af44-344c1e75ad8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#AccruedExpensesScheduleofaccruedexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d2e31a50-3f4c-4828-95f6-bbb5a5922d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedResearchAndContractCostsCurrent_84c53ecc-f32b-41dc-9406-7886c2446a26" xlink:href="sttk-20210930.xsd#sttk_AccruedResearchAndContractCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d2e31a50-3f4c-4828-95f6-bbb5a5922d5e" xlink:to="loc_sttk_AccruedResearchAndContractCostsCurrent_84c53ecc-f32b-41dc-9406-7886c2446a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_69b408fb-51c9-4043-995a-5e7b6626aeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d2e31a50-3f4c-4828-95f6-bbb5a5922d5e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_69b408fb-51c9-4043-995a-5e7b6626aeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3156f5e-151c-4e21-92e1-9ad3a54eddbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d2e31a50-3f4c-4828-95f6-bbb5a5922d5e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3156f5e-151c-4e21-92e1-9ad3a54eddbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_3934a08e-a15f-48eb-a423-1ca71ae5406a" xlink:href="sttk-20210930.xsd#sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d2e31a50-3f4c-4828-95f6-bbb5a5922d5e" xlink:to="loc_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent_3934a08e-a15f-48eb-a423-1ca71ae5406a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sttk-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8f5f95d-1b44-4cf1-9dd3-adf67c22e4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_00648d73-8977-4b60-8a2f-d069a68054a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8f5f95d-1b44-4cf1-9dd3-adf67c22e4c1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_00648d73-8977-4b60-8a2f-d069a68054a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="sttk-20210930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7cb70c64-1aff-478f-bed2-b517356ec74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_d9769bcb-6621-441b-8d97-8b6b8c8f1e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7cb70c64-1aff-478f-bed2-b517356ec74f" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_d9769bcb-6621-441b-8d97-8b6b8c8f1e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_24e6f6dd-d18a-4a8b-92ba-f3f1c0f4c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_24e6f6dd-d18a-4a8b-92ba-f3f1c0f4c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_78ab7612-78d8-4fe0-b3ac-83280b9fccd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_78ab7612-78d8-4fe0-b3ac-83280b9fccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_a941770f-92d7-44e0-a021-021b6aaa0a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_a941770f-92d7-44e0-a021-021b6aaa0a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_3af6f2fe-ce4d-48f9-af81-c7444ec68633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_3af6f2fe-ce4d-48f9-af81-c7444ec68633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_3e8e4557-8e62-4b6a-a2ce-75e5d85624d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_3e8e4557-8e62-4b6a-a2ce-75e5d85624d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_dedb59fc-3d7a-4061-bc2d-05d6a8eb91d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_dedb59fc-3d7a-4061-bc2d-05d6a8eb91d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_019d1256-f205-4ce7-8b9b-4437241c453d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7857a280-9cfb-4dca-8c83-4af305c82f40" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_019d1256-f205-4ce7-8b9b-4437241c453d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_439ba4ca-ab94-493f-80e3-f1a2e75a78fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_LicenseAgreementRoyaltyPaymentsMaximum_a242f2c0-ce19-46aa-9583-9670858e553d" xlink:href="sttk-20210930.xsd#sttk_LicenseAgreementRoyaltyPaymentsMaximum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_439ba4ca-ab94-493f-80e3-f1a2e75a78fa" xlink:to="loc_sttk_LicenseAgreementRoyaltyPaymentsMaximum_a242f2c0-ce19-46aa-9583-9670858e553d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_8c9c63dc-52ba-49c1-974a-5dc8ed7ee131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_439ba4ca-ab94-493f-80e3-f1a2e75a78fa" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_8c9c63dc-52ba-49c1-974a-5dc8ed7ee131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/PreferredStock" xlink:type="simple" xlink:href="sttk-20210930.xsd#PreferredStock"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/PreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_11d804cc-3ed9-46ec-82a3-6bf8686fd441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_9bc5e69c-7785-4f65-94b2-36cee714d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_11d804cc-3ed9-46ec-82a3-6bf8686fd441" xlink:to="loc_us-gaap_PreferredStockTextBlock_9bc5e69c-7785-4f65-94b2-36cee714d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/PreferredStockDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#PreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/PreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_f5582959-aeaf-4d2d-b6f2-fc716eb49edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_f5582959-aeaf-4d2d-b6f2-fc716eb49edd" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de4f037c-2280-43fb-a20d-c01eef4a20c2" xlink:to="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0a865e97-afcd-40fc-b7f2-9f1cfe3c72bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0a865e97-afcd-40fc-b7f2-9f1cfe3c72bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_SeriesB1PreferredStockMember_166b3e88-6450-4a99-9277-5fa04bc5474d" xlink:href="sttk-20210930.xsd#sttk_SeriesB1PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c396e4f8-520f-437c-9ce1-675adcb2f677" xlink:to="loc_sttk_SeriesB1PreferredStockMember_166b3e88-6450-4a99-9277-5fa04bc5474d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_038238a2-102d-4cac-b918-016bb7bdce8c" xlink:to="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1ea30a76-5d1f-4799-991b-01f70cd42fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1ea30a76-5d1f-4799-991b-01f70cd42fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_9b95974c-3aa8-4d05-a5bf-a37aff94488f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_9b95974c-3aa8-4d05-a5bf-a37aff94488f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2182b316-3051-4d81-bad1-4f0cb81123a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_2b7e8152-3a40-4259-84af-3d30096630a3" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2182b316-3051-4d81-bad1-4f0cb81123a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_740e1b5c-ed79-4cd7-801a-1b8d027e2e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6651cd84-1f56-44ea-b25a-4ab4051b287d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_740e1b5c-ed79-4cd7-801a-1b8d027e2e82" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6651cd84-1f56-44ea-b25a-4ab4051b287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ff4f76be-4e3d-4a6b-b931-81ccb168890e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c2cac1d9-775d-474e-a1e9-6f7b9b16cfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ff4f76be-4e3d-4a6b-b931-81ccb168890e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c2cac1d9-775d-474e-a1e9-6f7b9b16cfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_97eb6dae-67bb-412f-9ff3-f3cce25c1d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ff4f76be-4e3d-4a6b-b931-81ccb168890e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_97eb6dae-67bb-412f-9ff3-f3cce25c1d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1363b801-9237-421e-9a6c-c6554cac685e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ff4f76be-4e3d-4a6b-b931-81ccb168890e" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1363b801-9237-421e-9a6c-c6554cac685e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_34316277-e81f-4556-ac99-a4dac778a343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ff4f76be-4e3d-4a6b-b931-81ccb168890e" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_34316277-e81f-4556-ac99-a4dac778a343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1746ccc2-7ff4-4267-9355-2639a2b9fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1746ccc2-7ff4-4267-9355-2639a2b9fc40" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:to="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f3ed79ae-7a17-4c63-b3b4-e789fa92f0df" xlink:to="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020StockIncentivePlanMember_40df97a0-27be-4456-b289-80be693799a0" xlink:href="sttk-20210930.xsd#sttk_A2020StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:to="loc_sttk_A2020StockIncentivePlanMember_40df97a0-27be-4456-b289-80be693799a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020EmployeeStockPurchasePlanMember_70b95fcc-d43a-4049-993a-f2ec2f8d59a5" xlink:href="sttk-20210930.xsd#sttk_A2020EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4380dce6-7ec5-449c-8928-bc3f1aba840d" xlink:to="loc_sttk_A2020EmployeeStockPurchasePlanMember_70b95fcc-d43a-4049-993a-f2ec2f8d59a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:to="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_873829f6-3ab7-49ce-ae62-f9161abb6eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9583d5a0-9a2e-442c-b232-9e78a19d94ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:to="loc_us-gaap_RestrictedStockMember_9583d5a0-9a2e-442c-b232-9e78a19d94ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_23281afe-9d05-4304-8e8a-9cf9b5b660f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9bd35896-d2af-47ab-bd08-c75eb426b3be" xlink:to="loc_us-gaap_EmployeeStockOptionMember_23281afe-9d05-4304-8e8a-9cf9b5b660f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1d48af8-ee88-4322-8d19-00422c842f89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_d105c035-dc17-41a9-8f02-15fa3041febd" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage_d105c035-dc17-41a9-8f02-15fa3041febd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_befa47ed-d37e-4028-811c-814c00b6429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_befa47ed-d37e-4028-811c-814c00b6429a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_481e1657-3181-45ea-8d21-1b99bfb8f184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_481e1657-3181-45ea-8d21-1b99bfb8f184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6fd4603d-0803-44c5-ac7d-29b2789deb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6fd4603d-0803-44c5-ac7d-29b2789deb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18cb6c30-a67c-4613-82c0-61aab7088bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18cb6c30-a67c-4613-82c0-61aab7088bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b4981b03-f34d-486c-8c07-0b4187a5ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b4981b03-f34d-486c-8c07-0b4187a5ced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_d5fe8cb3-a9c1-441c-8354-1d57b9b5a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_d5fe8cb3-a9c1-441c-8354-1d57b9b5a9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_752738f0-2d4b-4a47-88dd-9b77af9c6e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_752738f0-2d4b-4a47-88dd-9b77af9c6e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_8e589b6e-8ea0-4707-bfd9-1c5125b61043" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue_8e589b6e-8ea0-4707-bfd9-1c5125b61043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_94afe130-b27e-41b7-81e0-dcfe7723c55c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_94afe130-b27e-41b7-81e0-dcfe7723c55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_3d30fcc9-5f94-4c65-938a-060597a79603" xlink:href="sttk-20210930.xsd#sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm_3d30fcc9-5f94-4c65-938a-060597a79603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_56390997-79ce-4109-9814-c239cdd12f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_56390997-79ce-4109-9814-c239cdd12f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2eab6d2f-ef07-4d29-9194-8d0eb35bacf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2eab6d2f-ef07-4d29-9194-8d0eb35bacf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15982d98-5788-4630-b02b-cb443bd33560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15982d98-5788-4630-b02b-cb443bd33560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_723146b9-e34c-4e87-a11f-0fcc15bd4570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_723146b9-e34c-4e87-a11f-0fcc15bd4570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df67f67e-0a25-4982-9145-1c9b5de228b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df67f67e-0a25-4982-9145-1c9b5de228b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fcfa4aeb-34da-405b-b38d-784604a16d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fcfa4aeb-34da-405b-b38d-784604a16d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4577ca81-6c5d-47ce-818f-41b7a55510de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4577ca81-6c5d-47ce-818f-41b7a55510de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_10d972a8-e6c2-4551-adec-75640344b565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc5e0e0-81db-48d4-a091-86579a2e4614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_10d972a8-e6c2-4551-adec-75640344b565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14bf0d46-7ffe-4e4b-bd3f-a2f7c37486b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14bf0d46-7ffe-4e4b-bd3f-a2f7c37486b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b1cf8aab-4dac-4afe-95fe-65bc6ef5c117" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ae5fda5e-d19f-4b53-bbbc-41af46cf8254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ae5fda5e-d19f-4b53-bbbc-41af46cf8254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9291f860-4c9e-4fd7-9c4e-355931bdeff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6791b53a-19ef-4e35-a2a7-67a711bdd95d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9291f860-4c9e-4fd7-9c4e-355931bdeff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3425c9d5-25f6-4265-8cc2-24cb37a7ba9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_815ef0d0-9715-40ec-a939-d83a7a1cb7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_134834f7-4f6b-4e07-ab24-0389c739db48" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_815ef0d0-9715-40ec-a939-d83a7a1cb7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofoptionactivityDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_347c1a84-91ce-4261-bbfa-b9e4833f1bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_347c1a84-91ce-4261-bbfa-b9e4833f1bf6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_29eacc7b-33d9-4dc4-b64a-d20b02f43da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_29eacc7b-33d9-4dc4-b64a-d20b02f43da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f831038-1f5b-4f3e-96d8-53e559b80ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f831038-1f5b-4f3e-96d8-53e559b80ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_56590c98-29ec-4153-9044-1d11bf30432c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_56590c98-29ec-4153-9044-1d11bf30432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8d99b22b-8a1a-4477-b69f-12a4e35af1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8d99b22b-8a1a-4477-b69f-12a4e35af1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0350a4a6-f899-47a8-9b9d-d35a60de3e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0350a4a6-f899-47a8-9b9d-d35a60de3e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_553caa0d-9c3f-4423-9dd0-c4c215c5a91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_553caa0d-9c3f-4423-9dd0-c4c215c5a91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b70de1e6-2cb8-4d0d-967f-4d71b918d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3d30d513-3128-4936-9415-383b0e3d5c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b70de1e6-2cb8-4d0d-967f-4d71b918d4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_347c1a84-91ce-4261-bbfa-b9e4833f1bf6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f5aead4d-8285-4d3d-aa63-0817d6b91be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f5aead4d-8285-4d3d-aa63-0817d6b91be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a7cd8d0f-7ad7-4120-9ec4-41c5eab52ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a7cd8d0f-7ad7-4120-9ec4-41c5eab52ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8ca50470-93ae-4310-b12b-b2a48b546b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8ca50470-93ae-4310-b12b-b2a48b546b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_341d5640-4042-4b00-86f2-f948fbf49ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_341d5640-4042-4b00-86f2-f948fbf49ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9a0708c-cb48-4fb0-8b1d-60159af627ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9a0708c-cb48-4fb0-8b1d-60159af627ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c228e4cf-9043-4d50-b78b-6449d6ffcfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c228e4cf-9043-4d50-b78b-6449d6ffcfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b5c630f0-abbd-406e-b6db-734be3c57f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2a724ae4-fe47-4ec0-8891-96a9427a0613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b5c630f0-abbd-406e-b6db-734be3c57f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e424a69f-7a45-408a-acd8-66279bc3604e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_347c1a84-91ce-4261-bbfa-b9e4833f1bf6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e424a69f-7a45-408a-acd8-66279bc3604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_da6e52de-e2aa-49f5-ae19-bdfc86720a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e424a69f-7a45-408a-acd8-66279bc3604e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_da6e52de-e2aa-49f5-ae19-bdfc86720a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bc58b5dd-5c4e-4d0e-b35a-f81c34c6fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e424a69f-7a45-408a-acd8-66279bc3604e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bc58b5dd-5c4e-4d0e-b35a-f81c34c6fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_68659b80-1d45-480a-8663-3c30e3164648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e424a69f-7a45-408a-acd8-66279bc3604e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_68659b80-1d45-480a-8663-3c30e3164648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofvaluationassumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48fb9b2d-e40d-47e1-9c7d-99db4a68d6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48fb9b2d-e40d-47e1-9c7d-99db4a68d6e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:to="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6c845864-dd00-4ac8-9a40-d435b8089608" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_57b32cff-81f2-431c-bbbe-24dfa43adb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_edf6e894-70f6-42b8-925a-3a3a6f063659" xlink:to="loc_us-gaap_EmployeeStockOptionMember_57b32cff-81f2-431c-bbbe-24dfa43adb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:to="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_69d95937-2ce5-42b8-a65b-8b6206e331e2" xlink:to="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020StockIncentivePlanMember_e245d663-8320-4e52-a5fe-6740fc8adb69" xlink:href="sttk-20210930.xsd#sttk_A2020StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:to="loc_sttk_A2020StockIncentivePlanMember_e245d663-8320-4e52-a5fe-6740fc8adb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_A2020EmployeeStockPurchasePlanMember_93e455a6-079e-41bd-84e5-495f0a9b3166" xlink:href="sttk-20210930.xsd#sttk_A2020EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c448fa34-64a0-48f7-a177-443fbdf3aa25" xlink:to="loc_sttk_A2020EmployeeStockPurchasePlanMember_93e455a6-079e-41bd-84e5-495f0a9b3166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0a5a492-12d5-4e32-9c0c-76bb76181382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_af4680d6-0391-4c6e-8979-1ae27cd16103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_af4680d6-0391-4c6e-8979-1ae27cd16103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ad7af4c-a651-48de-9898-787543ad8ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ad7af4c-a651-48de-9898-787543ad8ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_593e8705-9e10-4f6c-aae0-8aee39cc992a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_593e8705-9e10-4f6c-aae0-8aee39cc992a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2d3f4-8887-4d68-9a73-af6efc5eee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_63b6438b-8477-4ae2-9c59-60d678c9bd77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2d3f4-8887-4d68-9a73-af6efc5eee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#StockBasedCompensationScheduleofrestrictedstockactivityDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c2c13b12-fec5-42ab-b87c-bccac209f94a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c2c13b12-fec5-42ab-b87c-bccac209f94a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:to="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2b0c1715-88e3-476f-8ea0-3347392de195" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_36d3b9ae-31f2-4a84-a87e-4a1e95189164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d62bbe7-0625-46dd-8df4-88d185ff00eb" xlink:to="loc_us-gaap_RestrictedStockMember_36d3b9ae-31f2-4a84-a87e-4a1e95189164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe8a5e20-8e3b-436a-8d45-2c543906a78b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea70961f-7bcc-4e6e-b669-cbfba6bedcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_554c1c5b-8d1a-42f6-93be-3f059664163c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_554c1c5b-8d1a-42f6-93be-3f059664163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02882407-c571-499c-b887-c79e53864198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_02882407-c571-499c-b887-c79e53864198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8d80ee15-2a93-40e0-bf3f-6241c4b39cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_31f856f9-a31c-4c00-bbd0-aa02a2e3e8c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8d80ee15-2a93-40e0-bf3f-6241c4b39cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty" xlink:type="simple" xlink:href="sttk-20210930.xsd#CollaborationAgreementRelatedParty"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_93a79c7e-1855-4ebf-979b-055be4a58f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_016ff4b0-8731-430f-b6cb-8d75bb941e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_93a79c7e-1855-4ebf-979b-055be4a58f99" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_016ff4b0-8731-430f-b6cb-8d75bb941e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#CollaborationAgreementRelatedPartyDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_7cf3f40e-920f-4fd7-a9e0-9b7b17de44b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_7cf3f40e-920f-4fd7-a9e0-9b7b17de44b0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_87e529e4-35d1-42dd-af59-0972f987c049" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TakedaMember_d37359ae-c226-4866-80dd-10b60e579792" xlink:href="sttk-20210930.xsd#sttk_TakedaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7aa01cc2-9c2d-4caf-8d89-09c23ec8f049" xlink:to="loc_sttk_TakedaMember_d37359ae-c226-4866-80dd-10b60e579792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d10c437-ca1e-40b4-b07b-480fec78ec1f" xlink:to="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_3f920dcb-aa27-401b-9533-eccb3ea6097b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_db3595b8-3445-403a-b8d6-647f14434c3e" xlink:to="loc_us-gaap_InvestorMember_3f920dcb-aa27-401b-9533-eccb3ea6097b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e640040d-3a19-4c82-91e4-6c9e3118663b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c1a9ffc9-ce39-4cd7-b96f-7a75dfef6a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_933e9e30-f34d-4c2a-ab81-9d836187be2c" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c1a9ffc9-ce39-4cd7-b96f-7a75dfef6a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAxis_2765f302-d717-4b53-bc33-4aa4158c3a41" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_e9bf8b0a-f27f-4362-95ed-4a1af468aa29" xlink:href="sttk-20210930.xsd#sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sttk_CumulativeEffectChangeOfAccountingEstimateDomain_02a459ce-ad27-4004-9019-f69117920be7" xlink:to="loc_sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember_e9bf8b0a-f27f-4362-95ed-4a1af468aa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_b6b95385-8d18-4241-a1ae-e9813b55a165" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_f7a81720-92ec-4c31-b540-70dc48eac6a3" xlink:href="sttk-20210930.xsd#sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_4372f95d-5433-43b2-81de-bc78b2b0b01f" xlink:to="loc_sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember_f7a81720-92ec-4c31-b540-70dc48eac6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9b5e424a-0438-47b9-818a-840690907503" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_dbb08359-069d-40f8-a168-23fdcc68f9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_ProceedsFromCollaborators_dbb08359-069d-40f8-a168-23fdcc68f9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_247302e2-7f11-43b9-abba-8c5530dce90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_247302e2-7f11-43b9-abba-8c5530dce90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2538c7f4-777b-461c-ab05-d8bd2589c987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_NetIncomeLoss_2538c7f4-777b-461c-ab05-d8bd2589c987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cd702ad8-8694-4691-b61f-5bfbbf5c7711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_EarningsPerShareBasic_cd702ad8-8694-4691-b61f-5bfbbf5c7711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6ad7d1f8-9da6-45c2-bbd6-2526b2a763f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f77b1483-74ae-4f3e-a493-6b2ae3a5c4d7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6ad7d1f8-9da6-45c2-bbd6-2526b2a763f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="sttk-20210930.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b3c2d1f2-f75d-4da1-b7a7-13a41edd6211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c8631781-305d-48c6-b3bc-506ee2e099ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b3c2d1f2-f75d-4da1-b7a7-13a41edd6211" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c8631781-305d-48c6-b3bc-506ee2e099ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sttk-20210930.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_2718821a-d772-4c36-b571-7ccdc055b2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_2718821a-d772-4c36-b571-7ccdc055b2b5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:to="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2f4cb31b-0242-41e9-82ff-a9515006c44d" xlink:to="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_TakedaMember_61539ce0-d877-442e-9e6c-cf81da0abd6b" xlink:href="sttk-20210930.xsd#sttk_TakedaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a7662632-35bd-4428-bcce-57858f48a3f5" xlink:to="loc_sttk_TakedaMember_61539ce0-d877-442e-9e6c-cf81da0abd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_32fc5054-7b25-454e-9a61-f91a27a61bde" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sttk_ShareholderOwnershipPercentage_e2e26d72-39d3-4f69-b454-e2f96d201cd5" xlink:href="sttk-20210930.xsd#sttk_ShareholderOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a554cae4-4203-4b0e-a10b-fb5a101c395a" xlink:to="loc_sttk_ShareholderOwnershipPercentage_e2e26d72-39d3-4f69-b454-e2f96d201cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>sttk-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:sttk="http://www.shattucklabs.com/20210930"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sttk-20210930.xsd" xlink:type="simple"/>
    <context id="i648e824fd76a426abee666fe49416d9d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i93a317c1a7d84009b921894351c426c0_I20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2021-11-01</instant>
        </period>
    </context>
    <context id="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37a4198438794812abb2a3e7db2d6f87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id58e597f9f7d46458c21b5a0f8ab9047_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic334605d7f4246e181eb1c8111b616b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c4a2cabec5f4f27845ee6841b8be4df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie96ef38430374065aa351d78dde24230_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2cfe2dbcff99405cb545328603445374_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i539441c1f66142d988ac8a86e1e60786_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6723234f96b643e39508fa8cd095b0be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iecbf0ce013994b84a0cccab6bf9a37cf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ieecbc9f345de45c8985aa172294da8c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1affb3b7e9094b82acca963bb310ca93_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1eafc60eecc549488af6e45cca422737_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib85362d00b9044bfa041363b53990d12_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifceed151b34344ed86926861240827c3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i647bbb979fc246cd8580c17d002c985d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i422b3aaa79e941b292e79ba9cc1d14be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8f9cca7a385d4bf9aa954d58badb8169_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0448f37d4bcf4007a6cb6cf701810497_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i94489e3bdc0a4a6c8676351116f086b7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0eb983b0880943a3816d1b106ac9db6b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3a0848129044470a9b012f37f9e64867_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37a3d9d9644d4497a319db83511ea7a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia3a4962c656b42f3a8214dfcc801e8d5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id0c872b9d01144a280f248a1e16beef6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2734afb6faf8484a9447edac1f84134e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf6dbb88304d4595865f7e6425907d5e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i96ac7f784c484cb6b645b04089e32903_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie8ed9359c48a4172993da7b129d56e5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19b72630e4874757aac99920f0790b3f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc4e64d4ece4416db8aa1774732dcf60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba4476799e6c43e9b11f139b87f6e3eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9db48e68792b4cb48b1ababe34ca2b87_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5f046b755a624db096bbc2345de726fc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6afcf491686b407a8a99dbe8013777f9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb02004041e34aeea7a968c4f7d726f2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i65da78330c124c72b6daf2f158858f87_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id1c37493a8ff4212aee79aea73e76b60_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i95620647f2f44d4aba93d095901e26f6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5fff4b70e84e4503b828997e45293717_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i16bf9ea147614ea3979c329a7c40111e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9de96e067aed44aabf2d79bbccfb2d4a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib36be3855f8b4adbaeb7b5fb0bf4460f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8bc7158f78fe423f8b8d304e7f23a82c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iae6291564a37483d8bb66b65731f4101_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i31c0536199104f62b96d3be8d78a773e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia45c4fa1189d41e6b75f3b2c4224f632_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i46f763e24d914335a16f2797cbdcda54_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic8a2d81f76074762b59a86c90d441d3e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i180732543f574734a093e1fdd359c31e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icca3a5a03c7944b58f29193146f4a6f0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifc5b787ecb8c4de78e65e2d9759d48a4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id9c24c935fc14f9d9bb20f6d1b1478e7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2b2e4eca1d1b49aab71c8126e08eba38_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2ae5c9d2028648418dd51b0c2b0a3cbd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i86c197370694420e8139fb6bcd63799c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55b9b9e789cd442da7cfa75ff1ec86c0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cb009f0275b4b66b6ea526dcbca7e9f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8d43c4f21e4f400181e8380a945fa403_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic0c391d040a942e288e05836aa0b34d9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iebf65494900a4dfa992c067bfe66b21e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8b32de77fd41426fb9250157c316291b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibbfd6109d71a41d88ac7cd90ef87419a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5dc7e714b56844a881c19fc1a46f7a81_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf10a010e6f24e1ead5edad126efe989_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i74d3aa8f82514539b0c9f923f0819cdb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifdec66eb26c346dead446844d3d02964_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf949b23f20d4f72b56403c3fbb43149_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sttk:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91d5a84837714480a2462e3255a83730_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">sttk:OperatingAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i28e6d73e46e34e999b3a2520c34da2bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i21077307da9c4396a282390e1aaac1c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">sttk:OperatingAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i385459190ef7464a90ce28ba7fe7883d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ebaf8f49a6941a0976a2367d5cc1bfb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e370dfdd2f54ea4bad75c57602b4f93_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9abbbff0f64c4386a4848428859c93ba_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6638d6e20b5438bbca39e3e66ef5663_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib919ed52ea1544a19151e99891e1459d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i19b470f64d144b129fbaa7ad42808a35_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf359afbf3d0464cbc86a41f24df0d16_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib884e0584c7e460bb651ba32ee4192a7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida0e12191e2b43dbaece2abe6a654ebf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic89ca81d8e0f45f3a4c92829a40b2cce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf97f887b14842219aa9e7a7b036371c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib92a6e56c17649fab1775c0e60491710_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i194ff9146a844c808f5d4fb8b42bb2e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib605418e82994024ac2bd308fcb0a15e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a8b88813b564305a3bb126dd933c59e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i603740bc9b8f4f0ca57d85369f7746a2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ice4dbadf32e44468af44b532a149cff7_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i376022fb5be548d7b02b791a7e12fad2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i00fdc47817734e7ca45bf62b16f9b05b_I20201014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-14</instant>
        </period>
    </context>
    <context id="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-14</startDate>
            <endDate>2020-10-14</endDate>
        </period>
    </context>
    <context id="i5f3e8f93f0194647bd923c62f2e5dc30_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="idf00a598b8c6468a94061606fb02f883_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i960ac8b054b342bca15ba993defe9d57_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iac8f4bd6f6784868a4bd2c6922fc91f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i43e49e14bbd84c24b4f815c8d1dfae1e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i835dbb9acf224e57a9b3e913c4fd5221_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cf510c1ae944ae08e8125331902ce05_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f271066a7004316b41caf3035fe59f9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b7aad25409a4bcd8dceb360cb97572a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id1ee9db78b134988a76150158dd2ccfb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i06f9516b552346dd9f85244630963fdf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad1e9586e3094edfbbdb9d027470e968_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sttk:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i127f4a4b929a4584b3d952f63d22eadf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib024077106554c22ae7c122e594a1c2b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd69357ae18f462e8804de875b0c3a5c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia2da1c40adc24adf8f575ee3530eea18_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if068c55e44bb4ae2a4f17a023aa75fd7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1661a0a2b3aa4bcca5712ebab54e17ae_D20170801-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sttk:TakedaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sttk:RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sttk:CumulativeEffectChangeOfAccountingEstimateAxis">sttk:CumulativeEffectChangeOfAccountingEstimateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7842c9c91ac44eb081775b9eeb02a4f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sttk:TakedaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl8yLTEtMS0xLTA_d5bb7110-98d5-427b-b2e8-97dad39d0820">0001680367</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl80LTEtMS0xLTA_4a613fd1-26a2-4f1d-bd32-9877f906d41a">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl81LTEtMS0xLTA_01d1f0dd-3792-4f95-9d36-7989660b1488">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl82LTEtMS0xLTA_bb850aa6-9919-4717-855c-aa64889940fd">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80L2ZyYWc6MWNhMmZhODQ3OGE1NDFkMmJkNzE0NDZiOGMwNmI3NTYvdGFibGU6MGJhN2VjYjQyZDk0NDQ5YThmODc2ZTkxNzlhYjI1MDIvdGFibGVyYW5nZTowYmE3ZWNiNDJkOTQ0NDlhOGY4NzZlOTE3OWFiMjUwMl83LTEtMS0xLTA_3028673c-d06e-4204-b880-efa7109fb80d">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi0wLTEtMS0w_f1acb055-7b86-4c00-997d-facea2ac076f">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <dei:DocumentType
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgw_95bb4e6a-6268-40dd-bc59-0fddea0aa4ee">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmUzNDYxOWZlOWVmNDMyN2JhMWVlODAzNTU3ZmIwYzIvdGFibGVyYW5nZTo2ZTM0NjE5ZmU5ZWY0MzI3YmExZWU4MDM1NTdmYjBjMl8wLTAtMS0xLTA_68a57b33-6b0e-4e55-afec-e43b4c8a6e1e">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8xMzg_aeffc0c9-c9ab-460f-a055-279e7220110f">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6MGZmMzY1ZmQxZjBiNDVkZTk4NWJkYzE4ZmZmYzMzYjkvdGFibGVyYW5nZTowZmYzNjVmZDFmMGI0NWRlOTg1YmRjMThmZmZjMzNiOV8wLTAtMS0xLTA_d3e763e7-fa87-4449-8347-6b1f9422ee93">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDY5_13b1521f-5611-4ebb-8fd7-e6c79267a823">001-39593</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcw_bf8f6b43-cd78-4abe-8e74-dba021f2cc7d">Shattuck Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmE2Mzc4ZTFlZWE3NGY5YzlkMGVkODI3ZWRiNzIwMDUvdGFibGVyYW5nZTo2YTYzNzhlMWVlYTc0ZjljOWQwZWQ4MjdlZGI3MjAwNV8wLTAtMS0xLTA_040e5866-6807-49fd-bfdc-7ed687b13ea5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6NmE2Mzc4ZTFlZWE3NGY5YzlkMGVkODI3ZWRiNzIwMDUvdGFibGVyYW5nZTo2YTYzNzhlMWVlYTc0ZjljOWQwZWQ4MjdlZGI3MjAwNV8wLTItMS0xLTA_2c7bd2e6-5143-4e33-8900-38868394b2fa">81-2575858</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcx_6cc53c30-e485-4e8b-a8c7-aa6830150fa0">500 W. 5th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc1_759a0ce3-d222-4280-a44c-c7f6c75546bb">Suite 1200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc2_e7b56b0e-8e0f-4137-9600-68a702fe5649">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc4_51a47230-1536-43f3-b75f-4bfd22b6ec4a">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgy_8c80a39d-1246-4b04-9f64-017eafd7ee43">78701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDgz_bd2fbc1f-5bf5-4d20-9523-9e90b7eae679">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDcz_559ad2f8-f1e9-4e34-b04c-862cc239819c">900-4690</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTAtMS0xLTA_bdc46603-9a93-4be0-85a8-bfcdc81ed143">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTEtMS0xLTA_9932613f-1a49-46b6-b55b-276559a5029d">STTK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6YjgzZjkxODMzOWRlNDdjOTkyNWVhMzIyMDJkOTg4MjQvdGFibGVyYW5nZTpiODNmOTE4MzM5ZGU0N2M5OTI1ZWEzMjIwMmQ5ODgyNF8xLTItMS0xLTA_8a79ae28-f1d8-43b2-b16c-ecd6d3f446f4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDg0_682f0c78-8799-4315-8090-b64d51984919">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDg1_2675e429-097e-4438-a575-f65e42af69f1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8xLTAtMS0xLTA_76d2c154-f43b-4b59-b884-6f29249c7a6f">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8xLTMtMS0xLTA_5a6be9d8-4f5a-489c-aadd-b5d50c27cded">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGFibGU6M2YyYzA1YjBjMTY5NDJhMzkxZGU0YWU1MzM5ZTIyYmEvdGFibGVyYW5nZTozZjJjMDViMGMxNjk0MmEzOTFkZTRhZTUzMzllMjJiYV8yLTMtMS0xLTA_1cfecc27-81ca-4e87-a0c7-f8ae02b2fc3e">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc5_9b5dcce7-cc14-4baf-8f5e-eb8f3ff7356e">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDc0_810bcb7d-5c25-4b2b-b0d8-72a3c73ef477">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i93a317c1a7d84009b921894351c426c0_I20211101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xL2ZyYWc6ZTRhMTkzNzJjMmVhNGExYzg5MTY0NWM2YjdkM2YxN2UvdGV4dHJlZ2lvbjplNGExOTM3MmMyZWE0YTFjODkxNjQ1YzZiN2QzZjE3ZV8yMDAw_1c060b4e-8a2a-4080-8c0c-df4e3b757689"
      unitRef="shares">42246539</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNC0xLTEtMS0w_5d8cc030-ae37-4ded-9e27-ba2a534e460b"
      unitRef="usd">85094000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNC0zLTEtMS0w_20a1d2a1-bad7-471a-8bfb-8cabf5320317"
      unitRef="usd">157898000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNS0xLTEtMS0w_a285a883-30a6-4953-95fc-c5f27dea2703"
      unitRef="usd">205121000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNS0zLTEtMS0w_bc19d59b-eef2-4de4-bb66-7dede020ec0c"
      unitRef="usd">177551000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNi0xLTEtMS0w_afeac9fa-64ca-4934-8de8-739ab0c94de6"
      unitRef="usd">11429000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNi0zLTEtMS0w_fef9698c-5528-4ab0-9ccb-ab3816942959"
      unitRef="usd">10190000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNy0xLTEtMS0w_bb6b2c34-70b7-4a20-976d-5097553137c6"
      unitRef="usd">301644000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfNy0zLTEtMS0w_574350fc-2a78-42e3-835e-5d2e29d729ba"
      unitRef="usd">345639000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOC0xLTEtMS0w_917bf8e2-c2e5-4315-9e51-3716941b2fa4"
      unitRef="usd">8651000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOC0zLTEtMS0w_287d3fc5-b07a-4da1-90bc-aad926e60104"
      unitRef="usd">3000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOS0xLTEtMS0w_7fbc6f33-9590-44a6-8ee1-4eab0dc80d45"
      unitRef="usd">273000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfOS0zLTEtMS0w_bd56ee69-fda8-4866-8284-6a123f77b15d"
      unitRef="usd">349000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTAtMS0xLTEtMA_f8ceffab-7af1-44ad-88d7-3a65c9ff2fd1"
      unitRef="usd">310568000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTAtMy0xLTEtMA_98a45834-8598-4485-b671-965534f10910"
      unitRef="usd">348988000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTQtMS0xLTEtMA_5db2a912-7488-4539-a68c-e20fe6222184"
      unitRef="usd">3251000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTQtMy0xLTEtMA_944a7367-b4dd-4b52-9c07-841c7ceabae0"
      unitRef="usd">1754000</us-gaap:AccountsPayableCurrent>
    <sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTUtMS0xLTEtMA_fb030559-71d0-4f6a-b7d6-3c305630b5c0"
      unitRef="usd">13783000</sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent>
    <sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTUtMy0xLTEtMA_10e82637-a90d-465c-8e3c-5fa5a945f114"
      unitRef="usd">7352000</sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTYtMS0xLTEtMA_41c92bbc-ddb1-4f68-ac2b-b4c3390f45b1"
      unitRef="usd">2801000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTYtMy0xLTEtMA_f543b5cf-3380-45ed-a405-48870b9b10ff"
      unitRef="usd">7728000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTctMS0xLTEtMA_66d1dabc-7d18-4ff3-bec7-550391b85108"
      unitRef="usd">19835000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTctMy0xLTEtMA_7bbf2fa6-a856-4489-8dbe-a97c49f3e9ce"
      unitRef="usd">16834000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMS0xLTEtMTcxMjU_1901d6e4-7223-4681-bf4e-a2d0b307ef12"
      unitRef="usd">27277000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMy0xLTEtMTcxMjU_f4a8a1b1-efd1-4458-b1ee-bf6c829cdb72"
      unitRef="usd">21306000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMS0xLTEtMTM1NTc_e252bfa7-66bb-430d-9eb2-2d68e1322359"
      unitRef="usd">2290000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMTgtMy0xLTEtMTM1NTc_ddf58a8e-82c4-424e-b293-3ba06d5c14e1"
      unitRef="usd">987000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:Liabilities
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjAtMS0xLTEtMA_148573c1-28bd-4066-8097-6fd3031135b0"
      unitRef="usd">49402000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjAtMy0xLTEtMA_d0e5a33a-4a36-40d9-b90d-e60c21a7ab45"
      unitRef="usd">39127000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjEtMS0xLTEtMA_c4ef7e0d-7b6b-44c3-82e8-03f4e7697e7a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjEtMy0xLTEtMA_de5ce6cb-b911-41df-94ae-08715d7fe2f2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzE5_4367695c-a3bd-4611-b4b5-f2086801f7a8"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzE5_f9326f4c-4ca3-4a8f-8cfa-552413694b41"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzMz_96caad9e-4ff1-46fa-8390-afdd2846174c"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzMz_a107cedf-8a98-4e26-a765-249942b218d5"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzU1_75631d18-2872-49b4-8de9-98118cfe7061"
      unitRef="shares">42241981</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzU1_ed44acc5-a72f-471f-98d1-11e995f252f4"
      unitRef="shares">42241981</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzYy_e5426870-c173-4e88-a87f-df318f31af53"
      unitRef="shares">41779183</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZjYzE5MjE4NzYxYTQ0OGY4N2UzZTRiNmQ3YzVmZWYwXzkw_24367ef8-4e84-4f72-89aa-9f69c8753b78"
      unitRef="shares">41767431</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMS0xLTEtMA_fbc5fa6c-2efc-4b41-851d-79a9f7f27fcb"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjMtMy0xLTEtMA_d38aaae5-38d0-42c6-b54a-716114cd4232"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjQtMS0xLTEtMA_3dd743d0-142f-443f-ba33-5171d6eda965"
      unitRef="usd">387902000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjQtMy0xLTEtMA_fe8f8304-a7e7-487e-9346-a31464a3b6e3"
      unitRef="usd">382012000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjUtMS0xLTEtMA_a51e7c41-a89d-42a6-8710-d06b857ae3af"
      unitRef="usd">-1827000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjUtMy0xLTEtMA_2890f254-98af-47b1-91b6-3e75ed6fc39d"
      unitRef="usd">-63000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjYtMS0xLTEtMA_e2ff2c4c-d261-458c-986e-c91619a5909d"
      unitRef="usd">-124914000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjYtMy0xLTEtMA_febf56d5-402e-481c-822f-422b44502a05"
      unitRef="usd">-72093000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjctMS0xLTEtMA_f76af572-199f-4da9-ab29-aa72b73b0a1e"
      unitRef="usd">261166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjctMy0xLTEtMA_b50329fc-5c44-4da0-9bda-5ecd4d5cf948"
      unitRef="usd">309861000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjgtMS0xLTEtMA_39cac91f-fb17-4cd6-927f-fe0a66279c7a"
      unitRef="usd">310568000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xNi9mcmFnOjMxZGNlYTcwOTgzYjRkZjJhZjVmMzcwMzNjN2MxZjkyL3RhYmxlOjI4ZTlmMWUwM2U4ZDRkMjVhM2FkM2Q2OGI0ZGYwODRhL3RhYmxlcmFuZ2U6MjhlOWYxZTAzZThkNGQyNWEzYWQzZDY4YjRkZjA4NGFfMjgtMy0xLTEtMA_f3f7be95-99c6-4b94-b72a-7b6a8311973c"
      unitRef="usd">348988000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi0yLTEtMS0w_2d9c0b0a-73b6-4dbf-b97d-ca5d21dd4050"
      unitRef="usd">1900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi00LTEtMS0w_86a528e7-baa7-4780-8b1b-81a67d589395"
      unitRef="usd">2435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi02LTEtMS0w_ca6b58f2-0198-43ae-a5ee-b60cbe968e5f"
      unitRef="usd">-61000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMi04LTEtMS0w_7e389548-4f7c-453a-b1e0-54a5b9c69952"
      unitRef="usd">8592000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC0yLTEtMS0w_bb7ac85c-b510-456f-9e68-dc40acd67fc1"
      unitRef="usd">15137000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC00LTEtMS0w_27889e5d-c353-427d-a008-4730850a500d"
      unitRef="usd">11804000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC02LTEtMS0w_5a04adf4-b173-46e7-ada1-482b33d95328"
      unitRef="usd">40356000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNC04LTEtMS0w_f2a54856-81c9-497f-b4df-827fd76fe26c"
      unitRef="usd">27696000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS0yLTEtMS0w_bb55008f-473e-44b3-8bab-05e9f465ea95"
      unitRef="usd">4343000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS00LTEtMS0w_98f75b4d-045c-4e93-9e5f-991d19e4f939"
      unitRef="usd">2470000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS02LTEtMS0w_38db8a34-4334-4ec4-a72d-907300d25d1e"
      unitRef="usd">14098000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNS04LTEtMS0w_cb660519-84c2-44ba-9f2d-cab1bad748bc"
      unitRef="usd">5816000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi0yLTEtMS0w_1f84e37b-8000-4363-9259-ef2602279c57"
      unitRef="usd">19480000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi00LTEtMS0w_21bf2b6e-de45-4691-94d8-0e90fdbd5247"
      unitRef="usd">14274000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi02LTEtMS0w_f99d09ab-bd3a-484e-9434-6051c3e843d8"
      unitRef="usd">54454000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNi04LTEtMS0w_ccb54c55-9c0b-4156-89af-d0c05438cc0b"
      unitRef="usd">33512000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy0yLTEtMS0w_cc73576c-ecfe-45b2-87fa-2d003075823e"
      unitRef="usd">-17580000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy00LTEtMS0w_23b435f7-a26a-47b0-8f84-0799b8734c8a"
      unitRef="usd">-11839000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy02LTEtMS0w_ddaab30c-09ff-4cec-af94-6ebf9c5df379"
      unitRef="usd">-54515000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfNy04LTEtMS0w_fe42b08a-e3fb-43ba-ae99-6b13dee6926b"
      unitRef="usd">-24920000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtMi0xLTEtMA_e56cc38e-b95c-48ab-bef8-0816c7f9f5f1"
      unitRef="usd">251000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtNC0xLTEtMA_2fad4df2-4b73-4c5f-8ffc-4b1debc2eb13"
      unitRef="usd">86000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtNi0xLTEtMA_33a4fed1-e27b-4e5f-aa77-b20683b1d6c9"
      unitRef="usd">1947000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTAtOC0xLTEtMA_fc6aa55f-548c-470e-84e4-d1abf619d9bf"
      unitRef="usd">474000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtMi0xLTEtMA_fdcf7740-2c47-4af2-9255-091720bad7b5"
      unitRef="usd">-81000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtNC0xLTEtMA_9748c5fb-5547-4444-b399-dd5a78ab1e39"
      unitRef="usd">-76000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtNi0xLTEtMA_980e6c8f-b3b3-4146-8ad4-20df2ae5c699"
      unitRef="usd">-253000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTEtOC0xLTEtMA_dcf40075-3092-4d6e-a523-2bb03d798ccb"
      unitRef="usd">-145000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItMi0xLTEtMA_e0865ecb-2792-4bfd-b692-fa9b3ae284cb"
      unitRef="usd">170000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItNC0xLTEtMA_c5aa9ce8-b605-437d-afed-44bdcbe589c3"
      unitRef="usd">10000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItNi0xLTEtMA_f0562675-f570-4ec2-8c3c-59e7e89abe96"
      unitRef="usd">1694000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTItOC0xLTEtMA_a07565d4-78f2-4c08-aafd-07cecad33374"
      unitRef="usd">329000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtMi0xLTEtMA_9ef5757a-c910-4610-8929-2a76b67885cf"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtNC0xLTEtMA_0e5a9913-1e9f-4aa5-b6a5-b77c91876919"
      unitRef="usd">-11829000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtNi0xLTEtMA_2d85f8af-e104-46b7-b0dc-4c7a4dc34717"
      unitRef="usd">-52821000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTMtOC0xLTEtMA_927e9f68-ae84-446e-a324-8f5b630fca25"
      unitRef="usd">-24591000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtMi0xLTEtMA_ac8d4c91-74f3-46f9-a787-9073e4806e09"
      unitRef="usd">-207000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtNC0xLTEtMA_6e75341c-b658-4043-99e0-21091680ac3a"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtNi0xLTEtMA_9378db31-0ae5-41d6-96f3-f7b4c08bbfcc"
      unitRef="usd">-1764000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTQtOC0xLTEtMA_ec8666f2-e345-467a-a1e7-c7c664e4ed82"
      unitRef="usd">-64000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtMi0xLTEtMA_fab8a514-fde0-4cb8-998f-2b33f45c26aa"
      unitRef="usd">-17617000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtNC0xLTEtMA_e011e050-dd25-48d6-8180-c0ff2e3ea70b"
      unitRef="usd">-11857000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtNi0xLTEtMA_55bad109-f427-4b88-ac39-1a5330619fad"
      unitRef="usd">-54585000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTUtOC0xLTEtMA_cc883d5c-f88b-4f52-b6ca-73e2c3f552fd"
      unitRef="usd">-24655000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctMi0xLTEtMA_24a40f49-7128-49d5-9e44-4c7ee05ebeee"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctMi0xLTEtMA_b3f0819c-2c87-4279-8f9c-405a3c3a1c27"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNC0xLTEtMA_79efd573-6281-46dd-9822-5f791fc2eb37"
      unitRef="usdPerShare">-1.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNC0xLTEtMA_a927c1d6-f4da-4d72-a7df-bb3e25e035ef"
      unitRef="usdPerShare">-1.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNi0xLTEtMA_a434ca0a-51e8-455a-8e66-fceb214e1cf2"
      unitRef="usdPerShare">-1.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctNi0xLTEtMA_b48e2e8d-ac34-4627-a8f7-972b569ca2a9"
      unitRef="usdPerShare">-1.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctOC0xLTEtMA_033ab070-f378-40ab-b2a8-4d78826ba11d"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTctOC0xLTEtMA_d9e930e7-6976-44ad-9d9d-de7738bcfd2a"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtMi0xLTEtMA_399f946e-9a69-435f-8dce-2f315602f54f"
      unitRef="shares">42155981</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtMi0xLTEtMA_ea08f51c-d341-4670-ae86-3fe9197360b1"
      unitRef="shares">42155981</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNC0xLTEtMA_cc464389-4f0e-4762-95b0-8a751961932a"
      unitRef="shares">7700371</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNC0xLTEtMA_d59f113b-e6ec-4d72-a854-bfef001fda52"
      unitRef="shares">7700371</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNi0xLTEtMA_b16684a3-da6c-4d34-9d9e-3c98aa648939"
      unitRef="shares">41946852</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtNi0xLTEtMA_cfb651b8-4ff3-4456-856e-9ee88417712d"
      unitRef="shares">41946852</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtOC0xLTEtMA_52a08b9b-ba58-4ae4-9b7b-6ad94c151eb1"
      unitRef="shares">7656077</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8xOS9mcmFnOmE5YWE0MDU0ZmUyZTRmOGQ4ODU3OWE2NzAzMTcwZTRkL3RhYmxlOjNmODhiMzY1MDllZTQ0Y2U5NTAwOGVmMGIwMGQzY2ViL3RhYmxlcmFuZ2U6M2Y4OGIzNjUwOWVlNDRjZTk1MDA4ZWYwYjAwZDNjZWJfMTgtOC0xLTEtMA_dd3be0ab-4dd8-47e6-b307-640d515c277c"
      unitRef="shares">7656077</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="i37a4198438794812abb2a3e7db2d6f87_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0xLTEtMS0w_ab38046a-8d8f-4e04-b305-cfc0989ac38e"
      unitRef="shares">41767431</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i37a4198438794812abb2a3e7db2d6f87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0zLTEtMS0w_0ba1ec02-f69b-4b5f-8df7-bd820559920c"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id58e597f9f7d46458c21b5a0f8ab9047_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy01LTEtMS0w_7f899a3e-db3d-45ad-9f98-6e58f06c4086"
      unitRef="usd">382012000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic334605d7f4246e181eb1c8111b616b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy03LTEtMS0w_817a2a5f-a20a-44b2-a6d1-7f5a7081d840"
      unitRef="usd">-63000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c4a2cabec5f4f27845ee6841b8be4df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy05LTEtMS0w_4c6e702e-6b95-478e-bbab-e5428a621bf6"
      unitRef="usd">-72093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMy0xMS0xLTEtMA_61e73801-0815-42f2-bc3e-00f1f18498f9"
      unitRef="usd">309861000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xLTEtMS0zMDg_6420f2e9-225f-4be7-9ca0-32dab055546c"
      unitRef="shares">13543</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie96ef38430374065aa351d78dde24230_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC01LTEtMS0zMDg_6656b638-cda3-40b8-bcfc-b1f6de636044"
      unitRef="usd">31000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xMS0xLTEtMzA4_251ce7b9-7af7-4716-80b9-6cec6e1f11be"
      unitRef="usd">31000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibec3059bb98d49698cf8a28a5d99315e_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNS0xLTEtMS0zMDg_413d465e-d6d1-4386-bccc-81e82557ae5d"
      unitRef="shares">5037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie96ef38430374065aa351d78dde24230_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi01LTEtMS0zMDg_507ef3ef-3d76-450f-81a2-8d2f1067bbfb"
      unitRef="usd">1180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi0xMS0xLTEtMzA4_394d0941-3682-4888-93dd-8d135f44a912"
      unitRef="usd">1180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2cfe2dbcff99405cb545328603445374_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy03LTEtMS0zMDg_4aa88ac7-90d8-4375-96bc-fa5059ddac3d"
      unitRef="usd">-597000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy0xMS0xLTEtMzA4_a9edbeb2-f3be-4523-b5ab-edb7779c02a9"
      unitRef="usd">-597000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i539441c1f66142d988ac8a86e1e60786_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC05LTEtMS0zMDg_d8e9e66d-0f0f-4612-becc-b06d9de7327a"
      unitRef="usd">-11813000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4d793e7af8fa4f44af54c06ed3d9f6f0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC0xMS0xLTEtMzA4_9695c0bb-34ae-4769-be64-94c512a8d49c"
      unitRef="usd">-11813000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i6723234f96b643e39508fa8cd095b0be_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xLTEtMS0zMDg_806de3ba-662c-4656-a62f-030cc6ee8386"
      unitRef="shares">41786011</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6723234f96b643e39508fa8cd095b0be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0zLTEtMS0zMDg_f928d284-f5ff-425c-8778-c9a8a3fe0af3"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iecbf0ce013994b84a0cccab6bf9a37cf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS01LTEtMS0zMDg_159c323e-8150-4cd4-a122-ea093ba0c364"
      unitRef="usd">383223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieecbc9f345de45c8985aa172294da8c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS03LTEtMS0zMDg_37a74bff-b5b7-4846-aed9-9bdd2537baf5"
      unitRef="usd">-660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1affb3b7e9094b82acca963bb310ca93_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS05LTEtMS0zMDg_80e8576d-4dc5-4a4b-818d-9e9f773966f3"
      unitRef="usd">-83906000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1eafc60eecc549488af6e45cca422737_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xMS0xLTEtMzA4_39069d2d-cbea-4b4b-bfb4-440f32cda124"
      unitRef="usd">298662000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtMS0xLTEtMzQ2_73f49f4f-e039-4e58-aa65-3adb5a081665"
      unitRef="shares">324342</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtNS0xLTEtMzQ2_92c79e47-8621-499c-b43c-2140a0d4799f"
      unitRef="usd">1256000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTAtMTEtMS0xLTM0MA_0266e687-0f5f-417d-8816-4a7948fc67b8"
      unitRef="usd">1256000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2d41bb4da9d241e7986cbde5581c645a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTEtMS0xLTEtMzQ2_d4681aed-eef6-425a-b2a7-34067eb4ce1f"
      unitRef="shares">5037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i008f18aad60b42f283990d1f21430bc7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTItNS0xLTEtMzQ2_6fe55b3a-5af2-4523-b143-e5871ae04a91"
      unitRef="usd">1727000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTItMTEtMS0xLTM0MA_cd010ce7-a314-4ec7-88a3-f09200f82bcc"
      unitRef="usd">1727000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifceed151b34344ed86926861240827c3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTMtNy0xLTEtMzQ2_161eb18f-275d-468d-beee-2c6ef3962392"
      unitRef="usd">-960000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTMtMTEtMS0xLTM0MA_db99d53f-0dcc-4f02-9c8c-22a7d423840d"
      unitRef="usd">-960000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i647bbb979fc246cd8580c17d002c985d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTQtOS0xLTEtMzQ2_f66912b4-576d-400e-b2c4-5c18d8ea68b4"
      unitRef="usd">-23598000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib85362d00b9044bfa041363b53990d12_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTQtMTEtMS0xLTM0MA_bd0a477c-121b-48f2-9d5e-d916cd4025b8"
      unitRef="usd">-23598000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMS0xLTEtMzQ2_0f1dfab4-8d5b-4978-977c-b2a0aa3594c9"
      unitRef="shares">42115390</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaa98f342b9ec40f2af6c6d229c6ffcac_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMy0xLTEtMzQ2_799f4bbd-20e5-4c13-ab8c-c98eadc86174"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i422b3aaa79e941b292e79ba9cc1d14be_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtNS0xLTEtMzQ2_d89fd7c2-7f2d-4326-9781-31b0554109e1"
      unitRef="usd">386206000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f9cca7a385d4bf9aa954d58badb8169_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtNy0xLTEtMzQ2_b2b03413-13d4-4f06-b709-4fb1d5f38f6d"
      unitRef="usd">-1620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0448f37d4bcf4007a6cb6cf701810497_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtOS0xLTEtMzQ2_5d89fb5d-d8d9-4a42-8364-37855d89cbb2"
      unitRef="usd">-107504000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94489e3bdc0a4a6c8676351116f086b7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfMTUtMTEtMS0xLTM0MA_2e6fdc2d-2c45-45d8-8c37-def74127620b"
      unitRef="usd">277087000</us-gaap:StockholdersEquity>
    <sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod
      contextRef="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xLTEtMS0w_d4ba5b92-5a75-4dd8-9d32-eb8111e4d258"
      unitRef="shares">124913</sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod>
    <sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased
      contextRef="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC01LTEtMS0w_7345c771-7775-4be1-abcc-61223f2476aa"
      unitRef="usd">352000</sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased>
    <sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNC0xMS0xLTEtMA_7f9d8377-25a5-418c-b126-7be50f85e9c0"
      unitRef="usd">352000</sttk:StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic0e6bb05bfd040ff8bb7b3dff2d4667c_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNS0xLTEtMS0w_d5ea532d-b4fc-4baa-9bec-4407a37d44f0"
      unitRef="shares">1678</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i70eafd2cb89e4a9b8c03728c83d79a18_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi01LTEtMS0w_15eb0025-55d7-4fdc-ae11-f9c04c9d9327"
      unitRef="usd">1344000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNi0xMS0xLTEtMA_95e620d5-ac32-4001-8a11-335dcfa418af"
      unitRef="usd">1344000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0eb983b0880943a3816d1b106ac9db6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy03LTEtMS0w_8232d630-b6d4-48a0-bef9-e31e8fd37ea0"
      unitRef="usd">-207000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfNy0xMS0xLTEtMA_a93e6e30-0145-41e3-946d-20f48e178add"
      unitRef="usd">-207000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i3a0848129044470a9b012f37f9e64867_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC05LTEtMS0w_681d8118-f81c-40c8-a11b-5f4622af285a"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOC0xMS0xLTEtMA_e0b320ef-3d3c-4b82-b575-dc3ad0eea3ff"
      unitRef="usd">-17410000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i37a3d9d9644d4497a319db83511ea7a4_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xLTEtMS0w_fd4a6fe7-7f8a-491c-9ef4-12187aaa9f6f"
      unitRef="shares">42241981</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i37a3d9d9644d4497a319db83511ea7a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0zLTEtMS0w_34c631f5-74f0-44cf-bd9a-85ce3bb79867"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia3a4962c656b42f3a8214dfcc801e8d5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS01LTEtMS0w_4b3f49b3-65da-4bb9-a589-93e398346fba"
      unitRef="usd">387902000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0c872b9d01144a280f248a1e16beef6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS03LTEtMS0w_bfd7bb90-fe02-4c50-9971-754724219852"
      unitRef="usd">-1827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2734afb6faf8484a9447edac1f84134e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS05LTEtMS0w_7296e447-92a6-465e-b8cb-6b687aea5128"
      unitRef="usd">-124914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yMi9mcmFnOjllNjY0ZWEwNzk0NjQxYmNhZjk3NjFmY2RmYzc4Y2E1L3RhYmxlOjIxZGI0MGM3M2Y4NTQ4MzFiN2EyMDZhYjM2ZWIzNDI3L3RhYmxlcmFuZ2U6MjFkYjQwYzczZjg1NDgzMWI3YTIwNmFiMzZlYjM0MjdfOS0xMS0xLTEtMA_7ece402e-c4be-4b3a-a1c0-5479f7fc1046"
      unitRef="usd">261166000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMS0xLTEtMjUx_84f56a48-8271-41ff-a9e5-ec531398de00"
      unitRef="shares">1093019</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2bcd9ce9e9114e7590f80b0f2346173c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMy0xLTEtMjUx_3e195c19-1786-4de6-8392-8bd5471beaaa"
      unitRef="usd">49064000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="idf6dbb88304d4595865f7e6425907d5e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtNS0xLTEtMjUx_22b1998d-eb5a-4e52-a665-8f95220a325e"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="idf6dbb88304d4595865f7e6425907d5e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtNy0xLTEtMjUx_2f44d095-2fd8-4919-a3e1-084d97711291"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i96ac7f784c484cb6b645b04089e32903_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtOS0xLTEtMjUx_6efc836d-b903-4fa2-b1bb-d4807ce5b94e"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i96ac7f784c484cb6b645b04089e32903_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTEtMS0xLTI1MQ_c8340444-cc75-4cc5-ad85-906676f7d6eb"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ie8ed9359c48a4172993da7b129d56e5d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTQtMS0xLTI1MQ_721c3757-3aa7-4084-be1f-09d8d6c64ee0"
      unitRef="shares">7600877</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie8ed9359c48a4172993da7b129d56e5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTYtMS0xLTI1MQ_e6977a19-df70-469a-8d1e-21a5d8f261a3"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i19b72630e4874757aac99920f0790b3f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMTgtMS0xLTI1MQ_7bd0aff6-6fd6-4eff-827d-a661016dd824"
      unitRef="usd">887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc4e64d4ece4416db8aa1774732dcf60_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjAtMS0xLTI1MQ_196f67bf-86d4-4229-8577-2deee0874d74"
      unitRef="usd">54000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba4476799e6c43e9b11f139b87f6e3eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjItMS0xLTI1MQ_815b6078-1054-4666-a5a1-8f4c2561c637"
      unitRef="usd">-35490000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9db48e68792b4cb48b1ababe34ca2b87_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzMtMjQtMS0xLTI1MQ_7d505f51-e658-4c59-a5ba-f7f36b8f08a0"
      unitRef="usd">-34548000</us-gaap:StockholdersEquity>
    <sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzQtNS0xLTEtMjUx_1031276f-7af8-4b26-b756-4dcf995a3643"
      unitRef="shares">550571</sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="idb402b2c6c294373ba3ea1db22c3adaa_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzQtNy0xLTEtMjUx_cca621c8-a926-43cc-90ba-61717f3e254d"
      unitRef="usd">34427000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMTQtMS0xLTI1MQ_e5356834-0f46-472c-bbfd-e733f5206dc4"
      unitRef="shares">28113</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5f046b755a624db096bbc2345de726fc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMTgtMS0xLTI1MQ_ae80dad6-d9de-4684-b3d2-6e11874e02f4"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzUtMjQtMS0xLTI1MQ_5b6f736f-222f-4b13-91b1-0692ecd5fd64"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzYtMTQtMS0xLTI1MQ_4c5a71b2-12b2-4df5-8562-d323b919a14e"
      unitRef="shares">5037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5f046b755a624db096bbc2345de726fc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzctMTgtMS0xLTI1MQ_ce671901-7919-4cf5-b5b8-043bd0be2b89"
      unitRef="usd">180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzctMjQtMS0xLTI1MQ_b2a8de93-761f-4f57-a06d-37cca25f59a7"
      unitRef="usd">180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6afcf491686b407a8a99dbe8013777f9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzgtMjAtMS0xLTI1MQ_38c1fd4f-7adc-4db7-83b7-c6338442db3e"
      unitRef="usd">61000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzgtMjQtMS0xLTI1MQ_02b5ccf7-8c1d-4b56-922a-0dd3c7fcd2e5"
      unitRef="usd">61000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ifb02004041e34aeea7a968c4f7d726f2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzktMjItMS0xLTI1MQ_244c8d53-2a6b-4830-9805-6438bf617338"
      unitRef="usd">-6554000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2a1999f3bb254fd89a7bc0801def9521_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzktMjQtMS0xLTI1MQ_b95ea786-396e-441a-b19f-b088c041662c"
      unitRef="usd">-6554000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i65da78330c124c72b6daf2f158858f87_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTEtMS0xLTI1MQ_4163e79d-b65a-44ce-bdc5-ea406abff994"
      unitRef="shares">1093019</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i65da78330c124c72b6daf2f158858f87_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTMtMS0xLTI1MQ_d2ff0a62-20dd-4e36-a4a2-e6744ead1fc7"
      unitRef="usd">49064000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="id1c37493a8ff4212aee79aea73e76b60_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTUtMS0xLTI1MQ_fee95a8c-7a1e-4bf3-a0a4-ab1131ca0a0f"
      unitRef="shares">550571</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="id1c37493a8ff4212aee79aea73e76b60_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTctMS0xLTI1MQ_793cfddd-3b43-4dfa-aba5-3de140467018"
      unitRef="usd">34427000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i95620647f2f44d4aba93d095901e26f6_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTktMS0xLTI1MQ_e81617c3-63ee-4f63-a728-7299ff2611fa"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i95620647f2f44d4aba93d095901e26f6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTExLTEtMS0yNTE_5bdd250c-435a-483a-9fce-a1fe9f5c50d3"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i5fff4b70e84e4503b828997e45293717_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE0LTEtMS0yNTE_36813429-8dab-4d1d-96c1-d7fcea23be33"
      unitRef="shares">7634027</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5fff4b70e84e4503b828997e45293717_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE2LTEtMS0yNTE_a4252aef-89fd-447e-8077-b8bd271b5354"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i16bf9ea147614ea3979c329a7c40111e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTE4LTEtMS0yNTE_ca87f769-b449-4453-b751-2f38b3d5c6a5"
      unitRef="usd">1067000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9de96e067aed44aabf2d79bbccfb2d4a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTIwLTEtMS0yNTE_376bc862-d56a-4f0f-a777-69e7a5f82dad"
      unitRef="usd">115000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib36be3855f8b4adbaeb7b5fb0bf4460f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTIyLTEtMS0yNTE_e0289711-831b-4337-936e-594290655c3b"
      unitRef="usd">-42044000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8bc7158f78fe423f8b8d304e7f23a82c_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEwLTI0LTEtMS0yNTE_ead79d38-3463-4310-a003-f0eaf99ded1c"
      unitRef="usd">-40861000</us-gaap:StockholdersEquity>
    <sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="iae6291564a37483d8bb66b65731f4101_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEyLTktMS0xLTI1MQ_00c9f6a9-0f55-4a78-aca1-ef845251a3fe"
      unitRef="shares">1319964</sttk:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="iae6291564a37483d8bb66b65731f4101_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEyLTExLTEtMS0yNTE_1667cb2d-ecd4-4234-a1a8-daef7e1782c0"
      unitRef="usd">82618000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTE0LTEtMS0yNTE_00a69f80-f822-4380-b5d8-251e99fb7517"
      unitRef="shares">20131</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTE4LTEtMS0yNTE_2e046d07-3625-471b-a9a6-0f398cb3ebf4"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzEzLTI0LTEtMS0yNTE_05268225-b544-4f51-9260-46705b9ae322"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i7a88501989434e22a48af18c1b4a8547_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE0LTE0LTEtMS0yNTE_e9912391-ed7a-40a7-93ab-0820089e06e7"
      unitRef="shares">5037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icf6c201696844600b17e6fd01d96cbb4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE1LTE4LTEtMS0yNTE_65d4c091-5855-4cb9-a6a1-8691debb0218"
      unitRef="usd">137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE1LTI0LTEtMS0yNTE_8fae3350-96d9-4506-9954-e126b01989f8"
      unitRef="usd">137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i31c0536199104f62b96d3be8d78a773e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE2LTIwLTEtMS0yNTE_7c3d5651-87ae-4d1e-a4ad-edf85e89bede"
      unitRef="usd">-97000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE2LTI0LTEtMS0yNTE_f3bc72a7-da79-404d-9183-4ed253345060"
      unitRef="usd">-97000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ia45c4fa1189d41e6b75f3b2c4224f632_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE3LTIyLTEtMS0yNTE_ea87ca88-3b07-4fd5-bc0c-66742a20b35d"
      unitRef="usd">-6208000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4dfd9a66a0384c11bf2a87cc69999819_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE3LTI0LTEtMS0yNTE_22f40083-2722-4f57-b779-df41bedc6bae"
      unitRef="usd">-6208000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i46f763e24d914335a16f2797cbdcda54_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTEtMS0xLTI1MQ_0d8461fc-ab5b-4efa-88d8-d5ac966ee715"
      unitRef="shares">1093019</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i46f763e24d914335a16f2797cbdcda54_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTMtMS0xLTI1MQ_25bca5c9-b73f-445f-bab9-03eea2e9c2c6"
      unitRef="usd">49064000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic8a2d81f76074762b59a86c90d441d3e_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTUtMS0xLTI1MQ_dd3f71cc-adce-44d1-b362-cf187a805eb6"
      unitRef="shares">550571</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ic8a2d81f76074762b59a86c90d441d3e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTctMS0xLTI1MQ_0158be75-1f2f-4f3d-8032-a338443e2ebc"
      unitRef="usd">34427000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i180732543f574734a093e1fdd359c31e_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTktMS0xLTI1MQ_078ae559-ba27-42c6-b022-ce9556f6aef8"
      unitRef="shares">1319964</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i180732543f574734a093e1fdd359c31e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTExLTEtMS0yNTE_a20eb592-31d6-471a-9aa5-e7391b8b5c44"
      unitRef="usd">82618000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE0LTEtMS0yNTE_ab17c9aa-55c3-4bff-a683-376def174cc7"
      unitRef="shares">7659195</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7721b58e902c4e2ab5fb699ef19e25ad_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE2LTEtMS0yNTE_8145c8dc-cf27-4370-9cfa-2c78550d72ee"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icca3a5a03c7944b58f29193146f4a6f0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTE4LTEtMS0yNTE_353642be-bc21-4b46-95e1-eabe1895a013"
      unitRef="usd">1204000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc5b787ecb8c4de78e65e2d9759d48a4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTIwLTEtMS0yNTE_2668c06c-9622-4159-bb31-76cb9c8fdfeb"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9c24c935fc14f9d9bb20f6d1b1478e7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTIyLTEtMS0yNTE_a99eecfc-cfd2-45b6-840e-f737f034d783"
      unitRef="usd">-48252000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b2e4eca1d1b49aab71c8126e08eba38_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzE4LTI0LTEtMS0yNTE_21c4e498-b5bc-4dd2-b888-93f91883afe6"
      unitRef="usd">-47029000</us-gaap:StockholdersEquity>
    <sttk:TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts
      contextRef="i2ae5c9d2028648418dd51b0c2b0a3cbd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIwLTExLTEtMS0yNTE_b4570120-4b23-45bd-b035-a4534e05653f"
      unitRef="usd">5000</sttk:TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i86c197370694420e8139fb6bcd63799c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTE0LTEtMS0yNTE_9f65f9b5-633a-491a-91d9-a7ddb8bc75e6"
      unitRef="shares">115048</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTE4LTEtMS0yNTE_6831b471-95fc-4d3b-9de4-32b380ff85bd"
      unitRef="usd">214000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIxLTI0LTEtMS0yNTE_a75393b8-62c9-4097-8aa5-8ef9e8d2fddc"
      unitRef="usd">214000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i86c197370694420e8139fb6bcd63799c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIyLTE0LTEtMS0yNTE_d03e6224-4b8f-4aaa-a6eb-18fa88d08276"
      unitRef="shares">5037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i577b3341c32b409fbccf4d236f63a30b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIzLTE4LTEtMS0yNTE_d99dca64-ee43-4ca1-b7ed-369b9eb2df04"
      unitRef="usd">312000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzIzLTI0LTEtMS0yNTE_982f37c4-28b7-4aa2-8226-4649aa4f3ab7"
      unitRef="usd">312000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i55b9b9e789cd442da7cfa75ff1ec86c0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI0LTIwLTEtMS0yNTE_0809e23b-f4c7-41a9-beb7-f4bf015ae888"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI0LTI0LTEtMS0yNTE_dcd40a7b-5386-4395-b8de-d81b03fb4003"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i2cb009f0275b4b66b6ea526dcbca7e9f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI1LTIyLTEtMS0yNTE_515aeb97-a837-42fa-a25a-759f3b3c65db"
      unitRef="usd">-11829000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI1LTI0LTEtMS0yNTE_7e2ff64e-048a-4de6-a453-57c89edb827d"
      unitRef="usd">-11829000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8d43c4f21e4f400181e8380a945fa403_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTEtMS0xLTI1MQ_71a4c02f-48a3-499d-a017-b2eb2b47aa7f"
      unitRef="shares">1093019</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8d43c4f21e4f400181e8380a945fa403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTMtMS0xLTI1MQ_ee296261-faf7-40b5-840b-cef1ee28988f"
      unitRef="usd">49064000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTUtMS0xLTI1MQ_9f936f49-6ce7-4ad7-8335-a7ab5d9929d5"
      unitRef="shares">550571</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTctMS0xLTI1MQ_71ec2756-9777-4894-aea7-3188f8f9feda"
      unitRef="usd">34427000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTktMS0xLTI1MQ_7e8a5b92-3255-4fd7-a1ab-81fad5f75203"
      unitRef="shares">1319964</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTExLTEtMS0yNTE_3bc77ddd-e972-410d-9380-b91477452091"
      unitRef="usd">82613000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i8b32de77fd41426fb9250157c316291b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE0LTEtMS0yNTE_1bca9b6f-3d08-43dd-9456-ffcf7c7c467d"
      unitRef="shares">7779280</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8b32de77fd41426fb9250157c316291b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE2LTEtMS0yNTE_6336f366-ac49-4d9c-9806-b55e546ea6e0"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbfd6109d71a41d88ac7cd90ef87419a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTE4LTEtMS0yNTE_f99dad98-b8a5-4bb1-854a-c0ce56b858be"
      unitRef="usd">1730000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5dc7e714b56844a881c19fc1a46f7a81_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTIwLTEtMS0yNTE_882026ea-0306-46bb-96ca-74a9cae85512"
      unitRef="usd">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icf10a010e6f24e1ead5edad126efe989_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTIyLTEtMS0yNTE_48bc0a86-5be7-4cc3-b5b1-8daea9a64f34"
      unitRef="usd">-60081000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i74d3aa8f82514539b0c9f923f0819cdb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNjcvZnJhZzpmZTRkMzQ4NTc0YzE0MzliOTlmMGFhYWMyMTE5ZjIxNy90YWJsZToxYTUzNTM0ODZlMGQ0YTJiYWRkMTc1ZTgwMjRiYmYyNi90YWJsZXJhbmdlOjFhNTM1MzQ4NmUwZDRhMmJhZGQxNzVlODAyNGJiZjI2XzI2LTI0LTEtMS0yNTE_532d79db-5d65-46da-96f5-5d2fc785c474"
      unitRef="usd">-58360000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMy0xLTEtMS0w_3e3d8857-22f9-4fea-8875-e95d6aa173ca"
      unitRef="usd">-52821000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMy0zLTEtMS0w_63d5c925-6a5f-4cf0-b5c8-dbc441eebe0f"
      unitRef="usd">-24591000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0xLTEtMS0xMzUxMw_ac218fb3-dbab-491e-8d35-45babc683821"
      unitRef="usd">4251000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0zLTEtMS0xMzUxMw_57b20f6a-04f3-4a89-aa5a-fe5fb923a9c4"
      unitRef="usd">629000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0xLTEtMS0w_a8118752-06ed-4cfa-9f3c-bba9bcd6dd95"
      unitRef="usd">937000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNS0zLTEtMS0w_fdf38a79-d25b-4b6b-9e70-be1b2d08add8"
      unitRef="usd">448000</us-gaap:Depreciation>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNy0xLTEtMS0w_81a3eb70-83b8-4ba5-b943-f44ca60ef12a"
      unitRef="usd">-774000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfNy0zLTEtMS0w_81e0f9be-f076-403b-afc4-d6d311e1c6ba"
      unitRef="usd">22000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfOS0xLTEtMS0w_8d91ee21-d538-42b3-9c89-5a568b64bef6"
      unitRef="usd">1239000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfOS0zLTEtMS0w_72d66497-7ee5-4b57-8739-4a4061ae49d2"
      unitRef="usd">2214000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTAtMS0xLTEtMA_418aee68-b063-4378-ae79-fe677cf9ec4a"
      unitRef="usd">-75000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTAtMy0xLTEtMA_2feadd70-6188-41da-9e5f-2367c4cd9b45"
      unitRef="usd">33000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTEtMS0xLTEtMA_99b7d025-4a4a-493e-b5c6-975956785473"
      unitRef="usd">846000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTEtMy0xLTEtMA_555ac97c-34bc-40b9-b935-448e4f29bcd8"
      unitRef="usd">-1701000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTItMS0xLTEtMA_43b64789-f744-4042-ae38-1962090aee65"
      unitRef="usd">6431000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTItMy0xLTEtMA_7c30f1c1-b236-4edb-af5d-3e0e17da2141"
      unitRef="usd">1985000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTMtMS0xLTEtMA_dded0050-d580-4a92-a12c-cadbbbab1a0a"
      unitRef="usd">1044000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTMtMy0xLTEtMA_bb0e7bc7-a8c8-4bd9-80b8-8ddb17ae8feb"
      unitRef="usd">5870000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <sttk:IncreaseDecreaseInDeferredRentCredits
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTQtMS0xLTEtMA_50cfebe1-2683-441b-b461-40c8ef7396d0"
      unitRef="usd">-1303000</sttk:IncreaseDecreaseInDeferredRentCredits>
    <sttk:IncreaseDecreaseInDeferredRentCredits
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTQtMy0xLTEtMA_215bf7eb-425a-4b97-8b5e-f06a2a86f3da"
      unitRef="usd">-13000</sttk:IncreaseDecreaseInDeferredRentCredits>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTUtMS0xLTEtMA_510be5e8-c0dc-44e7-9c7e-1c6511464cf3"
      unitRef="usd">-38399000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTUtMy0xLTEtMA_2875fd46-ae66-4626-9b07-7fa0ab14a293"
      unitRef="usd">-19616000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTgtMS0xLTEtMA_5f3b0899-55e5-4615-8598-5eb4b5944b98"
      unitRef="usd">5936000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTgtMy0xLTEtMA_deefc1b6-6632-4dbd-9bba-db5b391f39f4"
      unitRef="usd">526000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTktMS0xLTEtMA_8d657ec4-a33c-4d73-af63-8a901a4482f7"
      unitRef="usd">134975000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMTktMy0xLTEtMA_8dd564d5-7b39-4ca1-9b54-108101e26af1"
      unitRef="usd">31270000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjAtMS0xLTEtMA_4a8a69a9-115b-4818-9da4-1c78317baa6e"
      unitRef="usd">165083000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjAtMy0xLTEtMA_1131e23f-7716-418d-90ec-2a9e94d73586"
      unitRef="usd">5578000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjEtMS0xLTEtMA_812ef08e-0046-48e9-a26f-b5bc0c7b9e75"
      unitRef="usd">-36044000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjEtMy0xLTEtMA_30e89e08-851a-4824-b35d-d7d6861d143b"
      unitRef="usd">25166000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMS0xLTEtMTM1MzQ_01eb70a7-3508-4fa6-a53c-bcd036671938"
      unitRef="usd">1639000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMy0xLTEtMTM1MzQ_23c61acb-0ac1-42bb-a934-41669af18e1a"
      unitRef="usd">214000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMS0xLTEtMA_ae53692b-c798-4da0-bd08-9f07ea5cc7e1"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjQtMy0xLTEtMA_dfb85f93-1103-45df-b4c4-d2dec47d66cc"
      unitRef="usd">1251000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="ifdec66eb26c346dead446844d3d02964_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjUtMS0xLTEtMA_61eb5281-8240-4992-9002-8dcde929bbb4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjUtMy0xLTEtMA_72532141-a651-41e1-a038-cbd9f305afea"
      unitRef="usd">34461000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="iaf949b23f20d4f72b56403c3fbb43149_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjYtMS0xLTEtMA_aeaa175f-42fd-4a6e-97e2-7681d2576f4a"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjYtMy0xLTEtMA_790bfdc0-05c1-4f4c-90d0-9091b10c6611"
      unitRef="usd">82613000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjgtMS0xLTEtMA_08782eeb-ae56-4a4f-9616-85f80b5ddbda"
      unitRef="usd">1639000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjgtMy0xLTEtMA_52e15de0-79e5-40c9-9491-2044984c6fbc"
      unitRef="usd">116037000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjktMS0xLTEtMA_c121af2e-8c59-4326-97ed-85d65007953a"
      unitRef="usd">-72804000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMjktMy0xLTEtMA_f08ec996-a282-4f1d-a9b0-900fdd06bdd9"
      unitRef="usd">121587000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzAtMS0xLTEtMA_dc1ce9a6-ab88-4d0f-86d0-db280c532fe9"
      unitRef="usd">157898000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9db48e68792b4cb48b1ababe34ca2b87_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzAtMy0xLTEtMA_49be4350-444a-435e-9330-ff67e4b55106"
      unitRef="usd">7013000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzEtMS0xLTEtMA_46c49ffa-d668-4d92-b582-d10ebe98c251"
      unitRef="usd">85094000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i74d3aa8f82514539b0c9f923f0819cdb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzEtMy0xLTEtMA_8e3bd085-a5e2-452b-9305-9a08800a3e33"
      unitRef="usd">128600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzQtMS0xLTEtMA_7382b94a-eb16-4f8f-b164-781b2d90e0bb"
      unitRef="usd">-1764000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzQtMy0xLTEtMA_42428c5e-1260-4611-b639-2ee779f4e88c"
      unitRef="usd">-64000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <sttk:StockIssuanceCostsIncurredDuringNoncashTransaction
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzUtMS0xLTEtMTQy_09d12913-21aa-4427-a50f-9367db43d2c5"
      unitRef="usd">0</sttk:StockIssuanceCostsIncurredDuringNoncashTransaction>
    <sttk:StockIssuanceCostsIncurredDuringNoncashTransaction
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzUtMy0xLTEtMTM4_820d6597-2e86-40aa-8535-d2ca25e91c73"
      unitRef="usd">495000</sttk:StockIssuanceCostsIncurredDuringNoncashTransaction>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzYtMS0xLTEtMTI5NTk_3c38f1a5-1a3a-4bf2-afee-05ec5b9dee99"
      unitRef="usd">651000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8yNS9mcmFnOjM4NzljNjEyZTdkYzRkNDZhMTY4N2NmNGU4M2JhMGJiL3RhYmxlOmU3MTI2OGJjYWRkNzQ3NDhhMmU2NDFjMThhYThjM2ViL3RhYmxlcmFuZ2U6ZTcxMjY4YmNhZGQ3NDc0OGEyZTY0MWMxOGFhOGMzZWJfMzYtMy0xLTEtMTI5NjU_2ab79127-746e-408a-b628-5cdb81043c21"
      unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfMzc5NQ_7cf12131-925d-4e3c-a878-3625c4c251b2">Organization and Description of Business &lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shattuck Labs, Inc. (the &#x201c;Company&#x201d;) was incorporated in 2016 in the State of Delaware and is a clinical-stage biopharmaceutical company developing dual-sided fusion proteins, including its ARC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and GADLEN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; platforms, as novel classes of biologic medicines capable of multifunctional activity with potential applications in oncology and inflammatory diseases. Using its proprietary technology, the Company is building a pipeline of therapeutics, initially focused on the treatment of solid tumors and hematologic malignancies. The Company has two clinical-stage product candidates, SL-172154 and SL-279252, and has several compounds in preclinical development. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred losses and negative cash flows from operations since inception and has an accumulated deficit of $124.9 million as of September&#160;30, 2021. The Company anticipates incurring additional losses and negative cash flows from operations until such time, if ever, that it can generate significant sales of its product candidates currently in development, and is highly dependent on its ability to find additional sources of funding in the form of licensing of its technology, collaboration agreements and/or public and private debt and equity financings. Adequate additional funding may not be available to the Company on acceptable terms, or at all. The failure to raise funds as and when needed could have a negative impact on the Company&#x2019;s financial condition and ability to pursue its clinical operations, research and development and commercialization of its product candidates. Management believes that the Company&#x2019;s cash and cash equivalents and short-term investments of $290.2 million as of September&#160;30, 2021 are sufficient to fund projected operations of the Company into the second half of 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;10, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The virus and actions taken to mitigate its spread have had, and are expected to continue to have, a broad adverse impact on the economies and financial markets of many countries, including the geographical areas in which the Company operates and conducts its business and in which the Company&#x2019;s partners operate and conduct their business. The Company is currently following the recommendations of local health authorities to minimize exposure risk for its team members and visitors. However, the scale and scope of this pandemic is unknown and the duration of the business disruption and related financial impact cannot be reasonably estimated at this time. While the Company has implemented specific business continuity plans to reduce the potential impact of COVID-19, there is no guarantee that the Company&#x2019;s continuity plans will be successful. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has already experienced disruptions to its business such as work-from-home orders for offices and similar disruptions have occurred for its partners. Specifically, the outbreak has caused disruptions in its ability to manufacture clinical trial materials, including the acquisition of raw materials needed for such manufacturing, enrollment and treatment of patients in clinical trials in process and slowdowns and shutdowns of the laboratories and other service providers that are being relied upon in the development of the Company&#x2019;s product candidates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extent to which the COVID-19 pandemic or any other health epidemic may impact the Company&#x2019;s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of COVID-19 and the actions to mitigate its impact, among others. Accordingly, the COVID-19 pandemic could have a material adverse effect on the Company&#x2019;s business, results of operations and financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfODQz_792007eb-02ab-468a-a26b-7c7c6432c4f6"
      unitRef="usd">-124900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zMS9mcmFnOjA1ODA1ZTQ5MjI5YjQ0NWU5MjhjMDgwMTFhNzQzZTgxL3RleHRyZWdpb246MDU4MDVlNDkyMjliNDQ1ZTkyOGMwODAxMWE3NDNlODFfMTY4OQ_ffe48361-1cb8-4b4d-bd64-d66cbf7d8b47"
      unitRef="usd">290200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODE_aadff70f-965e-46b0-a1a1-8be037ced9f6">Basis of Presentation and Summary of Significant Accounting Policies &lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying interim financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company&#x2019;s financial position, its results of operations, statements of changes in redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for the interim periods presented. Operating results for interim periods presented are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. These interim financial statements, presented herein, do not contain all required disclosures under GAAP for annual financial statements. The accompanying unaudited interim financial statements should be read in conjunction with the annual audited financial statements and related notes in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates, if any, are recorded in the period in which they become known and actual results could differ from management&#x2019;s estimates. A&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;change in the Company&#x2019;s estimates occurred in the second quarter of 2021, which impacted the Company&#x2019;s revenue recognition and related balance sheet accounts. See Note 8 to the Company&#x2019;s unaudited interim condensed financial statements included elsewhere in this Quarterly Report on Form 10-Q for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon the sale of an asset or paid upon the transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. Fair value measurements are classified and disclosed in one of the following categories: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets the reporting entity has the ability to access as of the measurement date; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are classified based on the lowest level of input that is significant to the measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The determination of the fair values stated below takes into account the market for its financial assets and liabilities, the associated credit risk and other factors as required. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that the carrying amounts of the Company&#x2019;s financial instruments, including short-term investments and accounts payable, approximate fair value due to the short-term nature of those instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at two accredited financial institutions in amounts that exceed federally-insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company invests in only highly-rated debt securities that management believes protects the Company from risk of default and impairment of value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue is derived from its collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (&#x201c;Takeda&#x201d;) (see Note 8). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is highly dependent on a single third-party contract manufacturing organization (&#x201c;CMO&#x201d;) to supply drug products for its research and development activities of its programs, including clinical trials and non-clinical studies. These programs could be adversely affected by a significant interruption in the supply of such drug products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is highly dependent on three contract research organizations (&#x201c;CROs&#x201d;) and a limited number of third-party service providers to manage and support its clinical trials. These programs could be adversely affected by a significant disruption in services provided by these CROs and third parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all demand deposits with financial institutions and all highly liquid investments with original maturities of 90 days or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents consisted of $14.0 million held in operating accounts and $71.1 million held in money market funds as of September&#160;30, 2021 and $2.7 million held in operating accounts, $80.2 million held in money market funds and $75.0 million held in government obligations as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of highly-rated U.S. Treasury securities with maturities of more than three months but less than one year at the date of purchase. The Company classifies its short-term investments at the time of purchase as available-for-sale securities. Available-for-sale securities are carried at fair value. The Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on January 1, 2020, which amended its accounting for available-for-sale debt securities. Credit impairments are recorded through an allowance rather than a direct write-down of the security and are recorded through a charge to the statements of operations. Unrealized gains or losses not related to credit impairments are recorded in accumulated other comprehensive income, a component of stockholders&#x2019; equity, until realized. The Company reviews available-for-sale debt securities for impairments related to credit losses and other factors each quarter. As of September&#160;30, 2021, there were no impairments related to credit losses of short-term investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs will be recorded against gross proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records shares of redeemable convertible preferred stock at their respective fair values on the date of issuance, net of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#x2019; equity on the balance sheet because the shares contain liquidation features that are not solely within the Company&#x2019;s control. Upon the completion of the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;) in the fourth quarter of 2020, all outstanding shares of the Company&#x2019;s redeemable convertible preferred stock were converted into common stock. See Note 6 to the Company&#x2019;s unaudited interim condensed financial statements included elsewhere&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in this Quarterly Report on Form 10-Q for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaboration revenue is recognized in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;). Arrangements with collaborators may include licenses to intellectual property, research and development services, manufacturing services for clinical and commercial supply and participation on joint steering committees. The Company evaluates the promised goods or services in the contract to determine which promises, or group of promises, represent performance obligations. In contemplation of whether a promised good or service meets the criteria required of a performance obligation, the Company considers the stage of development of the underlying intellectual property, the capabilities and expertise of the customer relative to the underlying intellectual property and whether the promised goods or services are integral to or dependent on other promises in the contract. When accounting for an arrangement that contains multiple performance obligations, the Company must develop &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;judgmental assumptions, which may include market conditions, reimbursement rates for personnel costs, development timelines and probabilities of regulatory success to determine the stand-alone selling price for each performance obligation identified in the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the amendment of an existing agreement, the Company evaluates whether the amendment represents a modification to an existing contract which would be recorded through a cumulative catch-up to revenue, or a separate contract. If it is determined that it is a separate contract, the Company will evaluate the necessary revenue recognition through the five-step process described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company concludes that a contract should be accounted for as a combined performance obligation and recognized over time, the Company must then determine the period over which revenue should be recognized and the method by which to measure revenue. The Company generally recognizes revenue using a cost-based input method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes collaboration revenue when its customer or collaborator obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the following five steps are performed: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;identify the contract(s) with a customer;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;iii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt"&gt;determine the transaction price; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;iv.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt"&gt;allocate the transaction price to the performance obligations within the contract; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;recognize revenue when (or as) the entity satisfies a performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company only applies the five-step model to contracts when it determines that it is probable it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within the contract to determine whether each promised good or service is a performance obligation. The promised goods or services in the Company&#x2019;s arrangements may consist of a license, or options to license, the Company&#x2019;s intellectual property and research, development and manufacturing services. The Company may provide options to additional items in such arrangements, which are accounted for as separate contracts when the customer elects to exercise such options, unless the option provides a material right to the customer. Performance obligations are promises in a contract to transfer a distinct good or service to the customer that (i)&#160;the customer can benefit from on its own or together with other readily available resources and (ii)&#160;are separately identifiable from other promises in the contract. Goods or services that are not individually distinct performance obligations are combined with other promised goods or services until such combined group of promises meet the requirements of a performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract. Consideration may be fixed, variable or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most-likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes variable consideration in the transaction price to the extent it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded as deferred revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts received prior to satisfying the revenue recognition criteria are recognized as deferred revenue in the Company&#x2019;s accompanying balance sheet. Deferred revenues expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability. Deferred revenues not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Company&#x2019;s collaboration revenue arrangements may include the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Up-front License Fees: If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Milestone Payments: At the inception of an agreement that includes research and development milestone payments, the Company evaluates each milestone to determine when and how much of the milestone to include in the transaction price. The Company first estimates the amount of the milestone payment that the Company could receive using either the expected value or the most-likely amount approach. The Company primarily uses the most-likely amount approach as that approach is generally most predictive for milestone payments with a binary outcome. The Company then considers whether any portion of that estimated amount is subject to the variable consideration constraint (that is, whether it is probable that a significant reversal of cumulative revenue would not occur upon resolution of the uncertainty). The Company updates the estimate of variable consideration included in the transaction price at each reporting date which includes updating the assessment of the likely amount of consideration and the application of the constraint to reflect current facts and circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalties: For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i)&#160;when the related sales occur or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To date, the Company has not granted a development and commercialization license nor recognized any revenue related to sales-based royalties or milestone payments based on the level of sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and Development Services: The Company will record costs associated with development and process optimization activities as research and development expenses in the statements of operations and comprehensive loss consistent with ASC 730, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company considered the guidance in ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and will recognize the payments received from these agreements as revenue when the related costs are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred, and include salaries, stock-based compensation and other personnel-related costs, equipment and supplies, depreciation, preclinical studies, clinical trials and manufacturing development activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A substantial portion of the Company&#x2019;s ongoing research and development activities are conducted by third-party service providers, including contract research and manufacturing organizations. The Company accrues for expenses resulting from obligations under agreements with CROs, CMOs and other outside service providers for which payment flows do not match the periods over which materials or services are provided to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals are recorded based on estimates of services received and efforts expended pursuant to agreements established with CROs, CMOs and other outside service providers. These estimates are typically based on contracted amounts applied to the proportion of work performed and determined through analysis with internal personnel and external service providers as to the progress or stage of completion of the services. In the event advance payments are made to a CRO, CMO or outside service provider, the payments will be recorded as a prepaid asset which will be amortized as the contracted services are performed. As actual costs become known, the Company adjusts its accruals and prepaid assets accordingly. Inputs, such as the services performed, the number of patients enrolled or the study duration, may vary from the Company&#x2019;s estimates, resulting in adjustments to research and development expense in future periods. The Company makes significant judgements and estimates in determining the accrual and/or prepaid balance in each reporting period and changes in these estimates may result in material changes to the Company&#x2019;s accruals that could materially affect the Company&#x2019;s results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during each period. Diluted loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as redeemable convertible preferred stock, convertible notes, stock options and unvested shares of restricted stock, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, dilutive securities are not included in the calculation as the impact is anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,538,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock as converted to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,300,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,855,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Comprehensive Income (Loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) is comprised of the net loss and unrealized gains and losses on short-term investments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued ASU No. 2019-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes: Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU removes certain exceptions to the general principles in ASC 740,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company adopted this pronouncement effective January 1, 2021 and it did not have a material impact on the financial statements or related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements (not yet adopted) &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No.&#160;2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The FASB deferred the effective date of this ASU until the annual periods beginning after December 15, 2021. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTQ_b6989cb2-0256-4edd-ac5d-6c92294c47e9">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;Unaudited Interim Financial Statements In the opinion of management, the accompanying interim financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company&#x2019;s financial position, its results of operations, statements of changes in redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for the interim periods presented. Operating results for interim periods presented are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. These interim financial statements, presented herein, do not contain all required disclosures under GAAP for annual financial statements. The accompanying unaudited interim financial statements should be read in conjunction with the annual audited financial statements and related notes in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODY_d4d9c66d-5dc0-4d1d-93f1-9f13cf149bcf">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates, if any, are recorded in the period in which they become known and actual results could differ from management&#x2019;s estimates. A&lt;/span&gt;&lt;/div&gt;change in the Company&#x2019;s estimates occurred in the second quarter of 2021, which impacted the Company&#x2019;s revenue recognition and related balance sheet accounts.</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTA_b892cd72-65a3-47a5-9f93-082ea5152115">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon the sale of an asset or paid upon the transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. Fair value measurements are classified and disclosed in one of the following categories: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets the reporting entity has the ability to access as of the measurement date; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt"&gt;Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are classified based on the lowest level of input that is significant to the measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The determination of the fair values stated below takes into account the market for its financial assets and liabilities, the associated credit risk and other factors as required. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that the carrying amounts of the Company&#x2019;s financial instruments, including short-term investments and accounts payable, approximate fair value due to the short-term nature of those instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODc_2fc2142c-4519-43ab-af48-ea17ba53b130">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at two accredited financial institutions in amounts that exceed federally-insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company invests in only highly-rated debt securities that management believes protects the Company from risk of default and impairment of value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue is derived from its collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (&#x201c;Takeda&#x201d;) (see Note 8). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is highly dependent on a single third-party contract manufacturing organization (&#x201c;CMO&#x201d;) to supply drug products for its research and development activities of its programs, including clinical trials and non-clinical studies. These programs could be adversely affected by a significant interruption in the supply of such drug products. &lt;/span&gt;&lt;/div&gt;The Company is highly dependent on three contract research organizations (&#x201c;CROs&#x201d;) and a limited number of third-party service providers to manage and support its clinical trials. These programs could be adversely affected by a significant disruption in services provided by these CROs and third parties.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTY_065a43af-4315-4872-8811-a6bf11459e9d">Cash and Cash Equivalents The Company considers all demand deposits with financial institutions and all highly liquid investments with original maturities of 90 days or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents consisted of $14.0 million held in operating accounts and $71.1 million held in money market funds as of September&#160;30, 2021 and $2.7 million held in operating accounts, $80.2 million held in money market funds and $75.0 million held in government obligations as of December&#160;31, 2020.</us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i91d5a84837714480a2462e3255a83730_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTQ4Mg_e93fa48c-b87e-4a32-b4a2-74fbb0edb573"
      unitRef="usd">14000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i28e6d73e46e34e999b3a2520c34da2bb_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTUxMw_9dffaa94-d239-4291-a245-d34e4317bec9"
      unitRef="usd">71100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i21077307da9c4396a282390e1aaac1c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTU5NA_dbe29b17-b16c-4074-ba5a-fdf0e2bf9757"
      unitRef="usd">2700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i385459190ef7464a90ce28ba7fe7883d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTYyNQ_9bbac408-cf62-4764-a49e-209d82fbad32"
      unitRef="usd">80200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ebaf8f49a6941a0976a2367d5cc1bfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfNTY1OQ_eaac4f09-be62-4fe9-ac26-e17e5813dad9"
      unitRef="usd">75000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzc_531f8e98-f954-4104-8c7b-8cbaf787d9ed">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of highly-rated U.S. Treasury securities with maturities of more than three months but less than one year at the date of purchase. The Company classifies its short-term investments at the time of purchase as available-for-sale securities. Available-for-sale securities are carried at fair value. The Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on January 1, 2020, which amended its accounting for available-for-sale debt securities. Credit impairments are recorded through an allowance rather than a direct write-down of the security and are recorded through a charge to the statements of operations. Unrealized gains or losses not related to credit impairments are recorded in accumulated other comprehensive income, a component of stockholders&#x2019; equity, until realized. The Company reviews available-for-sale debt securities for impairments related to credit losses and other factors each quarter. As of September&#160;30, 2021, there were no impairments related to credit losses of short-term investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzg_474a8a06-a64b-4a48-a86a-0d069c313263">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs will be recorded against gross proceeds.&lt;/span&gt;&lt;/div&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <sttk:TemporaryEquityPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1Nzk_66fa4481-4110-40d2-a180-13fe6284b616">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records shares of redeemable convertible preferred stock at their respective fair values on the date of issuance, net of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#x2019; equity on the balance sheet because the shares contain liquidation features that are not solely within the Company&#x2019;s control. Upon the completion of the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;) in the fourth quarter of 2020, all outstanding shares of the Company&#x2019;s redeemable convertible preferred stock were converted into common stock. See Note 6 to the Company&#x2019;s unaudited interim condensed financial statements included elsewhere&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in this Quarterly Report on Form 10-Q for further information.&lt;/span&gt;&lt;/div&gt;</sttk:TemporaryEquityPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTE_da19a851-ea02-4a56-a59a-36c5e3b0d7c7">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaboration revenue is recognized in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;). Arrangements with collaborators may include licenses to intellectual property, research and development services, manufacturing services for clinical and commercial supply and participation on joint steering committees. The Company evaluates the promised goods or services in the contract to determine which promises, or group of promises, represent performance obligations. In contemplation of whether a promised good or service meets the criteria required of a performance obligation, the Company considers the stage of development of the underlying intellectual property, the capabilities and expertise of the customer relative to the underlying intellectual property and whether the promised goods or services are integral to or dependent on other promises in the contract. When accounting for an arrangement that contains multiple performance obligations, the Company must develop &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;judgmental assumptions, which may include market conditions, reimbursement rates for personnel costs, development timelines and probabilities of regulatory success to determine the stand-alone selling price for each performance obligation identified in the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the amendment of an existing agreement, the Company evaluates whether the amendment represents a modification to an existing contract which would be recorded through a cumulative catch-up to revenue, or a separate contract. If it is determined that it is a separate contract, the Company will evaluate the necessary revenue recognition through the five-step process described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company concludes that a contract should be accounted for as a combined performance obligation and recognized over time, the Company must then determine the period over which revenue should be recognized and the method by which to measure revenue. The Company generally recognizes revenue using a cost-based input method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes collaboration revenue when its customer or collaborator obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the following five steps are performed: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;identify the contract(s) with a customer;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;iii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt"&gt;determine the transaction price; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;iv.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt"&gt;allocate the transaction price to the performance obligations within the contract; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;recognize revenue when (or as) the entity satisfies a performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company only applies the five-step model to contracts when it determines that it is probable it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within the contract to determine whether each promised good or service is a performance obligation. The promised goods or services in the Company&#x2019;s arrangements may consist of a license, or options to license, the Company&#x2019;s intellectual property and research, development and manufacturing services. The Company may provide options to additional items in such arrangements, which are accounted for as separate contracts when the customer elects to exercise such options, unless the option provides a material right to the customer. Performance obligations are promises in a contract to transfer a distinct good or service to the customer that (i)&#160;the customer can benefit from on its own or together with other readily available resources and (ii)&#160;are separately identifiable from other promises in the contract. Goods or services that are not individually distinct performance obligations are combined with other promised goods or services until such combined group of promises meet the requirements of a performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract. Consideration may be fixed, variable or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most-likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes variable consideration in the transaction price to the extent it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded as deferred revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts received prior to satisfying the revenue recognition criteria are recognized as deferred revenue in the Company&#x2019;s accompanying balance sheet. Deferred revenues expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability. Deferred revenues not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Company&#x2019;s collaboration revenue arrangements may include the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Up-front License Fees: If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Milestone Payments: At the inception of an agreement that includes research and development milestone payments, the Company evaluates each milestone to determine when and how much of the milestone to include in the transaction price. The Company first estimates the amount of the milestone payment that the Company could receive using either the expected value or the most-likely amount approach. The Company primarily uses the most-likely amount approach as that approach is generally most predictive for milestone payments with a binary outcome. The Company then considers whether any portion of that estimated amount is subject to the variable consideration constraint (that is, whether it is probable that a significant reversal of cumulative revenue would not occur upon resolution of the uncertainty). The Company updates the estimate of variable consideration included in the transaction price at each reporting date which includes updating the assessment of the likely amount of consideration and the application of the constraint to reflect current facts and circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalties: For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i)&#160;when the related sales occur or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To date, the Company has not granted a development and commercialization license nor recognized any revenue related to sales-based royalties or milestone payments based on the level of sales. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and Development Services: The Company will record costs associated with development and process optimization activities as research and development expenses in the statements of operations and comprehensive loss consistent with ASC 730, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company considered the guidance in ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Agreements&lt;/span&gt; and will recognize the payments received from these agreements as revenue when the related costs are incurred.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODk_eb4ebca5-123a-4b46-834a-05c1b07c0115">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred, and include salaries, stock-based compensation and other personnel-related costs, equipment and supplies, depreciation, preclinical studies, clinical trials and manufacturing development activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A substantial portion of the Company&#x2019;s ongoing research and development activities are conducted by third-party service providers, including contract research and manufacturing organizations. The Company accrues for expenses resulting from obligations under agreements with CROs, CMOs and other outside service providers for which payment flows do not match the periods over which materials or services are provided to the Company. &lt;/span&gt;&lt;/div&gt;Accruals are recorded based on estimates of services received and efforts expended pursuant to agreements established with CROs, CMOs and other outside service providers. These estimates are typically based on contracted amounts applied to the proportion of work performed and determined through analysis with internal personnel and external service providers as to the progress or stage of completion of the services. In the event advance payments are made to a CRO, CMO or outside service provider, the payments will be recorded as a prepaid asset which will be amortized as the contracted services are performed. As actual costs become known, the Company adjusts its accruals and prepaid assets accordingly. Inputs, such as the services performed, the number of patients enrolled or the study duration, may vary from the Company&#x2019;s estimates, resulting in adjustments to research and development expense in future periods. The Company makes significant judgements and estimates in determining the accrual and/or prepaid balance in each reporting period and changes in these estimates may result in material changes to the Company&#x2019;s accruals that could materially affect the Company&#x2019;s results of operations.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODg_77f8eb62-639d-47c0-9441-8d96bdbc667d">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during each period. Diluted loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as redeemable convertible preferred stock, convertible notes, stock options and unvested shares of restricted stock, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, dilutive securities are not included in the calculation as the impact is anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,538,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock as converted to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,300,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,855,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1OTM_fd9750f2-b97d-4c7e-a60e-fe7eecb604fe">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,538,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock as converted to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,300,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,855,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3e370dfdd2f54ea4bad75c57602b4f93_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0xLTEtMS0w_bf71ec97-14e7-48a7-999a-328ae4ed890f"
      unitRef="shares">2491187</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9abbbff0f64c4386a4848428859c93ba_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0xLTEtMS0w_f76a8dd3-94c1-4f35-b30b-15e65e0a100c"
      unitRef="shares">2491187</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib6638d6e20b5438bbca39e3e66ef5663_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0zLTEtMS0w_b54a0e05-e4ca-4986-a3c7-1e6937531786"
      unitRef="shares">2538225</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib919ed52ea1544a19151e99891e1459d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMi0zLTEtMS0w_e68c799c-2656-4925-9c6c-0f8885d308dd"
      unitRef="shares">2538225</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i19b470f64d144b129fbaa7ad42808a35_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0xLTEtMS0xMzQ3MQ_4658f593-5dc1-4d32-8337-e8ffb0e94e46"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibf359afbf3d0464cbc86a41f24df0d16_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0xLTEtMS0xMzQ3MQ_519135ba-3abe-4667-afad-4ea23de36151"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib884e0584c7e460bb651ba32ee4192a7_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0zLTEtMS0xMzQ3MQ_c90cbce2-efb5-41a9-8320-08efe582d991"
      unitRef="shares">20300253</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ida0e12191e2b43dbaece2abe6a654ebf_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfMy0zLTEtMS0xMzQ3MQ_cf77d3ab-5b8a-4db3-a8dc-a1d3852271bc"
      unitRef="shares">20300253</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic89ca81d8e0f45f3a4c92829a40b2cce_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0xLTEtMS0w_855905c0-eaf8-45d5-a479-cc947b4cb49c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icf97f887b14842219aa9e7a7b036371c_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0xLTEtMS0w_c4a07dbc-4b28-4115-8515-3a04f3339f3d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib92a6e56c17649fab1775c0e60491710_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0zLTEtMS0w_5317de1c-4558-4e39-9dbd-de3546b54022"
      unitRef="shares">16789</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i194ff9146a844c808f5d4fb8b42bb2e5_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNC0zLTEtMS0w_e5aa174c-d2fd-4f03-9a54-31453a6cd4ad"
      unitRef="shares">16789</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0xLTEtMS0w_9db749f6-3c99-4989-9971-d232a68aa670"
      unitRef="shares">2491187</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0xLTEtMS0w_f8730bad-ce9b-43af-a48a-cd9f58e74fe8"
      unitRef="shares">2491187</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0zLTEtMS0w_3b64a4dc-06e7-40b0-a048-bff421ecef09"
      unitRef="shares">22855267</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RhYmxlOmIxZWExN2ZlNmRlZTRhMmRhZmExMTgwZmRiN2QwNWNmL3RhYmxlcmFuZ2U6YjFlYTE3ZmU2ZGVlNGEyZGFmYTExODBmZGI3ZDA1Y2ZfNS0zLTEtMS0w_cf43f19d-a9be-4590-8cc5-1afdf0b3bba3"
      unitRef="shares">22855267</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODQ_08c40216-63d7-4e6a-88ee-388592f03c35">Other Comprehensive Income (Loss) Other comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) is comprised of the net loss and unrealized gains and losses on short-term investments.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNC9mcmFnOjdjMjg0ZGQ2NzNkZTQ3YmJiZjcwM2M3ZTdlYWJjYWE3L3RleHRyZWdpb246N2MyODRkZDY3M2RlNDdiYmJmNzAzYzdlN2VhYmNhYTdfMjI1ODU_9704dd3a-be4f-41aa-a789-975e1603b775">&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued ASU No. 2019-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes: Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU removes certain exceptions to the general principles in ASC 740,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company adopted this pronouncement effective January 1, 2021 and it did not have a material impact on the financial statements or related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements (not yet adopted) &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No.&#160;2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The FASB deferred the effective date of this ASU until the annual periods beginning after December 15, 2021. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTMw_aa3433d7-c5f0-4e7c-84a3-2057ab85ab01">Short-Term Investments &lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s available for sale short-term investments by major security type (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized &lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total &lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;205,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;205,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Unrealized &lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total &lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term investment instruments and cash and cash equivalents are classified using Level&#160;1 inputs within the fair value hierarchy and are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Debt securities as of September&#160;30, 2021 have an average maturity of 0.48 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTMx_06d54dff-f5c0-40a9-930b-556f9f2279de">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s available for sale short-term investments by major security type (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized &lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total &lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;205,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;205,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Unrealized &lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total &lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;177,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy0xLTEtMS0w_08225b31-b79f-4484-a478-cf13ea6eb8de"
      unitRef="usd">206948000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy0zLTEtMS0w_9c1099cb-8d44-4071-b941-7ba3b336d4e2"
      unitRef="usd">-1827000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib605418e82994024ac2bd308fcb0a15e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfMy01LTEtMS0w_a73a3024-b1f3-4f85-9fcf-bca0b9fdb1eb"
      unitRef="usd">205121000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC0xLTEtMS0w_5bf29313-9dfd-4a64-bad1-d1b72cef02cb"
      unitRef="usd">206948000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC0zLTEtMS0w_5b76e6fd-bb2f-4b05-976c-03c8011643d4"
      unitRef="usd">-1827000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOmYwNDgyMzkxNTMzMjRhNGRiMjZhZjdiOTllYWU3OTVjL3RhYmxlcmFuZ2U6ZjA0ODIzOTE1MzMyNGE0ZGIyNmFmN2I5OWVhZTc5NWNfNC01LTEtMS0w_079fc356-4b17-4810-a3bb-6d3de69a5a34"
      unitRef="usd">205121000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy0xLTEtMS0w_6ed080d9-6d6a-440f-b2d9-7b650253e965"
      unitRef="usd">177614000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy0zLTEtMS0w_961f0646-f250-468d-ba26-b5e5d2aa9ed4"
      unitRef="usd">-63000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a8b88813b564305a3bb126dd933c59e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfMy01LTEtMS0w_20cc5178-e499-4b9e-a021-9576b37e26bb"
      unitRef="usd">177551000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC0xLTEtMS0w_05c2a6b2-bb2e-401d-b6a7-3c363203d3ff"
      unitRef="usd">177614000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC0zLTEtMS0w_2ee48ecf-1f4f-49bd-a241-9573ab2f0d95"
      unitRef="usd">-63000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RhYmxlOjA4OTZjODJiMzYxODRjZjFhMTQ3YzUwNGE2ZWY4NTA0L3RhYmxlcmFuZ2U6MDg5NmM4MmIzNjE4NGNmMWExNDdjNTA0YTZlZjg1MDRfNC01LTEtMS0w_8f9f37da-6c0d-4c43-914e-78ed4c0c535f"
      unitRef="usd">177551000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl8zNy9mcmFnOjNlMzRmZGQxODBhYzRkNjNhMzJiMDIxNzFmYjUxNGFkL3RleHRyZWdpb246M2UzNGZkZDE4MGFjNGQ2M2EzMmIwMjE3MWZiNTE0YWRfNTIx_52d9f78c-d56d-416a-ab8a-d6915f97f7b6">P0Y5M23D</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RleHRyZWdpb246ZjYyNDBmOTI5N2FhNDM4ZGE0OTMzYWMxMTU5ZTE2MzJfOTY_55f9d2e6-3b20-48e4-95be-b5aa7e8ebd04">Accrued Expenses &lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development contract costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RleHRyZWdpb246ZjYyNDBmOTI5N2FhNDM4ZGE0OTMzYWMxMTU5ZTE2MzJfOTU_cc5909ae-9738-4e7f-b340-bb65bcbeda66">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development contract costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <sttk:AccruedResearchAndContractCostsCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMS0xLTEtMS0w_7fa55b5d-997c-4d39-b036-61cafc9190d7"
      unitRef="usd">10412000</sttk:AccruedResearchAndContractCostsCurrent>
    <sttk:AccruedResearchAndContractCostsCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMS0zLTEtMS0w_f132f898-c592-4a50-95a8-28add9b93f3a"
      unitRef="usd">5382000</sttk:AccruedResearchAndContractCostsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMi0xLTEtMS0w_a78fd922-c888-4a95-9d23-5181db95a98f"
      unitRef="usd">2733000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMi0zLTEtMS0w_b87e5dad-e371-4d06-9033-3e21284f0128"
      unitRef="usd">1551000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMy0xLTEtMS0w_83b4e20d-76a4-4d66-b44c-11784ba7fd78"
      unitRef="usd">638000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfMy0zLTEtMS0w_44914e60-cb6a-4385-862f-b8ee49885705"
      unitRef="usd">419000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfNC0xLTEtMS0w_b5664bca-5922-45c2-a1a0-5f544d829ad2"
      unitRef="usd">13783000</sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent>
    <sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80MC9mcmFnOmY2MjQwZjkyOTdhYTQzOGRhNDkzM2FjMTE1OWUxNjMyL3RhYmxlOmM5ZTdmYmYyYjI2ODQ2ZDQ5ZTRiYTUwMjFmNjJhNmUxL3RhYmxlcmFuZ2U6YzllN2ZiZjJiMjY4NDZkNDllNGJhNTAyMWY2MmE2ZTFfNC0zLTEtMS0w_31aaa34e-025f-4175-aa48-6fffe982d701"
      unitRef="usd">7352000</sttk:AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMjM3Ng_8253b480-23e0-461a-89f3-a2040ac7ea7f">Commitments and Contingencies &lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments, by year and in aggregate, under non-cancelable operating leases consist of the following as of September&#160;30, 2021 (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heat License Agreement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with a license agreement with Heat Biologics Inc. (&#x201c;Heat&#x201d;), the Company is required to make payments of up to $20.6 million in aggregate for the achievement of specified development, regulatory and commercial sales milestones for certain licensed products.&#160;The Company is required to pay Heat a percentage of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;upfront fees or other non-royalty payments not tied to milestone events that it receives in connection with certain sublicenses of the licensed patents.&#160;The Company is also required to pay Heat a royalty on all of its worldwide net sales, those of its affiliates, and sublicenses of certain licensed patents in the low single digits. The Company has not recorded a liability for the payments aforementioned given the achievement of specified development, regulatory and commercial sales milestones for certain licensed products is not probable as of the balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in various legal actions arising in the ordinary course of business. As of September&#160;30, 2021, management was not aware of any existing, pending or threatened legal actions that may have a material impact on the financial position, results of operations or cash flows of the Company. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contractual Obligations &lt;/span&gt;&lt;/div&gt;Contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude contingent liabilities for which the Company cannot reasonably predict future payment. The Company&#x2019;s contractual obligations result primarily from obligations for various CMOs and CROs, which include potential payments that may be required under its agreements. The contracts also contain variable costs and milestones that are hard to predict as they are based on such things as patients enrolled and clinical trial sites. The timing of payments and actual amounts paid under CMO and CRO agreements may be different depending on the timing of receipt of goods or services or changes to agreed-upon terms or amounts for some obligations. Such agreements are cancellable upon written notice by the Company and, therefore, are not long-term liabilities.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMjM3Nw_e1a7adaf-d409-4950-835e-e3d54e15fa56">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments, by year and in aggregate, under non-cancelable operating leases consist of the following as of September&#160;30, 2021 (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMC0xLTEtMS0w_75276b28-0645-4ca6-958b-08429ab23a6c"
      unitRef="usd">190000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMS0xLTEtMS0w_41dfa453-31e8-4297-8696-1f3fd2983293"
      unitRef="usd">1058000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMi0xLTEtMS0w_0c469d1a-7ba3-4cfe-8e5c-778e45b715a1"
      unitRef="usd">1089000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfMy0xLTEtMS0w_f3a1a103-2dd9-4c74-9608-a16088db672f"
      unitRef="usd">1120000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNC0xLTEtMS0w_78745916-5b22-456c-8e2f-0d64c637c37d"
      unitRef="usd">1152000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNS0xLTEtMS0w_ecb88607-3e2b-4168-a15a-41ea9c351c1d"
      unitRef="usd">2814000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RhYmxlOmZlMWY4ZTdiOTJlYzQyZGQ4MTQ4ZGYwYzJkMDM3OTkyL3RhYmxlcmFuZ2U6ZmUxZjhlN2I5MmVjNDJkZDgxNDhkZjBjMmQwMzc5OTJfNi0xLTEtMS0w_dec765a8-bfca-4a0e-ad12-4ab0c2d03dce"
      unitRef="usd">7423000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <sttk:LicenseAgreementRoyaltyPaymentsMaximum
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfMzU1_d60f6b33-44d1-4877-9ab3-9dd5c225e81a"
      unitRef="usd">20600000</sttk:LicenseAgreementRoyaltyPaymentsMaximum>
    <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80My9mcmFnOmJiNGYxZTMxMTRiMDRmZTZiYzUzMzRhMzBlZTFiYzYzL3RleHRyZWdpb246YmI0ZjFlMzExNGIwNGZlNmJjNTMzNGEzMGVlMWJjNjNfODkz_f578e3e8-3b12-4cdf-9108-e7cc3215c3c0"
      unitRef="usd">0</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
    <us-gaap:PreferredStockTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfNTgx_d1b051c4-9d54-4181-a0b8-220653e90dc4">Preferred Stock &lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2020, the Company entered into various stock purchase agreements with new and existing investors pursuant to which the Company sold an aggregate 550,571 shares of Series B redeemable convertible preferred stock and 1,319,964 shares of Series B-1 redeemable convertible preferred stock at $62.88051 per share for net proceeds of $117.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Series A, Series B and Series B-1 redeemable convertible preferred stock converted into common stock upon the completion of the Company&#x2019;s IPO and the rights, preferences and terms are no longer applicable.&lt;/span&gt;&lt;/div&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i9f602f1ae9e24dacad909af426c3f57e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMTk1_0ae68aa9-2cd0-4f47-9621-171e964128d8"
      unitRef="shares">550571</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i4ffac0bbd62a4268818f3c244309a741_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMjYw_94adeb34-4330-466c-b8b9-db2811dc1663"
      unitRef="shares">1319964</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ic0c391d040a942e288e05836aa0b34d9_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzI2_a018d4a5-afc7-4463-9f23-3e9730599f54"
      unitRef="usdPerShare">62.88051</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iebf65494900a4dfa992c067bfe66b21e_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzI2_e726ab8b-633b-4d82-9dfc-5b2c14b8a5d2"
      unitRef="usdPerShare">62.88051</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80Ni9mcmFnOmM0NmJiMGU5YTViMjRhZmNhNDFmNzQ4NmNhZTdlYWI5L3RleHRyZWdpb246YzQ2YmIwZTlhNWIyNGFmY2E0MWY3NDg2Y2FlN2VhYjlfMzU5_445128d4-fcfd-449c-a8a4-a69aeb7d1d7c"
      unitRef="usd">117000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0Mw_3c911613-c974-4694-8349-af938330f47f">Stock-Based Compensation &lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, the Company adopted the 2020 Stock Incentive Plan (the &#x201c;2020 Plan&#x201d;) which, as of the adoption date, replaced the 2016 Stock Incentive Plan. Under the 2020 Plan, the share reserve automatically increases on January 1st of each year beginning in 2021 and ending with a final increase on January 1, 2030 in an amount equal to 4% of the Company&#x2019;s outstanding common shares on December 31st of the preceding calendar year. The Board of Directors may provide that there will be no increase in the share reserve for any such year or that the increase in the share reserve may be smaller than would otherwise occur. The Board of Directors authorized an increase of 445,809 shares available for issuance under the 2020 Plan effective as of January 1, 2021, and as of September&#160;30, 2021 there were 3,951,085 shares available for future grants. The 2020 Plan permits the granting of options and restricted stock. The terms of the agreements under the 2020 Plan are determined by the Company&#x2019;s Board of Directors. The Company&#x2019;s awards vest based on the terms in the agreements and generally vest over four years and have a term of 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Employee Stock Purchase Plan (&#x201c;2020 ESPP&#x201d;) became effective in connection with the Company&#x2019;s IPO. A total of 395,795 shares of common stock were reserved for issuance under the 2020 ESPP. Eligible employees may purchase shares of common stock under the 2020 ESPP at 85% of the lower of the fair market value of the Company&#x2019;s common stock as of the first or the last day of each offering period. Employees are limited to contributing 15% of the employee&#x2019;s eligible compensation and may not purchase more than $25,000 of stock during any calendar year or more than 600 shares during any one purchase period. The 2020 ESPP share reserve automatically increases on January 1st of each calendar year, for ten years, commencing on January 1, 2021, in an &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amount equal to 1% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase of the share reserve for such year or that the increase in the share reserve for such year will be a smaller number of shares of common stock than would otherwise occur pursuant to the preceding sentence. Under the 2020 ESPP, the Company issued 2,106 shares of common stock for aggregate cash proceeds of $0.1 million during the three months and nine months ended September 30, 2021. There were no shares of common stock issued during the three and nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim statements of operations and comprehensive loss (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Price &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&#160;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Contract Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(Years) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,742,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;235,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(460,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(25,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$10.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,458,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$10.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,186,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$4.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted during the nine months ended September&#160;30, 2021 had a weighted-average grant-date fair value of $19.00. As of September&#160;30, 2021, unrecognized compensation cost for options issued was $11.9 million, and will be recognized over an estimated weighted-average amortization period of 2.5 years. The aggregate intrinsic value of options outstanding and exercisable as of September&#160;30, 2021 was $19.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model which takes into account inputs such as the exercise price, the estimated fair value of the underlying common stock at grant date, expected term, expected stock price volatility, risk-free interest rate and dividend yield. The fair value of stock options was determined using the methods and assumptions discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The expected term of employee stock options with service-based vesting is determined using the &#x201c;simplified&#x201d; method, whereby the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to the Company&#x2019;s lack of sufficient historical data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The expected stock price volatility is based on historical volatilities of comparable public entities within the Company&#x2019;s industry. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The risk-free interest rate is based on the interest rate payable on U.S. Treasury securities in effect at the time of grant for a period that is commensurate with the expected term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The expected dividend yield is 0% because the Company has not historically paid, and does not expect for the foreseeable future to pay a dividend on its common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Prior to the Company&#x2019;s IPO, its Board of Directors periodically estimated the fair value of the Company&#x2019;s common stock considering, among other things, contemporaneous valuations of its common stock prepared &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;by an unrelated third-party valuation firm. Subsequent to the Company&#x2019;s IPO, the shares are issued at no less than the market price on date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant date fair value of options granted under the Company&#x2019;s 2020 Plan and shares issued under the Company&#x2019;s 2020 ESPP were estimated throughout the nine months ended September&#160;30, 2021 using the Black-Scholes option-pricing model using the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.98%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.08%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.68%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounting purposes, the restricted shares are considered the issuance of share-based payments as opposed to the sale of stock and as such, the Company has recognized compensation expense for these awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity relating to these shares:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Awards &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,752)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage
      contextRef="i603740bc9b8f4f0ca57d85369f7746a2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNDAz_00ddb420-fdfa-4f19-a87f-7a99ece9c840"
      unitRef="number">0.04</sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ice4dbadf32e44468af44b532a149cff7_D20210101-20210101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNzM4_77f57d56-512f-4fb8-8aee-fea5f0b494af"
      unitRef="shares">445809</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i376022fb5be548d7b02b791a7e12fad2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfODQ4_105e9cad-4ef8-4d82-8ec7-d162765486d9"
      unitRef="shares">3951085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTE0Mg_5b86fd73-1560-4cc7-a745-f647e632a1ba">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i16476bd69be54e89a7cabbae9717940d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTE2NA_c907a3e1-4a52-444b-8ef9-0551b4ce5f11">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4NQ_7a4451ef-7048-4bae-8c3b-e08305213bcb"
      unitRef="shares">395795</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTQ3Mw_9f561d56-0405-4313-bc69-319d5909c8d6"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTYzOQ_a6caf802-8d95-401e-aea6-051a01ebba5d"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue
      contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTcxMw_fb4b2729-0a67-4c1a-863e-d8c38c6d3a82"
      unitRef="usd">25000</sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i9b8e75d02c4d4253bcd804e39edce59e_D20201014-20201014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTc2Mw_b933b726-5714-4eef-bf67-203e1c88f857"
      unitRef="shares">600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm
      contextRef="i5f3e8f93f0194647bd923c62f2e5dc30_D20210101-20210101"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg5MDIyNQ_a415f433-0e47-4fb5-afd3-f4827d3ed99c">P10Y</sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm>
    <sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage
      contextRef="i00fdc47817734e7ca45bf62b16f9b05b_I20201014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTk2Mw_f35154f2-7402-418d-b51d-dfae8c3b7456"
      unitRef="number">0.01</sttk:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4OQ_72bdfde0-25d2-4f74-82d8-a2b3bee202c0"
      unitRef="shares">2106</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY4OQ_de8f8e4c-391d-41c8-aacc-808bf0066127"
      unitRef="shares">2106</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY5Mw_71a7fbb4-ec71-4c8e-8602-d0c87be6fcda"
      unitRef="usd">100000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMTA5OTUxMTYzMzY5Mw_a42b5ff3-71ce-421d-a29a-9ac7abd647a6"
      unitRef="usd">100000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idf00a598b8c6468a94061606fb02f883_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg4OTIxMA_39df3b1c-6163-4865-9c44-e8e9391c1389"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i960ac8b054b342bca15ba993defe9d57_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzI5ODUzNDg4OTIxMA_ded32b1a-7554-4340-a07e-4d9ce12de44f"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0NQ_afab2097-2812-4bc0-8027-0fd258694f93">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim statements of operations and comprehensive loss (amounts in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iac8f4bd6f6784868a4bd2c6922fc91f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0xLTEtMS00MjA_0a3e1fa2-ba3d-4d87-8f68-2942a2502362"
      unitRef="usd">620000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i43e49e14bbd84c24b4f815c8d1dfae1e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0zLTEtMS00MjA_bd80dde3-a2b2-44d8-8ba6-54412a353ab7"
      unitRef="usd">159000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i835dbb9acf224e57a9b3e913c4fd5221_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0xLTEtMS0w_ba291626-3086-47a6-b0ce-25d5a2ef3371"
      unitRef="usd">1542000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8cf510c1ae944ae08e8125331902ce05_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMi0zLTEtMS0w_a15a2ddd-a29a-4c5f-99c7-5914e07adcaa"
      unitRef="usd">350000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3f271066a7004316b41caf3035fe59f9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0xLTEtMS00MjA_ce92b687-2031-4ea8-b74c-41102520582c"
      unitRef="usd">724000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b7aad25409a4bcd8dceb360cb97572a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0zLTEtMS00MjA_814e4eef-4f0b-4620-8d09-98d5ce406c36"
      unitRef="usd">153000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id1ee9db78b134988a76150158dd2ccfb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0xLTEtMS0w_655ea6f5-f465-4ef2-b43a-f78f0b18ad02"
      unitRef="usd">2709000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i06f9516b552346dd9f85244630963fdf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfMy0zLTEtMS0w_f7b62d59-1db9-44e9-972e-a8b256326527"
      unitRef="usd">279000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0xLTEtMS00MjA_88d2c83c-6a23-419c-9a2d-01ac5d31194f"
      unitRef="usd">1344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife8fd98aec6f4231b6939668a5d8c403_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0zLTEtMS00MjA_c7d5ea9a-50aa-4605-a443-496039ed5c3e"
      unitRef="usd">312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0xLTEtMS0w_79595ac4-10a4-4774-8b6b-1f909ea2906d"
      unitRef="usd">4251000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmUyNDkyZGFhMTFhNDQ5MGE4MjdlNWYwYmU5NzNkOGEzL3RhYmxlcmFuZ2U6ZTI0OTJkYWExMWE0NDkwYTgyN2U1ZjBiZTk3M2Q4YTNfNC0zLTEtMS0w_a12f3416-3e2a-4a4d-a5dd-49604dde9419"
      unitRef="usd">629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0MA_869f84bc-a178-4562-8777-30733d55880d">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Price &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&#160;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Contract Life&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(Years) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,742,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;235,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(460,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(25,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,491,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$10.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,458,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$10.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,186,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$4.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS0xLTEtMS0w_f8be04c8-456a-4c13-9370-36b23945502a"
      unitRef="shares">2742022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS0zLTEtMS0w_b3afec4d-9105-442d-832d-20af2e81a04e"
      unitRef="usdPerShare">7.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iad1e9586e3094edfbbdb9d027470e968_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMS01LTEtMS0w_037bbea2-2672-4d01-866d-fa0160b0846f">P8Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMi0xLTEtMS0w_f4f81727-43c6-448d-ac5e-c806ef90db61"
      unitRef="shares">235704</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMi0zLTEtMS0w_b7e47937-66f0-46c4-97a5-f3734d814be4"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMy0xLTEtMS0w_1e10bb07-b10b-4e57-afe5-b05cc6c613f4"
      unitRef="shares">460692</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfMy0zLTEtMS0w_94f9dab5-e325-4563-9433-badcd182afbf"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNC0xLTEtMS0w_a9469d0d-6fb3-46e9-9f7b-652166edb7ed"
      unitRef="shares">25847</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNC0zLTEtMS0w_3e6d8cb0-dda0-4cf4-ab98-ab3360c15324"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS0xLTEtMS0w_7e0c2b53-cffe-470d-a9fa-e4638000b7f5"
      unitRef="shares">2491187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS0zLTEtMS0w_39928b50-cb05-4cea-98c8-23eab701ffe1"
      unitRef="usdPerShare">10.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNS01LTEtMS0w_8c138e0e-a404-44e4-864f-289641870d35">P8Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi0xLTEtMS0w_8d9a0544-5617-43c2-8fe8-38d9c00a0d44"
      unitRef="shares">2458242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi0zLTEtMS0w_c21a8206-db76-4d7a-b6c8-c6d48df73050"
      unitRef="usdPerShare">10.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNi01LTEtMS0w_d2c9bae3-853c-4434-8228-6b521644857d">P8Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy0xLTEtMS0w_5bc9a118-701b-45e0-82ed-c617c26126f7"
      unitRef="shares">1186961</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy0zLTEtMS0w_a1470040-0987-437f-90be-755c0ffc5fb4"
      unitRef="usdPerShare">4.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmVhNjdhZGYzYWU5NzQ3MGE5MGNjNGRlZWM3YzY5ZWMyL3RhYmxlcmFuZ2U6ZWE2N2FkZjNhZTk3NDcwYTkwY2M0ZGVlYzdjNjllYzJfNy01LTEtMS0w_7a5787ef-aafa-48d0-89f5-114f861ee5f6">P7Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjgwMw_f1f387cb-cf82-4013-93ee-fae8151c214f"
      unitRef="usdPerShare">19.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjg3MQ_1caf0992-76b6-428b-a1c9-5e8cb6dd25aa"
      unitRef="usd">11900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMjk1Ng_777174d6-b7a2-4c8d-be70-7f22f985326b">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzA0Mg_7979bc21-72c8-40be-b75a-84482d701e96"
      unitRef="usd">19300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i403cb7cee0ba466091fcfc1ad0c176f8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfMzA0Mg_f5d73e99-c482-417a-b23c-c7652c3cb7aa"
      unitRef="usd">19300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNDE5Nw_22774862-9f1c-4954-a149-041f8c0964a2"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0MQ_fe5971a8-a1f6-4e53-8f41-6c90cb093ba3">&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant date fair value of options granted under the Company&#x2019;s 2020 Plan and shares issued under the Company&#x2019;s 2020 ESPP were estimated throughout the nine months ended September&#160;30, 2021 using the Black-Scholes option-pricing model using the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.98%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.08%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.68%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMC0xLTEtMS0w_da6f467b-745c-4929-b927-c36bf8535f81">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMS0xLTEtMS0w_dff515b0-3ba3-4d1a-8e3c-61c1fb3c9c39"
      unitRef="number">0.8135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMi0xLTEtMS0w_3804087a-da6b-43ea-8355-a431ae42198c"
      unitRef="number">0.0098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfMy0xLTEtMS0w_d5209313-7703-4376-8391-1b3847fb9ffb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNS0xLTEtMS0xMjU4NQ_82b59f65-de8d-4008-a67a-0b9ca7220856">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNi0xLTEtMS0xMjU4NQ_e1a6a7fe-a90e-4181-9fed-37e68466226a"
      unitRef="number">0.8108</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfNy0xLTEtMS0xMjU4NQ_e5ea5dec-224e-4552-8630-d9991ad468d8"
      unitRef="number">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2547d8a7ac464369a2691f1dfbaa5c25_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOjE1MjhjYjlkNWI4YzQ3MDg4ZDljNDQ2NjBhM2I1YjRlL3RhYmxlcmFuZ2U6MTUyOGNiOWQ1YjhjNDcwODhkOWM0NDY2MGEzYjViNGVfOC0xLTEtMS0xMjU4NQ_65519dd6-a13d-4dee-8be1-485af2ba9eed"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RleHRyZWdpb246MDU3NWY3ZDcxZjFhNDBmM2FhNWExOTg1MTZmNGI4ZGRfNTM0Mg_186495fe-c1f7-48c6-9fb6-c0922e3f1c43">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Awards &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,752)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i127f4a4b929a4584b3d952f63d22eadf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMS0xLTEtMS0w_0862a8d4-a682-4d34-b3f1-4593b92255c4"
      unitRef="shares">11752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib024077106554c22ae7c122e594a1c2b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMi0xLTEtMS0w_b1d8e3e1-74aa-4d84-b5ac-657adbe6681e"
      unitRef="shares">11752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icd69357ae18f462e8804de875b0c3a5c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl80OS9mcmFnOjA1NzVmN2Q3MWYxYTQwZjNhYTVhMTk4NTE2ZjRiOGRkL3RhYmxlOmI1YzFjNmYyNGFmNTQ2YWRiYjcxMDEyMDAzMjkxZGE5L3RhYmxlcmFuZ2U6YjVjMWM2ZjI0YWY1NDZhZGJiNzEwMTIwMDMyOTFkYTlfMy0xLTEtMS0w_ee783d8a-ce00-4874-8440-b82ae5927640"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMjQ1Nw_0fd731ac-d079-4517-b85b-7ed1c6c1fb59">Collaboration Agreement - Related Party&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2017, the Company entered into a Collaboration Agreement with Takeda related to the development of certain ARC molecules, as amended in April 2018, October 2018 and March 2020 (the &#x201c;Collaboration Agreement&#x201d;). The Collaboration Agreement was mutually terminated pursuant to a termination agreement dated November 8, 2021 (the &#x201c;Termination Agreement&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Termination Agreement, the Company is not required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated. The termination of the Collaboration Agreement is a type II subsequent event and, therefore, had no impact on the Company's the financial statements as of September 30, 2021. The remaining deferred revenue will be recognized as revenue in the fourth quarter of 2021. The Company received cash of $3.6 million and $12.1 million for the nine months ended September&#160;30, 2021 and 2020, respectively, from Takeda and has recognized total aggregate revenue of $51.9 million through September&#160;30, 2021 under the Collaboration Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue for the allocated up-front payments using a cost-based input measure. In applying the cost-based input method of revenue recognition, the Company used actual costs incurred relative to budgeted costs expected to be incurred for the combined performance obligation. In the second quarter of 2021, in&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;connection with the Company&#x2019;s modifications to the SL-279252 clinical development plan and its intention to&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expand the dose-escalation portion of its ongoing Phase 1 clinical trial, the estimated total costs related to the&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SL-279252 development program increased. The increase in expected total cost of the development program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;required to satisfy a specific performance obligation in the Collaboration Agreement, or the denominator in the cost-based input method, resulted in a cumulative-effect adjustment under ASC 250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Change in Accounting Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Actual consideration received and total revenue expected to be recognized in accordance with the development of SL-279252 under the Collaboration Agreement remain unchanged. The Company recognizes revenue related to the&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reimbursable cost as they are incurred. The effects of this change in the Company&#x2019;s estimates were a $4.2&#160;million&lt;/span&gt;&lt;/div&gt;increase in 2021 net loss and a $0.10 increase in 2021 basic and diluted loss per share.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ProceedsFromCollaborators
      contextRef="ia2da1c40adc24adf8f575ee3530eea18_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTI4Mw_f63b413c-74d5-4a81-851d-8d48188978de"
      unitRef="usd">3600000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators
      contextRef="if068c55e44bb4ae2a4f17a023aa75fd7_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTI5OQ_c0c75990-997a-4522-99aa-29fbb23fd3c8"
      unitRef="usd">12100000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1661a0a2b3aa4bcca5712ebab54e17ae_D20170801-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNTQxMw_20f7fa0b-6ac4-4862-b645-2f8aa1f23ee3"
      unitRef="usd">51900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetIncomeLoss
      contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUwMQ_58a42786-ebe7-423e-b2dd-bc6aff27db68"
      unitRef="usd">-4200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUzNw_0e162501-f859-41cc-b37f-b52fb56183f5"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81Mi9mcmFnOjVkYzFlOGM5ODRmNTQyODRhOTlmOGNmMWNhZDE3M2IzL3RleHRyZWdpb246NWRjMWU4Yzk4NGY1NDI4NGE5OWY4Y2YxY2FkMTczYjNfMTA5OTUxMTYzNjUzNw_339213df-4f4f-403c-9d7c-4e623b860a91"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i648e824fd76a426abee666fe49416d9d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81NS9mcmFnOmQxNGU2YzNmZWQ3NjQ1NDM5Yjc1ZGU0MTE3ZDk1YWM0L3RleHRyZWdpb246ZDE0ZTZjM2ZlZDc2NDU0MzliNzVkZTQxMTdkOTVhYzRfMjk5_8684b8df-7a73-45d8-a729-dfc635a002cb">Related-Party Transactions As of December 31, 2020, Takeda held an approximate 5.0% ownership interest in the Company&#x2019;s outstanding shares. Considering the resignation of the Takeda director and percent ownership of the Company&#x2019;s common stock as of December 31, 2020, the Company no longer considers Takeda a related party.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <sttk:ShareholderOwnershipPercentage
      contextRef="i7842c9c91ac44eb081775b9eeb02a4f3_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmOGJhZmQxMzFlZDQzZjZiOWY4ZWVjM2M5OWE2MWMyL3NlYzo1ZjhiYWZkMTMxZWQ0M2Y2YjlmOGVlYzNjOTlhNjFjMl81NS9mcmFnOmQxNGU2YzNmZWQ3NjQ1NDM5Yjc1ZGU0MTE3ZDk1YWM0L3RleHRyZWdpb246ZDE0ZTZjM2ZlZDc2NDU0MzliNzVkZTQxMTdkOTVhYzRfODg_d3f81877-2d78-4e9e-87b3-327a2bb10936"
      unitRef="number">0.050</sttk:ShareholderOwnershipPercentage>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260863976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Shattuck Labs, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2575858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. 5th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">900-4690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STTK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,246,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001680367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213261323416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 85,094<span></span>
</td>
<td class="nump">$ 157,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">205,121<span></span>
</td>
<td class="nump">177,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">10,190<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">301,644<span></span>
</td>
<td class="nump">345,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">8,651<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">310,568<span></span>
</td>
<td class="nump">348,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,251<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">13,783<span></span>
</td>
<td class="nump">7,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">7,728<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">19,835<span></span>
</td>
<td class="nump">16,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">27,277<span></span>
</td>
<td class="nump">21,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
<td class="nump">2,290<span></span>
</td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">49,402<span></span>
</td>
<td class="nump">39,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 300,000,000 shares authorized; 42,241,981 shares issued and outstanding at September&#160;30, 2021 and 41,779,183 shares issued and 41,767,431 shares outstanding at December&#160;31, 2020</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">387,902<span></span>
</td>
<td class="nump">382,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(124,914)<span></span>
</td>
<td class="num">(72,093)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">261,166<span></span>
</td>
<td class="nump">309,861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 310,568<span></span>
</td>
<td class="nump">$ 348,988<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Employee-Related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919140-209958<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341045480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS - Parenthetical - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">42,241,981<span></span>
</td>
<td class="nump">41,779,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">42,241,981<span></span>
</td>
<td class="nump">41,767,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341269240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">License [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration revenue - related party</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 2,435<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">$ 8,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">15,137<span></span>
</td>
<td class="nump">11,804<span></span>
</td>
<td class="nump">40,356<span></span>
</td>
<td class="nump">27,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,343<span></span>
</td>
<td class="nump">2,470<span></span>
</td>
<td class="nump">14,098<span></span>
</td>
<td class="nump">5,816<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Expense from operations</a></td>
<td class="nump">19,480<span></span>
</td>
<td class="nump">14,274<span></span>
</td>
<td class="nump">54,454<span></span>
</td>
<td class="nump">33,512<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(17,580)<span></span>
</td>
<td class="num">(11,839)<span></span>
</td>
<td class="num">(54,515)<span></span>
</td>
<td class="num">(24,920)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">1,947<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,410)<span></span>
</td>
<td class="num">(11,829)<span></span>
</td>
<td class="num">(52,821)<span></span>
</td>
<td class="num">(24,591)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments</a></td>
<td class="num">(207)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (17,617)<span></span>
</td>
<td class="num">$ (11,857)<span></span>
</td>
<td class="num">$ (54,585)<span></span>
</td>
<td class="num">$ (24,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share &#8211; basic (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.54)<span></span>
</td>
<td class="num">$ (1.26)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share &#8211; diluted (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.54)<span></span>
</td>
<td class="num">$ (1.26)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding &#8211; basic (in shares)</a></td>
<td class="nump">42,155,981<span></span>
</td>
<td class="nump">7,700,371<span></span>
</td>
<td class="nump">41,946,852<span></span>
</td>
<td class="nump">7,656,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">42,155,981<span></span>
</td>
<td class="nump">7,700,371<span></span>
</td>
<td class="nump">41,946,852<span></span>
</td>
<td class="nump">7,656,077<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213248401880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Series A Redeemable Convertible Preferred Stock &#160;</div></th>
<th class="th"><div>Series B Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Series B-1 Redeemable Convertible Preferred Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (34,548)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 887<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="num">$ (35,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,634,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="num">(40,861)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="num">(42,044)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Sale of redeemable convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Sale of redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, ending balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(34,548)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">887<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="num">(35,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(24,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,779,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">(58,360)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,730<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(60,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="nump">1,319,964<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="nump">$ 82,613<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,634,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="num">(40,861)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="num">(42,044)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,659,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="num">(47,029)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(48,252)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, beginning balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Sale of redeemable convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,319,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Sale of redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,618<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="nump">1,319,964<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, ending balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="nump">$ 82,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,779,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">(58,360)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,730<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(60,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,019<span></span>
</td>
<td class="nump">550,571<span></span>
</td>
<td class="nump">1,319,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts', window );">Series B-1 additional issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred stock, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,064<span></span>
</td>
<td class="nump">$ 34,427<span></span>
</td>
<td class="nump">$ 82,613<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,767,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">309,861<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">382,012<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="num">(72,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(597)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(597)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,786,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">298,662<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">383,223<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="num">(83,906)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,767,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 309,861<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">382,012<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="num">(72,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">460,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">$ (1,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(52,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,241,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">261,166<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">387,902<span></span>
</td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(124,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,786,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">298,662<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">383,223<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="num">(83,906)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(23,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,115,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">277,087<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">386,206<span></span>
</td>
<td class="num">(1,620)<span></span>
</td>
<td class="num">(107,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod', window );">Exercise of stock options and ESPP purchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased', window );">Exercise of stock options and ESPP purchases</a></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vesting of common stock previously subject to vesting requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on investments</a></td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,241,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 261,166<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 387,902<span></span>
</td>
<td class="num">$ (1,827)<span></span>
</td>
<td class="num">$ (124,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options Exercised And ESPP Purchased in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options Exercised And ESPP Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Additional Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213340899112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (52,821)<span></span>
</td>
<td class="num">$ (24,591)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">4,251<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Accretion (amortization) of short-term investments</a></td>
<td class="nump">774<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,239)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">75<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">846<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">6,431<span></span>
</td>
<td class="nump">1,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue - related party</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">5,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_IncreaseDecreaseInDeferredRentCredits', window );">Deferred rent</a></td>
<td class="nump">1,303<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(38,399)<span></span>
</td>
<td class="num">(19,616)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(5,936)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sale and maturities of short-term investments</a></td>
<td class="nump">134,975<span></span>
</td>
<td class="nump">31,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of short-term investments</a></td>
<td class="num">(165,083)<span></span>
</td>
<td class="num">(5,578)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(36,044)<span></span>
</td>
<td class="nump">25,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Exercise of stock options and ESPP purchases</a></td>
<td class="nump">1,639<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for public offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,639<span></span>
</td>
<td class="nump">116,037<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(72,804)<span></span>
</td>
<td class="nump">121,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">157,898<span></span>
</td>
<td class="nump">7,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">85,094<span></span>
</td>
<td class="nump">128,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of non-cash financial activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments</a></td>
<td class="num">(1,764)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction', window );">Accrued public offering costs in other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid amounts related to purchases of property and equipment</a></td>
<td class="nump">651<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from the sale of Series B redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember', window );">Series B-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from the sale of Series B redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 82,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_IncreaseDecreaseInDeferredRentCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Deferred Rent Credits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_IncreaseDecreaseInDeferredRentCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_StockIssuanceCostsIncurredDuringNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Incurred During Noncash Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_StockIssuanceCostsIncurredDuringNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213259998152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Description of Business</a></td>
<td class="text">Organization and Description of Business <div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck Labs, Inc. (the &#8220;Company&#8221;) was incorporated in 2016 in the State of Delaware and is a clinical-stage biopharmaceutical company developing dual-sided fusion proteins, including its ARC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and GADLEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms, as novel classes of biologic medicines capable of multifunctional activity with potential applications in oncology and inflammatory diseases. Using its proprietary technology, the Company is building a pipeline of therapeutics, initially focused on the treatment of solid tumors and hematologic malignancies. The Company has two clinical-stage product candidates, SL-172154 and SL-279252, and has several compounds in preclinical development. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred losses and negative cash flows from operations since inception and has an accumulated deficit of $124.9 million as of September&#160;30, 2021. The Company anticipates incurring additional losses and negative cash flows from operations until such time, if ever, that it can generate significant sales of its product candidates currently in development, and is highly dependent on its ability to find additional sources of funding in the form of licensing of its technology, collaboration agreements and/or public and private debt and equity financings. Adequate additional funding may not be available to the Company on acceptable terms, or at all. The failure to raise funds as and when needed could have a negative impact on the Company&#8217;s financial condition and ability to pursue its clinical operations, research and development and commercialization of its product candidates. Management believes that the Company&#8217;s cash and cash equivalents and short-term investments of $290.2 million as of September&#160;30, 2021 are sufficient to fund projected operations of the Company into the second half of 2024. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;10, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The virus and actions taken to mitigate its spread have had, and are expected to continue to have, a broad adverse impact on the economies and financial markets of many countries, including the geographical areas in which the Company operates and conducts its business and in which the Company&#8217;s partners operate and conduct their business. The Company is currently following the recommendations of local health authorities to minimize exposure risk for its team members and visitors. However, the scale and scope of this pandemic is unknown and the duration of the business disruption and related financial impact cannot be reasonably estimated at this time. While the Company has implemented specific business continuity plans to reduce the potential impact of COVID-19, there is no guarantee that the Company&#8217;s continuity plans will be successful. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has already experienced disruptions to its business such as work-from-home orders for offices and similar disruptions have occurred for its partners. Specifically, the outbreak has caused disruptions in its ability to manufacture clinical trial materials, including the acquisition of raw materials needed for such manufacturing, enrollment and treatment of patients in clinical trials in process and slowdowns and shutdowns of the laboratories and other service providers that are being relied upon in the development of the Company&#8217;s product candidates. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic or any other health epidemic may impact the Company&#8217;s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of COVID-19 and the actions to mitigate its impact, among others. Accordingly, the COVID-19 pandemic could have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255815176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies <div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Statements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying interim financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company&#8217;s financial position, its results of operations, statements of changes in redeemable convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the interim periods presented. Operating results for interim periods presented are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. These interim financial statements, presented herein, do not contain all required disclosures under GAAP for annual financial statements. The accompanying unaudited interim financial statements should be read in conjunction with the annual audited financial statements and related notes in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates, if any, are recorded in the period in which they become known and actual results could differ from management&#8217;s estimates. A</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">change in the Company&#8217;s estimates occurred in the second quarter of 2021, which impacted the Company&#8217;s revenue recognition and related balance sheet accounts. See Note 8 to the Company&#8217;s unaudited interim condensed financial statements included elsewhere in this Quarterly Report on Form 10-Q for further information.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon the sale of an asset or paid upon the transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. Fair value measurements are classified and disclosed in one of the following categories: </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets the reporting entity has the ability to access as of the measurement date; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are classified based on the lowest level of input that is significant to the measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The determination of the fair values stated below takes into account the market for its financial assets and liabilities, the associated credit risk and other factors as required. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including short-term investments and accounts payable, approximate fair value due to the short-term nature of those instruments.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at two accredited financial institutions in amounts that exceed federally-insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company invests in only highly-rated debt securities that management believes protects the Company from risk of default and impairment of value. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue is derived from its collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (&#8220;Takeda&#8221;) (see Note 8). </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is highly dependent on a single third-party contract manufacturing organization (&#8220;CMO&#8221;) to supply drug products for its research and development activities of its programs, including clinical trials and non-clinical studies. These programs could be adversely affected by a significant interruption in the supply of such drug products. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is highly dependent on three contract research organizations (&#8220;CROs&#8221;) and a limited number of third-party service providers to manage and support its clinical trials. These programs could be adversely affected by a significant disruption in services provided by these CROs and third parties. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all demand deposits with financial institutions and all highly liquid investments with original maturities of 90 days or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents consisted of $14.0 million held in operating accounts and $71.1 million held in money market funds as of September&#160;30, 2021 and $2.7 million held in operating accounts, $80.2 million held in money market funds and $75.0 million held in government obligations as of December&#160;31, 2020. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of highly-rated U.S. Treasury securities with maturities of more than three months but less than one year at the date of purchase. The Company classifies its short-term investments at the time of purchase as available-for-sale securities. Available-for-sale securities are carried at fair value. The Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on January 1, 2020, which amended its accounting for available-for-sale debt securities. Credit impairments are recorded through an allowance rather than a direct write-down of the security and are recorded through a charge to the statements of operations. Unrealized gains or losses not related to credit impairments are recorded in accumulated other comprehensive income, a component of stockholders&#8217; equity, until realized. The Company reviews available-for-sale debt securities for impairments related to credit losses and other factors each quarter. As of September&#160;30, 2021, there were no impairments related to credit losses of short-term investments.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Offering Costs</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs will be recorded against gross proceeds.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records shares of redeemable convertible preferred stock at their respective fair values on the date of issuance, net of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#8217; equity on the balance sheet because the shares contain liquidation features that are not solely within the Company&#8217;s control. Upon the completion of the Company&#8217;s initial public offering (&#8220;IPO&#8221;) in the fourth quarter of 2020, all outstanding shares of the Company&#8217;s redeemable convertible preferred stock were converted into common stock. See Note 6 to the Company&#8217;s unaudited interim condensed financial statements included elsewhere</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Quarterly Report on Form 10-Q for further information.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue is recognized in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). Arrangements with collaborators may include licenses to intellectual property, research and development services, manufacturing services for clinical and commercial supply and participation on joint steering committees. The Company evaluates the promised goods or services in the contract to determine which promises, or group of promises, represent performance obligations. In contemplation of whether a promised good or service meets the criteria required of a performance obligation, the Company considers the stage of development of the underlying intellectual property, the capabilities and expertise of the customer relative to the underlying intellectual property and whether the promised goods or services are integral to or dependent on other promises in the contract. When accounting for an arrangement that contains multiple performance obligations, the Company must develop </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgmental assumptions, which may include market conditions, reimbursement rates for personnel costs, development timelines and probabilities of regulatory success to determine the stand-alone selling price for each performance obligation identified in the contract. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the amendment of an existing agreement, the Company evaluates whether the amendment represents a modification to an existing contract which would be recorded through a cumulative catch-up to revenue, or a separate contract. If it is determined that it is a separate contract, the Company will evaluate the necessary revenue recognition through the five-step process described below. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company concludes that a contract should be accounted for as a combined performance obligation and recognized over time, the Company must then determine the period over which revenue should be recognized and the method by which to measure revenue. The Company generally recognizes revenue using a cost-based input method. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes collaboration revenue when its customer or collaborator obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the following five steps are performed: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">identify the contract(s) with a customer;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">identify the performance obligations in the contract; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">determine the transaction price; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">allocate the transaction price to the performance obligations within the contract; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">recognize revenue when (or as) the entity satisfies a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company only applies the five-step model to contracts when it determines that it is probable it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within the contract to determine whether each promised good or service is a performance obligation. The promised goods or services in the Company&#8217;s arrangements may consist of a license, or options to license, the Company&#8217;s intellectual property and research, development and manufacturing services. The Company may provide options to additional items in such arrangements, which are accounted for as separate contracts when the customer elects to exercise such options, unless the option provides a material right to the customer. Performance obligations are promises in a contract to transfer a distinct good or service to the customer that (i)&#160;the customer can benefit from on its own or together with other readily available resources and (ii)&#160;are separately identifiable from other promises in the contract. Goods or services that are not individually distinct performance obligations are combined with other promised goods or services until such combined group of promises meet the requirements of a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract. Consideration may be fixed, variable or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most-likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes variable consideration in the transaction price to the extent it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded as deferred revenue. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received prior to satisfying the revenue recognition criteria are recognized as deferred revenue in the Company&#8217;s accompanying balance sheet. Deferred revenues expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability. Deferred revenues not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as non-current liabilities. </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Company&#8217;s collaboration revenue arrangements may include the following: </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up-front License Fees: If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Milestone Payments: At the inception of an agreement that includes research and development milestone payments, the Company evaluates each milestone to determine when and how much of the milestone to include in the transaction price. The Company first estimates the amount of the milestone payment that the Company could receive using either the expected value or the most-likely amount approach. The Company primarily uses the most-likely amount approach as that approach is generally most predictive for milestone payments with a binary outcome. The Company then considers whether any portion of that estimated amount is subject to the variable consideration constraint (that is, whether it is probable that a significant reversal of cumulative revenue would not occur upon resolution of the uncertainty). The Company updates the estimate of variable consideration included in the transaction price at each reporting date which includes updating the assessment of the likely amount of consideration and the application of the constraint to reflect current facts and circumstances. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalties: For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i)&#160;when the related sales occur or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not granted a development and commercialization license nor recognized any revenue related to sales-based royalties or milestone payments based on the level of sales. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and Development Services: The Company will record costs associated with development and process optimization activities as research and development expenses in the statements of operations and comprehensive loss consistent with ASC 730, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company considered the guidance in ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and will recognize the payments received from these agreements as revenue when the related costs are incurred. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred, and include salaries, stock-based compensation and other personnel-related costs, equipment and supplies, depreciation, preclinical studies, clinical trials and manufacturing development activities. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of the Company&#8217;s ongoing research and development activities are conducted by third-party service providers, including contract research and manufacturing organizations. The Company accrues for expenses resulting from obligations under agreements with CROs, CMOs and other outside service providers for which payment flows do not match the periods over which materials or services are provided to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals are recorded based on estimates of services received and efforts expended pursuant to agreements established with CROs, CMOs and other outside service providers. These estimates are typically based on contracted amounts applied to the proportion of work performed and determined through analysis with internal personnel and external service providers as to the progress or stage of completion of the services. In the event advance payments are made to a CRO, CMO or outside service provider, the payments will be recorded as a prepaid asset which will be amortized as the contracted services are performed. As actual costs become known, the Company adjusts its accruals and prepaid assets accordingly. Inputs, such as the services performed, the number of patients enrolled or the study duration, may vary from the Company&#8217;s estimates, resulting in adjustments to research and development expense in future periods. The Company makes significant judgements and estimates in determining the accrual and/or prepaid balance in each reporting period and changes in these estimates may result in material changes to the Company&#8217;s accruals that could materially affect the Company&#8217;s results of operations. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during each period. Diluted loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as redeemable convertible preferred stock, convertible notes, stock options and unvested shares of restricted stock, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, dilutive securities are not included in the calculation as the impact is anti-dilutive. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:68.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.531%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,538,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock as converted to common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,300,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,855,267&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Comprehensive Income (Loss) </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) is comprised of the net loss and unrealized gains and losses on short-term investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU No. 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes: Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU removes certain exceptions to the general principles in ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company adopted this pronouncement effective January 1, 2021 and it did not have a material impact on the financial statements or related disclosures. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements (not yet adopted) </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No.&#160;2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span>which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The FASB deferred the effective date of this ASU until the annual periods beginning after December 15, 2021. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255748312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Short-Term Investments</a></td>
<td class="text">Short-Term Investments <div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s available for sale short-term investments by major security type (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized <br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized<br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,827)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized <br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term investment instruments and cash and cash equivalents are classified using Level&#160;1 inputs within the fair value hierarchy and are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Debt securities as of September&#160;30, 2021 have an average maturity of 0.48 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255886856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses <div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (amounts in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development contract costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,352&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213259949720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments, by year and in aggregate, under non-cancelable operating leases consist of the following as of September&#160;30, 2021 (amounts in thousands): </span></div><div style="margin-top:6pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum lease payments </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heat License Agreement </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a license agreement with Heat Biologics Inc. (&#8220;Heat&#8221;), the Company is required to make payments of up to $20.6 million in aggregate for the achievement of specified development, regulatory and commercial sales milestones for certain licensed products.&#160;The Company is required to pay Heat a percentage of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upfront fees or other non-royalty payments not tied to milestone events that it receives in connection with certain sublicenses of the licensed patents.&#160;The Company is also required to pay Heat a royalty on all of its worldwide net sales, those of its affiliates, and sublicenses of certain licensed patents in the low single digits. The Company has not recorded a liability for the payments aforementioned given the achievement of specified development, regulatory and commercial sales milestones for certain licensed products is not probable as of the balance sheet date.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in various legal actions arising in the ordinary course of business. As of September&#160;30, 2021, management was not aware of any existing, pending or threatened legal actions that may have a material impact on the financial position, results of operations or cash flows of the Company. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations </span></div>Contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude contingent liabilities for which the Company cannot reasonably predict future payment. The Company&#8217;s contractual obligations result primarily from obligations for various CMOs and CROs, which include potential payments that may be required under its agreements. The contracts also contain variable costs and milestones that are hard to predict as they are based on such things as patients enrolled and clinical trial sites. The timing of payments and actual amounts paid under CMO and CRO agreements may be different depending on the timing of receipt of goods or services or changes to agreed-upon terms or amounts for some obligations. Such agreements are cancellable upon written notice by the Company and, therefore, are not long-term liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213259882456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text">Preferred Stock <div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, the Company entered into various stock purchase agreements with new and existing investors pursuant to which the Company sold an aggregate 550,571 shares of Series B redeemable convertible preferred stock and 1,319,964 shares of Series B-1 redeemable convertible preferred stock at $62.88051 per share for net proceeds of $117.0&#160;million.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Series A, Series B and Series B-1 redeemable convertible preferred stock converted into common stock upon the completion of the Company&#8217;s IPO and the rights, preferences and terms are no longer applicable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255516328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation <div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company adopted the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;) which, as of the adoption date, replaced the 2016 Stock Incentive Plan. Under the 2020 Plan, the share reserve automatically increases on January 1st of each year beginning in 2021 and ending with a final increase on January 1, 2030 in an amount equal to 4% of the Company&#8217;s outstanding common shares on December 31st of the preceding calendar year. The Board of Directors may provide that there will be no increase in the share reserve for any such year or that the increase in the share reserve may be smaller than would otherwise occur. The Board of Directors authorized an increase of 445,809 shares available for issuance under the 2020 Plan effective as of January 1, 2021, and as of September&#160;30, 2021 there were 3,951,085 shares available for future grants. The 2020 Plan permits the granting of options and restricted stock. The terms of the agreements under the 2020 Plan are determined by the Company&#8217;s Board of Directors. The Company&#8217;s awards vest based on the terms in the agreements and generally vest over four years and have a term of 10 years. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (&#8220;2020 ESPP&#8221;) became effective in connection with the Company&#8217;s IPO. A total of 395,795 shares of common stock were reserved for issuance under the 2020 ESPP. Eligible employees may purchase shares of common stock under the 2020 ESPP at 85% of the lower of the fair market value of the Company&#8217;s common stock as of the first or the last day of each offering period. Employees are limited to contributing 15% of the employee&#8217;s eligible compensation and may not purchase more than $25,000 of stock during any calendar year or more than 600 shares during any one purchase period. The 2020 ESPP share reserve automatically increases on January 1st of each calendar year, for ten years, commencing on January 1, 2021, in an </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount equal to 1% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase of the share reserve for such year or that the increase in the share reserve for such year will be a smaller number of shares of common stock than would otherwise occur pursuant to the preceding sentence. Under the 2020 ESPP, the Company issued 2,106 shares of common stock for aggregate cash proceeds of $0.1 million during the three months and nine months ended September 30, 2021. There were no shares of common stock issued during the three and nine months ended September 30, 2020.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim statements of operations and comprehensive loss (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,251&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">629&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contract Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Years) </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,742,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.82</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(460,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.18</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,458,242&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at the end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,186,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.66</span></td></tr></table></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted during the nine months ended September&#160;30, 2021 had a weighted-average grant-date fair value of $19.00. As of September&#160;30, 2021, unrecognized compensation cost for options issued was $11.9 million, and will be recognized over an estimated weighted-average amortization period of 2.5 years. The aggregate intrinsic value of options outstanding and exercisable as of September&#160;30, 2021 was $19.3 million. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model which takes into account inputs such as the exercise price, the estimated fair value of the underlying common stock at grant date, expected term, expected stock price volatility, risk-free interest rate and dividend yield. The fair value of stock options was determined using the methods and assumptions discussed below.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected term of employee stock options with service-based vesting is determined using the &#8220;simplified&#8221; method, whereby the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to the Company&#8217;s lack of sufficient historical data.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected stock price volatility is based on historical volatilities of comparable public entities within the Company&#8217;s industry. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The risk-free interest rate is based on the interest rate payable on U.S. Treasury securities in effect at the time of grant for a period that is commensurate with the expected term. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expected dividend yield is 0% because the Company has not historically paid, and does not expect for the foreseeable future to pay a dividend on its common stock. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Prior to the Company&#8217;s IPO, its Board of Directors periodically estimated the fair value of the Company&#8217;s common stock considering, among other things, contemporaneous valuations of its common stock prepared </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by an unrelated third-party valuation firm. Subsequent to the Company&#8217;s IPO, the shares are issued at no less than the market price on date of grant.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of options granted under the Company&#8217;s 2020 Plan and shares issued under the Company&#8217;s 2020 ESPP were estimated throughout the nine months ended September&#160;30, 2021 using the Black-Scholes option-pricing model using the following weighted-average assumptions: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.08</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.98%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.08%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.68%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the restricted shares are considered the issuance of share-based payments as opposed to the sale of stock and as such, the Company has recognized compensation expense for these awards.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity relating to these shares:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,752</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,752)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213259892472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement - Related Party<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreement - Related Party</a></td>
<td class="text">Collaboration Agreement - Related Party<div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the Company entered into a Collaboration Agreement with Takeda related to the development of certain ARC molecules, as amended in April 2018, October 2018 and March 2020 (the &#8220;Collaboration Agreement&#8221;). The Collaboration Agreement was mutually terminated pursuant to a termination agreement dated November 8, 2021 (the &#8220;Termination Agreement&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Termination Agreement, the Company is not required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated. The termination of the Collaboration Agreement is a type II subsequent event and, therefore, had no impact on the Company's the financial statements as of September 30, 2021. The remaining deferred revenue will be recognized as revenue in the fourth quarter of 2021. The Company received cash of $3.6 million and $12.1 million for the nine months ended September&#160;30, 2021 and 2020, respectively, from Takeda and has recognized total aggregate revenue of $51.9 million through September&#160;30, 2021 under the Collaboration Agreement.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue for the allocated up-front payments using a cost-based input measure. In applying the cost-based input method of revenue recognition, the Company used actual costs incurred relative to budgeted costs expected to be incurred for the combined performance obligation. In the second quarter of 2021, in</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">connection with the Company&#8217;s modifications to the SL-279252 clinical development plan and its intention to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expand the dose-escalation portion of its ongoing Phase 1 clinical trial, the estimated total costs related to the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-279252 development program increased. The increase in expected total cost of the development program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required to satisfy a specific performance obligation in the Collaboration Agreement, or the denominator in the cost-based input method, resulted in a cumulative-effect adjustment under ASC 250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Change in Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Actual consideration received and total revenue expected to be recognized in accordance with the development of SL-279252 under the Collaboration Agreement remain unchanged. The Company recognizes revenue related to the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursable cost as they are incurred. The effects of this change in the Company&#8217;s estimates were a $4.2&#160;million</span></div>increase in 2021 net loss and a $0.10 increase in 2021 basic and diluted loss per share.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260066376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-Party Transactions</a></td>
<td class="text">Related-Party Transactions As of December 31, 2020, Takeda held an approximate 5.0% ownership interest in the Company&#8217;s outstanding shares. Considering the resignation of the Takeda director and percent ownership of the Company&#8217;s common stock as of December 31, 2020, the Company no longer considers Takeda a related party.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341156904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Unaudited Interim Financial Statements</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></div>Unaudited Interim Financial Statements In the opinion of management, the accompanying interim financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company&#8217;s financial position, its results of operations, statements of changes in redeemable convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the interim periods presented. Operating results for interim periods presented are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. These interim financial statements, presented herein, do not contain all required disclosures under GAAP for annual financial statements. The accompanying unaudited interim financial statements should be read in conjunction with the annual audited financial statements and related notes in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates, if any, are recorded in the period in which they become known and actual results could differ from management&#8217;s estimates. A</span></div>change in the Company&#8217;s estimates occurred in the second quarter of 2021, which impacted the Company&#8217;s revenue recognition and related balance sheet accounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon the sale of an asset or paid upon the transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. Fair value measurements are classified and disclosed in one of the following categories: </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets the reporting entity has the ability to access as of the measurement date; </span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are classified based on the lowest level of input that is significant to the measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The determination of the fair values stated below takes into account the market for its financial assets and liabilities, the associated credit risk and other factors as required. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including short-term investments and accounts payable, approximate fair value due to the short-term nature of those instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risk</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and short-term investments. The Company maintains its cash and cash equivalents at two accredited financial institutions in amounts that exceed federally-insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company invests in only highly-rated debt securities that management believes protects the Company from risk of default and impairment of value. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue is derived from its collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (&#8220;Takeda&#8221;) (see Note 8). </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is highly dependent on a single third-party contract manufacturing organization (&#8220;CMO&#8221;) to supply drug products for its research and development activities of its programs, including clinical trials and non-clinical studies. These programs could be adversely affected by a significant interruption in the supply of such drug products. </span></div>The Company is highly dependent on three contract research organizations (&#8220;CROs&#8221;) and a limited number of third-party service providers to manage and support its clinical trials. These programs could be adversely affected by a significant disruption in services provided by these CROs and third parties.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash Equivalents The Company considers all demand deposits with financial institutions and all highly liquid investments with original maturities of 90 days or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents consisted of $14.0 million held in operating accounts and $71.1 million held in money market funds as of September&#160;30, 2021 and $2.7 million held in operating accounts, $80.2 million held in money market funds and $75.0 million held in government obligations as of December&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of highly-rated U.S. Treasury securities with maturities of more than three months but less than one year at the date of purchase. The Company classifies its short-term investments at the time of purchase as available-for-sale securities. Available-for-sale securities are carried at fair value. The Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on January 1, 2020, which amended its accounting for available-for-sale debt securities. Credit impairments are recorded through an allowance rather than a direct write-down of the security and are recorded through a charge to the statements of operations. Unrealized gains or losses not related to credit impairments are recorded in accumulated other comprehensive income, a component of stockholders&#8217; equity, until realized. The Company reviews available-for-sale debt securities for impairments related to credit losses and other factors each quarter. As of September&#160;30, 2021, there were no impairments related to credit losses of short-term investments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Offering Costs</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs will be recorded against gross proceeds.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_TemporaryEquityPolicyTextBlock', window );">Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records shares of redeemable convertible preferred stock at their respective fair values on the date of issuance, net of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#8217; equity on the balance sheet because the shares contain liquidation features that are not solely within the Company&#8217;s control. Upon the completion of the Company&#8217;s initial public offering (&#8220;IPO&#8221;) in the fourth quarter of 2020, all outstanding shares of the Company&#8217;s redeemable convertible preferred stock were converted into common stock. See Note 6 to the Company&#8217;s unaudited interim condensed financial statements included elsewhere</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Quarterly Report on Form 10-Q for further information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue is recognized in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). Arrangements with collaborators may include licenses to intellectual property, research and development services, manufacturing services for clinical and commercial supply and participation on joint steering committees. The Company evaluates the promised goods or services in the contract to determine which promises, or group of promises, represent performance obligations. In contemplation of whether a promised good or service meets the criteria required of a performance obligation, the Company considers the stage of development of the underlying intellectual property, the capabilities and expertise of the customer relative to the underlying intellectual property and whether the promised goods or services are integral to or dependent on other promises in the contract. When accounting for an arrangement that contains multiple performance obligations, the Company must develop </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgmental assumptions, which may include market conditions, reimbursement rates for personnel costs, development timelines and probabilities of regulatory success to determine the stand-alone selling price for each performance obligation identified in the contract. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the amendment of an existing agreement, the Company evaluates whether the amendment represents a modification to an existing contract which would be recorded through a cumulative catch-up to revenue, or a separate contract. If it is determined that it is a separate contract, the Company will evaluate the necessary revenue recognition through the five-step process described below. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company concludes that a contract should be accounted for as a combined performance obligation and recognized over time, the Company must then determine the period over which revenue should be recognized and the method by which to measure revenue. The Company generally recognizes revenue using a cost-based input method. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes collaboration revenue when its customer or collaborator obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the following five steps are performed: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">identify the contract(s) with a customer;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">identify the performance obligations in the contract; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">determine the transaction price; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">allocate the transaction price to the performance obligations within the contract; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">recognize revenue when (or as) the entity satisfies a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company only applies the five-step model to contracts when it determines that it is probable it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within the contract to determine whether each promised good or service is a performance obligation. The promised goods or services in the Company&#8217;s arrangements may consist of a license, or options to license, the Company&#8217;s intellectual property and research, development and manufacturing services. The Company may provide options to additional items in such arrangements, which are accounted for as separate contracts when the customer elects to exercise such options, unless the option provides a material right to the customer. Performance obligations are promises in a contract to transfer a distinct good or service to the customer that (i)&#160;the customer can benefit from on its own or together with other readily available resources and (ii)&#160;are separately identifiable from other promises in the contract. Goods or services that are not individually distinct performance obligations are combined with other promised goods or services until such combined group of promises meet the requirements of a performance obligation. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract. Consideration may be fixed, variable or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most-likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes variable consideration in the transaction price to the extent it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded as deferred revenue. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received prior to satisfying the revenue recognition criteria are recognized as deferred revenue in the Company&#8217;s accompanying balance sheet. Deferred revenues expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability. Deferred revenues not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as non-current liabilities. </span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Company&#8217;s collaboration revenue arrangements may include the following: </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up-front License Fees: If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Milestone Payments: At the inception of an agreement that includes research and development milestone payments, the Company evaluates each milestone to determine when and how much of the milestone to include in the transaction price. The Company first estimates the amount of the milestone payment that the Company could receive using either the expected value or the most-likely amount approach. The Company primarily uses the most-likely amount approach as that approach is generally most predictive for milestone payments with a binary outcome. The Company then considers whether any portion of that estimated amount is subject to the variable consideration constraint (that is, whether it is probable that a significant reversal of cumulative revenue would not occur upon resolution of the uncertainty). The Company updates the estimate of variable consideration included in the transaction price at each reporting date which includes updating the assessment of the likely amount of consideration and the application of the constraint to reflect current facts and circumstances. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalties: For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i)&#160;when the related sales occur or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not granted a development and commercialization license nor recognized any revenue related to sales-based royalties or milestone payments based on the level of sales. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and Development Services: The Company will record costs associated with development and process optimization activities as research and development expenses in the statements of operations and comprehensive loss consistent with ASC 730, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company considered the guidance in ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span> and will recognize the payments received from these agreements as revenue when the related costs are incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred, and include salaries, stock-based compensation and other personnel-related costs, equipment and supplies, depreciation, preclinical studies, clinical trials and manufacturing development activities. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of the Company&#8217;s ongoing research and development activities are conducted by third-party service providers, including contract research and manufacturing organizations. The Company accrues for expenses resulting from obligations under agreements with CROs, CMOs and other outside service providers for which payment flows do not match the periods over which materials or services are provided to the Company. </span></div>Accruals are recorded based on estimates of services received and efforts expended pursuant to agreements established with CROs, CMOs and other outside service providers. These estimates are typically based on contracted amounts applied to the proportion of work performed and determined through analysis with internal personnel and external service providers as to the progress or stage of completion of the services. In the event advance payments are made to a CRO, CMO or outside service provider, the payments will be recorded as a prepaid asset which will be amortized as the contracted services are performed. As actual costs become known, the Company adjusts its accruals and prepaid assets accordingly. Inputs, such as the services performed, the number of patients enrolled or the study duration, may vary from the Company&#8217;s estimates, resulting in adjustments to research and development expense in future periods. The Company makes significant judgements and estimates in determining the accrual and/or prepaid balance in each reporting period and changes in these estimates may result in material changes to the Company&#8217;s accruals that could materially affect the Company&#8217;s results of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during each period. Diluted loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as redeemable convertible preferred stock, convertible notes, stock options and unvested shares of restricted stock, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, dilutive securities are not included in the calculation as the impact is anti-dilutive. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:68.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.531%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,538,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock as converted to common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,300,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,855,267&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive Income (Loss)</a></td>
<td class="text">Other Comprehensive Income (Loss) Other comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) is comprised of the net loss and unrealized gains and losses on short-term investments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements (not yet adopted)</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU No. 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes: Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU removes certain exceptions to the general principles in ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year, with early adoption permitted. The Company adopted this pronouncement effective January 1, 2021 and it did not have a material impact on the financial statements or related disclosures. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements (not yet adopted) </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No.&#160;2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span>which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The FASB deferred the effective date of this ASU until the annual periods beginning after December 15, 2021. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_TemporaryEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_TemporaryEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255688776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of antidilutive securities excluded from computation of net loss per share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding in the three and nine months ended September 30, 2021 and 2020, as they would be anti-dilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:68.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.531%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,538,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock as converted to common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,300,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,855,267&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255815176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of available for sale short-term investments</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s available for sale short-term investments by major security type (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized <br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized<br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,827)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Unrealized <br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255781192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (amounts in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development contract costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,352&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255852184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum rental payments for operating leases</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments, by year and in aggregate, under non-cancelable operating leases consist of the following as of September&#160;30, 2021 (amounts in thousands): </span></div><div style="margin-top:6pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum lease payments </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260062888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim statements of operations and comprehensive loss (amounts in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,251&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">629&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of option activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contract Life</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Years) </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,742,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.82</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(460,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,491,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.18</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,458,242&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at the end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,186,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.66</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of valuation assumptions</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of options granted under the Company&#8217;s 2020 Plan and shares issued under the Company&#8217;s 2020 ESPP were estimated throughout the nine months ended September&#160;30, 2021 using the Black-Scholes option-pricing model using the following weighted-average assumptions: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.08</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.98%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.08%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.68%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of restricted stock activity</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,752</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,752)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260702456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Description of Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 124,914<span></span>
</td>
<td class="nump">$ 72,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and short-term investments</a></td>
<td class="nump">$ 290,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213261328296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 85,094<span></span>
</td>
<td class="nump">$ 157,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=sttk_OperatingAccountMember', window );">Operating Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 71,100<span></span>
</td>
<td class="nump">80,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">Government Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=sttk_OperatingAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=sttk_OperatingAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213261109240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">2,491,187<span></span>
</td>
<td class="nump">22,855,267<span></span>
</td>
<td class="nump">2,491,187<span></span>
</td>
<td class="nump">22,855,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">2,491,187<span></span>
</td>
<td class="nump">2,538,225<span></span>
</td>
<td class="nump">2,491,187<span></span>
</td>
<td class="nump">2,538,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock as converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,300,253<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,300,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,789<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,789<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213340844856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Schedule of available for sale short-term investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 206,948<span></span>
</td>
<td class="nump">$ 177,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Gross&#160;Unrealized Loss</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total Fair&#160;Value</a></td>
<td class="nump">205,121<span></span>
</td>
<td class="nump">177,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">206,948<span></span>
</td>
<td class="nump">177,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Gross&#160;Unrealized Loss</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total Fair&#160;Value</a></td>
<td class="nump">$ 205,121<span></span>
</td>
<td class="nump">$ 177,551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260998104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Debt securities, average maturity term</a></td>
<td class="text">5 months 23 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213340868136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of accrued expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_AccruedResearchAndContractCostsCurrent', window );">Research and development contract costs</a></td>
<td class="nump">$ 10,412<span></span>
</td>
<td class="nump">$ 5,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and related benefits</a></td>
<td class="nump">2,733<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 13,783<span></span>
</td>
<td class="nump">$ 7,352<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Employee-Related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_AccruedResearchAndContractCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Contract Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_AccruedResearchAndContractCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213253950616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of minimum lease payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2024</a></td>
<td class="nump">1,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2025</a></td>
<td class="nump">1,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">2,814<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 7,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213255830984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_LicenseAgreementRoyaltyPaymentsMaximum', window );">License agreement, maximum payment</a></td>
<td class="nump">$ 20,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent', window );">Accrued royalty</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_LicenseAgreementRoyaltyPaymentsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Royalty Payments, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_LicenseAgreementRoyaltyPaymentsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213262150584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, proceeds received | $</a></td>
<td class="nump">$ 117.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Preferred stock sold (in shares) | shares</a></td>
<td class="nump">550,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of preferred stock (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 62.88051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember', window );">Series B-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Preferred stock sold (in shares) | shares</a></td>
<td class="nump">1,319,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of preferred stock (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 62.88051<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sttk_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341411464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 14, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock issued under ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from ESPP | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember', window );">2020 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage', window );">Increase in number of shares authorized, percentage of capital stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of shares authorized (in shares)</a></td>
<td class="nump">445,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,951,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,951,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based compensation, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember', window );">2020 Stock Incentive Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage', window );">Increase in number of shares authorized, percentage of capital stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock in percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Contribution limit in percentage of employee's eligible compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue', window );">Maximum value of shares per employee during any calendar year | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee during any one purchase period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm', window );">Share-based compensation arrangement by share-based payment award, annual increase in number of shares authorized, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock issued under ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase In Number of Shares Authorized, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Increase In Number of Shares Authorized, Annual Increase Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Shares Per Employee, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341463080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of stock-based compensation expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,344<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 4,251<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 724<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 2,709<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213340941320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of option activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, beginning balance (in shares)</a></td>
<td class="nump">2,742,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, granted (in shares)</a></td>
<td class="nump">235,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, exercised (in shares)</a></td>
<td class="num">(460,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options, forfeited (in shares)</a></td>
<td class="num">(25,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, ending balance (in shares)</a></td>
<td class="nump">2,491,187<span></span>
</td>
<td class="nump">2,742,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options, vested and expected to vest (in shares)</a></td>
<td class="nump">2,458,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options, exercisable (in shares)</a></td>
<td class="nump">1,186,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 7.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted (in dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised (in dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited (in dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, ending balance (in dollars per share)</a></td>
<td class="nump">10.51<span></span>
</td>
<td class="nump">$ 7.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and expected to vest (in dollars per share)</a></td>
<td class="nump">10.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable (in dollars per share)</a></td>
<td class="nump">$ 4.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted&#160;Average Remaining Contract Life (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted&#160;average remaining contract life, outstanding</a></td>
<td class="text">8 years 2 months 4 days<span></span>
</td>
<td class="text">8 years 9 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted&#160;average remaining contract life, vested and expected to vest</a></td>
<td class="text">8 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted&#160;average remaining contract life, exercisable</a></td>
<td class="text">7 years 7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213341322760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of valuation assumptions (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2020 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term - years</a></td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">81.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.98%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term - years</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">81.08%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.68%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sttk_A2020StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sttk_A2020EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260273592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of restricted stock activity (Details) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Awards, beginning balance (in shares)</a></td>
<td class="nump">11,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards, vested (in shares)</a></td>
<td class="num">(11,752)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Awards, ending balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213344819768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement - Related Party (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">47 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration revenue - related party</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">$ 8,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Increase in net loss</a></td>
<td class="nump">$ 17,410<span></span>
</td>
<td class="nump">$ 23,598<span></span>
</td>
<td class="nump">$ 11,813<span></span>
</td>
<td class="nump">$ 11,829<span></span>
</td>
<td class="nump">$ 6,208<span></span>
</td>
<td class="nump">$ 6,554<span></span>
</td>
<td class="nump">$ 52,821<span></span>
</td>
<td class="nump">$ 24,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increase in basic loss per share (in dollars per share)</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase in diluted loss per share (in dollars per share)</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_CumulativeEffectChangeOfAccountingEstimateAxis=sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember', window );">Cumulative Effect, Change Of Accounting Estimate, Adjustment | Revision In Estimated Total Costs Related To Development Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Increase in net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increase in basic loss per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase in diluted loss per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sttk_TakedaMember', window );">Takeda | Investor | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration revenue - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_CumulativeEffectChangeOfAccountingEstimateAxis=sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_CumulativeEffectChangeOfAccountingEstimateAxis=sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sttk_TakedaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sttk_TakedaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140213260095512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related-Party Transactions (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=sttk_TakedaMember', window );">Takeda</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sttk_ShareholderOwnershipPercentage', window );">Shareholder ownership percentage</a></td>
<td class="nump">0.050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sttk_ShareholderOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholder Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sttk_ShareholderOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sttk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sttk_TakedaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sttk_TakedaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>49
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M]8-I4V30F)-C!0  D18  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RE
M6%USHS84?=[^"HVG#^U,;$#X<\?QC.,D;6:SB3>XN]UV^B"#;)@ HD+8R;_O
M%=C@9/"%Z;[8"+B'HROIW(_I7LCGU.=<D9<HC-/+CJ]4\M$P4M?G$4M[(N$Q
M/-D(&3$%0[DUTD1RYN5&46A0TQP:$0OBSFR:WUO*V51D*@QBOI0DS:*(R=<K
M'HK]9<?J'&\\!5M?Z1O&;)JP+7>X^B-92A@9)8H71#Q. Q$3R3>7G;GU<6'W
MM4'^QM> [].3:Z*GLA;B60_NO,N.J1GQD+M*0S#XV_$%#T.-!#S^/8!VRF]J
MP]/K(_IM/GF8S)JE?"'";X&G_,O.N$,\OF%9J)[$_G=^F-! X[DB3/-?LB_>
M[?<[Q,U2):*#,3"(@KCX9R\'1YP:T#,&]&! WQE8Y[Y@'PSL?*(%LWQ:UTRQ
MV52*/9'Z;4#3%[EO<FN831#K9724A*<!V*G9XO'KS1/IDM1GDJ=30P&F?F*X
M!_NKPIZ>L9^0SR)6?DIN8H][;^T-X%(2HD="5Q0%='C2([9Y0:A)K1H^"]S\
M0>QZQ+3JS-_0L4O_V#F>?<X_8L<E^7N^3I6$+?</ MDO(?LY9/\,Y+5P,S@(
MBJQ>$U[G<=S<,KM?$!:#DL6@'8LO&9.*R_"5//%$2%7'"(=2,N,(HV'):-B.
MT9++0'AZ1Q'8T[4NPI&.>^BG#Q\:ML&HY#9JN6:2@83E"G3>73C6AH4IYJ]Q
MR6F,XMS$*E"OY#8(.7G(HC67=5QP#-.TNO9D,+$1/I.2SZ0-GR>^#?1A 6<]
ML*AV]7 <QV=*9>XSN6?K](+<Q6X/86>9E=*9;?@!GI"P<DPOX@5Q%&PQ(B19
MB"Q6\A7^O5K2#>C7-QC)$SFVVI!<L1=RY\&&"S:!FS-%EK@!<FQUZ6 T& _&
M&$-:,:1M&,X]#P(&K,_A@MS#>^0QKO<=#CDP3?*M1P;*A^60$,HPHI5R6_;_
M)[K:BUJB.*23!;!9+,B1,(95(+!P*7_/<*%'L!578A_7LL/AYI N!#'&K H.
M%B[I[YF5IV0IQ2Z(W?I5QC%7?V+4JBAAX>+^GMI2I(J%Y*\@.7]T<<31>&1B
M0<*JHH2%2WN^@'-(I\]3P0$&%L6(5*'!PG7]7KC@DZ4O8BPV-(!,3+/;'T[0
MO5X%!PM7]56@($Z)#9R>7]:_$H>[F01OU=+"D18BBD /'27<YPN2,$EV+,PX
M^=GLF1#/2 ()6Y[.8MEH%34HKNL0\+T@WA+G-5J+L(YN X"S6GW"F%2A@>(Z
M?G09N7EQ?19O^=GXV@#T,'>NYU@.2:M@0%L%@T4FI<Z.BI0H=Q<(1E9;3S0@
M?G]?A;QE5JD_;:7^=S'DMD6MJ)-)=J1:RPQ';&!6J3YMI?HZ;X.L W1U*V3M
M.6C >1!QE[DN5,20RW"O ,085NI/6ZF_$[$P)%=9"H_3^K7\H<* 5II/6VG^
M3<3E5N^NWP !D@50@H3%];[# 9N858I/<<$^,GLYK0R* J:6UH^5!K0* +15
M<>#X')80\Q,.TTBHTG_:JCIX*]Y.WG4@CYF"&!YKG:VM^ OD08ZL^U*[69_2
M_G!@3Z;&KH:57:F[W:HF6( B2 B8=[''7\@G7NNJ!B@=>X9CTQZ.L+9#I?8V
M+M)S*#>]O.2\#5F=6ZX: )J6SJY$WL8EN2Q^;X-4IQ7?.<3<6[A9JPD-8$U]
MF9/&#"['[UD=N@;G>>%P7[ 2V*[$W<9%^1@)3UV%-3(:X+I=BW;M6H<9)TT_
MK8MY+S0EKBYCB_Y?>;?LM\[S+J-1O5XT:S\S+:LI"?D&3,W>"(Z:+/J?Q4")
M)&\AKH52(LHO?<X\+O4+\'PCA#H.] ?*+O3L/U!+ P04    " #U@VE3KJ^P
MT3D%  !@$P  &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*58;6_;-A#^
M*X1;%"W@Q"3UGCH&4J=%!VQ=4+?;9T8^1T0ET24II]FO'RD[DB)12H9]2*R7
MN^-SQ^,]=UK>"_E#90 :_2KR4EW.,JWW%XN%2C,HF#H7>RC-FYV0!=/F5MXM
MU%X"V]9*1;Z@&(>+@O%RMEK6SV[D:BDJG?,2;B1255$P^? !<G%_.2.SQP=?
M^5VF[8/%:KEG=[ !_7U_(\W=HK&RY064BHL22=A=SJ[(Q9H&5J&6^(O#O>I<
M(^O*K1 _[,UOV\L9MH@@AU1;$\S\'& ->6XM&1P_3T9GS9I6L7O]:/U3[;QQ
MYI8I6(O\;[[5V>4LGJ$M[%B5ZZ_B_C.<'*H!IB)7]7]T?Y+%,Y162HOBI&P0
M%+P\_K)?IT!T%(@_HD!/"O2E"MY)P:L=/2*KW;IFFJV64MPC::6--7M1QZ;6
M-M[PTF[C1DOSEAL]O?IP]?O5E_5'M/G\\>.W#3I#WS?7Z.WK=^@UXB7ZEHE*
ML7*KE@MM%K,JB_1D^,/1,!TQO('].?+P'%%,B4-]/:U^#:E1)[4Z?JJ^,"XV
M?M+&3UK;\T;LK2LIH=2(*05:74Q8]!J+7FW1'[/(5(9,;%!J+^!GQ0\L-TLX
M8W4T%=:F[,DZK.( )_YR<>B&9"A%@BA.XD;L"5"_ >I/ MUD0NHS#;(P6WH
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M,S-BI6S/S>%S@G0P:QPE@Q/GE*.8C' 7[<Q,S[)K550YT]!TXJ(PJ9W9,?X
M*!?*62GHD$K/2$S[I=8E%GHCH%O"I=.$VP5MYGF><F>YI4,V/2/43TB_(7<)
M1A0G8T!;XJ4O(5XU>K*=J!TC6DA(&/9!#^4\G,3AR(Q&6P:FTPP\8(KZ9/Y'
M)X+!G.MLEUURKGYYT?G\8;\]_<'D'2\5RF%G%/%Y9.S(X^><XXT6^_J+R*W0
M6A3U90;,@+<"YOU.&#(YW=B/+,U'M=6_4$L#!!0    ( /6#:5.E5[UI@P(
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MY9JF&>4:H'Y_8$P^W^@!V@/AR5]02P,$%     @ ]8-I4RX;UE']"P  MD\
M !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6S%G&USVS82Q[\*Q^WTDIFJ
M)I[!U/&,)<N.>VWBLYS<W-S<"T:B8UXD425I.[U/?R#-""*P "5:3MXDM/T'
ML'C\[2XA'3UD^>?B-DG*X,MBOBQ>']R6Y>K5X6$QO4T6<?%+MDJ6ZB\W6;Z(
M2_5C_NFP6.5)/*L++>:'. SYX2).EP?'1_7O+O/CH^RNG*?+Y#(/BKO%(L[_
M&B;S[.'U 3KX^HNK]--M6?WB\/AH%7]*)DGY?G69JY\.U[7,TD6R+-)L&>3)
MS>N#$_3J H5A5:*6?$B3AV+C.:CZ\C'+/E<_7,Q>'X252<D\F995';'Z[SX9
M)?-Y594RY,^FUH-UHU7!S>>OM9_5O5>]^1@7R2B;_S.=E;>O#^1!,$MNXKMY
M>94]O$F:'K&JOFDV+^I_@X=&&QX$T[NBS!9-867!(ET^_A]_:49BHP BC@*X
M*8"W+4": L0H@(6C &T*4*, <15@30%FMN#J-&\*<*, <Q4030%A%*#244 V
M!>2V+41-@:A>#H_S5T_^:5S&QT=Y]A#DE5K55CW4*Z@NK>8\75:K?5+FZJ^I
M*E<>3ZY/KL=_C-]>3X)W9\'HS<G;\_$DN'@;7(U/Q^,_3H:_CX/1N[<?QE?7
M%]7SY=7X;'RE_AA,KM^-_AZ<O&V>WKS[_71\-?GI!XF1^#48_^/]Q?6_@A>G
MX[.+T<7URV 0O)^<!B]^?!G\&*3+X/HVNROBY:PX.BQ5-RIC#J>-R<-'D['#
MY.NLC.= L9&_V"A;+-3NFI39]#-0^M1?^F0V2ZO=&<^#RSB=#2Z6P2A>I; E
MXXZZIM.[Q=T\+I-9\*Z\3?) V:;.JMOJ$+E/@M^S AJ6L^UK/4UNTFE: I6<
M>RNISM97Q2J>)J\/E$%%DM\G!\>3)$^3(C@)KI)9H@[;C_-$6;R\3_(RK9XO
MU?F4Y+EJMQ[<X*<?$ ]_!1I_X^]!T\YPRW: !BZV:V" >C5QJ/;6>H/A]0;#
M=9O4T>8P^90NE^GRDSJ3Y_%RF@0OU/(O;F,UO"^#N%1S-?TE(.CG (<H@I;U
M8_VLKK^"U_VQX&$HA3@ZO <,(VO#R(Z&;6',\+%.OF',@%!&Y=J61YMM&6HK
M3FV%E**M&=L:1MN2,\@>1J,0'ANZ'AM:ER..L;E83I7K4*BY4@-2/[VL#JUZ
M3=QF\UF2%W\+QG_>I>5?P;^OLOD\4.1]B//9?SPKAJT;9]Z)&7])\FFJ&L]N
M@J+>4-FJ.GJ*S94#+11F+10L$2+P4/"U-;R?-=#JX)8%H3'M/D7+/K&V3WCM
M^Y 49;6(E7G3QQ/^T4IU?-VGBC'SOY0G]_&_RK<*RBRX;]1YHB8O3Y3;5G8.
MJ[!,9B%Q;#ZYMEIZK:Y7TJ#RTF:5V<IW+>+:^4N^5,\)-+C2L@-)<WC]FI:I
MT=K4R&OJ^Z7: //T?\K23\I[#E[,%9Y>!LK6=%D-9SV&D+V190LW#H&Q5]*R
M%H7:H0F]]KY5(<(<)NBP*;K9X( SZU#IE+5-V_"UD'\O+6<>$/P1YU_/7AR"
M_@T"2$!HB!V+$6E&(3^D#,.V,&:(;"P-:"C-*1XU.A\*@*I0R$T80"K$S)F#
MK,(A=4V=AB7RTU([!O7Q\G/P\:E</V]:;'<[(K5ZLU-O *&Q[R^\DG:7-0,1
M?6J7M^HFM1: XC.G9B=MF=5)GZ3=2<U:Q/J0_CI9K+)<A?\[4QYIL"(_62?Q
MO*9JKEW1Z88KNC*'?ZD.-B5/B^*N'OQI5G3"ZPVR@<M8R(3KF-7817[N[L5Z
MT&)AS3*AU'G&:>(B/W*MY9P\Z30^1P!KX>UK"XTI:):WK7,M;\UNY(=W5Z>W
MZFBTW0:V9>UY:WIIRQR]Q!KYV(_\/<18-O&]01;6S,=^YO<+L["->C#.:G0^
MN@)5V9$6(+*\(M F=ZR%-R)D_.VC+:S1COUH[^W@8ANZ ^[P-+#&+O9CU^>_
M-D5;+6+*(L=ICC4&<4?,Z3T+)\E*+=?0[9EB._040D38%7M@#4G<$7Y:YU67
M,4-L(V_ ).&AN7=X]]ZQJT*"A.;F 1I$H;E[ %%UPKBF3H,8^T'\#)XIMD->
M&&V T'3:O))VES7*\8XH[^>9-JUT@0V069WT2=J=U.C&3T/WCGOT'-O!MF-2
M;2'HKT 5$A1%KB.0:)X3/\^W\%HZN]LTT36Y@ SR6@"9Q-R56R/:.R"[>@>[
M)@7(CDD!HK%,=LU<;Y,7(%OF!4AW7@"H"L@+0"HK+P!:Y<X+D(TD.OGVO@O1
MS@+Q.PN]<\7$]B34,4D<-"+:D2 ]D]?@6K'=!C.AZ96T;=0^!?'[%,^?,B9
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MXP]EMJJ_0.QC5I;9HGZ\36*%EDJ@_GZ39>77'ZKO)%M_5=_Q_P%02P,$%
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M"O_ (E>K*_NA9:#)0.2%N.^#2#-<IL:H$P2XE#S432WJ%UT8!9IJQ)/8./8
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M-:GL*+I.ZVC&HX#0)%;B19(P#"1_&<*#\6B@XMBT5%VKKX])0[W.QV "\F0
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M.?*?<N,,+^*\T-CB T(#D<'A[9(R R-K#NP@8>%PZ/B-M#6E?+_*DS'!1KT
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MF8>6L)U$F'4X5RU.<@+G+7Q6TA8&WLL<\Y_U0_*I=RS9.W:5/ NXPFH(HV@
M293$S^"-^D!''F]T N\@N@'<8&J!R1S>/];<-K#"K-;<<C3P]3(U5E.Q?'O&
MZ+@W.O9&Q[^<W?^# W<%PEH):BPN-V!9*I :A9K3^&M+U]>JK)AL7KV8)?'T
MG0&V95QX06IH,(P(X\&M ^<'X&E#=?;=";7):< V%<)K5JK:W7-)!E1M*(WF
M[()26%DL4]3]H\%E2<#\'\SA#ZV,@7M)8T-XQIVR3,#JN.7[X6H(&[5%+1UC
M[X![G9>$?#YX.YX1]3H>S)+IF>=-!C$9;%%/Q/.\Z@UFG?>Q]S[Z/=['T^G@
M/!X[%\Y'9QUC,OE/UT_K'7GCHRA$4EW7+: K_8R9X@>!U A;J@9_JQ$RP8SA
M:T[1UL95UR?<HH"88*J:9';<%KX"J) 8UT"Z-4+!43.=%8T'=CB>O\=XK)6E
M TW_!UHWE>894C.F6CU0XJG2<DHP44Z,N9E-E\1E@D*1S$UOK^.0C*HU*7LW
MJ.294=(7M7!>&E#K%AVHDZ6IR!&9-<.V[0_>@WG)(Y5;,++%:&?0*])J(H]M
MVP(D'@VIA!IDV@R/38CP8!:7J#=^XQC(7-.T8[GG]DOMLIWE/\3;C?B9Z0V]
M&@6U)M5H.)T$H-LMTQZLJOQD3Y6E/>')@A8S:B= ]VM%^>X.SD"_ZI?_ E!+
M P04    " #U@VE35_KTJ84"  !C!0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6RE5,ENVS 0_96!T$,+"-%FQXYA&["3%.VAJ)%T.10]4-+($L)%
M):DX^?L.*5EUE_C2BS0SG/=FD1Z7!Z4?3(UHX4EP:59!;6V[B")3U"B8N5 M
M2CJIE!;,DJOWD6DULM*#!(_2.+Z,!&MDL%[ZV$ZOEZJSO)&XTV Z(9A^WB)7
MAU60!,? 7;.OK0M$ZV7+]GB/]G.[T^1%(TO9")2F41(T5JM@DRRV$Y?O$[XT
M># G-KA)<J4>G/.^7 6Q:P@Y%M8Q,'H]XC5R[HBHC1\#9S"6=,!3^\C^UL].
ML^3,X+7B7YO2UJM@'D")%>NXO5.'=SC,,W5\A>+&/^'0YV99 $5GK!(#F#H0
MC>S?[&G8PPE@'K\ 2 = ZOON"_DN;YAEZZ56!] NF]B<X4?U:&JND>ZCW%M-
MIPWA['I3%+K#$FZ?Z#,;-,O($JL[BXJ!8=LSI"\P7,$')6UMX%:66/Z.CZB;
ML:7TV-(V/4MXC^T%9'$(:9PF9_BR<<3,\V4O\.W8,\LY&F"R!#\OXP:^;7)C
M-?T4W\^4F(PE)K[$Y#^V>);!:6]A6E;@*B!Q&=2/&/Q%"\< '@.%(GD82R%5
M@:T1*L5)9XW<PVLF5">M@4;2B>H,C6_>+(#6:U'DJ/V.;[ 8G"2$.RK,=%'[
M397X2))M28#6E?&[(L,0XRM(XG"2I&1,PVR>PK42KB'6"XW &CES7>4HL6H(
MDH:S+(,DG$X3^$B-:KC,YC!)KN"3LHR3.O^8C&IDX6R>D3$+LVD*__I,T<F/
M+U#OO;S=5FCP7@-C=+Q!-KUP?J7WU\\'IO>--,"Q(FA\,9L&H'M)]XY5K9=1
MKBR)TILUW8*H70*=5TK9H^,*C/?J^B=02P,$%     @ ]8-I4[2#^8Z[!
MV H  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULQ5;;;MPV$/T50@V*
M!-CN15XGMF,;L)T:"9 @1IRV#T4?*&DD$:9(A:1VO7^?,]3%E\8N4!3HRRY%
M<LZ<.3,<\GAKW8VOB8*X;;3Q)TD=0GNT6/B\ID;ZN6W)8*6TKI$!GZY:^-:1
M+*)1HQ?I<OEZT4AEDM/C.'?E3H]M%[0R=.6$[YI&NMTY:;L]25;)./%%577@
MB<7I<2LKNJ;P6WOE\+684 K5D/'*&N&H/$G.5D?G:]X?-_RN:.OOC05'DEE[
MPQ\?BI-DR81(4QX80>)O0Q>D-0.!QK<!,YE<LN']\8A^&6-'+)GT=&'U'ZH(
M]4ERD(B"2MGI\,5NW],0SS[CY5;[^"NV_=[]-!%YYX-M!F,P:)3I_^7MH,,]
M@X/E$P;I8)!&WKVCR/*=#/+TV-FM<+P;:#R(H49KD%.&DW(='%85[,+IA6T:
M%:!R\$*:0EQ8$Y2IR.2*_/$BP 5O7.0#W'D/ESX!=R@^ :#VXE=34/'0?@%J
M$[]TY'>>/@MX3>U<["UG(EVFJV?P]J9X]R+>WK^)5[Q3/M?6=X[$GV>9#PY%
M\]<S7M>3UW7TNOZO5'X6C@_JD6]E3B<)3J(GMZ'D'R+[W)*3_"T^$HK8B\LN
M<)@H*=5TC6CE+IK.1+83.Y(N8B@<FZIR5,E ,]$AITX8:W[)I<E)RTR3L!.P
M[H%SBQ/K@["E"#6)TFH<?%Z7GN>0T$!-!J QJ^*E;&S'M.$NU+;S<.U?'?6+
M+\3J<,G#5*QFR_T#'N[Q\."0AVL,5VG<L,_#_51\K0GMJ0QPD<X.5FOQU0:I
MIT@CS2E>X+^9K8'XGF00'U6.?D/B##$3KXL/A@,R0P_9JE +*?2P34[;XD*$
M.%=6VTKE'J;Y7+S\^:>#-%V^Y;4X7+U]-8O"(%^M-#NA/)K;MTXY*D2P.-LW
M]]A!L*[EZ1?I<OX:,6C-/.[G!0J[""CS6M&FYP,[WU*N2@74 K/:MKPP@Z^J
MTS)8MXL9SE$UY'(%@;S42!]<$+J.P9"!<W(!K7T,N1"MLT67XR)@G9\* OQ[
M-:1 >< RH,'WP90.=2E* C[@+8CW)>7L3NJPNPO=V"""&D0920F$PHNA!K@*
M<)H3NGHLG<=Y&JG[+AO8^[$H[Z*!@.8'P4CM[5,1C4SY3M&:(148X?+1!7HW
M"8.K-&K)>;:>QAVR+)56<(@%EOX1K[\KW7/K3P4XH^5XG".<N4)5ZC'I6O:2
M01'KT'MCF<H,'D%U+)%)7(F96"E0"WLK:&C^AR)BJ9DTOK/83>24HDQJ;C*B
M?YH4T&*.XQD42IXS?.EL@_)HB)/#_P\/58-T95 "Z\ILK-Y0;&8;Z13Z"WI
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M<MLV$/T5C)KI94;6A;9C)[$]([OIU#--Z[&=]J'3!Y!<D6A @@; *.K7]RQ
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MU,)Y>!3ID2%<#"X?:Z>?7M'=3?9PBI#E_%JVWU+,5,HBF2EJ]1^V@-7OJNC
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M:CS>).%GB4<@61; _M(8WR_8P/"LO/H?4$L#!!0    ( /6#:5/4"[4T>0(
M *D%   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*U437/3,!#]*SMF
MX 2QXZ2T0)*9I(6!0V<R;8$#PT&Q-K8FEF2D#6[_/2O9,>&C.3!<;.UJW]NW
MDG9GK74[7R$2W.O:^'E2$36OT]07%6KA1[9!PSM;Z[0@-EV9^L:AD!&DZS3/
MLI>I%LHDBUGTK=UB9O=4*X-K!WZOM7 /*ZQM.T_&R<%QH\J*@B-=S!I1XBW2
MQV;MV$H'%JDT&J^L 8?;>;(<OUY-0WP,^*2P]4=K")5LK-T%XX.<)UD0A#46
M%!@$_[[C)=9U(&(9WWK.9$@9@,?K _N[6#O7LA$>+VW]64FJYLE% A*W8E_3
MC6W?8U_/6> K;.WC%]HN=L+!Q=Z3U3V8%6AENK^X[\_A"'"1/0+(>T >=7>)
MHLHK06(Q<[8%%Z*9+2QBJ1'-XI0)EW)+CG<5XVAQ@[4@E"_6PM$#W#EAO(CG
MY6<I,7^(2HN>:]5QY8]PO8)K:ZCR\-9(E+_B4]8UB,L/XE;Y2<);;$8PR9Y#
MGN7C$WR3H=A)Y)N<+A;^+!:^+#>>'%M?3^29#GFF,<_TOQSJOW+!TH/=PA46
MJ#?H8#*.!\7'=2=V* 546$L0_/*;QME[Q4\8X6R4/07;&G2^4@TH0^C0$R^
M*H1+JQMA'IX]N<C'YV^8?T^>A)'*E. KP:$CCN&6E.B"+V#8J4HC8I.QGN#J
M!4CEN/FL8Q$2&G0%&CI*W@?_GK.P6C,5/_UB!^*Q&H^08"S4UI2\7_3:_$&"
M8'G=I3?A $=_N]WTJ'TTNC(.B:!C;ZCKI,$[S*%EUWX_P[LA=BU<J?AJ:MPR
M-!N=GR7@NL'0&62;V(P;2]S:<5GQ+$47 GA_:RT=C)!@F,Z+'U!+ P04
M" #U@VE3JC%BH,@:  "H6   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6SM/%EO&T>:?Z6@"08R0-$B;<NR? "R,I[Q(HX]5CSSL-B'8G>1K+C9U>GJ
MUI%?O]]15Y]6'&"P#_N0F"*KJ[[Z[K-?W9KZJ]TKU8B[0U':UT?[IJDN'C^V
MV5X=I%V:2I7PR];4!]G G_7NL:UJ)7-ZZ% \7I^>GCT^2%T>O7E%WWVJW[PR
M;5/H4GVJA6T/!UG?OU6%N7U]M#KR7WS6NWV#7SQ^\ZJ2.W6MFB_5IQK^>AQV
MR?5!E5:;4M1J^_KH<G7Q=G6&#]"*?VEU:Y// J^R,>8K_O$^?WUTBA"I0F4-
M;B'AGQMUI8H"=P(X?G.;'H4S\<'TL]_]'5T>+K.15EV9XM\Z;_:OC\Z/1*ZV
MLBV:S^;V'\I=Z!GNEYG"TO_%K5M[>B2RUC;FX!X&" ZZY'_EG4/$0QY8NP?6
M!#<?1%#^*!OYYE5M;D6-JV$W_$!7I:<!.%TB5:Z;&G[5\%SSYJVTV@JS%9]J
M95792,95F8MKIA/^=JUWI=[J3):-N,PRTY:-+G?BDRETII45Q_[3HU>/&P *
MMWZ<.0#>,@#K"0!>B ^F;/96_*W,5=Y]_C%<)MQH[6_T=CV[X;6JEN+)Z4*L
M3]>KF?V>! P]H?V>3.SWL=[)4O].B%F(*U-:N&P>\=1!'"#KG2YEF6E9B&OX
M4@$'-U;\]^7&-C6PX/_,0/0T0/24('KZAVGVI91MKAN5B_=EHVI]&(5FC$C?
M<^(O>P52E9E#)<M[9(@V'*_=\=MPO(W(V,L;)39*E0(4225K6B\R4Z*2T<T]
MB$"SIYT=HU6UADVJ EAMITI5RZ*XQ]]5Q6>)!B#Y4M+)=$V"]?( (&12'/_U
M+^?K]>G+OU]>?J*/JY>/EC-D>!;(\&P6*5^LPF/^9AM]P#/'T/K'=B",,DX"
M.XUB< 1=>#M0D[^U&D@$&J($G8J+16/@KZ]*J' *<HJTH(<K/,0"]F0CY'8+
MBI(P*0^(> N[5:9.,#P*"FV6,D%IX(QE1V=,'PTJ&/5S.,-.G +T+]I<+<2F
M!5!KA:>(0A^(Y(U9P$8WJFP5_)L9.)B%M6$&K5O8#%")O"OK;$]0Y/! 82I"
MD;H#(V<=>/C0C2S:0 '0P=G7$U3] /NMK'.X7209 E,!HYD<[HI\"9" Z> ;
M%6@3<(]L+\N=8L+I.FL/<+<R4W8AMJ 4^&"$HM8*OEZ*J[@^(&\A]!86WB_H
M3+QHG4?B, SXU^U>PQWANWL0,B",$E]+<ULZ2C6(#, $6"T+3-06@ H-M*_%
MMC:'A'%05%;/7]H(P%)<SHC-61";LUFF?R=U+?X%"%9=;?F^! W93BJH/[VI
MH#4WM :4&5ANV .YD=$'JD*Q)-P24C:$8@4N0R[:RC"2K2SH %DB%X//9&I1
M29VL "5?6L0FK@+ZRXTN4$8UXE\@Q6K@$5HEV2_9J.86=2$8VZ^P(\A^ [84
MI G9@@7RH*1M:Q9GL#R*2.GISKH1.;P6!V-!//(;>!BH:%KK=P55X<3<@QU
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MMWN0MA,D+'P)1S1=7XGVKN0]RC=8\PIN<4<F-F67O%6>E9/M@$_:VJE=1G
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M2A5D[:'E)SBZPI1IK?98X+I!/QXS=>@ZX/? FTPMRCV"+X&:W'DNI N;^X5
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M0BB?&65103N.U[8<:&[H;A-\@*R7F#5,0A%CCDA*@R!U^<_UH]!3OA[-5X]
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M    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;(U5WV_:,!#^5TZ9-&U2VH0
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MQJ>C80"Z&9S-QJK*#ZN-LC3Z_+*@;PUJ9T#WN:*V:C<N0/?UFO\#4$L#!!0
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MU]I1OP>SI@&+QCO0>:FUVR\\03^R%W\!4$L#!!0    ( /6#:5/SOA\'! 4
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MD"8 YU,A]+%C%FB>=HM_ %!+ P04    " #U@VE3J%YS0L0"  "*"   &0
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M-N :4^KN'13FE/Y.Y9KEBG!8(='K]+%061Y\Y42+C3T[ED+C262'*7XL@#0
MO+\20C]/S'%4?WY,_@!02P,$%     @ ]8-I4Z>Z HOT 0  "00  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL?5-+;]LP#/XKA$\;D,:.O:Q#X1AH
MF@WK84/0;-UAV$&QF5BH'JY$Q\V_GR0[1@HTO=BBQ.]!4LH[;9YLC4CP(H6R
MBZ@F:F[BV)8U2F:GND'E3G;:2$8N-/O8-@99%4!2Q&F2?(XEXRHJ\K"W-D6N
M6Q)<X=J ;:5DYKA$H;M%-(M.&P]\7Y/?B(N\87O<(/UNUL9%\<A2<8G*<JW
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MA [ ]8QS=9CHBZ?_SL1_ 5!+ P04    " #U@VE3:K_F7VP"  "F!@  &0
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MI%U@YFLA]%O'%K?QUU2\ E!+ P04    " #U@VE3!^25.! "  !O!   &0
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R=5$N+VS 0_BO"]+"%;>0XCY;%
M,>1!::$M8<.VA]*#8D]LL7JXTCC>_/N59,>$;78/]<'22/,]1AH[;;5YM!4
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M287L+_0PDDTF, 60WU>4BL-$;5"VK<._4$L#!!0    ( /6#:5/^W15 / 0
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M*%2E@5<W %5#LM(<HI^95$=R\[@%F@#7'=3W-6/RV- !FGN8Q3]02P,$%
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M5)RXJ8-POQ:/)I#E5<)1!]E]ZT0T!D4T!IVC$811DN[ #\=CT"4>=5!#/)I
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M@H]2/=Q0$E"1 N#]BG/U_I J*"YX)O\"4$L#!!0    ( /6#:5/)E\TT[P$
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M96Y-1VR(]FS!B*5&M!<G=&C*!JT_%1Z'Y1HD1ZC?KKC%9_)HN78\WI<CKY:
M7$CW.F?H,X5X5@VLBYXUN\*ZA&I"IND;DB59\C><>8&CRFQ4F46^V16^1WZ
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MDL2/ .9W$$48 F\CCF .P .&1%&U#^[M1^%FGPK;7\/&OP!02P,$%     @
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MIA6,O'AVERR:Y]$_,,G;9U,:RHJ4.&.Z04QR@^<.Y5=T$TWCA*372;),+:8
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MGW7_P&=?4$L! A0#%     @ ]8-I4P=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #U@VE3?F^YT^T
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ]8-I4Z57O6F# @
MPP8  !@              ("!%!,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( /6#:5.*NP$HJ@4  !P6   8              " @<T5
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #U@VE3+AO6
M4?T+  "V3P  &               @(&M&P  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ ]8-I4X'(UFBA!@  'AL  !@
M ("!X"<  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( /6#
M:5-)XJYT;P@  -T3   8              " @;<N  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " #U@VE3;DP*L> <  !"70  &
M        @(%<-P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( /6#:5,#+;MV_0H  &H>   9              "
M@?9B  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ ]8-I
M4PEB3FV[!0  8@X  !D              ("!*FX  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " #U@VE3U NU-'D"  "I!0  &0
M        @($<=   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( /6#:5.J,6*@R!H  *A8   9              " @<QV  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ ]8-I4Y2]O6PU P  R08
M !D              ("!RY$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " #U@VE3?/E(K]$"  "?!@  &0              @($WE0
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( /6#:5.F:>C.
ME0(  &<%   9              " @3^8  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ ]8-I4XG]78>P @  O@4  !D
M ("!"YL  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #U
M@VE3\[X?!P0%  !,#   &0              @('RG0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( /6#:5/2=3()8 (  $D%   9
M          " @2VC  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#
M%     @ ]8-I4\8IF<W- @  R @  !D              ("!Q*4  'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #U@VE3&,+JVX(#  #F
M#0  &0              @('(J   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM
M;%!+ 0(4 Q0    ( /6#:5.H7G-"Q (  (H(   9              " @8&L
M  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ]8-I4Z>Z
M HOT 0  "00  !D              ("!?*\  'AL+W=O<FMS:&5E=',O<VAE
M970R-BYX;6Q02P$"% ,4    " #U@VE3Z(CU_XP"  !S!@  &0
M    @(&GL0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M /6#:5-JO^9?; (  *8&   9              " @6JT  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ ]8-I4P?DE3@0 @  ;P0  !D
M             ("!#;<  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " #U@VE36L-?!>$"  "K"   &0              @(%4N0  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( /6#:5.VBO7;Y@4
M ,(:   9              " @6R\  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ ]8-I4VB!_SH9 P  P@H  !D              ("!
MB<(  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #U@VE3
M_MT50#P$  "3$0  &0              @('9Q0  >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( /6#:5.[-GA($P,  #,+   9
M      " @4S*  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ ]8-I4RXG']!' @  C@4  !D              ("!ELT  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #U@VE3YQHNP'\$  #L$0
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M+G)E;'-02P$"% ,4    " #U@VE3X+1I&),#   S&0  #P
M@ $QVP  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ]8-I4YD^HH1\ 0
MEA8  !H              ( !\=X  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ ]8-I4ZIG%&&8 0  "Q<  !,              ( !
MI>   %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "T +0 R#   ;N(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>140</ContextCount>
  <ElementCount>262</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>26</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - COVER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/COVER</Role>
      <ShortName>COVER</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BALANCESHEETS</Role>
      <ShortName>BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - BALANCE SHEETS - Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BALANCESHEETSParenthetical</Role>
      <ShortName>BALANCE SHEETS - Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS</Role>
      <ShortName>STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness</Role>
      <ShortName>Organization and Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/ShortTermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Collaboration Agreement - Related Party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty</Role>
      <ShortName>Collaboration Agreement - Related Party</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/ShortTermInvestmentsTables</Role>
      <ShortName>Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/ShortTermInvestments</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/AccruedExpenses</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2316304 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/CommitmentsandContingencies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/StockBasedCompensation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization and Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails</Role>
      <ShortName>Organization and Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Short-Term Investments - Schedule of available for sale short-term investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails</Role>
      <ShortName>Short-Term Investments - Schedule of available for sale short-term investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Short-Term Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails</Role>
      <ShortName>Short-Term Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Accrued Expenses - Schedule of accrued expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of accrued expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Commitments and Contingencies - Schedule of minimum lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of minimum lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/PreferredStockDetails</Role>
      <ShortName>Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/PreferredStock</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Stock-Based Compensation - Schedule of stock-based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of stock-based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Stock-Based Compensation - Schedule of option activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of option activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Stock-Based Compensation - Schedule of valuation assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of valuation assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Stock-Based Compensation - Schedule of restricted stock activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of restricted stock activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Collaboration Agreement - Related Party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails</Role>
      <ShortName>Collaboration Agreement - Related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sttk-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Related-Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related-Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.shattucklabs.com/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sttk-20210930.htm">sttk-20210930.htm</File>
    <File>sttk-20210930.xsd</File>
    <File>sttk-20210930_cal.xml</File>
    <File>sttk-20210930_def.xml</File>
    <File>sttk-20210930_lab.xml</File>
    <File>sttk-20210930_pre.xml</File>
    <File>sub-certxsection302xceoxq3.htm</File>
    <File>sub-certxsection302xcfoxq3.htm</File>
    <File>sub-certxsection906ofthesa.htm</File>
    <File>terminationagreement-ex101.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>54
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sttk-20210930.htm": {
   "axisCustom": 1,
   "axisStandard": 13,
   "contextCount": 140,
   "dts": {
    "calculationLink": {
     "local": [
      "sttk-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sttk-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sttk-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sttk-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sttk-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sttk-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 294,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 6
   },
   "keyCustom": 14,
   "keyStandard": 248,
   "memberCustom": 7,
   "memberStandard": 16,
   "nsprefix": "sttk",
   "nsuri": "http://www.shattucklabs.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - COVER",
     "role": "http://www.shattucklabs.com/role/COVER",
     "shortName": "COVER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Accrued Expenses",
     "role": "http://www.shattucklabs.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Commitments and Contingencies",
     "role": "http://www.shattucklabs.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Preferred Stock",
     "role": "http://www.shattucklabs.com/role/PreferredStock",
     "shortName": "Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Stock-Based Compensation",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Collaboration Agreement - Related Party",
     "role": "http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty",
     "shortName": "Collaboration Agreement - Related Party",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - Related-Party Transactions",
     "role": "http://www.shattucklabs.com/role/RelatedPartyTransactions",
     "shortName": "Related-Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Short-Term Investments (Tables)",
     "role": "http://www.shattucklabs.com/role/ShortTermInvestmentsTables",
     "shortName": "Short-Term Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://www.shattucklabs.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - BALANCE SHEETS",
     "role": "http://www.shattucklabs.com/role/BALANCESHEETS",
     "shortName": "BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316304 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.shattucklabs.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization and Description of Business (Details)",
     "role": "http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails",
     "shortName": "Organization and Description of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i91d5a84837714480a2462e3255a83730_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details)",
     "role": "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Short-Term Investments - Schedule of available for sale short-term investments (Details)",
     "role": "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails",
     "shortName": "Short-Term Investments - Schedule of available for sale short-term investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Short-Term Investments - Narrative (Details)",
     "role": "http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails",
     "shortName": "Short-Term Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sttk:AccruedResearchAndContractCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Accrued Expenses - Schedule of accrued expenses (Details)",
     "role": "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails",
     "shortName": "Accrued Expenses - Schedule of accrued expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sttk:AccruedResearchAndContractCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Commitments and Contingencies - Schedule of minimum lease payments (Details)",
     "role": "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails",
     "shortName": "Commitments and Contingencies - Schedule of minimum lease payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sttk:LicenseAgreementRoyaltyPaymentsMaximum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sttk:LicenseAgreementRoyaltyPaymentsMaximum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - BALANCE SHEETS - Parenthetical",
     "role": "http://www.shattucklabs.com/role/BALANCESHEETSParenthetical",
     "shortName": "BALANCE SHEETS - Parenthetical",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i403cb7cee0ba466091fcfc1ad0c176f8_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Preferred Stock (Details)",
     "role": "http://www.shattucklabs.com/role/PreferredStockDetails",
     "shortName": "Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "idfcc0f4a792b448fb51f91b0f2a59e3e_D20200101-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Stock-Based Compensation - Schedule of stock-based compensation expense (Details)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails",
     "shortName": "Stock-Based Compensation - Schedule of stock-based compensation expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i0ca0b7d0da2e41569af9e27e49cc9cc2_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Stock-Based Compensation - Schedule of option activity (Details)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails",
     "shortName": "Stock-Based Compensation - Schedule of option activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i53d501358f0f40a391f8c8d1a5bb6624_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Stock-Based Compensation - Schedule of valuation assumptions (Details)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails",
     "shortName": "Stock-Based Compensation - Schedule of valuation assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7d5b05e7331844e1a0d22b8edf0e660d_D20210101-20210930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i127f4a4b929a4584b3d952f63d22eadf_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Stock-Based Compensation - Schedule of restricted stock activity (Details)",
     "role": "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails",
     "shortName": "Stock-Based Compensation - Schedule of restricted stock activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i127f4a4b929a4584b3d952f63d22eadf_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Collaboration Agreement - Related Party (Details)",
     "role": "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
     "shortName": "Collaboration Agreement - Related Party (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i5c7bb72760a94fcc8de574e18c30c762_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7842c9c91ac44eb081775b9eeb02a4f3_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "sttk:ShareholderOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Related-Party Transactions (Details)",
     "role": "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related-Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7842c9c91ac44eb081775b9eeb02a4f3_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "sttk:ShareholderOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "role": "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "shortName": "STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i7fb909771ce142b4b92d97f311d9463c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "ie8ed9359c48a4172993da7b129d56e5d_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "role": "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i5941b69e501e49f1814e1f78be0b586f_D20200101-20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - STATEMENTS OF CASH FLOWS",
     "role": "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
     "shortName": "STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Description of Business",
     "role": "http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness",
     "shortName": "Organization and Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Short-Term Investments",
     "role": "http://www.shattucklabs.com/role/ShortTermInvestments",
     "shortName": "Short-Term Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210930.htm",
      "contextRef": "i648e824fd76a426abee666fe49416d9d_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 26,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/COVER"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r36",
      "r38",
      "r80",
      "r81",
      "r186",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r37",
      "r38",
      "r80",
      "r81",
      "r186",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_A2020EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Employee Stock Purchase Plan",
        "label": "2020 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2020 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "A2020EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_A2020StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Stock Incentive Plan",
        "label": "2020 Stock Incentive Plan [Member]",
        "terseLabel": "2020 Stock Incentive Plan"
       }
      }
     },
     "localname": "A2020StockIncentivePlanMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities And Employee-Related Liabilities, Current",
        "label": "Accrued Liabilities And Employee-Related Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails",
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_AccruedResearchAndContractCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails": {
       "order": 2.0,
       "parentTag": "sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Research And Contract Costs, Current",
        "label": "Accrued Research And Contract Costs, Current",
        "terseLabel": "Research and development contract costs"
       }
      }
     },
     "localname": "AccruedResearchAndContractCostsCurrent",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_CumulativeEffectChangeOfAccountingEstimateAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Change Of Accounting Estimate, Adjustment",
        "label": "Cumulative Effect, Change Of Accounting Estimate, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Change Of Accounting Estimate, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectChangeOfAccountingEstimateAdjustmentMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_CumulativeEffectChangeOfAccountingEstimateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Change Of Accounting Estimate",
        "label": "Cumulative Effect, Change Of Accounting Estimate [Axis]",
        "terseLabel": "Cumulative Effect, Change Of Accounting Estimate [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectChangeOfAccountingEstimateAxis",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sttk_CumulativeEffectChangeOfAccountingEstimateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Change Of Accounting Estimate [Domain]",
        "label": "Cumulative Effect, Change Of Accounting Estimate [Domain]",
        "terseLabel": "Cumulative Effect, Change Of Accounting Estimate [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectChangeOfAccountingEstimateDomain",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_IncreaseDecreaseInDeferredRentCredits": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Deferred Rent Credits",
        "label": "Increase (Decrease) In Deferred Rent Credits",
        "negatedTerseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRentCredits",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_LicenseAgreementRoyaltyPaymentsMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreement, Royalty Payments, Maximum",
        "label": "License Agreement, Royalty Payments, Maximum",
        "terseLabel": "License agreement, maximum payment"
       }
      }
     },
     "localname": "LicenseAgreementRoyaltyPaymentsMaximum",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_OperatingAccountMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Account",
        "label": "Operating Account [Member]",
        "terseLabel": "Operating Account"
       }
      }
     },
     "localname": "OperatingAccountMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revision In Estimated Total Costs Related To Development Program",
        "label": "Revision In Estimated Total Costs Related To Development Program [Member]",
        "terseLabel": "Revision In Estimated Total Costs Related To Development Program"
       }
      }
     },
     "localname": "RevisionInEstimatedTotalCostsRelatedToDevelopmentProgramMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_SeriesB1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-1 Preferred Stock",
        "label": "Series B-1 Preferred Stock [Member]",
        "terseLabel": "Series B-1 Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesB1PreferredStockMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase In Number of Shares Authorized, Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase In Number of Shares Authorized, Term",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, annual increase in number of shares authorized, term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfSharesAuthorizedTerm",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Increase In Number of Shares Authorized, Annual Increase Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Increase In Number of Shares Authorized, Annual Increase Percentage",
        "terseLabel": "Increase in number of shares authorized, percentage of capital stock outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorizedAnnualIncreasePercentage",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Shares Per Employee, Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Shares Per Employee, Value",
        "terseLabel": "Maximum value of shares per employee during any calendar year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumSharesPerEmployeeValue",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options Exercised And ESPP Purchased in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options Exercises And ESPP Purchases in Period",
        "terseLabel": "Exercise of stock options and ESPP purchases (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesAndESPPPurchasesInPeriod",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "sttk_ShareholderOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Ownership Percentage",
        "label": "Shareholder Ownership Percentage",
        "terseLabel": "Shareholder ownership percentage"
       }
      }
     },
     "localname": "ShareholderOwnershipPercentage",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sttk_StockIssuanceCostsIncurredDuringNoncashTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuance Costs Incurred During Noncash Transaction",
        "label": "Stock Issuance Costs Incurred During Noncash Transaction",
        "terseLabel": "Accrued public offering costs in other assets"
       }
      }
     },
     "localname": "StockIssuanceCostsIncurredDuringNoncashTransaction",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Stock Options Exercised And ESPP Purchased",
        "label": "Stock Issued During Period, Value, Stock Options Exercised And ESPP Purchased",
        "terseLabel": "Exercise of stock options and ESPP purchases"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedAndESPPPurchased",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_TakedaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Takeda",
        "label": "Takeda [Member]",
        "terseLabel": "Takeda"
       }
      }
     },
     "localname": "TakedaMember",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sttk_TemporaryEquityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity",
        "label": "Temporary Equity [Policy Text Block]",
        "terseLabel": "Series A, Series B and Series B-1 Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityPolicyTextBlock",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sttk_TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Additional Issuance Costs",
        "label": "Temporary Equity, Stock Issued During Period, Additional Issuance Costs",
        "negatedTerseLabel": "Series B-1 additional issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodAdditionalIssuanceCosts",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sttk_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Sale of redeemable convertible preferred stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.shattucklabs.com/20210930",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r27",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r349",
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.",
        "label": "Accrued Royalties",
        "terseLabel": "Accrued royalty"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r40",
      "r41",
      "r42",
      "r359",
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r39",
      "r42",
      "r48",
      "r49",
      "r50",
      "r83",
      "r84",
      "r85",
      "r267",
      "r369",
      "r370",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r17",
      "r249",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r246",
      "r247",
      "r248",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r215",
      "r217",
      "r252",
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r217",
      "r242",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r79",
      "r127",
      "r130",
      "r136",
      "r154",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r264",
      "r268",
      "r276",
      "r297",
      "r299",
      "r346",
      "r358"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r35",
      "r79",
      "r154",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r264",
      "r268",
      "r276",
      "r297",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r145",
      "r161"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r142",
      "r146",
      "r161",
      "r348"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Total Fair\u00a0Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r144",
      "r161"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r218",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Unaudited Interim Financial Statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid amounts related to purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r25",
      "r71"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS",
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Cash, cash equivalents, and short-term investments"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r65",
      "r71",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r65",
      "r277"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r91",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r91",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r78",
      "r79",
      "r98",
      "r99",
      "r100",
      "r102",
      "r104",
      "r111",
      "r112",
      "r113",
      "r154",
      "r175",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r189",
      "r190",
      "r192",
      "r193",
      "r276",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r258",
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration Agreement - Related Party"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedParty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r32",
      "r173",
      "r350",
      "r363"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 5)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r174",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value: 300,000,000 shares authorized; 42,241,981 shares issued and outstanding at September\u00a030, 2021 and 41,779,183 shares issued and 41,767,431 shares outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r47",
      "r52",
      "r352",
      "r366"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r117",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r198",
      "r199",
      "r210"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r198",
      "r199",
      "r210"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities [Abstract]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax",
        "terseLabel": "Gross\u00a0Unrealized Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of available for sale short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-sale, Term",
        "terseLabel": "Debt securities, average maturity term"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Accretion (amortization) of short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r12",
      "r285",
      "r288"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r69",
      "r166"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r53",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r96",
      "r98",
      "r102",
      "r103",
      "r104",
      "r107",
      "r108",
      "r273",
      "r274",
      "r353",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "negatedTerseLabel": "Increase in basic loss per share (in dollars per share)",
        "terseLabel": "Net loss per share \u2013 basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r53",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r98",
      "r102",
      "r103",
      "r104",
      "r107",
      "r108",
      "r273",
      "r274",
      "r353",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "negatedTerseLabel": "Increase in diluted loss per share (in dollars per share)",
        "terseLabel": "Net loss per share \u2013 diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails": {
       "order": 1.0,
       "parentTag": "sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Compensation and related benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average amortization period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r48",
      "r49",
      "r50",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r110",
      "r155",
      "r195",
      "r196",
      "r246",
      "r247",
      "r248",
      "r256",
      "r257",
      "r272",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r369",
      "r370",
      "r371",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r163",
      "r164",
      "r165",
      "r187",
      "r194",
      "r271",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r168",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r68",
      "r330"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue - related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r56",
      "r126"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r153",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r345",
      "r355",
      "r376",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]",
        "terseLabel": "Investor"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r79",
      "r131",
      "r154",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r265",
      "r268",
      "r269",
      "r276",
      "r297",
      "r298"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r79",
      "r154",
      "r276",
      "r299",
      "r347",
      "r361"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r79",
      "r154",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r265",
      "r268",
      "r269",
      "r276",
      "r297",
      "r298",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r114",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Organization and Description of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/OrganizationandDescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r65",
      "r67",
      "r70"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r43",
      "r45",
      "r50",
      "r51",
      "r70",
      "r79",
      "r86",
      "r88",
      "r89",
      "r90",
      "r91",
      "r94",
      "r95",
      "r101",
      "r127",
      "r129",
      "r132",
      "r135",
      "r137",
      "r154",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r274",
      "r276",
      "r351",
      "r365"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedTerseLabel": "Increase in net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements (not yet adopted)"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Expense from operations"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r127",
      "r129",
      "r132",
      "r135",
      "r137"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r284",
      "r286"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesScheduleofminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r2",
      "r82",
      "r123",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r30"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails": {
       "order": 3.0,
       "parentTag": "sttk_AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpensesScheduleofaccruedexpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r262",
      "r263",
      "r266"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized loss on short-term investments",
        "verboseLabel": "Unrealized gain (loss) on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payments for public offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r59",
      "r61",
      "r143"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r218",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r23",
      "r24"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollaborators": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from collaborators during the current period.",
        "label": "Proceeds from Collaborators",
        "terseLabel": "Proceeds from collaborators"
       }
      }
     },
     "localname": "ProceedsFromCollaborators",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from the sale of Series B redeemable convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r63",
      "r245"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Exercise of stock options and ESPP purchases"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r59",
      "r60",
      "r143"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Sale and maturities of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r167",
      "r299",
      "r356",
      "r362"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock as converted to common stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r214",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r214",
      "r291",
      "r294",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r289",
      "r290",
      "r292",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related-Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r255",
      "r331",
      "r378"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Unvested restricted stock",
        "verboseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r196",
      "r249",
      "r299",
      "r360",
      "r372",
      "r374"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS",
      "http://www.shattucklabs.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r155",
      "r246",
      "r247",
      "r248",
      "r256",
      "r257",
      "r272",
      "r369",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r124",
      "r125",
      "r128",
      "r133",
      "r134",
      "r138",
      "r139",
      "r140",
      "r208",
      "r209",
      "r332"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Collaboration revenue - related party"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r77",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of stock, proceeds received"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Preferred stock sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of preferred stock (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofantidilutivesecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of antidilutive securities excluded from computation of net loss per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r217",
      "r241",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of stock-based compensation expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of future minimum rental payments for operating leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails",
      "http://www.shattucklabs.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r218",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r223",
      "r231",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock-based compensation, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Awards, ending balance (in shares)",
        "periodStartLabel": "Awards, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Awards, vested (in shares)",
        "verboseLabel": "Vesting of common stock previously subject to vesting requirements (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofstockbasedcompensationexpenseDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Contribution limit in percentage of employee's eligible compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee during any one purchase period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for future grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted\u00a0Average Remaining Contract Life (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options, exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options, forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options, granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r225",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options, ending balance (in shares)",
        "periodStartLabel": "Options, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, ending balance (in dollars per share)",
        "periodStartLabel": "Weighted average exercise price, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options, vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r216",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofrestrictedstockactivityDetails",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based compensation, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r236",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term - years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofvaluationassumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted\u00a0average remaining contract life, exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted\u00a0average remaining contract life, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted\u00a0average remaining contract life, vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock in percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r78",
      "r79",
      "r98",
      "r99",
      "r100",
      "r102",
      "r104",
      "r111",
      "r112",
      "r113",
      "r154",
      "r175",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r189",
      "r190",
      "r192",
      "r193",
      "r195",
      "r276",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails",
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r34",
      "r48",
      "r49",
      "r50",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r110",
      "r155",
      "r195",
      "r196",
      "r246",
      "r247",
      "r248",
      "r256",
      "r257",
      "r272",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r369",
      "r370",
      "r371",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r110",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r15",
      "r16",
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Stock issued under ESPP (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r195",
      "r196",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options, exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.shattucklabs.com/role/StockBasedCompensationScheduleofoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r34",
      "r195",
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r20",
      "r21",
      "r79",
      "r141",
      "r154",
      "r276",
      "r299"
     ],
     "calculation": {
      "http://www.shattucklabs.com/role/BALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS",
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of non-cash financial activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r9",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r175",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Preferred stock, ending balance",
        "periodStartLabel": "Preferred stock, beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/PreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Preferred stock, ending balance (in shares)",
        "periodStartLabel": "Preferred stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Sale of redeemable convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r187",
      "r194",
      "r271",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/CollaborationAgreementRelatedPartyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "Government Obligations"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r213",
      "r354",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/ShortTermInvestmentsScheduleofavailableforsaleshortterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r97",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares outstanding \u2013 diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r96",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares outstanding \u2013 basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.shattucklabs.com/role/STATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e777-108305"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r379": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r380": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r381": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r382": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r383": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r384": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r385": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r386": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r387": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r388": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r389": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r390": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r391": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r392": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r393": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001680367-21-000057-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001680367-21-000057-xbrl.zip
M4$L#!!0    ( /6#:5/CF>U3(5H! !)H#P 1    <W1T:RTR,#(Q,#DS,"YH
M=&WLO6E7&TFV+OS]_HI\.>>]MVHM$L<\4-7<10%VTVT)&V1SX(M7C)"@@=;
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MJ61P5CGF@U1!\)".L.-@""HS3R;"#!KVKP*9UXXPIRF/#K.HO;:6H%C6A&"
MGWPSD$TZXCTF?(@E@05G,"#"M#%6IF.RB A(!6NHFAP^4YL!$[C3GJ03P9EB
M6'G/L46.6&0H.!]3.-QQWLVG^\[DY$^>!+\$:TDE$J#/"0H*4PW6EG5>4*FU
MFT=09RCB/7E N9264H8=)98AP-*YR#RA(@IJ*+)O#]"I1;RG "ZWVFJPY[3S
MP*[>2!>-Y#'BX%0ZW_SM@3L+D=O) TV<!?0B(I);5BXL!\.)\,XZ(X..;P_H
MR4=NIZ!L/:..18(#2S5$TV&KBBID-./1L'YU@3D!<\8BMV,JH.*0HQJG\IF
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M+#7U^C[!Y,\0TL9:&R.*@H$>5,*P=*H&48IKIZDU<^3HO5VRF+RK:(6@RHM
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MX;/_ M'QQ^!BMW5V_\J9\1XD]BK*<-GXL&>+-\S &THJ>%=*@<<D5E\NI,:
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MT+VO'I9?/[#Z$##RZP&&OTFN#7*!YIX0DJ?#Z7/#F,N=C,))SIFP=FEMKU>
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M0;^,AYZ5+9H?=CWMAP@ETT!'S!!B>&TB_Y$,_7M;".[$.Q\!\XD;A>C2CRF
MW@#^F):?)ZOH&9,BQK%[BI#28'\58VI6-DSUB^-F>?9^N[I>W=A>_WBW)NN3
M),R4^CXH/OJ=DTZ>(1MG (>]?Z[7:E\V_IU]7/]K;QDPV/B!P3,KG?YK_2/0
MS%:V]\^MK:?MI:,S-.6_;2<]T^I!&VE[5KATX:P+!J\99%6!13/\UFCU@*9^
M?\H(RX3ZQX98;EJ]E9IM']IYN59RU@FKPP]_@!XZJYNKU:)9=KA\Z(]!\P-1
MRQ^N.)?OZU^^%5<KJ"^R!ON]!V\>7%XI+PVW"=^Y)MD*5=^_C%;P=Z_]J%D,
M%Z7^J69_?(VQGWORAYU%*P(]>0X>V64]Q+'<V/W#T@ $C[<VP$]LNI^87%%/
MDX7#,^3ZA3V&![(]>X?[CR:MW;KH?R8_OS'^=0HA/6V.-H/K'Z9-\7)I;_1/
MJAO9*O]2NDR"[)7I<O:F];?>\!RUWY\PF<^8A1_,^_<>L<:='K5!\_A\,'KG
M0HCQCY_E]&DHV?5.)XQ88]^?H.^.=J J2]V:]'.K7O@L=?R/9TS_W\[E2]H8
M2P_'0B"Q_&=&">3QJ,#&8#NN*0EE]:<HY=ZP?PK+Z;3QBF(A*__J68??##)O
M7?J0%KW/3?V. W?7_GK2Z%$V#Y3_WR\:XNC0RNS+F1K;G\5EHNGW*:LH1<!3
M LIN*F[4Z_BE8<R__*%@B#HK883(&B8$TCBZZ+#QR&$IHOJVG8P_I"E:RGQP
M1</4._]8RH$A^H$U:.*RN]KL-7+?*FLJI3N6LJ9IA/2Z_,B8L]5$9NM-G_YL
MW=+8>G?#M-M7,*=?3;T7@,5@^D+);&6<R=.O5W:S=?Z1[)X?T$K/GVR='W[0
M)SLG7QL['_YU?-CX?%FY?E\_W/Q\?7AR6.SL'[##_:\G%5+A._M;I+)?N?I(
MJ_6#ZQ8^/#DN#O8/3RNURN7A_F=4(0?DX*0.[7R%Z]63G5K]N'KR_J125Y?5
M0C=<XWUSYP3N_0#/U]S%3NWH^N!D]_3P!-X+[Z]<NXL*/%<E<,_)*;QG]_B@
M<5G?.=EFA[5ZH[+_Y:)"OK##S=W3RLG7XPIY?UHAG\G.AVUT^.'@8F=S]WCX
M#+RK=TB^B,K)<1W&<'E86[\^K!V?5C]\OJKN;UT?[,/X-@]8__WKK/KA?:QN
MH,N/M:UN90]=?.->.8<HRDV@,F<^^%P'(G-KB.&4!2:075I3?!EI]N>[N[2Q
M-BS?]_/,,)1VSV"*<=H*"]'T1D43<@99Z9$W)##,A38QD75@VCGXEY2B"6%"
M\4(TS99HNKX13009[(G!((L\B":)3:YLM+ERQD9.":)8+JUA+I>55C,OFU[1
M2Y@/>W'ON-7NYFG#058TST.GVWC,6+R9!O*\:7A4.L^U")N(=;4^W"OROM5.
MAXC<GE^P&6SW]MO UUL(L^<(L[T1.\L0Q8U2-*?(B)QI3G/-H\L=CT3Z8(A,
M1RL2Q)=QBI>^3)C]0$R\EJ'U5 ?ZEV?KB5@F"[9^5;:^M5&LP]IS;7.P'DAR
MGUANK1 YL+0/@&-PR(&-(N4RY[//UK]\3.M3.YR9PM_LZAC)JG-WHIT_9;8\
MU:F<:_DV$;-E@--6'R;PP<K#+/HK%@N9]A,RK1@U56(P3D>3"^8,F"J4Y<H'
ME4NJC45.@Y03(-/P,DLEOF?<[?KYY:-?GI,G8JDL.'GLG'QKG<00M=#*Y9P3
ME3/@WAR L[FQ5&&A@7^Y!DY&RUBCF>?DUPZ@4#GCQDFME;:7CL$.&4S"WR]^
MOTVY-IG RD*"_:P$NQJQ1<"9LL2!!2)!%8$$(R#!I/ Y1UIR3C&5#FP1BO"R
M8"]>GWH67\Q10.579?3)A%H6C/[SC'YKJG#)*$?1Y<1(,%5(H+FB/.3<DT"T
MET1; XS.^+*@+_8ZILCH;S^;\'N1E4&]L7(OY']Z1;E++^TS["YB*5..I?21
M^50WS2XX8%M#<*IA(<^>(\]V1O-J-)8VJD!R1P+/&<4\UX'CG,KD>&%+HF%+
M:VI9O#PLO(BAS"X'3RB&LN#@<7'P2/J)DIY&QW.+I,F9-SC7R+K<&*^)" )A
M!!Q,EX'69IZ#?]44]9W!WNZ7ADK>MI#Z>3/CKAP:"=U66TVW<(F>+X!&4T9D
MM$Y$FA)%-,H9,R)7(>"<!6.1=PIYQM/1YG3FUY47Z2)3," 6O#EVWAS)^_!<
MA"!T'KU1.5,">),HE@L#4$0I+>8^A2O&%:J8<=/@!P;,G"RK/&XCO'S_X!O>
M.?#$P;\943S!=:.%8'Z&8*[4UI-0[AM.Z]^B<D"=QN;21)S,)I\KY65.C>!.
MQTBBQR":,5KF8ES;!F9CR>B%FYT6PNP7$F837!M;"+/G"K.K&V&FE6%<I0P\
MKL'.9(KG5DB<:\$Y91&T#4;)SE3+6LVS,!M3<9-7+0XP,B\4!N];O506ZN7U
M+&:NBV]_C?+QBB<?BWX-_F$YU;UNRYT>M^HPI9U!K=XLQ=:[5R^IBC(KM4\6
M%4Z>7.&D?DL8BS(GO]B6D'7GRA*"V9FY2CNJ%M5-?I$2 I-Q]P?4]:E/7(LT
MLI^QF#^/NO_<6V(T)KED"BQF3G5NA')Y("@&00C!JERV)6\Q\6(AC-ZH,)J,
MN[X01F,11B/N.V-&4B%SR[S/F>4DUP[)7#'L0+48:P*X[WA9\MDOKO3+%S !
M]FCWPNWFX$5"R51,ITZW>[HZP&+$8T]Y;XVS>NLJA-UT\L&=BPM1]C.B[,N=
M916+*.)<YQ)[E+,H3 X*2>34P<^"(LM=$F5T6:I%0LH;YNU7M406O#U!WKXU
M4S *B@@J<Z,1F"F"NUP%ZG(>#3>:\8@Q^$QRF7(R\ZS]RP>L-H?'C[73846]
M!P&K17+^9.O7MOHG=.\7W>.-7@<F)K2'TNMJ(;M^1G8=C-HEX$EI8JW+O;<X
MV24J-XY8\+@<I1I%QBU>6B/+"KW!>,^"ER=;\'7!RZ_ R[=V2.2,@A\1<TH5
M^!@\^-PPQ'.FE$166XQB3':()(MZKW.25^L>+J$N:I;,J*FR<*I>*,S<J&$B
MA,?>@&$B/59@F$2:V^!DSCFB&EO%,5)+:U@O*\KGN*#!HG+)O%HS"W9_.;O?
MVB[2VDBB$;E17*1,39TK;T-NM'1,1QJT SL "V#W>2Y4]/9S Y\652DKEZ23
MHH<&3CKF&J!<1%MF-]JRV/CXDX+NZ-:NJ;G+RLF7;U@C[$5@N22$YDPHG-O(
M0-H1CRQ%,D1,TM[D92+ES+MJB[#+;!LJ"Z9^)::^NLO4D1EEL,5YB#[MG.,J
MMS@$X&SA%-'.6YF8&B]3)&:>J7_5G/410Z7Y<Z75?HEE[(E8(T,L=@&*#?A;
M=!?2:@PF2 57:^Y;()S8:&0NA+4YHRB=7&A)3KQ0 5.P2U)Q:[),7E[;>I&/
M,KN,/*X"*0M>?17+HL^KWD>NC JY(H[EC("G8(FF.;4&"<\=9@$OK6GU8E]A
M[M-+YF19YZ7+.2\O.3#70FO2RSD+ ?8< 79RIYX(9HI+ZG!.E/4Y0ZG4$])@
M=D1/$<68<HN6UIA>9NC%V7'S5$YDP><S$AY9\/D+^/QV <>CP VE)F>&"N!S
MKW.;TF&#0(Y@(XU-Y1:I7L9D7"'-N5W F<.XR$:KT2CZ9PZ7Q1T2GT+?0].E
M<@^_55O=D/'?Q[F[_W7,@<M.L=HLZO]8ZK;3X>+W(Z4W@TP'DX\.<2$0GB 0
MMD85OV,AR@ 20%IA<\8<!?<EJ!S1R((46@9I$@?=$P4S4]7A==34@OY>E_Y&
M%%+@+@AG00UAG#/L8ZZ9"3E2$G,O8R"1/)/^?M75^\<J^82RDL_/U7-9E/)Y
MB?KWQ?FP[4$3>;I_E=S$/HJF!QFRFNMR.-,R%UKIK4 XR]E__TB8?@KMO6/3
M#F/Q\;>K[Q\3JJUF2<*?3'NGO==-.^"^FGHOW+YZ8/>CA9A]@IBM="O#LUHV
M-#K\GV/D&E^;9E_W=AJ')P?76QQ$,:M>'UP>U#ZCG0\'K$J^0+N[1;7QF1Y<
M?VT<[A]<_ _<]XU1 :8 =[FA*3H@0%);9GD>"5)"(1RE43_6Q=\AGY]S'1?D
M,U_D$S4E(C*7,V<H>)XJYLI%DPYL99@*S2S#2VMH!83=P^U+#W[(SDP[.T_(
MKF;?);E.0KPS/FI[5B+'#2F6=-=9[W6/6VT0RWY!@E,AP<KU-RU<.M(FI!1U
M,#,%4)^B&N4F>D\42#3)W \DV*/D] +=MR"G^28G@Q$ #[Z*,JEB;2 B-U+P
MG#"M&;$$*Y_": BE@Y,>/3SIH5CKTUAF;N#]XYGB;4KTN-WI]!:T."5:_(*_
M22XH3KMOB)(D9]JR7/F@<ZTP!C4;)!)X3D3;3J_;Z9IF<I86]#0M>@J>,>,<
M!XE&8LXDCD!*'N<8!ZUY))Q$MK3&R#(8;\M 9$\7;44I*<K =.L6Z<QTL[UP
MU@T-&]K])0:*EK-$8.6M<V'C+83@%(GVX.I;X(P()5$.\@E<C*!4;I2,N8\4
M*_B_B9P"T>)E*?4R?J1XTR,T.A>$MQ"9TZ:^TXMO) 5(0DR6H&+@8H >5MJ8
M7$>AG9*<6JGZU"?D,J,/1>:0^NZ)Q<W@1J4B+J4BN@GF^N)\D2SY>B<]CO!:
M&4A:Y!T\E[]&"^LY'HUP.0G1Y2G@DRN.?2ZUT5%&(J.S2VOCVB*^R&&>0;8<
M5P[S@BU?RI8CJZ]4&6,"SZE*]2Z)$[GES.02"XR9\XQ0,@]L^<O7PUN'/B=D
M3#T[,X7/BV;FS%G1-?7%7NWIGGUP \PGP&6[N=%'92&TGB6T[AQ^0+V7C(*\
MPBP%*!B-N364YAS+M%W;&RU2\%7)93VV9.4Y34E^VPP\F?,"%@P\'@8>J8 7
M5%04L=S(('.F9,@U92(W%#/!#+4BT,3 9!G FWD&7AP9X%ROT2LK5F>M= ([
M#+EQU@['H=DISD-6;W5^M6,$?IN(&=*!<<*GYQY_,@1K)V&U,0K5=A.0"Q\!
MKVKH[L2:N5R(N6>)N3N'"1B.@W0,YT9I#\Z5$;F2&.4>":NX-(&:F,Y%48]L
MM7B0H[\(><PC;_^\A7+#VPOVG2C[WEHI1&D4"6>Y5B:M@UJ<:VQ%3H/DP8OH
MJ/9+:^+A4M(,\>XB+C)BF_@0"U?\7+F8^?6G9M<4V0U= ]WU6Z;=A$GMC&"U
MV8=J(;Z>);[N'!D02(S$,9=[(G#.N'(@R$3(G<8":\,U2N(+$[:L\<-:G4^7
M88L R0PS]!CLCP5#3Y6A1Z,F-G+A><X0"3E3V.6*I  H(98QCHA!?&E-DF60
MS[/,SXLS \KB,IWO[M9;'!TPHVLYHQLLMTJH%O+L6?+LSM$!40H3N20YUAJD
MF#<Z-Y; ?XPD5E*+# ;Y ,;+,A8OKL0YQ6+BB[,#YG7I9\'O+^?W6_O%<D2)
MCB[GCK'$[RC7UIN<!^>9YRYJIM*>&;VLQ(M/,9LBOR^*Y]TOGE=F4S_=WGEB
M0:'^&%<I3(MO]6P]](%]@42<N9G\[ZE,S9M1$I,N0+C>] N5\4*5<70GTT<[
MXP"U/%HL<^:\R#61\#4@(P21VJ7B1!2C92[&=5C>.%AHR@&PA0!="-#YL;(7
M G3< G0D9DBCM$'S7&LG<F8URZTD)A5[,XIBK"5U($"96M;J[0K0[UKD[[H&
M.C;<2352L:EAVD=%L^SE/6O;!>"/]K0J?(60&9>RJTSS*NT1:[:ZT'JW!4QL
M>KY(JYQ%ZE_12(SL0[,#O\2B:9JN*&..IAO*PG5W]Y"-C'SP/LZ@0V>M3IGZ
MN-H.==,MSL,?%X7O'D-O2SDR\M0 ;'3[B+$ ;:_[_4=F94[QO>UT(_]-O2TE
M#H_*FN@QQ<$S&H75487@J-/:" QR$.NEX4/'[=NR7T<AM^U@3G,388"KIGYA
MKCI+[^Z2&M#9H$.20(^?.U]K?]HVM/C((!ZG9TRF0M#R<8+^YWJM]F7CW]G'
M];_VEK/MZL9*]EW2G)E.U]9K6Y6M:FTOVWF?[7S:VEVO;>]4][+UZF:VL5/Y
MM+OUSZWJWO;7K>SCSM[>[ _HMR]#Z?'[]SL[0D)TABCHM^UFUCUN]: -WUG.
MPJ4+2:VD[;1EV.$LM(??&J"LNIU'A@AZ(^F!6V%6JB@80=V<=<+J\,,?0SU2
M-,M^E _],9B7@03D9P\T5#E3_<NWS)UJ724&'\2$!F\>7%XI+]W3M_UKC*P(
M_OW+: 7_Y#7&?N[)'W46DQ6P#N>GLT*1^>GL7,TLN E/:O9OXJ0S48U5/<FL
M>-QV_L&8OKL*I)\R_+X,GLX$/"Z8:\=ML%8K<-]Q)]L"6]3?5GG)*%K^A:>F
M"K\\=686'/'#T-A3O<G9)H@4AGY*B>:_'>TO-65H04L+6GH56OH5JL7?>2DT
MXO+B,C\NO _-U:F%6'?V!B'6QA8_V-]"E<TOZ+#QY>JPM@OW?V8[FU]H:K]Z
MO7Y=J;D+^/WT-L1:;>QL'A>5ZP-<V:S7#VN?T0'YPJNU]0MX5Z/R8?NB\N'S
M]0'Y6CP(L9(#MO-A&WKSY6)G_VN]NKE[<E@[A7;66:KR='"R?G&X63TYW/]7
MK!3HH@RO[J&+;Q$;9Q'GN;1*Y,PAE&LM/4#F@B'&(2EBJK,.'B0PBRD#[NUP
M'IJ]D.59&5<#]7]FVB/+X.,OU?_$D.TOO>3SRRSJR&@UTE)B%S CEEE-O):1
M8NPU$]1]VRQ7Q27"^1B6QW?[Q/Z^W6H\=L+YUJ6K]](DKW<Z ?[UL[1I;4ZD
MT=6-- (@';+(Y)):D$;>QMPF:>0,]P1[SQ!':<>I?J0@\?P<[K40?POQ]_/B
M+Q6?\%J9X$1DA&(K--5"*& 1Y1BBI?A#0_&'%N)OUL4?NA%_2AA.5)"Y-4;F
M3"J4*XMMKK 1TG,%0/-T6#JC+ZYHMA!_"_$W.Z-^SI9 P510A$4OA6%$&!N"
M$"(&IAD67ON!^8=_8/Y]IS;!0M:]NJPC-[+.&6&YBB1'.)U 04W(#0\AMP(Y
M&[10@8/C^4@B_;-W BYDW$+&S<"HGR'B?'0.16:D3CMC5;0<1XTMBL1P'6@8
MF'AX8>+-B=AC-V)/!JHT9RH567<YX]3D%@>4<V:XU4YHS<G2FEKF>CZ.J?\5
M#J7>.0LI\MD\RL+E64I)[/S<>:2O>(KPHHT9;N.7*EBT&SK!M-UQF;SF0;74
M6V<I8_=53_!]FX529C@FWL=XO>DW;Q'>Z@O'A6WP#-N@NC$2_;96&J>XR\'>
M0V ;B)CK(%3N'4/&>2&CPTMKF"]C^K#@XJQ5E5TP\]Q$>!?,/#9FOHWE$JF4
M#APHEW*:,R)];A "NU]2I#@R'*%4O@PO*_2P>MF"F=\,,X\A7+E@YNDP\VVP
MDAO$C(\,?/5T.I\(,C?>X)PI8BGUFE.2SD=#RY2_N-+/@IEGEYDG'9A;,//8
MF/DV!)? 8HJ+7&&G<P9N4FY9.@J;R"2E8R#"+:T1N2ST+#'S+W4DPX?0#&U3
M+X,(_X^]=VUJ*TG6A?^*@G?'&S,1*N^Z7[IW$$';= ]S&G ;W'/<7QQ955E&
M;I#8DK"-?_VI); 1-QLA&9903LQX!)(6:]53^53>$_)1K]\;C8>3$MX?ZGE[
MF@W?6^M'.$>Y\MO&)8R)XNY!<7N7/ FFVA>^Z?JND&D=%?,1(N,&0]'6(#2)
M)+JK]/5.JVT;C4?2O"2.!)+FA4KSA2LA^.),55$8UR8QC4&Q@*:P$$06 76I
MJ$[2PMS<6;$DS>V5YH?U)) T+U2:+WP)RN?H06FF5?,/IF:,G,PL<*<XS]+D
MIFVPT%T>YNYH1.+<7G%^6%\"B?-"Q?G"FY"BM=R(P+Q.LE&U@84BFY*5*")D
MIWU,:^NFZ\6B>H _BC-AF?OYGN_Q3AD.CCJ#LV2>0?_VD8X/Y"I=U=;G#^MC
M^)J\=;X+1D1ULU#=='6>*%ZC<I'YNI>J^F*K'2)-8%BDY;+I9FM<U5Q"5_N5
M*L\CH6^;*X*$?DZAG\IC$+'(:+$NM39,VR!8T-DSCH&7'+.1VDW,%>D6E<=
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M<-\^&N!;P>QO\S %MN_,PY>Z14KDVF;NF++2,.U$9!# ,EY4\"DJC$4O;#0
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M_J<W/GA^,JIKAL,OO-6:CM%+PEK;TZI(SI@Y-YQEXSG3$*HJ(F1B"7*,$:(
M#@UK<4WYOD]8OA];%2'Y7JA\7V@E,7)T,3D&/C79_#DPSZ-G/N<HW/]C[TV;
MXLB5MN&_TN&XGXB9B!:G5*5:-/.\CF ,]LUY!O""SX3Y0FB%PKV=ZFYC^/5O
MIE1;;RPVV-VX[\4#=%>52DI=N2CS2F$R:^2+EW$W2[^[.]LV"O+=5LE@L@V!
MK FWWW@R^;P$J*K%>@]K]0K^FV\/>Q\(3^_:YD<<*  @ TN69!%AC$HB64()
M"U1F;!KQ1&.SW6X4+)[W;B,ASV9O/^;1RW;[/O7V;>5JT%C:U$C"PEB =<%3
MDLD8*X\2$8HLL9%&[V&=]NYC!CQ8LN:FQ=$*\KL9ANSOB7I\1]NP]0.LS6 :
M1M+SM\7P2PZ>^U_7'V%A#P9-^EF]JEM8>Q"L?9RQ2F@@36PRH@*MP"HQ*>$J
M-82J)*:4)4S9Z,7+*.M&_!&*4]:CN^ CADI^65#X>6R_6U!X(E!HV3I9&EO-
M$B( Z0E+PH1P&:0DM2(0DC(1<@ %RKL)7<P36S-0*(V@:A2EP'/?BFGMFUBL
M_P@?R<A<:]MROOF*)\AYC.8K]U5%/_,>OQ31]MMIH2[ ?T9*I%&!/L3DVE6T
MF_].\U'_UPM;KF\9^UMQ[3BJ3H:["A:G,&_+]7K;$X/)[D#O5TNVM04>9 N<
MSS@(-I)!QCF)8ZQM36A,LIAG)#:2R9@S)GF&IRH\^AY38!NQ7.-M_>B59=N=
M^W0[M['B-<BFHC(A21*%A&FIP8J7@F@9RXA3&W&+S;'#-=FWOU2_-B0"<V8%
M*+N2)VQ+PKCNN5J 4B#N>OP:? !<0 "J0[]\U\=VGN:M(8#;8MB#,.QSV_K(
M=!*G1C$BHD@!AJ41$3:)2"9X0 4HH]"F>.K"NOS[R]NW65OKN]-_;-;6=J?_
MH)U^W=KI.DZ8CDDJD3E'"0K62LP(#3)85 /@;NF+EQ'MAL\V?6OMK98J./+8
MMLJOX4;]Y.C(:MA"OMHM=#T$NBYGZ7=$)A(N.*$4>>\SFA&N!4"72K.(IE*(
MQ("1DL3=(%L3+H]MD&0-@R3;W;T^N[LQ3"B-P/R(+$E3FA!&,TUX8!0)!3<<
M/9(X2S  &J>+?2TV/I"R.6E?OY5Y7[_CL8U+#NC(ZZ4G==LDL(U/ CNHEG6;
M[_&-$#=#"I31T-@@,R0(&$!<9C@186*)C*4*5"JY29&'+%E:&K=F^1[;)+!G
M&I/90L'304%C[42!R;@),I+%5  4A(S(*-9$ISK)$JHIB^2+EV'<I<EC481M
M\[^V^5_K;63.YW_9?" &:IO_]0Q#G/M?3:%RG_\UG@S5Y\YPA-CFVYKL?WC[
MMC.JHJ"_6*QS?4.=K=.:@_%X"GO3'%O7W7O\<0!@=@!_&,!&Q7.<Y4V_,?%D
M#%_K37%5/N#"'_MUWQH3#S(F6B6O)X?T\.;=64"QQ9Y(212#6<&L2(B(L6.O
MTD&4)"GED>,E3)9T/]G6O3X;2'C\)++MKE^G77\]N^O#2"54*$D"H2CV/))$
M\(@1P/^$"TLS0[$SWY*&*,^C7G;M#9WJ! $5+9@TLI<KL'DLW S,6C4<;]/.
M?IAY8_.O1I,;4PQ7'?, KB$X53#W"I=G"U'?:ICLG@D31PDH(J)2#C:)%@&1
M&JP3;H/4B%BIU- 7@$192,,_URC;9)M6]CR.;;?[^3%-CMTS;6466QX12H.(
ML%A;(AGV 0YA(5BJDT0IUV$Q?H;<Y^MO:I26N@^>32Y,9XSI[T/;^0 WA.?\
MU2F,-J:/^0NX/=W@\>=141&&N5A,MS,P$[PN+S?.=Q@JOX3394'\D\3(,%$1
M2[01FK$D8TQ'.@AYPA[/4%GJC+VO5_55LZAOJS5U$+A%O0>AW@QW1T*-C,.,
M$K!% \(X#PD/@I!D6FG#0RZE9(]FQ6QC*^N[S;E-@M!28;@)P9A50O, G&R&
MV][&Z1,FQV_W^I/N]1;E>AA'2*M.1!)3PJB!GX(H(TIJ;J,@%M:(%R\CUF7)
M.C52^+5"*G?:.83^!$MG<QVY!T"@L)QQ&48V##2S:2CCA 41P!_HP(@ROK5T
M-@S]/LW&:X2@:6P)"ZTF3"2&\-2$)$TRJL,X32PVN-W&:Y[]-F?6"A5(J9,0
M(Z]91C,;J9"Q" R>E-&MI;.A>[UEZ?! 6JT"$L1X<F29 J]&!_ /IY(&X,]2
M^N)E%G:3[R=;7=.(SN9DW;=S[9=E17U/:.973:O]L<DS*])J7U>+N4VK_490
MFV%1"K(T"XV11)@XP=Z[EO"$)B2+;1;(6&OIV*,?,0EF/;+L'S&$\ZO"P5ID
MV6_AX!'@H-6K-S0TUB8@*4=2M4!Q NXK+B!C/&,JL1+/JVC2#:)T(P#A5T@#
M1ZLG+_LL='[39:>%WY%LWAE#F"'L?D"NR"^P-[Z3N^E9(=X&%!LB\.'_[S?+
M]]Z,)T6N)D;C![L#/?N'UC??PK0,]6(;CC*Y</^KNA"#<_->3,R^M49M:[(?
MAI\SM%"*AE38T)!,Q9RP" FJ4Z/!G-))' 0ICR,PI]*PFP7;@L5G#BQK:TIM
MX62]X:0QQ[#V67&>$!%F(6&6:B*XQ)!38+4.$JDU!W,LI-TX^VYS[$=6/7YO
M-&JMS;%7JVRN;D>:\WPPP% 4TGB[K;1-$EJ%BH$2@4QUH$5H&(TQ/9^;, 5K
M2RGXO_#L ,&0AA']66"XQ;:'8-O-##F55E09CD57,L-4Y\"2+-$!T3+, A5'
MH36(;7':S?@B@<TV2>C9;'.N);A52>:,'P4_2RHDN%814R*468K;G/+M-M^D
M;=Z8,(Q+PZ(X((PQ 1Y1; B/HH!8FP"2RSBF00(>43=XCAT*-]5,,?#7E0;*
M$SIQ:S='__-$+_]LP!MSF60*&R^0@B5)P*E55E&A T73Q&;.1OO>H\ M>/\X
M\)[AWV*)8MQ:0722H(W&0R)C\$0U#8PT/%-AC"D/<3?@WUTONTDQK2T$;B&P
MAL"4Z4B(S&:P&5@<<1DH;GD8V2"C7&GIW=0M!&X2!+;HWTV$%;@Q$;$)"8M#
M"?9K$!,N@BP+ A&9"%M.AEDW"1Z+__UG$(]1M@;,8Q&\DAY.,>]\7:G'[C7$
M7\%]^# =C7H&JX9%KZ/SL>H-Q]/"4_##%B#.JRA3[^ ;6T*R9U8\^W%0&!C&
MC=$=6'E8]L$].R]\=[1K[:;B_B;2LE=<;T-H ](CCB<7ID#ZI,)<F,$X_X+'
MD<-^0ST/]QK/4,_OZLNIE\XC,SFV)^+K6Y!<>+O="5A0<CK!JTZ&;T6Q;?7W
M4.MIAL\DC;)0<B:(D<A1;S-+X =&THS*4// !%)B>FF:?$\ZQ/I%][<8]UPQ
M[A%2-6J,V\+86L-8ZQ C9&&F8D-HF 38:Y@2F42<A,:D*;?,9)EZ\7)=,.R7
MJFW>5:J8@@VZE"D.,V"'N*TZ8CPV#S!%%QWQ57[?<T3P![[]>H/[.M'GC2>3
MSW\L,FP!SD^Q1'-OBJ)[-!R@[WQ2P$O[,6^A^T'0W>*B.7EW?19P34-.(Q)2
M(0AC84I$'%C"HR35DD4Z5/%CUVC?<^MLSC'&%OZ>/_P]&A/R%N9^$,PUW,;L
M+ L#G<0\!:,T U<[ *S+XB@F &\BC VG*HU>O&3\L;I1/S'$_6*QU)'(=4?T
MX87 :BU,3TS IIT,FYX.+A^G&(Y@U-<N:P<3=D;H^WUCO9U_X86U^T4Q_U'G
MYMEHA$<PB.>/L4?Y1/3VOX[,0.<3/"^JM,)?T\G1</+)3-["5MBJ@@>I@A8G
MT<E!?'3R^2Q246:IB D5$1B]TH9$6&-($!L52ZZ-X?S%RV0)[>QW%?%^W\99
M\Z#M%CBWP/ES"OI6L[YM ?6I /6Z!:B7'\]"(5-.PY2D+#%@7F>"R"3,2*RT
MS&C (A4^'C/_.H"J,\#_Y8X0X+\Z__+R_\(_U9A;]\)F-J8H]^3+_RN+?[VL
M7_2^E_WPY!5C.D*I81^>?8WAXL%P G<'@WLZ$%/82*YE,XPO[^/&UF: 39R;
M;);Q! STV>R&^5<MGY? VOPY&HYSE(,_G&6??S%_7N5Z<@&C=;C2NJI<ZZ"Y
M1,CQL#>=K+YD7>8TGIV*]K\X6H<ZL<VDL!H[EVL6V41RFQFC(L6Y2*@*S\+L
M177119VB-A+GALC"B,]@Q, +_B%Z5^)Z_.)?,_/0SP?5@-(01OS0^5HFNFL@
MP.ER ?[?W9.3CZ_^7^?OW;\^=#L'1Z]V.FNTZY8/^NCX9/]#Y^2X<_*_^YV/
M1[L?]PY.]O=@\"?[[P\..Z\/CG:/7AWL_MWY<+)[LG^X?W3R8?&=[B='$7VQ
M9"+ZHC@'*4'(3)SI]S-F@<)*>?5P-.W#+=0C^%QS7$D"#8%C>SPRA2C;AOU,
MI7]S6"O]77J\MTM/3][%AY<'\:?+=\'1/Q_A9U#:>^=7AR>O+T"IWYR>G'\%
M!=XS__O^^O0?/9(A2P[WP"#8^T_O:._S]>%E+S_:>P?W^7P-2OL*[OGU\)]]
M4.I'O>.]UZ# 57ST[BQ5EH8@(X2'L2;,1(J(+,U(E(2Q8EB\($-ON.6#J=&[
M:&U1*U)F9!12 TH]MD)J&>LTBICD<1;*%QT#EM0(=U4Q-2]>'A?G8I#?N&EV
M<9D]^+S(7;<VC-G\-1V#!(S'G<HF*!=]#FC@LW(<_DYNN>X<RRW"[;5]CJIK
M\D>8_@!I7Z%I+\1D,E6?.W^#(@.@&JB=SF](08VF4AC\^<KK8/<;_?/WSI7
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MGV76"$YMQ=0#V.GLWNY@NC^NC^EZ)^2]],M23>&\^=:(;7T@5WZSS!;Y[U3
M_BC*A!%:'6!XD[)*/U@X#UD0U!F-+44/)0,, F,F5;A@O$SM8I'C$6RV3C:7
MHE8_ZZ'%CM4V UGLC<V5/P\>^$/I=_Y=0< 7[8=WSGZPT\(=$+7.8'9^I&GP
M&@SQ_\#&-8=&H.&&K[0-6U9AR]TSF8&_IM.0)+&("$M%# 8#CTB0A4;$- XI
MC9^%%8""T'&2@#NS<=8/!F-XJ\I;WRC#P+W2%_=*L!?1D1N@-AI[Z"]R529J
M7#5>A#+@:97GV@ZSA*\9P81V9,O$4UU'2U1_8X)<7=;CF0#=5:4,N.-7G\2
MCF[#Z 4/FEQAQ-,G*[DT!9?H[ P#;TSTF\W8T57*4*6S? 04M7/1Z0_!AQ?Z
M"UP,&F@X'5=W];X)FBC5L.NA[71:$]-ZDE?+KHP&;!"<J4'MTGD4'];%*:UT
M)/!.S;E+(/CCVW+_(KH3SPD-X4\@-/>IB?)L!6'R$\N;9B>'[3B0^!L-KS*?
M[X_.L<0$#1?:R >CZ:3)H?GO=(B:RPFW,X1<<9.I$^-<  *GV">^.0+8,JJ
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MM--B,]VT\/*'Y=D6K</3F8.\CSL?=CHGA4MANFZ?Z#DO=M9Y[0]=>IJH HB
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M=PS&=\P%B1(5FT@&.E7I0I)*)()(9H&B+&+:BLRF,4VI$$R9* OYL]";I?2
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M^,GRTY5Y^K'KFEJR-19$(/P%*\XGIC_V))6N/73S9NV6T0LN]T*4H]R+,V<
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MXUCLV:L/"1Y48N)$T31AW I)TQ1@QB0!XS2EP=8LWG0@: XO\'A+&PI $,<
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M2?+S-.=K(PNW&4#%):7F!$4XIP!]1 6_0H)PW1K/_&T$^A&K^\RL<^>9;Y7
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M8"A[AJDH:PU#;&L+;08,O1Y.BRT*/1B%VCFK-A)4T" BH=8<4"AEA"=!1@0
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M;ZL/VI8)!.KWA.,W,BS]:I_[5W9M494OKT'!,K.DU/#DKB[(F%13DE:E68L
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M)2]>6VXO</Q;N Q="F'G7(8E8M0Y#7<G8K738',O">+(T).$&;H3IX[.HC"
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M!D@4V<!S%.=HTY+4KO;;@,47^N?X/!_4$!%CT.?X\3!/^$"[.L]@Y F[@ =
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M1P3T#$#?@+*HF!)#@DG9<K$[M7!/:N$C*.ABE7?VX>-)CTCQ6PZ2ALK],"N
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M?WSY=IP>??O#/ 9G'G;7-L&R)H8?@@MO^L#";J3[/#%C#V^LN*%0?\![/#E
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MZJW*JZW2)OD9)T@V2O7A]Z<C-H6OT8$0[@UF=)<7P8R22IA&.2:PP#IP1GJ
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M@4CBD@%,GF0@U_-1++2#LLUD8,#=&.1DGH&3Z4@5KRZ@1)&::+#QC4"C35M
M(S^XFW^-"0"-\E%2[$U%L1NM<*?"F,^_ZZ9OF:ZS9R8.)6F +MN"&/6T:DT]
MLB<1YR--A [$ZDT)6R'^E*@X=/Q?/G_X]/%__BMTW%^;*H$R,#*C!H-@,B87
M]A;\K$R?3(=8<R-L#];RYNH:!M[P40I$OL.8TR18$3*>"%3P*!^46)C'1O.C
M[5MAIO1(I+H8S"AN!;*1$;S*5Y2OE12]5>04E1OB DM6MNC(!6HSEQW74CZ9
M];0Q*+TAB]%3YZ@PZ[\DLQ&L,I8JO:99U7U,U,^(UZ)&' /[4!A&5I\EEUAZ
MD_3(CF2CZ9 2:B6YV>!OP=Q'R) 0TU&M975O2Y17,L%@MG<O)M#K._XMC+?=
M=X)UQGMR_JB&FXE(:,CYI!'D?,[!F@'9D%T^D/$2AI((^88(T0-#B-_.,=1.
M*BL,&H,)Y\IT:RJK2S[$:GC59Z$,,\[/\T)=PB)4[[Q^Z9J:38H-EW,[^:<B
MF"=%(>>*9CX3RJLQ6QI'%7^N>W?['8WP.:>K!(-4EOU:]'HJC$4OF+9G@J5.
M<K*_S8\D18ZBX*:HB.)C5A?M#C)@-2 ]3#__GA?3"&. 1:%JRTV;!*UY[J?J
M VV6-[4>4S18S@PKM[>]:?%4&B^M_'?*AOA#3/X>*V"38?)4#OKF\YLW],,Y
M6DS4>2.P96N_\G^/Z3OX[-52KEP4H&NJE8EC6TSX)&A+R3:R09*X>+?Q/"N2
MA5+L1[17,:;?AC.(Y;,$W*;I!1]F@LX'1[\+*I_#LGBA8TI2/)G,L/DBQK(0
M/X\2H# F&Y$U/NE'AY])7=2++R?39-:> \/<*7A<G%+$9V=TQWN>09JJ"Z?1
MU!Y2,@Y^F=<]9%1IYE?7S&%!&;$?+ ;&3?!6%K[ODL->Y_& ?>_)W*E<'_UV
M^M&U\<XVVO55[UO)LL^OZL][N*J_#6K['BF5>$V<=1U7KO("ENE;K%O>V+SO
MGVHED]G2KU1/TM*?XI F*:9GK5W%'LS%!*L=,CX71="94=O7J$][1"\H4JXW
MS%_L6G0O[@#L&?%/1*)S26 OEG.KP/[CH6[^ O_\;K8"^59V#Y\[^?\@.%?A
M.(DE^G%MOTS>L"!KM\*16QD]MIB-7C^8#<?GL'M=T+@O0:-CKP@:06FMC!FK
M.R>+X=\R;;>!6[W^%F!U#[@92>*IZ@"/=P3K;1YW7C^;N[=)NZMAL<701WF8
ML&=*%N\Q2Q)3"QK0N7-GA+BXQ6.*GCB2QL_4*0H0'>.'P4R>P155Y @* Z_W
M@WI,.!]KXVQ,*@$Y8 RZ57'*_(G#XEN% @:9B+,Q:FAYN9%"Z5&35V%BNCHU
M6QB&A'WIE>#5,:GV.]6IZ=CAAA3"D,U$TZ:VC&0EU6HS+-E6)2HTO>DDE^E;
M^0Q\?(4-;G"PYC'HRO/5:J=+\?(B1Y 484F04J !+K&2;MUIS,:'V+LK;.\/
M#G]_>[S/\H9VL6YFAC0O)PB-!BR/'9N $0H4//P -3+H57ER@(8!0FE1J8%G
MP!S+HJDU0#9(E JGU X=:=<,$_$9ZMUYF54LN.9,?QVK+3W"1O&,\H1*F*YX
MRV'/J(,G.4KH9PD7B";UG@V'3#ODX*UII]H;3$6]'9TQK RMYWHQRJ]&6&0@
M6."&S+S#9XN[7!FY/L3(%"'QA[&ZH6X9ID=,0 47H&AS M:91G1((FJ*J%^9
M*' J> G_P8(PK#X2:EFH=M'$@HNDJ7C-,DD0#<YZS0PKC,FIC1_=EVFH>IDU
M(S:MU30=;D\8E74U31-F>3"(5 5X2^QAXZ7S!UCR6T.ZC:P<_V5C "&F6*$U
M+=1"EUK>XHR-LA]J:V STU0]+VMXL)2N!#+AO: !.'/JV8)E5"H0LS%R*-G3
M)*?J%*(1E?^(5Y:B(N92MA1!!*/*H-.S^*4S/D*6I7*"6=UB!9U$-7/\8EF7
MW6 =#Q>:J%'=RJJ>?&DVH-I9BNLW*J-3CBTU6N+4WH&Z6]7E,A\^GN!8C3L1
M,-1/%FH"U2:GUX)I*C@X*D-YA7Q$$0W^#!PAV\2)&G?<E[E!3=?JAZTKPKT%
MS*CFD*)6=ME 1M]MC2/$0'6HJ7H&-!M'"@9HWNYG2QMG+GE=8/6-UNLVUZX[
MHH/>W:+7%FY<=8T66W3^!&0,%K?_)\OI>W/4;?;IJMD<A8-2$[#+:2:1CC*1
MPY,:LJ=PP)H="MM3E,I3W.B)94L.3*#S%%Q@*L?[R80YA<NF&AI]J_UWS#IB
M%T+*L>,/V'KD$GA>58F7&)N2CRMMM:SH7EAC'2FV[7N,S@Q6R6%)$79S%*!E
MJB29;C*2JA*B#S\-*#90GO<("[3Q_<VW*$>(!J+&C-6=R+8MH:QJNUD0Z1D9
M&#=5/A6TO[J9!V'/<[T>W@/7;]96E8J%O4>LHVMOC=,/<"N:3*'</*KH;)A4
M8L)E09BTEG-AZ#)#6*=S<; J$_=K1];[(6M5$+#,-6K1LU&YTXB.EU0[4H6B
M#*<1\G.2I;,J#*<&N!TU[XF:,E1L>6)X1%U?ZL&/A]45'EE!76YZ;^TQZ+&9
MJ[!C]'!%0%H9-2!&B69L(*UF6C!58B[OSXR%%SQ=GL;JM:.>=E#!TQ3SSVND
MZL&.K)?YD;MP@NWOP0EV)US;"9?(D.'MK4:63&02]/,<+T!1V%B6[23!@OA
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MQB:(EZ* PY6Q1"XM9R4>E<#<L!][(5I$CR9%/H"]O>1--J[WCWKM,=$*Z[-
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M'7%5Z(%I&A"7J*$+$DK$SLNC;#](W7AA+B,2O+;<92.:5;-.@WK))HWC/YK
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M$"[P;X<+@RE@,$J<";5_SDJEI#;>9:*I0 A29N*E%L1)*U+4+@E>T[KM/]P
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MKU3XP,!IRP4GFDEDGU4)0\@<"$V,<F$PIJRTWW-'X<,J]3UPBE;XX-,I^FG
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M\6I[X$U1YZJ!&U9O@[Y=\4+/H^6>U.*DP1*8D2%H2AT13I>7*]N(Z3W&!N"
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M<P:?83B%&:[A9(2#_F=_<O%B.IXTES Z_1('T])'^60\!OP/_:XO/8Z& N7
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M2(8$IS,QWJB4(6MOZ]PYO!_7[HV:JFIMJNFDZTHU+Z:7T\&L>59&$WWRXJ*
MPQD48PDR]8<?3\>3_B5N\;,L9J-5%I239)B9-V*+:*Q)[R53-@K\:Z5XVGK?
M>_P&4&UE='BVO";4J[L2*X"]VRC:FD%[.:>IK<_->+.%,KJ.TZ\-FG(OE8M
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MN_3 ?$<7:7VIG^=!XL)&D:.!HDW/:" YX,)&611.U:D@6^LB;3N!VEL5%\T
M"?WN]R&,QA?]3^_18L6IXC]"#SAPG0PGPB51^G(Z$J22!'"ZZL1QV$FMM&S=
M_ST'>&ME'77?6)(ZE&B-NJ8;N1B"YZ@HHC2AE#I0$HCSFI'LF.<&?PJI3J[.
MCWUS91,.[4Y1^[ZYDJ#?>P,?_> 4S8)YIA//,@;! J%<<B(9H"_+<R;>*:8H
MU5'*^RYCCR'^\6/S^1D^>L8Q_*&E5DNJ.[[PQ_+TU])NTXV4.[2C"Y09BJMX
M^0HX5G#:'];Z]6_=K1.^M?B;#F574Y?>:,VUP'U-A42*+8?6>P2BC%4V2^M%
MOB^@=P@Z7.(#5U/A.B*K>IU#,U6JN%*2;-LZA..Z CJ2F-$+\]2'I,-*5MY^
MKG-L)]BE-S;6D<JZSN'\Y?)'\&/XRQ_^/U!+ P04    " #U@VE3=5*3";^&
M  #ZTP4 %0   '-T=&LM,C R,3 Y,S!?;&%B+GAM;-R]>X_<.)8O^/_]%-J>
MQ=QJ(-DE491$]CPNLOQH&'#;N;:K^PX*BP"?MFY'1N1($5G._O1+ZA'O4) *
M2B'O#+J<3DOB.3]*/QX>GL>__Z_OC_/@619EOES\QQ^B/X5_".2"+T6^^/H?
M?_CURUN __"__O-__(]__[\ ^-^_?'H?O%[R]:-<K()7A:0K*8+?\]6WX.]"
MEO\(5+%\#/Z^+/Z1/U, _K.ZZ=7RZ:7(OWY;!3"$T>&_%G^.$$G"D$B0$((!
M$J$ %$<A2!C!4 DH0B3NOOXY%1+3*,, <RH!2C &1,D0J)1A&),DB8BH'CK/
M%__XL_D/HZ4,M'*+LOKK?_SAVVKU].>??_[]]]__])T5\S\MBZ\_PS",?VZO
M_D-S^?>CZW^/JZLC0LC/U;]N+BWS4Q?JQT8__^^_OO_,O\E'"O)%N:(+;@8H
M\S^7U2_?+SE=59A?E"LX>X7Y&V@O ^97(((@CO[TO11_^,__$00U',5R+C])
M%9@_?_WT[NR0Y&=SQ<\+^=7,[(,L\J7XO*+%ZCUE<JZEKYZV>GF2__&',G]\
MFLOV=]\*J4X_=EX4>T\U4A(C990:*?_EW& _7R&^)WE7Q[)Z$*Y2]X,O&;LP
M_>!-W"^:'^3P N\,<[7(]0OU9B'&>G<W0UTM^O 2^WHMEBLZ'^&UV ZS(_+<
M_.*]_JD9QCRH@TRK<1KJWA%5?E_)A9 U6^X].LC%?_Q!_S0K5ZM_S#X^R4+S
M]>+K/>?+]6+U5_G(9#&+,,E0F"F0J9@!Q(0$.-.*A'&$PC#E",5TMMJ\UC.Y
M +]^;B6HAKDXQA\<]%N=^4X+62[7!=^N<(_S4\N67K',&H=_7M!'63[1Y@8M
MJ#$&:MG_<R-ET(CY[S]OM>F'XGP,;.8CPQ+\5LOX_UZ/CVALKLI@&!JGO<&F
M\!HM^9X0<V,X+8M# );<!H":B\R%P)BC(8G#BFFZ;OWY:-+NBU8D6O +F#97
M_,R7V@!\6H&]U] 8S-:RKY;6\UPCI8?^0[ LA"RT87]"C<V[MR[!5TJ?9J]H
M^>U^(<P?;_Y[K<WTN7X/RE\7>MY71<XU%9^^XF$YS_G+#"I,4L4(0%@(@&*H
M;70"$Q *S&$*::H@LB%#/^),C3>-D %=B*#Z84=<.W[P-$?=5#L^\@.S\EG0
M[X)=;8*.ZVJ=@M^:/[]HBR'X17^R_SA/[-:,Y1?OK:%5:J@JL!4M6856,]+/
MAO5^EO-5V?ZFXD$01LVN\5\\B30*:?J%K^57ST_M2<5&\\6JJ%;A3WGYCU>%
M%/G*_#1#-(Y51F*@$J4TSPH(6!9JQJ52X01JWK4S.BW&FAR)[HH:+%5@A'0D
MT YD+=G1#UY#4]\>5$:XNZ 6M/G+*,1V&2J_K-4QWKB4=%GQ([ZQN*4?F7Q>
M/^G]>&74SPU9O9TO?W^W4,OBL1KKGFE"HWPU"\,HC$.N &7Z/PA&^B<:)2!F
M@D9("!HSZ$(LEN-.C61VQ0Y$7O+YLESK 0S?+)8+P(V-H/(%7?!<7Z$UR)_S
M52[+/[LQD>VTV+'2 & /S%![.%>&EY$YV!$Z^*T5VR,G.0+EE9]LQQZ5JQP!
M.>0MU]O[<=@;6BST=K=\D,7G;[20]:IE%JUJS9I!RI,(X0@H%2< H30$3#%S
M7A1Q'*=I@E#LPET7QIL:9WV0J^#]LBP#+6]0">S&19?@M>,@CZ -S#VMI%N\
MQC&(+!'R2CJ7QAR5;"P!."09V]MZ&DCFD;_04F_IEH]/<E'6S%44^I6IF.V7
ME^TE#_3%_.K^=UH(L^U;O;Q;:(JKG*;EQ]4W67SY1A<?G\PCRK_IS:(4[Q;U
M&=&,<Q(F4J4@32@#2"8*,"Y3;5)0F#">,:G"V;,LV-+:QAI)=)=O=U>!X3YA
M(Y_Q'VNKC"\?'[6U4*[TJQ \%?(Y7Z[+^4M0KMG_D7P5K);!<W-U(;7>185,
M&?R4ZYL,.N4?'4VWL5X82"G&/",@P1'2+TPJ@7Y3]-9?<D849Z&(R>SH^/3'
M>FOLSII]OCJ5*N5=]5)(\0.\!I9;@"G-ZDA["*,/,.$O(MA5.MC1.F OP>YU
MC>9!I?I=4"L?[&@?5.H'*ZU_T !P%]00!/I5J4'PN"$9>=K\[FC&$G[<+='(
M4W*TIQI[_'YVD]YUO%OHQ5>:K<>,(,Z8">632&4 *2$ 44B_-(@KDD8R2Q6:
MK3;!'!?I;._I3ANN,W$IOC=<<RV7VX*Q#U@,DX0+HG>J6:H!B[ "!%$)HI 1
MF&2()ZG3GK4_8"/M4*\%#$&*,H@X2$(4 Q03!*B((6"(9PG,"&29Z&$-N>,V
MOLFB!2RD"0;5"]#" Y1V%D7O-VK@9=^\3+5@P4]&M#\&]ZM5D;/UBK*Y-/;^
M@V9''T$EG4AX74GW1QAUN3NIW.&:=/HBMX5#R'SV9K'22]2;1UE\U1NROQ3+
MWU??S"I'%R^SC$K%5!@#IE"HMSLT!!0Q#&24,<A8%(O,ZFCSPCA3X\9:U*"5
M-:B%#1II[3[S2]!V?_ > 1O:<]</*^L/WA*)$Y]^*?F?OBZ??]9/J+]Z_4/U
ML5>?^:7GCO+!6RK7?OJVE[N10!7 UMO";1?"=XL/:Q/S]E%5UY7WZ]6W99'_
M4XK[Q6)-Y^UUVM UQZKTJYRQ* JS%!,0:5(!B#'-,S F@$H8)U EF'%E':U[
M P6F1EM[-DFEBW'&U9Z4@&[4N0N>-BI4WCKZE)LCO]I=MURO3':,23ARB)2]
MQ>O3S: _PDLQ?6?,YI5ZMP@^;%ZI&HO@?N>5JN'87K\%9.)OD4,P]\3?II$B
MQ2?^5KF%I]]P2CMCWV\AUWB!]3=$?2]J_Y9R]//PW3_3?&[VU&^7Q6<ZEY\E
M7Q=5L--KR5;;O[U:%V:_/1-8$!DF$F0\U296C!'0[UD&6$0R(2G$!!(7EY;C
M^%.SD#[KV5D!/=*CMI',:=.C>\2_ZQ38>78&!'9@*\/(%VP%U*3=J@+4L@"E
M5N8N:,3VY__IB9=7#Y&K#*/ZD'H"=.AEZON8GE%ECT_SY8N4G^2\RHO-*<OG
M>U\34S3EA%# $IP Q 4"6&4"0)HRE"H59I [Q95=&G%J%+9G<ID4F:*6/&!R
M(57NRF:7$;?C+Z\X#NVR:F0%+70[T@Y 5=;0^(TRNSCJN'%FMB <19I9W^CN
M^GZ5KU[NM8'V:BGD+*0AS&B*081""5":"$!C& (1,4FS+!9A9&4J'3YX<@1B
MW+5&N,!(9^_,W@/KLO>Z+P0#?_N6VCNYIT^IVLL?O?>@T1S0I\3?]3B?_/=^
MZWM]8/5YI;]D8WFW17?NO^?EC",<)10AH/?",4 P(8 F>J'GD4ID%A.H]'OG
ML+)WC#6U3[(Y.MW(&K3"!K\9<2U+%MB ;+>8>X)NX$^Y-VK.*[@%'E[7[J[Q
M1EVU+10_7*]M;NE''I_DBN8+*=K8\WO.UX_KRBIXK2U?GJ]F&<,XYIHYHCA!
M &&, (MQ"A"*< 0CH02Q.E&R'W)J5+(C82!J$=W8PP+E5&5IFG((B($:180#
M0F4$3$T)!E,5,XQZA/UX OL&X<LC8&Y'W'[?UX'YNQ4VV"3__+2+9"/P^1!P
M9QJW1\<KFUL,.RJIV\-PR.T.=_:-0[H70K]C9?/'>SU:I/D&D4Q0$XTIF-Z9
M20IH1C. DSC35B$F@H9N44@G1ID:D3=Q-8V(=^T/@1$V^+APV+B=!_;R+LX+
M7$.[<_HBU2,&J0.)*R*03CUUY/BC#L6.HX^Z+NX1>W2O(0E;/\]G$X7RH-^-
M;^;<3$]T4W0-982P4& 0ZS],;14""(X42$-,))029W8)Q=8C3HT0C,A!*W-0
M"1VT4@=&;(= "RO$N]EA$!P'9HJ+$/8I$FB%I4.4B6],1PH+Z?]ZND5LN,#3
M&6)A]:#Q8B)<]-H+8G"ZL>_.^UDNUO*MEOC5<E&5C_A[OOKV:EVN]%Z_>"B6
M8LU7]POQ61;/.9=O3!77,F=S^3XO5S,82ID(F (A1&(*9#% 0QZ#+,VB!$,N
ML4S==N77B#,U7F^TJ:NUM_K49=Q;C>Z"1J?JP*_1*OAMJU=@%'-T$UXYJ;8;
MTK&F:O#-JH=9>K/03%P7E/+HG?2#L><M[U4BC;P=]@'?\5;9RU/];:/A3,8P
MD::(&%,T!BB2>D--B00JEAP)BI($6X5.=(XR-7;MW!Q^^7UY_38:7K&-=H+K
MEMOH+J2\;*-A!P_UWT;#VV^CX2%#V%U\1>$<=CF@E1WEJ7]_RNN%J:V,HP2!
M*4F XIK>S=$LH%F*0)@IHD*H]^+$*7#4FV13(YC=,'>^H]I=(#>2FX2;KA(5
M \^EG:EVDQD:F--\E"/9SN(@A49\(NZ_DH@7Z<8O%>(3U).U0+P.T)/KVR/V
MCZK:]7];SO7-95UQQ+58J<VSIO1=;V(^3-[0CL3_LRT?-$BE4A>4_'Z+5B./
M^YVY@''T#3G=W/?[T ]^5Y9K*5ZOBWSQM>EI5B7JG/67E;,,QW&:AA"PQ,20
MQ#$$E(<81!G%"<TX)=RMZG(_.29GYU0>W;S2(U@O]#P$;SX_/%Q1K*WG_-@R
MVN"H#\YQ!O!:A:#6H;% [II4R;M.?_OY1( >Q'<5F)ZIL)\L(Y/C58 =T^5U
MCQNY"NM;FA=_H_.UO-<B/]9USDS9_+>%E.\6FJQDN?JD%X 9@JD4"6% B5A3
M;<HHH"H6 $4))"JE8:K<J'9HB:=&RD9&H+200=Y(&6@+T['6]/#S[+ !G<KL
M37]C:K0.*K6#';WOJFXB@5$]:'4//G6]$^/5QW2=IVD4QK26^L>HB.DZ"=Y*
M83H///*J]5?Z/7]</^XG].N%MEU?9X+%*DVS% AD-@:F"C3.1 90)A1.*<QB
M[.X2'4+2J:U2C;S'-8F>]-]D:\**VL2EBY=@N9#!4VO+UK[3&Q2%OOA"#+RL
M^9SFZ2]G[4MR5 _&=(1H59[ (F8[*]-8O"Y*^V,L6K:@>UNLK ?TD@?IZ*T]
M<_>$^. H-6\(=^P%&(;,R+N-R_6"PA<R\:YTJYICZWO]'&&>]79.O\XRB%1,
M8 B2D$. <*+MH0ABH"#D6:S?D9!9IV7L/7EJ]LM&N,!(9Q\QL@_7Y2B1WB ,
M_#5;ZN\4!W)2UUZQ'_M/&BW>XZ0"NS$>IR_H&]#U-I_+XI7^E+\NBY<9A% @
M2!20PF1$<1/4E2C-6C)-!4<PHZ%5GNN9YT_M VQ"DRH9@U9(U\BM?00O?XU7
MXC+P-^D&28\0K9.*7Q&<M?^\D<.R3BIS')!U^K*1_1!-8Y"WRT+)?&4:G6[:
M#F4$AQ1&(6 LE0"AC .21A1(2F)*8!SBE([9?>J\J%9?ROB9VION0:H6^2;-
MICHF>&"/PI7S]</X$C;3O*/II#I%79Z(:;@/.N3\,1P'EX'VYC*P&*I';NRK
M.L$^?Y9OE))\]>J;D>.CNN=\N5Z8%HIORE7^J FTJN^C4H4)A!2(5'*]0B $
MB,(*4$&IXIRF,+,JHM1C[*D9C5OI@UK\NZ!6(/BH@JT*0:N#4ZVE/G/33>X#
M(SXP:4\.;(>$V^% 'RGUUA5\3YFX_7#KS,EU?.1XV;G]=-W+T^WYB'Z[CR_R
M\6E9T.*E#JFL_=<?MZT]9A'%+(OC% B545-.(08LQ!2D,<NBA$.&LW!6'[U]
M7M%B9;>3N#2LR\=S./APW\^#?B5E46@[LFJ!<A<P^35?F HW :/Z2B[[[Q(N
M3X0(0R80!S F>L6&- ,T90+$C"LE8AIG,&DFXLU"W&H:VJ%'G 19B3K"#-AM
MNGQB.O!BO!&U"89OXT6#CQ:]?9PW0;; >-W17!QTU.V)+02'>PWK^_HM E6O
MV?NRE*OR@U:DJ>=-0Y*A$%' 4@P!"E,$,&88Q)##.$,R1M#JV*9SE*EM!NH.
MTK22THT^3H-HQQE70S,P4=2HU +>!5L1_9%#)P)>&>'T2*/20*>RA]]^]\4]
M?<[\FQ3KN6P"%KJ\&.4Y-\87T^QA1B"5/,8*H(1B8QY*0%2DZ0+%"4$,"F5Z
M1SNXF'U)-C5B:17;!"Q=\%R6G:[+X+=*2<=*+OZFW=+_?(O)'-KK/.X\NKN:
M?6/NU\'L3;IQW<J^03UR)GL?H-_"L-^KY["GSTX9U[\4R[+\=5%(.C==S/Y"
M\X5I+_V+5,M"?J'?9RF*$LZP!)APO5W%(0&,D!C(E",1)8Q&>EB'A<&;9%-;
M&"IY__5?HC3\MZW4P7OG-O'^ILZ.W&\R(0.3NU6+LMW:TY5NP<Z\&>V:UO;&
M/614#+2._OC=.^Q>^=V?=*/RNW=0#_G=_P 32-5\\_U)<E/2.W_.A5R(*H6/
MR03BJN@N,S7_68(!AH(!)D6:)C%'4HF;I6J>DGAJZT$K8R :(1W7@>&GV-+X
MG]+$#;TI&"Y+<_,ZM*I/.4FS:YJF$:AB+?6/$;;B.@F#)FEV#CSR>G70;GEG
MP?V+OG<U8P)2%"$)8@H90$@O6 P*"(A4*HQA)"BQJA(_M*!36YT^'*9FTE9B
M$RH9J+4): J^&M%O$#%Y:=8'7KD\SN7T%ZRC_,O[O3>ATG@"RY3EG$QC=;HD
M[(^Q*%E"[FTMLAVOWQ+TBI;?S/_,T>NSWJPM5N4G6:Z*W"QUYA_N]4JW]XN=
M*^NXSG<+KC=TI7PMZS_UW^=K<V[[YCNO@GO,2ED'^\Q23%.F-TI 120%"(82
MX"A# $(DXCB-,Y[JA6FYHG.[A6E<\9V6JXT2 RY7<A7DC?C!3Z)1X(\FQIMK
M5:L"[-4/<JNTVUHU\NMAMX)-=]('7M>,*G>!^6^PH]%=L%6V_D<S[X>_V[NA
M!B%XMWEW6AS^>!=LH A:+*H]61-3Z6_-N\TL>ET)1U9AU/7Q-M-SN&K>2(J!
MMG-G#[?.)TW\7>9?OVG5[I]E0;_*-]]EP?-2/FB%Y8S%$)I5$X0A1  E3 )"
M,P@HE3B%:8HY][O-\ZS U+9_K:QZVU<)&\A&VN#)B'N8+R>6\SDMZOH]U4[0
M]T;0]_OB:8-XP[=@ AO'[I"'2UEW=\'F)6NP"%HP@@J-$3>5 \WCN)M-WTI,
M:Q,ZT!0Y;TZ'DF-"YWQ_6YJTE'F^>JF.@40:J00C N(,Z9TJ-6NK5 HH3##.
MN)!A/(X+U5[FJ2VGF\.=YXV8$SCL.YCG&Q[W]9^]"2R#UQ[X;97_$8[\3D_5
M--RJ#G)/:W'S-Q&C'/R=&;K?$G8O_L^Z7%5+ZY?EO1"Y&8K.'VBN-ZROZ%.^
MHO-*1':HQ2?CS"OU)J1IF5>OMI\D7WY=5$^IY)_IMRQ-XU"!%"$,D(H1P'I'
M"+A <89IEC!E51MI+(&GMGA5=>1/-+0R_:STSX[%Q0>?;KME;$J3./ :=O_P
M[M7=Z15J2P-W6Q>H.=5[M315PK<Z^5N4Q@+>ZXHTN-"C+D=C3<'A6C3:N%?V
MSZJ3+\WXRX41MJH?@:($1W&B%Y"8<8!$&NJ/*:% KREAR$@64>04Y]XYVM26
M@*:'UE9(IW(==@!;;C]\P38PZ3HCUK_Y6!<2PS0=.SGB;9J-=2E_MLE8YTU#
M)-14*3M?Y/?5+UJ)?\Q2K,F$9 E(22@ HH0 &D4(0)0F.,ZD"JF31\5E\*E1
MRVZ>W7Z,F<G"",IORV(%M""/0;YXELWRX3-CYF!N[&AH*,0'9B6+O)<F4S$P
MX@>5_!XYJP]L(^:M' @PH=24T]"X99^<>4:/&G3WG!=K:8Z;I;[1G#RW+>W-
MOJ%\U=1$B)-0"((8P%(@@$*F $$A DE&$IAP@1.>6->>LQMS:NS6BEL%H@CY
M+.?+IVKKQ1OA]0^E+9^Y8-]-8P,A.O1&MA8XV("J10Y:F:LMJV:T5Q<J5O1&
MU*& G']D1RH<YP5AMZ)Q;EAU%HNS?-1X1>+<=-LK#N=X:T_7ZV*5BWR^-C7H
MMNO&F^\F+$B*MUH98R.OZ[?NHWI#"U,#S403U3[CE],/J+9S1.$X04("&H9Z
MT\RE I1!"$2<4D4%A))8D?\(LDYMT=B5=,=:Z[7G'G**+3VMTYBXH=>F?G/F
M[CX='DV_GM,!Y1W7:3H\\$?^TA&&[+EP5&6J6LM(T@P*S@7(LH@#Q)0A_0@!
M111/8LX4BYE+*L/>TZ>6:?#%C!$TY;EZ%9#;!\^21/M",C3M-:7BO-F$G0K[
M9::]$<;EDE/*'7W])R]R;Q?TNMDZO,U+3N?_I<W)M_HWY4RH2&4D@H! E0*4
M)1' *<U  J-(Q33A1%JW##HSQM0,JU;,H)8S,((&E:3VO8/.P=G]'7L":6CW
MH#L^3HV$+B#0JYG0N6>.UE#H@E*[384N7=JSJFOQE2[R?U96@-XDELMY+NHH
MGX5XT*]'ZS;XJ-[F"[K@.9UO3D)*QTZ37L::T!N_J\]=L*=1Y;+;U<F<4&RT
MVK:R+ ?I9>D5:+]U5;U(-FX=5I]@'M5M]?KP'M[XWB%^']NHOCH>O=0"O_G\
M\/#0--K>=J%*,H13&&&0\,3D*LL,D,CT!D P99 301.K\\IQQ)V:U;'):C'%
M-$PL7;"L-:D8QJBPZ6U>NM?2&.D5L#A/F-3$#KQN>(@+;[3>)#V5E;.]>ATV
MFEOT*+O%R^!P%#*IEV*D4Y0!7@YQ_'((GPWLQIVKSE.<X:48[P!H-$3WSH[&
M&_6:YL5U-9=91B1A6(4 *>,\5%$"J) 0,!A&J:F(PH25;7'JX9.S!+8]>INR
M2GUZ%C? 778X7 /'P.NG Q(]6Q7OJWQEG^+F83=H4KROQND.Q0?77!G]O+-/
M>5B6572UHY/ YE$3>A<WXNYO\%N)!]G>NT T3 QOU\"W">6U@.)L1*_-O3>)
MD;A_-+W\9CA3BB'"@$@9!BCA%!">9$#@"$D.,5?AF-$0M5136Q[WSM#+[1FZ
M;-0*S,M3I:"MMQZYA5P%<U.<?5-[I'\]2C]S/4I8A/L,WB@ XLW>Y+W:G[Q6
M*[./J;=#=T&MV60B)O:!GE)L1"/9CQ0%L0^FYWB'@X?WH_M-VO-?)2W71;6X
M/"SG.7^I_[M-%"!Q$K%$*$ ER@"BD0(,)Q& "0SC!%&>T,R%TJU'GAIM[Q0X
MV#.@WBWT KSND:]A/P=V5#L(L@/3Z0ZH.U+?!;7$P6_-GX-D:3CCY945[4<?
ME?F<03ED-_<']&.PG9#AU]N$@S=UKOY?9>4[8)!+&"4(9%&JN2N+(\"HP("R
MC"N.4\8H=.$NBS&GQEKG,C/<J,H&;#N2\@SAP/2TA]Z.O$$C</!;+;)'5G(
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MXJ ;?W,H,9&)WE9J'D( ,08!B44,%(M2QI,(<VK?Q+1SJ*GM)8VL323M1MK
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MS3Y8KZS NJH@XTD@!BNFN#_:S0HAGE2ZJXCAZ1OZGE W.0L49A&*%0.(A2E
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M^:!VZR?T\2/(QZ=E08N7YN%MO$\;X%.[*NKZ*A_D[]4_E;,XC+,,RQ"$F"0
M$9X $N$0\)C!4"448XGL'0Y]1)C:.MTFBA=6S4[N@D6==9:W,7%U[*=S#:@K
MYM#&&S+TS SM-FGE;[CP+MA&(FX##VLM[IH"428A\/?Z"I?8VWYSX.*0&7HN
MQO+<##4GCCZ?:^#L=@[U>O*(7J1K--]W-UWUI#ZI!_J!LOPE.MG+B2B.E6(4
M,$A"4^!% <PP!9Q31*,40<&D?9)!QTB36WHJ68-?0!38=7UR"6[O0MQB!?&%
MX]"GAEL(G3MD.8+F$OOO";RQHOS/@N@KCM\"C^Z(_:X'C!B;;Z''?A2^S0U]
M*VLLJCW$W_/5MU=K;9P^RJ+=I;==LV=2(0H)@R!&"0)("@$88PCPB$<D)0@A
M[.2"LQET:BR[Z2-1R&>Y6)^O_=0?9CL/A6_P!J;65MS@=RUOT I\M_'4O0S@
MIW.!R'.]#8N!1RZ\80_%<04.AWM[^O[;!JWO35G+\NUZM2[D7_-%_KA^;*(G
MRM=K^6[Q5K^0_R5I4<Y""257,@%,,@50F$A >)8!E%%*M;%'( V=S@.<19@:
M->F7$3D>$;C#;GEL,"B80Q\E;'H_U]+?!;7\0:- &RAFG*SKJ@:KT2*HU/!X
MR- ;0K\'#^YBC'L8T1NFHP.*_D_J67*P6'(I1?E6*V7\AO<+\5>Z,D[=EX_J
M_IGF<[.#>[LLS#]NW;TSP3&%C,2 Q%SO< 779IA*&5!24I7 2&&2.54G["?'
MU.BO<KV: X_'6GBS"5FJH*Q*&JU,2:.\;TFCOC-E1Y8CX#\P8[8:U)5=-A/1
M:F&FH3J.V@I_%VP4 VI9@%+?X['BXG6(^BW.V%.6<>LX7@?84<G'*Q_7CT^;
MQDRE)NNJ0W:SG4I0FL0<I2#$B:DZPCC @A& 211#QK(P"9U*,9T>9FILV$H9
M/-5BNA'>&2CM^.QZ@ :FJPTVC80#;#V[,?!*,&>&&I4_NM4]I(<+5P^4"E6>
M"\G_^&2N+-]\EP7/M>7W;E&?6!PT&6G_O:HZ/1-$F'9K$<!Q9+I_$ 48%Q 0
ME:4J,J4G$JNC[]N(/S6VVO3K:=LDR4;:X,F(>[?YNY_F(B._*W:T.=TW8.A3
M%XM<K?)"LE8#P5VP <'LR]OCXZ-V4.U5=27_$;.Z!IG#<?.^_*HPK<RP0:;'
M.7=L&"EZ&M5"5/41Z/R!YN+=XA5]RE=T/LM2&5$"M2W-8090FL6 8D0 IRAA
M$1<JC;&357UZG*DM5%LQM6&="Z!)AM>2.AK89V"UM+"O!VMH$WN+DQ'1D/&K
M"SBYV]C=*/@ULL^,-:Z5W:WPD9E]X?)A,L(V@=8DBS.A& 0(AC% C"F $8;Z
M/X@( L-$NC51MQUX:I1QF-&T*WF;&W8AR^FZB;#CE"'@'9AD3N>*#1+>[HK.
MJ.ECMPEM=X7$-9WLRK#V;?Q\W2OQM:S_W#1P;]T/LSB,"$Q4J#E*I'HK'\6
M( 5!G$H&)2*)M"M+;#WBU!CJ.E_A98#M",@K; ,SSZ8!YT^MM'\T)LZA8]%G
M>HTE.)ZS:BZ-.G(RC24(QSDTMC?V/GE8/ZZK2D]5FMN)GC5MB8XH4E&H4I"D
M" &D$FT4Q4D"]*^)2J5,D7 J &<]\@0YIQ4\J',W][LSO7?N8F4_"=;'&/ZA
M'7K;]?'5NS/=JRY',/<YY'!#R/>YA^7H8Q^%N(%RXG3$\0&]F^D]+A>5W774
M-WVF1$H%I\CTU>8 I:EQ]- (4,;3.(()%K%3F]RNP:9&3;6L;89>G8<7++?R
MNJ?G64%NQTJ^@!R8B!H,FWZY;?K6CJQ>F^E=1,1W-[WS X[=3N^BZB?ZZ5V^
MIQ^C5 4NE?Y"S7Y.%L^YJ:#]437%M.G\W4+OZ*H4E/*+'J$\_4^OEX\T7\R$
M1%$20PE"@?36#+(4,,QB$-($TX@I'$NKVMA#"#<UQMI(&NR(&OQ6"^M83M?K
M)-IQVJVF9F .[#DKS@0X!'Q>"=.K@*,2[!#0'A+R(&/T)/#]3-[7><GGRW)=
M2$=?\L7G3.@K/4Q$#[;2#N))ML;&[R=X<=1QORM;$(X^%NL;ATM$^B3-IZ:?
M:;[$DM.Y20:8I3%",0]#P#,) >(XU'LGR4$6*H:B%$M"G +">DLR->/$O)'^
MTY).3X(=/8T"[<"TY9"DM%'%Q.'7RE3)2N/F*G4".GK*TFEI)I>YU E:GP2F
M[@?Z.F$[8.E/R_G\[;(P$4PSSF.D8FHV<QD'2*028)(F()(Q$C2,-5>RZP[;
MS@\^-68\<XIT9)'\9G0(&B4<MW-.D]/WH,X/Y+<YL^N+MH<CO,NP#7R:UR'
MC0_V+D-S^8S/XAE7&HEOOIOPS9WBD@F*(YE "K*HZG L$,!80)"DE(E8I&&4
M.KG-SXXT-2K;FB.RD=2QE_MY3!UMNFN0&LUF:X4<9(=Y$8IAK*VCT6YC39U3
M^JRU=/:&'I7)/LGGO,R7BW>+-^4J?S1G>%6!^*IE;M,+ZLORM7R6\^63,<@>
MBN77@CXV!],\50H308'*J#0ADP@0'#.35 1#TRH]<ZBG>9TL4R.85IO@W2+8
MZ!/4U??K1M)M5[0ORV!'J:#1RJ%NUY63V,U7(T_-P(QV[:ST*:MVY?0X%%X;
M;YI&*LTVV$?D5L#-#ZZ=)=ZN'&*\(G!^L-@K$^?ID7U;H.I5-.=Z"--7^7Y1
M_6$,\&<Z-PZ(T[]MODV&$(ED&@&:)"9E0"F A?Z/2*%D'/.$$J<.A-<(,[4%
ML.H];J+<JQ]VQ.UYSGO51-G9Y&/!/W0L2W_D>[1:O1XRSVU8KQ!HY!:MUT-W
MW+[5PS-[UC,X74;Y;W2^EM6_'22#BIE^D=.0IS%($PX!$I@ DJ4*I$2*-(IC
M3-PB9IPEF!IE;K*\31FHJHKOLI;8L5J \TS8T>.@^ [,B5W%VBL%VGKNC0Z;
MC'N?+53[XN<W7]Y9BG%3WON"=)2UWOM!/7,J%JM<Y//U*G_>*1'UYCN?KX44
MIK*4"8Q>UUNFC^H-+19:J%)+584UOM^T?P\))83*#$ 2,X!2E0#,(@08ESB)
M610G;FVM?0DV-;;<U6NW6U"K65W<;4<W0ZNM=N;CK\-\[7K0#SOE=OQ[BXD<
MF)9'G4/W?!'/@/M-)_$EW+C9)IXA/4I&\?W\@>M#?_E]6=<IYC&GA(829()2
M@#A*-.&'$*241V$<"0ZYDS'L+,'4Z%V_]G"@ZM ;T!V/ZH: <K0C/-O:T%J)
MFY6&/@3P-I6A-U),+KSJ)$B]ZT(?/6B@0H87JD/MY//LQO;@) M9@@6(TY #
MA$FDS6 6 LE@HE)*(Q0YF<'#B#DUUOS8RV$PS Q:>A5N/B]#NQXLR@7:5@O<
M47:PN*]A)V3<VG_]1)U6C;^KX':NY7?=:+T#<I>/\K,VRBL1WIM75 _6)E9F
MC$&!(I#P, 5(06T9IQP"GH6<2)EP'#I9QIVC38W/:V&#C;1!*V[/4[1NJ.T8
MVQN  Q/O%=CU"9:]C(GOZ-B.$<<.A[VL_(GX5XN;^A&*:=ZPTV_ZH(#_E[J*
M%J(R3(D$B$2QR=>&@*8(@QA"15D4)0BG+K1B,>;4R,6BQT7P6R6Y(\O8X&_'
M-9Y1'9AQ? #J3#T.$'DE()MQ1Z4A!R .R<CEUI%WR1_6YG#^H]I61ZW+8-RO
M5]^61?Y/*68H9K'(L*8RS"A -.. 18P!+F28I!F-,NZ4HS2@K%.CP)VZOXM*
M^+H%4U5"AVZD[E]!9\AI'WA_[7<RI[_)_K"9_YV7HE8YV.H\@7VV_<1,8[-M
M(>^/L>.V!][;MMMA2+=U2<C<5/(P&_G/+X]LJ8D$$9:ED(&0,J$-8F)6D0P#
M$J8R"2'F"%J5>CQZ\M0XOQ$NJ*6SX_-CN+K9]RH0!N9*2_VM">VLKB?HIY3\
M3U^7SS_K>VKFT3]4A%-1S?&31B&&LPJTG_'Y"WIWTGR2Q>KE0<_+ZGXA3"QF
M%=G^0:YF4J9,0IR"!&,$4*PDP%1* !E#F81(9-#)W]4UV-0^S5;6*GQ9MH+>
M!0MYOM>9.\)VAI,OW ;^FELQ[X)*T$UA^0:Y#QW(]>E3>1$2W\THSP\X=L?)
MBZJ?:"MY^1Y/*=TSEJ&$$A2#1/ 8H#!, 6.:.V(5ACB4*E&0S%8FK\:.-HY&
M<.**S3C#O?B-7'6(V+*6UOGH\QA'.W*X"IV!&>$X;7O 7.UA0S4VH]PV-_MB
MJ,71A5?WJFF:3&ZJ"H@DC5D8,A"'G %$L="[V)@#+)&@.,8PDJ1G=YJ#H:9F
M$S3B!?.MQ(ZU&CI@M?O:_8 U\&>_(^2F0>S0O67.H#%4-YG#X6[5/^:,VAT=
M8\[=T8\G?OW\E^6S+!;&EGBU+$S5F&KMTS;&_5>YX'K K3>[K=40"Y-8D("D
MJM40F]ZODB,0I1E.F- [?1:Y$$@/&:;&+%L%@H]LGG_M8T#TF0H[TAD8X('9
MZ-?/P0Z\N_)7.Y16@]V@?_\-'ZZ T"N%]9%C5&Z[ JA#TKOF43TJV!P4S7I8
MSG/^\D5^7_VB]?O'+,4\)2G)0,2H  @K!:C*8B"HWBRIF#"JA'6%FNZQIL9N
MGV5AOJK[NZ#YZ9>ZG5_S%Q %GZ20\K%JN_)JN="3MLK-SP_ZU9=ZN6I:_SF4
M.KDP&=V\YQGBH9VH1V7X:ED#(VQ02>M2).8"<@Y%8/PA.%*1ET,D/15ML<.A
MLRC+A4>,5W3%3I>]HBJ6M_2S/_\B%WKC.S>4+A[S16Z,6I-QU6R#9S()8PY#
M B3+0H!$* $Q_50SR1@+(T1$ZA1;=6&\J3%O(VY%MW1/8#?;\A+,=G:D1_ &
MYM1=W/9E;3U9_DQ#2U2\FH&7QAS5Y+,$X-"\L[WMBBBIO2Y3,..2X1""#+(8
M(*D0()FF$I4Q'D6<2<*2V5.5VO]Y18N5':%<U8KJ<+3A/HA?Y-=\81)4 T;U
M/W!Y92#2'K))%H:,0P(2GE& ,I0 C%4*"*60)0F.8IDUR+Y9B-%P;<<:\."@
MSI\9 %([0IYR'[1!.Y^-T^[LQCW.K!N;^>YF]FHYUW]=UG2\$UK4.)U@IO\/
M"0$X3(G>":<1P"1)0!Q'B8JTO:8_>;<.B5W#3<TDVY-V-RC0M2%B)\9VW[\_
MY 8F@[.@#>"JLP/%<U_$SB%'[HQHH_YQ;T2KNVZ3U]T45C+NI;_+_.NWE13W
MS]IV_"K;DDL/1<[E+!8$$D1C(!.$ 5(R S@D$="D)*%,8Z:B;,Q$;TNYI\9P
MK:P!K84-9%M-[LF(>]?^O7+W&9M'F)>G* -M=M7VSUBA[8[OAX-1-:U9'\-4
M\Y17OJ/]7;!YDQH -K7P@@J""43 ]YNS:43#.\K^8T3&]YL0W\GIKL/W3"[=
M]/#[J';E;"I55U6KC\0LM[Y\&"D28\%!FM+$1/)D@$!,04HSIA)*4\R<UKLK
MY9G:.E:=.8%?CFC-,0/URDFR6W1&A'[$Q62S2.P:_#;'6NZIJW[P\YO6>J5,
MXZ:\^@'P*!W6TV-[5E+E?+G6S]//-51N7,V<%VLI=N*IMA)NOUDEPRB$+ 01
M5TIO)!(,<!QE@+-,[RIX',6)TZE33SFF1JB-T)>#@;U.AAV!C@#QP,39:A T
M*M2'5PWD.UKLM6D>A$ROQ-)O<=*>LHQ;B_0ZP(Y*CU[Y./?\S==-@,;_LZ:%
M9I+YRR?YM"Q6,Y%&G"3:I$P23@!*F0!8*0(HX3(**95Q3&TS.<^,,362:\4,
M-G(&M:#VZ9WGT.QF,D\8#<Q2[O X97]> *!7'NBY9XZ6$7I!J=W<T$N7]G3
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M-Q*,0$$P 9QSBD4&!4F=S%3;@:>V,]1)DGO21[7XT9O/FO#=6YG9X6]Y;QD
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MG]].CG_YBHOE=#[[US_P/[(__(*S-,_3V:=__<-?/KX$]X?_^6__]$__\O\
M_)_?WK_^Y?D\G9[@;/7+LP6&%>9??I^N/O_RMXS+O_]2%O.37_XV7_Q]^C4
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MI .@'7T-4WK[&%_.%Q^(H_,RIBDNGV-<7?[KHA8AVR2D8IXDAH*6IPD0M#.
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M[V_+S:.GRT.IB9=&FQC("\1(>9BAC"Q8&^NDW)P9"R$UJH?<D> NJX":H?8
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MP2G6YJSC.ATCS\;969_W &,'X8Y=27E$>F+KZ.C5+)',*!BJW)R7_Q&AQ=O
M0-@:/BL*9*-P'AR+:+RTW@?VLU#OYX_I P6[*&_>1))=8.+'1NZZ_N5TD3Z3
M0;W"D&71ZY(29"5K Q=5*ZGH51&8R(AF[6\VX7\(&C]YVLCCC89$R)!R[<"O
MG+E6^O#:B#HKG?#%@ S1UAO@"*$VH2J>&Q)--)C:-,&X1L:X:.DC5ME=+QV
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MR1E$+B)$$92+6IGH1G*8@_+Y9,Z^'L7J; ?!I[! [S@A>5 ^4O%<&Q6 8DJ
MBHQ4:8J XI4KL2B/.-+\T8$Y?3)G<8]BD;:$X6-8I@,%_\$'9IE+M9.I U4B
MB27R#(9Q[4,QPF*?1Q%#9IR/X:2OBT4Y NC^8<X&'Y18$L*A2J66ZTC*T34%
M&=9%,$KY;,JZ15V7RW0_OI_,.>)C6+T'A.@3<+!7#I,>%$O4R4A6&(08,P4?
M!B&:',%*%5$F;8OK[++L=@P^F5/*Q[!$6X#N":S%HYS7[8W#\>4IVN71&"K2
M5ZW7LT'5.Z$N0$C9@:$XP\<D#5,-NY:V8FO<+:%'?%HY'%AZ63GQY\*(6]N_
M]UC[9]#[S^:SM6A.PW$=VR4F.1C4(B.@" &4+QH"<@\QE^2,%2SHAGNNAV7V
M<1]8#@CU@1L'M\;=$UB:6X?C]TF.3V+2+NJ<0=?&-"HS"@>D#E <3U(E4YH6
M;G<A@\=]OMGO0AX)I4]@?=\?R]\O(N/,^MXA\%PU[5@ 9XP$F21#R8TR+3LO
M'9;9QWWFV>^*;8V[Q]Q6YVLX/EV_%2Y;LC=LKO/0XP[68F=CGOMHM%-/ZWP4
M&5"Q.E<".?AD,_C:/BH8EPVV*4A^*FW&$\7)07D!7&1=.R(*$B!+8$V,UG#'
MI1-M?,A_MQG?$K_MVHQO X(.8JTSRNG#ZS[%)CFEG5&0,V.@0G+@@V*0E=3D
MI)PWK$T4=(V,I])*?"LHW.S*M[->.@#5[H*[9'N6ZU#F-^$$S_O-8BX&G5=@
MV;HQ9R09"$IB9)#!%&8D!5*=53O=S\VX$-\#7(,5&PVDZ0[0?FUV_5DJ<-[
M6-LH12H%'"^B%C"FVC$;0:A<@I(A1]OFQN2])'6^Z]H<+?>-"-U+=1U@\$(F
M9PO:9Z^]M" 2ZC.)!*,CN&@$HR!(<FP3AUZEXJGT@]['B>^LE8X0=;[*DJ+P
M.D@%1@5R$J[4>=+6@E*RQ%QD"*)-7\2>_.;N^KP'&#L(=T1HU&V8R1'IB9TU
MR)HEDMGT*U9NSLTF"J5SW;]R4A GJ 6$]: 3JUA)CLRFN1&DW=[;^?EC^D#!
M+LJ;-Y%D%YBXYDO?G2[29S*H5QCR$I76P0"S=9H#CQF<JBO'Z\*"CY(;LSDT
M?O*T<;W/H @94JX=^)6=M_]?_^AV;V0T2CHRM;5AF I87;+V8%@VUB4?L^VL
MV^CKK:9DM#MZZ2(J.C ">L'\+@=+#PVR/3L_JJ.7''$-3'H.*AD$YZT'3C*Q
M*7/#6<,N(DUXZCQ''1B=0YU!#@N57A;-+HIX2!)_G1_3UQQ/5]_/YC^';$DL
MJ4;NO$ZG1O#..[#.ZIKDNQ [:UBZ.7./M"YGP&74$7B>VGIZ/UW^_>4"\=6,
M",3E:BT0RH;16:;!(V=U%!&))M31[P%1^I2\%XW&++=F[9%6S'2XEO8&SE-;
M21?&Y?GTZS3C+*\%HB@ES+(H<,Z1NK*I1S)60B@&2]*(*#KK#;<I:X_T*G^'
M*VEOX#SF<K)J.A;3ROZR?O( X]I^\L2#%95MPWD?=65))"XC%U PU8WR$"$Z
MFR"F%))@OGC5)BQX*G5E!5W0*,@?HHR@I G@:K6H2!1G>F:";36S[;_KRK;$
M;[NZLFU T$&,=+W$1$26>)T;ZHAZ4-848B,PD%)9Z45&[AO-?WV*=65;0>'!
MNK)M]-(!J)K4CU#<)F)$"\P(6MXF9Y+F.H+*W.E2&,.1)F(^\KJRK<!UB+JR
M;33= =K?_XCTUC'A^7&?-%E&'Y#05 N3ZE7OX"S2*XY><^>Y:=.OYDYR.M^K
M;XZ2^= JVQEW7W$1YV-O<%RFR1@L\X87L!0F@<)UGPSC(<42@XF84^EL+W"[
M,]I'4+FV3YAP8 1T8&UWYOC%?YY2_OUJ1BO_=*V5MZO/N/CX.<S.KP6^F<^^
MKN_R7IO6P8O3IG@(M;14)<8@QLP@!":"0(DN=5;#L!.?G?N'@5$\U")J#ZE_
MC 7W8W*32CS5TLQ<IPR*8L#+2.ZX,.V-4=S(SCIQ;LOB(UUF!\#YX9?D#J![
M/+,?=A;/63>+'X,_F7!.*&8A:<M!>9\@UA.+9#UJZ4@\OK/>?5MR^$BK+Y[2
MBMP#<D]@UNS6!LMEQQ YY0?!2U ,28E%%C!"\:2B]*FW?M5-O&1_51Q/:4WN
M [I!^U4W.+-^1M(/<;XX$]:G!:Y%=7[(](Y<]/==SJ4W^-;!SIZWY6"@\^6K
M#_A(&%O60^W:Z>?B!,[+8'VR"-SI6FT>"WCK(S"M(ZJ@7?%MRC1_1MF^UOV*
MP+_BE?5U>6+YD63\&_W*WR>,FU)4;>AN)?DOR0IEHJG&EU;'Z!7'1L?H6Q Y
M;AXR*(YNVL16JNJY"N?G]F"/@IO-O_R ]JUE&<U/X6D3N3[R@> %(4:5;"%X
M\H@^VLAM1D60>I1F[G)/^[XG_?;]VD_6^]<^ZG4W-V!*.E V>G#<!7"*&<\\
ML[K5U99=R.W<]&V#K?N+6%JI;\P+K(L5V?;36H[\I1+_XWZWLZB%1P529S+B
M(F<(17M@WHKBG4U,;11TT .N0(_^=1-V]U'02[E*,Z7/!]3 R AZCU_.;^;^
M<"LW63H_7K:4@/&4:M6PR)27A4)A@:M,)2$QN3(DK#8F:QRL#:/Y>6LUC'V]
M_F/X.^9P7DR0I96Z%A,D(0PH9PPX1O+A+!J&VE) *WX6>MWZUO'4WTAC\R'$
MU\$AV6:V=[UF;.8L*6DA!8Z@6%00F8VUIVS!9!TF7@X:/=ZFL9?*BM8>K;'V
M.L/E^?K,D1:6C@ZD6G=>E@&BRP:,LH4K)562;8;!W*:ESUA\7ZT_ *X=5- !
MB%ZM]X+GBXLRN4*Y24X10A"6J.<1O)82,*4H,1AR_FT*<:_3T0]X=M'J?# 1
M=P"06J#YMES9;%LO&C2*L=KB5P;N*1!P%!)PBA5-\B@YK^W3V^#D3G)ZZ>AR
M*)^VOTXZ -;5(LJC67XSGX7+=ZY*[T>/)8G$"(,B58T]18 0'0>?G33<V8BB
MS=GHEH2.:[L&@,;-VRH-]=0!#.\[4SCG)O'@2TD>$LHJN6PA>E-'6UB="Q83
M&@VX?)BND>^8M(3$AF<^.^AG[#V$9Z<GI\=K/EX4"BU7SSY79FBUIE33[>GL
MTXOE:GI"CN+L[HXUND@F(%M.@4+4$F*B0$&%H+AV2=)?&^TR;/?<D;L#'&[+
ML[%*'@_:+B[=B*"T3P@AKP-3IL S<A?%>,XM!:T1[<!X&W7CL[7^=\/9#LIX
M/$@[RO_W=+FZ8K[1Q^(B"U"$+?5^# 4F&G.]EK5NE48YTF:]:G>GX5&@;Q=4
M[&CG]E%1#_'<FK-7L]N<_?;]Q[78:"+EW$[7PG#R%T)Q(&X0T#LNH]:!FS9W
MX3>A;B- ZL?O@)MIK&L45H[.5[.2]21-9]"J^A 9!0DM([D4ZZ*(++)&IP6;
M4#=NAC$\)C8&W8X*&ML)O\>OTR5IY]7L@I'\<;X*Q^O.*N<+]N/\.7[%X_F7
M:M[?+>:?%N'DW,H7&QRW@H$76$N5)8>H%0/+<E(.0S)!;N2(]Z.C5]3M"HKY
M.!KJP +>XSU>_[C56:R-7#D)5M&:54525*.\!!-%0!ET4KG-[=N?4;81!LW3
M\;^#:JH#Y-&R28AY^9)D>[E[-%\L)SE&YF2M83&> EA6'#D,XT#(DE,RKOC
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M#,6;!#28I(]R,Z_W,\@EZYD&[=IHMWW\O?FC?M7B4._?_ 902P,$%     @
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M ))V=VUXS*S7S'K_B; !/? 8;AY?_>UV^_EQTW).W>U5]Q$W];W"S7LL 2V
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MW;MV@T+F[UF<"3I\$7C"+,8HY",48QT"KL."H/]D3%!]D#* '1<AS*WODCW
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M8BQ!<=5-\((=:6@/7+&G8Q@@X[[&&,IQEPQMTC2BX5[$([3::&$);LA<\A.
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M,C R,3 Y,S N:'1M4$L! A0#%     @ ]8-I4[N< / 3"P  IV4  !$
M         ( !4%H! '-T=&LM,C R,3 Y,S N>'-D4$L! A0#%     @ ]8-I
M4VZF@SHG$@  ;:(  !4              ( !DF4! '-T=&LM,C R,3 Y,S!?
M8V%L+GAM;%!+ 0(4 Q0    ( /6#:5.;DD%IK2T  /WU 0 5
M  "  >QW 0!S='1K+3(P,C$P.3,P7V1E9BYX;6Q02P$"% ,4    " #U@VE3
M=5*3";^&  #ZTP4 %0              @ ',I0$ <W1T:RTR,#(Q,#DS,%]L
M86(N>&UL4$L! A0#%     @ ]8-I4S(M46-(40  7+T# !4
M ( !OBP" '-T=&LM,C R,3 Y,S!?<')E+GAM;%!+ 0(4 Q0    ( /6#:5/3
MT\DF0@@  ! \   >              "  3E^ @!S=6(M8V5R='AS96-T:6]N
M,S R>&-E;WAQ,RYH=&U02P$"% ,4    " #U@VE3NSWB&6$(  #4.P  '@
M            @ &WA@( <W5B+6-E<G1X<V5C=&EO;C,P,GAC9F]X<3,N:'1M
M4$L! A0#%     @ ]8-I4X'Q6H"H!@  \2,  !X              ( !5(\"
M '-U8BUC97)T>'-E8W1I;VXY,#9O9G1H97-A+FAT;5!+ 0(4 Q0    ( /6#
M:5..0=4KEAH  ,R3   >              "  3B6 @!T97)M:6YA=&EO;F%G
G<F5E;65N="UE>#$P,2YH=&U02P4&      H "@"Z @  "K$"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
